>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bRsbRibLgbLsbLcbLibRsLsbLsbLgbRgbLibLsbLgbLgbLsbRjLsbLcLsmbRibLhbLibsb
RgbLgLsbLgbRsbLgLsbLgbLgLsbLgbLgbLsRsbLibLibLgbLsbLgbLibsbLsbLgbLgbLsb
LgbLsbLgLsbLgLcbLeLgLsbLgLsbLgbLgLsLsmbRgLsbLgbRsbLgbLsbLgbLgbLsbLgbLs
bLgbLgbRsbLiRsbRibRsbRsLsbRiRsmbRsbRgbLsbRiRsmbLsbLsbRibRsbRgbRsbRgbRs
bRgbRgbRsRsmbLsbLsLsmbsbRgLsRsbRgbRsbRgbLsbRgbRgbsbLgbsbsbRgRsmbRgbRsL
sbRgbRsbRgbLsbRgbRsLsbRgLsRsbRgbRgbRsRsmbRsbsbRgbRgbRsbRsbRgbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bLibLsbLgLsbRsRsmbsbsbLgLsbRjbLiLsbLgRsbRjRsmbsbLgLsLsmbRjbRobLibLobLh
bLcLsmbLiLsbLcLsmbsbRjbLibLgbRsbLgbRgbLibLobRobRgbRibRgbRsbRibRibRhLsL
smbLsLsLombLgbRiRsmbRgbRibLsRsRsmbRcRsmbRibRcRsmbLjbLcbRjbReRsmbsbLoLs
mbLebReRsmbLobLibRibRibRobRcLsbRgbRcbRsbRsbsbLsbRsRgLsbLjLsmbRsLeLeLiL
ibsbLiRsRsmbRsLibLgbLsRsbLiLsbLgbRsRsmbLgbLgbLgLsbRgbLiLsbRgbLiLsbsbLs
bLibRjbRcbRobRcRsmbRcbRhRsRsmmbRhbLjbLjbRjbRhbRgbLgLsbLjbRcbLebRcbLcbR
cbLcLsmbRjbLcRsbRjbLiLsbRsbReRsmbLsbRoRsmbRcRsLsmbRobsbLhbRcbLcbRobRcR
smbRibRiRsmbsbRcLsbLebRjRsmbRhbLjbRibLebLibLcbRhbRcbLcbRibRibLcLsmbLob
RcbRcbLcbRobRcbsbRhbLjbLobLibRibRibRgRsmbRgbRgRsmbLsbLhbReRsmbLjbLhbRj
bLcbRgbRcbRcbLhLsbLgbLobLibRsbsbLoLsmbsbRibRibLsLsLsmmbLcbRcbLiLsbRcRs
mbLjbsbLcbRjbRcbLhLsbLgbRjbRiRsmbsbRibRsRsmbLcbLhbRjbRcbRoRhRiRiRsRsmm
bLsRhLsbRhbRsbRibRgbLsbRibsbLsRsbsbRibLjLsmbLgbLjbRebLsbsbsbLsLsmbsbsb
RibRsbLsbsbLsbLcbRcbLjbLhbsbReb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bLgbRibRgbRsbRgbRoRibRhbLsbLibLibRsRsmbRgbLiRsbLibLibRcLsbRobRibRsbRsb
RibRcbRjRsmbRibLsbLgbLsbRjbLcbRgbLoLsmbRiRsmbLsbLcbLcbRgbRoLsbRhRsmbRg
bLibLhbRiLsbLibRhbRobRiRsmbRibLibRsLsbLgbRsbRobLjbRobRibRibRsLsbLsbLcb
LcbLeLsbLobLgbLiLsbLobRsbsbRsLsbRsbLcbRgbRobRibLobRebRiLsLsmbLebLcRsbL
iLsbRsLsbLsbRsbLibRsLsLcLsLsmmbRsbLoRsbLiLsLgbLjbRsbRsbRcbLhbLcbRoLsLg
bLcLsmbLibRjbRibLebRcbLcbRjRsmbRcbRsbRsbRsbRgbRsbLobLhbLiLsLsmbLcbLsbR
cbLcbLcbRsbRgLsbLgbLsbLibRgbLgbLsbLibLcbLcbLibLibRsbLibsbLgbRsbLsbLgLs
bRsbRebRhbRsbRsbLebLiLibLhbRjbLibRsbRsbLibLsbLsbRsbLgbLsbLsbLgbRjRsmbR
oRibRibRsbRgbRibRibRsbLcbLhbLgbLgbLgLsbLibRsLsbRsbLgLsbLsbLsbLsbLiLsbL
sbLsLsmbLiLgbLiRsRgLsbLibLsLibLgRsbRsbLsbLibLibRgbRjbRcbLgbRibRhbLsbRs
bLibLcLsRsmbRgbLiRsLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bRsbRgbRsbRgRsmbRgbRsRsmbRgbRgRsmbRgbRgbLgbRibLsbLhbLiLsbRgbLsLsmbLsbL
sbsbLibLibRsbLsbRhbRgbLgbLebLcLsmbLsLsmbRsbRgLsbsbRibLsbLjbLiLsbRsbsbs
bLgbLibLgbLgbLgLsbLgbRgbRsLsbRhbsbLcLsmbsbLsbRebRhbRgLsbRsbLeLsbsbRgbL
ibLibLgbLsLsmbLgbLsbLgLsLsmbLgbLibLsLsmbLgbLibRgLsbRsbLiLsbLibLsbLsbLs
bLsbLibLsLsmbLgLsbLgbLgLsbLsLsmbLgbLgLsbRsLsbLsLsmbLgbLgLsbLsbLgbLsLsm
bLsbLsLsmbLgbLgLsbLgLsLsmbLgbLgbLgbLibRsLsbLsbRsLsbLsbRsbLjbLhbLsLsmbL
gbLsLsmbRsLsbLsbLgbLsbLiLsbLsLsmbLgbLsbLgbLgLsbLgLsLsmbRsbLsbLsbLsbLsb
sbLsLsLsmmbLsLsLsmmbLgLsbLiLsLgbRsbRhRsmbRgbRgRsmbRibRgbRgbRgbRgbsbRgb
LsbRgbRgLsbLsRsbLsbRsbRgbLsLsmbRsLjbLgbLibLgbLsbLsbLsLsRsmbLgbLgbLgLsL
smbRgLsbLsLsmbLibLgLsbRsbRsbLsbLsbLsbLiLsLsmbRgbLsbsbLiLsbLibLgbLgbLgb
LgLsbLsLsLsmmbLsbLsbLebRjbLebRgLjLiRsRsmbRsRsLsmbLsLgbLgbLgbLgLsbLiLob
RebRgbReReRsmbRebRhbRibRgbRgbRjRgRsRsmmbLsbRsbRgbRsRsmbsbLsbRsRsmbRsRs
mbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bLibRsbLgbRsbLgbLsbLeRsRsmbRcbReRsmbRhRsmbRiRsmbRgbRsbRsbRebRgbRgbRgbL
gbLibsbLjLsmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bLgbRsbLsbLgbLsLeLsbLobsbLjbRsbRcRsmbRiRsLimbLcbRjbRsReRgLoRsbLcLsmbsb
LsbRsRgbsbRsRsmbRsbRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bRoLsRsRsmbLiRsLibLibLibLcLsmbLsbRsbRgbRiRsmbRsbLcbLibLgbRjbRobRsbRiRs
mbRsRsmbLsbRgbLibRcRsmbLsbLsbRibsbRcbLibRcbRcbLsLsmbLgbRgbLibRcbRcbLgL
sbLgbLibLgbRobRibRjRsmbRibRsbLibRhbRhbRibRibRsbRibRhbRcbRibRgbRcbRibRi
bLsbLgbRcbRibLibRcRsmbRgbLsbLsbRibLsbRhbLcbLobLobRhbLebLsbRibLobLcLsmb
RgRsmbRgbLhbRhbRhRsmbLgRsbRibRsRsmbRibLgRsbRcRsmbLgbRcRsmbLsbLsbRhbRsb
RsbRibRibLsbLjbRobRibRcbRgRsmbLsbRibRiRsmbRgbLsbRcbRgbLsbLsbRibRibLsbR
ibLsbRsRsmbRibsbLgbLsbRcRsmbLgbLsbRibRgRsmbRsRsmbRgbLsbRibRhbRsbLgbLsb
RcbsbLsbRsbRcLsbRibRibLibRjbRhbRsbRiRsmbRgRsmbRsbRiRsmbRiRsmbRsbRsbLsL
smbRcbRgbRcbRibRsRsmbRgbRsbLhbRiRsmbLibLsRcRsmbLsLsmbLsLsRsmbLsbRcbRcb
LcbRjRsmbLcbRibRcbRgbLsbLibLsbsbsbLgbLgbLsLsmbRsbLsbLibLcbLoRsbRibRhbL
gbLebLgbLsbLsbLcbRhbLiRsbLsLib

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bRgbRibLcbLjbRgbLhbLibLsbLhbRcbRcLsbRgbLsbRjRsmbLjLsmbRiRsmbRibLgbLgbR
ibRhbRobRibLobLobRhRsmbLibLsLsmbLobLibLobLibLibLibLiLsbsbRcbRcbRibLgbR
gbLobLibLobLiLsbLiLsbLibRsbLibRcbRhbRcLsbLsbLgbLibLibLsbLgLsbLgbRsLsbL
gLsLsmbLsLsmbLsbLgbLsRsbRsLibRcbRoLsbRhbLsbRoRsmbRsRibLsbLsbLibLiLsRsb
RibLcbRobRcbRsRhbLsbRsbRiLjbRgLsbRgRsRsmmbLsbRgbRsbRgRsmbRgbLsLsmbRgbL
sRsbRcbRhbRcbRibLgbRcbRhLsbRgbRsbRhbLsbLjbLgbLcRsRsLhmbLgbLhbLibLsbLsL
sRsmbLibLobLobLcbLibRsLsbLibLgbLsbLsbLgLsRsbLibLsbLibLsLsLgmbLgbLgbLgb
LsbLgbLobRgbLjbLcbLgRsLcbLgbLsbLiLsbLcbLibLiLsbLgbRobRiRsmbLgbRobRcLsb
RobRcbsbLgbRcbRhbRibLgbLibLgLsbLgbLgLsLgbLgbLgbLgbRgbRcbRgbLhbLgLsbLgb
LgbLgbLsLsmbLibsbRiRoRsmbRibRsbRgbLgbRibRsRhbLgbLjbLgbLibLcLsLgmbLgbLi
bRhbLcbLcbLibLsLhbLibLgbLiLsbLsbRoRsmbRgbRgbLsbRgbRibLsLsmbRibRsbRgbRs
bRgbRsRsRsmmbRgRsmbRsRsRsmmbRgRsmbRgbLsbLebLibLcRsbLibLgbRhRsmbRcLsLsm
bRhRsmbRibRibRhbLsbRhLsbRibRibLsbLgbLsLiLsRsbLsLsLsmmbLgbLgbLgLsbLsbLg
bRsbRobLjbRobRcbRhbRgbRhRsLsmbRibLsbRsbRgbRiRsmbRgbRgbRgbRsbRsLsbRiLsb
RcLsRcLsLsLsmmbRcbRcbRobRibLibRobRiRsmbRibRibRibLgLsbLiRsbLgbLgbLgbLgL
sbLgLsbLiLsbLibLsbLsLsmbLsLsmbLiRsbRobRcbRhbRhLsbLgbRibRcbRhLsRsbLgbLh
LsbRhbRcbRibRcbRsbLgbLjbLjbsbLibRobsbLcbRcbRoRsmbRcbRibLsbsbRjbRhLsbRs
bRibRibRiLsbLsbRiLsbRgbRiRsmbRgLsbRsbsbRgLsbRgbRsbRgbRsRsmbLjbLcLsmbLo
bLibLhLcbLibLsbRoRsmbRiRsmbRibRcbRibLgbLibLibLgbLgbLgbLgbLgbLgRsbRcRcb
sbLibRobRhbRcbRcbRcbRcbRibLgbLibLiLsbLgbLgLsbLgbLsLsmbLgbRjbRcLsbRcRsm
bRibRhRibRibRibLsRsbRhRsmbLgbRhbRiRsmbLgbRgbRhbLgbLjbLibLibLgLsbLibLgb
LgbRsbRobRibLgbRhbRibsbRibLsLsmbRcbRgbRgbRgRsmbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bRcbLjLgbLgLsbLsLsmbLgbLobLiLsbLhbLcbLsLsmbLgbLebRgbRsbRsbLibLibLhbLsb
RsbRibsbRibRgbReLsbLibRgbLcbRhbRsbRgbRsbLcLgLibLgbLsbLiLjLiLsbLibRgbsb
sbsbsbLsbsbsbLsLsRsLsmbLsRsRsLsLsLsRsmmmbsbRsbLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bRibLjLiLsbLibLgbRebRcbLgLsbLgbRobRcbRjbRebLgbLiLsbRcbLibRjbLsbLjLsmbL
obRobRsbRgbLobLcRsbLobLcbRsbLgbLgbLsbLgLsRsbLsbLsLgbLgbLgbRsbLgbRsbLgb
RgbLibLoLsRsmbLibLcbLhbRgbsbLsbLjbRcLsbLcbLoRsbLibLcbLgbLsbLgbLsbLgLsb
LsLsmbRsbLgbLsbLgbRebRgbLjLsmbLjbLjbLebRsRgRsLsmbLiLsbRgbLgbLgbRsbLiRs
bRsRsmbsbLgbLsbLobLobRcbLjbLcLsmbLibLibLsbLcRsbLoLsLsmmbRsbLobRiRsmbRs
bLiLsbLgbRgbLcRsbLcbRjbRjRsmbRibRsbRsbRcRsmbLibRgbRibRsbLsbRcbLgbLsbLh
bLhLsbLibRsbRgbRsbRsRsmbRibLoRsbLhbLcbRhbRjbRcbLhbLobRgbsbLiRsLsbRsbLg
bLibRsRsmbRsbRsbLibLibRsRsmbLgLsbLhLcRobLibLhbLcbRsbLsbRobLibsbLgbRobL
ibRobLobRcbRebRsbRcbLcbRjbRcbRjbRobRcRsmbRsRjbRcbRgbRibRibLgLsbRebLhbL
obRsbLibRjbRsRsmbRsbLjbRiLsbLgbLjbRcbRibRsbRsbLsbLsbsbRebLoRsbRobRcRsm
bRcbRjbRjbLsRsRsmbLsbRgbRsbLgbRjbLgRsbRiRsmbRsbLobRcbRobRhbRsbRjbRibLs
bRibRibLsbRjbLibRsbRibRhbRsbLsbRibRibRgbRjbRsRsmbRgbRsRsmbRsbRibRsbRgR
smbsbRcbLjbRjbRgRsmbRibRgRsmbRcbRebsbRjbRibRgbLgbRcbRsbRjbLiLsbLcbLjbR
sbRhRsmbsbRjbLsLcbRjbRcbLobsbLjbRjRsmbRgRsLsmbRibLobRjbLcbRjbLiLsbLibR
gbLibRcbRebRobRsbRebLsbRibRcRsmbRcbLsbRibRjbRsbLjbLobRgbRjbRjbRsbRsbRi
RsRsmmbLebLobRibRib

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bRsRsLsmbLgbLjbLgbLiLsLsmbLsbRobLcLsmbLhbRobRobLcbLebLobLcRsbLibLsbLcb
RcbLcbRoRsmbRobRobLhbLcLsmbLibLgbLgbLsbLgbLsLgLsRsbRobRcbLcLsmbLibLsLs
RsmbLibLiRsbRsRsRsmmbLhLsbLsLsLsmmbRoRsmbLcLsmbLoLsmbLhbRibLcLsmbLsbLs
bLcbLsbLjbLobLcbLoLibLhbLsbLgRsbsbLsbLsLsmbLhbLhbRebLibsbRsLobLgRsRsLe
mbLhbsbLibRsbLsbsbLiLsbLsbLiLsbLsbLsbLibLsbLhbRsbLsbLsbLcbLgLsbLsLiRgb
LcbLsbLhRsbLhLsbLibLgbLsbsbLgbLsbLobRcbLcbLebLebLgLsbLjLgbRcbLcLsmbLcb
LcLcbLsbLgbLibRgbLhLsRsLsbRobLjbLcbLsbLcbRsLsbLebLobLobLcbLebRgbRibRsb
LobRsbLsbRsLsbLiLsbLgbLgbLsbLibRsbLibRsbRsbLoRsbRsbLsLsmbLhbLhbLcLsmbL
eLsbLibLcbLcbLhbLhLsbLsbRsbLoLsmbsbRsbRcRsRsmmbRgRsmbRsbRsbLjLsmbsbLcb
LebRcbsbRobsbRsbLsbLcLsmbLcLsLhLsmbLcbLhbLibRsbLgbLiLsbLsLsmbLgLsbLsLs
mbLsbLgLsbsbLgLsbLsbLsLsLsmmbLob

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bLhbLibRcRsmbLhbRhbRcbsbLibLjLsmbRsbLcLsmbRiRsmbLoLibLibLibRsRsmbRgbLi
bLoLcbLibLiRsbLgbRsRsmbRgbLibLiLsbRsbRcbRcbLsbRgbLhbLibLobLibLcbLibLsb
RsLsbsbLiLsbLsbRjbRsbLobRsLsRsbRhbLibLcLiLsbLsbRibsbLjLsmbLcbLhbLiLsLs
mbLsbRibLsbRcbLgbLhbLcbRcbRjRcbRcbLsbLsbLgbRgbRibLsbLcbLibRibLcbLcbLib
RgRsmbRgbLcbRjbRobLibRjRsRsmmbRibRcbRhbsbLcRebLobLhbRgbLgbRcbRiRsmbRib
LhbRoLsRsbRcbLcLsmbLhLgLsbLibRgbLibLiLsbRsbLgbRsLsbRsbLsLsmbLsbLsbLgbR
sbLebLcbLjbLibLsbLsLgbLsLsmbLsbLgbRsbRjbLcLsmbRebRcbRjbRsLsbLgbRsRsmbL
sbsbRcbRcbLgbLgbLsbLsbRjbLibRsbLjbRhbLebLjbRhbLjbLibLsbLsbRsbLgbLsbLsb
LsbLibRcbRhRsmbRgbLsbRibLsbLjbRibRsbRsLsRsbRibRsbLsRsbsbLcbRoRibRgbRhR
smbRibLgbRgbRoLsbRibLsRsbLibLsbLsbLgbRsbLgbLgbLsbRsbRsbLsbLgLsbRsbRobR
ibRsbLsRsLsbRsbRgbRgLsRsbLsLsLsmmbRcbLcbRibRgbRibLsbLcbLcLsLcmbLhbLibL
gbRsbLgLsbRsbLsbLgbLgbRsbLsRsbLsLsLsLsmmmbLgbLsbLsbRsbLibRcRcbRgbRsLsb
RgRsmbRibRsbLsRsbRgbRsRsmbLsLsmbRgRsmbLsRsRsmbRsbRsbRgbRgRiRsmbRgbLsbL
sbLibLsbRcbRibsbLsbRiRsmbLsbLsbRibRibRibRibLibRjbRhbRgbRibLsbRsbLsbRhb
RibRsbRsbRgbRsbRiRibRgbLgbLsbRcbRsbRibLsbRibLsbLsbRibRsbRgbRhbRibRibRi
bRsRsRsmmbRhbRsRsmbRsbLsbRgbRgRsmbRsRsRsmmbRsLsbRgRsmbRsRsmbRsbLsRsbRs
bRgbRgbRgRsmbLgbRobRgRibLibLsRsLsbLsbLjbLgbLsLsmbRsRsmbLgLsbRsbLsbLsbL
iLsLsmbLoLcbLhbLibLgbRsbLgLsbRsLsbLeLgLsbLgbRsbLgbLgbLsbLsbLibLobRhbsb
RibLcbLhbLgbLebLsLgbLibLibRsbRsbLgbLiLsbLobLibRsbLobLgbLiLsbLibRsRsmbL
sbLgbLsbLgbLsbLgLsbLsbLcLsmbRgbRibLgbRibRibRibLsbLiLgbLibRsbsbLgRsLsbL
gbsbLsbLsbLsbLibLgbLsbRcbRcRiRsmbLgRsbRgbRibLgRsbRsbLsbRsbRibsbRibLibL
cbLibLhbLiLsbLebLiLsbLgbLsbLsbLgLsLiLiRsbLgbLgbLgbLsbLsRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bLcbLibLcbLobLcbLcbLsbRgbRcbRhbsbLibRsbRjbRibLibRjbRjbRibRgbLgLsbLgbRj
bRebLibRgbRibLsbRsbRsRsmbRgbRgbLobLibLiRsbLsbRobLsbRgbRcbLsbLcbLjbLibL
gbLsbLgbRsbRgbLsbRgbRobRsbRcLibLjRsbRcbLibLsbLjbRjbLcbLcbRgbLibLgLsbLh
bRsRsmbRsbLobLsbRobRiLsbRibLgbRhbRsbLsbRsbRcbRcbLsbLibLibLhbLibLsbLsbL
jbLhbLgbLgbLibLibLgbLgbLgLcbRgbsbsbLjLsmbRgbRcbRoRsmbRsbRcbRsbRsRobRgb
LoLsmbRsbLoLsmbLiRsbLsbLsbLcbLgbLsRsbLiLcRsRsmbRsbRcbRebLsRsbLcbLcRsbR
sbLsLgLsbLcbLibLibRsLsbLgbLoLsmbLsRsbLsbLobLgbLibLiLsbLcLsmbLgbLgbLobL
ebLibLibRsbLgbLgbLgbLgbLobLgbLebLibLgbLgbLgbLcbLibLsRsbLobLgbLcbLsbRsb
LoLiLsbLcbRsbLibLjRsLcRsbRsbsbLcbLibLsbLoLsmbLgLoLsLsmmbLgLsbLeLsbRsbR
gbLhbLibLsLsmbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bRoLsbRgbLcbLobLjbRebLcbRgbLobLobLcbLibLsbLobLoRsbLobRoLsbRcbLobLobReb
LcbLsbLoRsLsbLsbLsLsmbRobLobLobRsRjbRoLsbLobLobLobRgRsmbLcbLibsbRobRob
RobLhbsbLibLcbLcRsbLjbRcRgRsmbRsbRobRgbRibRiLsbRibReRhbLcbLcbsbsbsbsbL
cbRcbRsbLcRsbLcbLcbLhbsbLiLsbLgbsbLobLibRsbLcbLgbLobLgbLcbRsLsbLsbLcbL
hbRsbsbRgbRoLsbRgbRcbRibRcRsmbLgbLiLsbsbLibLsbRobRgbRhRsmbLsbRgbRgbRiL
sbRsRsmbLcbLobLgRiRcbRsbRibRsbRcbRsLsbLgbLebRobRibLsbRcbLgbLcbLcbRgbLc
bsbLsbLsbLcbRcbRsbRcLgLsbRgbRibRibRgbRsbRoLsbLgbsbLsbRobLsRsbRebRibRcb
sbsbLobLibLcbLsbRobLsbLoLsmbLcLsmbLgbLsbsbsbsbLcbRobRibRcbRibRsbRgbRib
RobRgbLsRsbRcLsRsbLsbLeLsbLoLsmbLiLsbLcbLgLsbLobLgbLhbLebLeLsbRsLgLsbL
ibLsRsLsbLgLsbLiRsbLsbRebRgbRcbRsbRibRgbRibsbRsRibLgbRob

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bRobLsbRobLsbLgbRobRcbLsbLiLsbLibLcbLibRcbRhbLsbRobRhbRhLsbLsbLibLjbLo
bLhbLcbsbRobRcbRibLsbLgbRsbRsLsbRcbRcbRcbRobRhbRsbLsLsmbLsbRobLsRsbLsb
RcbRibRgbRiLsbLsLsmbLsLsmbLgbLsbsbLobLcLcbLiLsbRcbRhbRiRsRcRsRsLgmmmbL
sbLgbLgLgbLsLgbLsLcRgbRcbRsRibsbRibRjbRcbRibRcbRhRsmbRgbRsRsmbRsRsmbRs
RsLsmbRobLgbLibLibLobLibLsbLcbLibLsRsbLgRsbLgbLsRobRgRsmbRibRsbRiLsbRs
LsbRibRcbRiRsRiLsmbRibRiRsmbRgbRgbRsRsmbRgbRsbRgLsRsbRgRsmbRsRsmbLsRsb
RibRsbRobsbLibLgLsbLgLsbLgRsLsbLgbLiLsbLibLsLsmbLgbRsRsmbLcLiLibLibRsb
LobRsbLhbLgbLsbLhLsbLibLhbsbLibLcbLcbLgbLhRsbLibLgbLsbLobRibRgbRcbRibR
gRsmbRebRsbRgbRgRsmbRsbLsbRsbRsbRgbLjbLobLsbLcbRcbRiRgbRgbRibRiLsRsLgb
LjbRjbRcbLsbRcbRsbLibRcRsmbRiRsmbRiLsbRibRgRgRsmbRsRsmbRgbRsRsmbLsLsmb
LsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
bLsbLgLsbLobLcLsmbRsbRgbLgbRobRcbRsbRsLsbRobRobRgbLobLcLsmbLobLgLsbLcL
smbRgbLgbLobRibLobLcbRoLsbRoLsbRgbLobLobRoLsbLsbRcbRgbLibRibsbRiLsbRgb
RgbRgbRobRsbRobRibRobRobRebLobLibLcLsmbLhbLcLsmbLoLsmbRsbRgbLibRobRobR
sbRsbLgbRobRgbRgRsmbRgbRgbRgbRgbRobRsbLsLsmbLobLobLibLibLgLsbRsLsbLgLs
bLsbLsbLgLsbLobLgbsbRsbRsbRsRhbRcbRiLsbLibRebLibLobLjbRibRgbRgbRibLsbL
obLjbLsbLiLoRsbRebRhbRjbRsbRgbRgbRsbLsbLoLsmbRsbsbRobRobRebRgbLcbLibLg
LsLobRsbRgbRgbRgbRgbRsRsmbRebRgRsRgmbRgbRibRgLsbRgbRsbRgbRobRgbRobRobR
obRcbRcbRgbRgbRsbRebLgbLsbRsbRibLsbLobLobLcbLgLsbLgbLgbLsbLiLsbLgLsbLs
RoRsmbRgbRgRsmbRibLibLiLsbLgbLgbLsbRobRhbLgbLgLsbLgbLgbLgbLgbRjbRibLjb
RgbRgLsbRiRsmbRgbLsbLsbRebRcbRhbRibRgbRibLsLgbLcbRgbLobLgbLgbLibLhbLgL
sbLgLiLsbLgbLgbLgLsbLgbsbLgbRobLcbLoLibLgLsRsbRgbLobLgbLibLsbLsLcbLibR
gbRgbRiRgbRhbRibRcbRibRiLsbRgbRibRgRsmbRgbRibLibLibLgbLjbRsbLgbLiLsbLg
bLcbLobLibLgbLhbLgLsbLgbLibLiLsbLibLhbLhbLibRobRcbRgbRibRgbRiLsbRgbRgb
RiLsbRsbRibRiRsmbRibRgbRibRiLsRsbRibRgbLobLobLcLsmbLgbLcbLiLsbLgbLgbLg
LsbLgbLgLsbLjbRcLsbRgbRebLsbRebRgbRhbRsbRjbLcbLibLsbLcbLhbRsbLhLsbLgbL
jbLiRsbRhbRsRsmbRhbRiRsmbRgRsmbRibRobRibRcbRhbRibLiLsbLsLibLiLsbLgbLjb
LsbLibLgbLgbLcbsbLibLgbLebRgbLoRsbRgbRebRoLsbRcbLcLsmbLiRsbLhbLgbRsbLi
b

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bRsbRgbLgbRsbRoLsbRiRsmbLibRhRsmbRibRibLjbRibRcbRgbLibRebRibLibRcbRhbR
hbLgbLebLcbLcbLjbRcbLcbLgbLobRcbRcbRjbRcbLjbLcbLcLsmbLibLhbLebRcbRcbRs
RsmbRobReRgRsmbRibRsRsmbRiRsmbRsbRsbRobRgbsbRcLsbRhbReLsbRsbRsLsbLsbLs
bLibRcbRibRibsbRcbRibLsbLibsbLiLsbLcbLibRsbRcbRgbRjbRcbRsRjRcbRibLiLsb
RibRibRibRibLcbLibLsbRibRgbRhbRjbLsbRibLsbLibLcbLibLsRsLsbRgbLsbRcbLsb
LibsbLhLsbLobLgbLebsbRobRoLibLebsbLiRsbRcbRobRcbLsbLsbLjLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bLsbRobLsLsmbRcbLsbRibRibLsbLgbLhbRsRsmbRjbRibLobRsbLcbsbLjbLibLibRjRs
mbRibLjbLcbLibLgbLsbLobLibRcbRsRsmbLsRsbRobRgRsmbLibLsbLgbRcbRibRsbRgb
LjbLcbLhLsbLsLibLgLsbRibLsRsLsbLjbLiLsbLgbLcbLgLsbRgbLiLsbLgbLgbLibsbR
jbRcbLsbRhRsmbLcbLgbRjbRhbLjbLibsbRobRhbLgbRsLsbRhbRsbRcbsbRsbRoRsLsmb
RibLsbLibLsbLsbLibRgbLibLgbRgbLibLhLsLibLsbRjbLhbLibLibLgbRsbRibLjbLib
LgbLsbRsbLgbLsbRjbLcbRsbLcbLibLgbsbRgbLgbLibLgLsbLgbLsLsmbLgbLsbLsbLgL
sLsmbLeLsbLgLsbRiLgLibLiLsbLsbLgbLsLsRsmbRobsbRhbRcbRibLsbLibLcbLhbRib
RjLsbRibRcbRsLsbRjbLjbLiLsbLhRsbLgbLgbLsbLibRcbRgbRobRhbRgbRsbLsbRibRs
bRiLsbRgbRsbRibRsbRibLsbRcbsbLsLsmbLsbLibRcbRjbRgbRjRsRgmbRibLsbLgbLsb
LgbLgbLgbLgbLsbLjbLcLsmbLhbLibLcbsbLibLgbRsLsbRobRibLjLsmbLibRjbRibLjb
LibRcbRibRgbRibRhbRgbRiLsLsmbLgbLsbLsbRhbRiLsbRibRsbRibRsbRibRsbRgbRib
LsbLibLgbLgbLibLcbLibLibLsbLhLsbLsbLibLgLsbLsLsmbLsLsmbLgbLgLsbLsLsmbL
gRsbRcbLcbRebsbLibRcRibRibRsbRjbRcbLsbRibRgbRgbRgbLsRsbRgbRhbRiRsmbRgb
RgLsbRibRgbRsbRibRgRsmbRibRgbRgbRiLsbLsbRibRgLsbRgLgbLobLibLiLibLgLsbL
gbRcbRiLsbRibRgbRsbRgRsmbRgbRgbRgbRibLsLsmbLgbLibRsbLiLsbLgbLcbLgbLibL
sbRsbRibRgbRsbRgbRgbRsbRibLcLibLgRsLsbLiLsbLgbLgbLoLsmbLhbLibLiLsbLsbL
sLibLibLhbLsbRsbRibRgbRiLsbRgbRsbRibRibRgbRgbLsRgbRgbRibLsbRgRsmbRgbLg
bRsLsbLjbLibLiLibLeLebLebRobRgbRibRhbRgbRibRibLebLgbLhbLgbLgbLgbLoLsmb
sbsbRebRcbRsbRibRibRgRiLsbRsbRsbRgbRgbRgbRibLibRibsbsbLjbLebLcbLobLhbL
ibLgLsbLsbRsLgbLsbLgbLsbLibLgLsbLibLobLibLjbLibLgbLibLgLsbLgLsbLgbLgbL
iLsbLgbLgbLhRsbLibLgbLibLibLgbLsbLhbLgLsbLgbLiLsLibLsbLgRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 19; Drug: Control Apo 50 然
bLhLsbLgbLgbLsbLgRsbRobLgRsbLibLjbLibLgbLcRsbLsLsmbRgbLcbLsRsLsbLibLob
RibRibRebLobLobLcbLsbLsbRebRsbLsbRgbRgbRcbLsRsbLcbLobRgbRhbRgbRgRsmbLs
RsbLsRgbRgbRgLsbRgRcbRibRsRibRcbRsbRcbRcbLhLsLsmbLibLsbLhbRgbRsLsbLhbL
ibLobRibLsbLsbLeLibLgbLsbLiRsbRgbLobRhbLibLcbLcbLjLsmbLjbLsRsbLibLsbLg
bLsLsmbLsbLsRsbLsbLsLsmbRsLsbRsbLsbLcLoLsRgRimbRsRobRhRsmbRcbRhbRobRgb
LebLobRsbLhbLobLibLibLsLcbLgbRjbLcbLiRsbLgbLibLeLsbLiLsbLibLobRsRoRsmb
RibRebRsbRoRsmbLgbRcbRcbRhRsmbRcLsLgbLibLiLsbsbLgbLgbLsbLgbLsbRsRsRsmm
bRsbLeLcbLgbRsbLcbLibLcbLibRibRobLgbRcbRibRhbsbRcbLsbLibRobRgbRcbRibLi
bLiLgbLibLsLsLsmmbLgbsbsbsbRcbRgLsbRcbLcbRsbLibLsRsRcRsmbRibRcbRibRiRs
mbRibRibRibLgbLibLcbLgLsRgbRgbRgRsmbRgRsmbRjbRsRsmbRgbRebRiRhbLsbRobRh
bLibLcbLsLcLsmbLgbLibLgbLgbLgbLgLsbLgLsbRjbRhbRibRibRcbRsLsbRcbRibRibR
ibRiLibLgbLebLgLsbRjbLibLeLsbLebLiRsbLsLhLsbLibLiRsbLcbRgRsmbLcbLhbLeb
LibLcRgbLcbLebRhbRibRgbRiRcRsmbRsLsbLibRibRcbRgbRebRsbRibRcLsbRibRibRh
RhbRiRhRebReRsmbRgbRgbLsbLsbRgLsbRibLsbLcbLhbLsbLgbLibLibRsbLibLibLcbR
sbRcRiRsRhmbRiRebRgLsbLsbsbsbRibLgbLcbLiLobLgbLibRobRgRsmbRibLjbLibLgL
sbLeLsbLeLgbLgRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 20; Drug: Control Apo 50 然
bLcbLsLobRcbRobRjbLjbLobLcbLsbLobLgbLjLsmbRhbLjbRcLsbLcLsmbRibRcbLhRsb
LcbLsbRobRcbRcbRibRibRcbRcbLsbRibRcbRibLibRcRsmbRibLiRsbRcbRsbRcbRhbLh
bRgbLoLsmbLsbLjbLgbLsbLcbLoRsbLsbRobRgbRcbRhbRgbRoLsbRebRgbRgbRgbRgbLs
bRibReRsmbRsbLjbLobRsbLhbLcLsmbLgLsbLeLsbRsbLcbLibRgbRobRsbRibRiRsmbRg
bRgLsbRcbRgbRiRsmbRibRiRsmbRgRsmbRhbRgRsRimbRgLsRsbRibRobLoLsmbLibRibR
ibsbRgbRcbLhbRcRsmbLobLcbLgbLobLgbLgbLebLibLebLsbLibLiLsLgbLiLibLhLsLs
mbRcbLsbRibRcbRgbRgbRibRiRsmbRsbRhbRcbRgbRoRsmbRibRcbLsbRobRgbRiRsLsmb
RibRcRsmbReRsmbRebRsbLjbLsbRhRsLsmbRebLcLsmbRcRsmbLjLsmbLobLhRsLsbLiRs
bLgbLcbLibLcbLhbLsbRoLsbRiReRsmbRibRibReLsbRiLsbRibRiLsRsbRcbRhbLsbRsR
ibRcbRhbLsbRibRgbRsbLsbLibLibLsbRcRsmbsbsbRhbRsbLeLsLcLgbLhbLebLsbLcLs
mbLibLeLibLgbLcbLgbLobLebLobRcbRgbRebRebRgRsmbRibRhbRcbRiRcRsmbRobLgbL
sLsmbRobRebRibRibRgbRcLsbLsbLgbLibLcbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 21; Drug: Control Apo 50 然
bLoLsmbLiLcRsbLgbLiLsbLcRsbLgRsbLgbRsbLsbRcbLobLiRsbLsLsmbRobRoRsmbLsL
sLsmmbLhRsbLjbLgbLgLsLsmbLibRgRsmbLibRjbLcbRsbLsLsRcmbRgbLjRsbLhRsbRiR
smbRebLsbLjbRoRcbLcLsRsmbRsLsbRoLsRsbRebLhbLiLcbRgbLjbLibLhbLhRsbLcbRc
RsmbLcbRsbLibLhbRcbLcbLgbLoLibRhRsmbRsbLcRsbLsLjLsmbLcLsmbLgLsbLcbLgLs
bRsbRsbLibLcbLibLjLsmbLcbLhbLcbRobRiRsmbRsbLcbLgbLoLibLsRsbLcLsLsmmbLs
bLgbRsRsmbLsbLibsbLcLsRsmbRcRebRoRgRiRebRcbRebRsbLsbsbRcRsRsmmbRhbRibR
sbRibLhbsbRjbLjbRhbRibLsbLcbRcbsbLibRcRsmbLcbRgbsbRcRsRsmmbRobRebRsRsm
bLcbLcbLcbLsLsmbLobLsbRjbsbRobLjbLobLgbRobRgbReb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 22; Drug: Control Apo 50 然
bLibLsbLiRsLsbLsbLgLsbLoLsmbLhbRgbLcbLibsbLjbRsbLhbLcbLcbLcLsmbLobLibL
cbLjbLhbLjLsmbLcbLcLsmbLgbLibLcbLibLcbLiLsbRobRjRibRobRcRsmbRcbLsbLgbL
obsbLcbLcbsbRcLsbsbLcLsmbsbsbLsRsbRsbsbRcLsbLibLjbsbsbLibRcbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 23; Drug: Control Apo 50 然
bRibRgbRgbLsbRcbRibRsbRgbRsbRgbReRsmbRibRsbLhbLjbLobRsbRcbRsbRcbLgbLsb
RcbRhbRhbRhbRsbRgbRgbLoRsbLcbRebRcbLsbLhbRebRibRobLoLsRsmbLebLebLebRcb
RcLsbRebRcbRibReRibRobLgbLjbRgLsbRebRebLjbLebLjbLebLsbRgbLjbLcbLjbLcbR
obRjbRjbRcbRebLcbRjRibRcbRjbRhbRhbRibLeRsLsbLobLsbRjbRhbRjbRjbLgbLsLsm
bLibLcbRsbRgbRcbRjbRgbLsbLjbRgbLjbLcbLgbRcLsbRibRobsbRibRgRsmbRgbRjbRh
bRgbLebLibRibLjbRebRcbRcbRjbLhbLgbLgbRsLsbLibsbLcbRsbRibLgbLobRjRgbRib
LgbLsbLibLebsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 24; Drug: Control Apo 50 然
bsbRobRhbRiLsbRibRsbRgbRiRsmbRibRobLsbsbRebRhbRsbRobLsbLcbLcRsbLobLgbL
cbLcLsmbLcbLgbLcbRobRjRgLsbRsRsmbRoLsbLsbLibLobLsbLobLgLsbLhbLebLiRsbR
gbRhRsmbRiRsmbRibRgRsRembRsbRgRsmbRgRsmbRgRsmbRgbRibRgRsmbRoLgbRjbRibR
gbRsbRsRsmbRibRoRhbRiRsmbRibRgRsRsRsmmmbRgbRgbRoRsmbLsRsbRsLsbRjbLsRcb
RibLhbRjbRiLsbLsbRgbLebLiLsRsbLsLsmbLgbLgbRobRoLsbRcLsbLgbLiLsbLsbLgLs
LsmbRsLsbRebRibLsbRibLsbLoRsLsbRibRibRgRgbReRebRgbLcbLoRsbRgbRcbRcbLsb
LgbRobsbsbRcbRcbsbRsbRibRgbRobRsbRebRgbRiRsmbRcRibRebRgbRgRsmbRsbRgRsR
smmbRiRsmbRobLsRsbLibLgbRebRgLsbReRgRebLgRsbRsbRgLsbRsbRcLibRibRiLsbLs
bRibLsbRebRgbRgbRsRgbRebLebRsLsbRgRsmbLgbLobLsLsmbLcbLsbLsRsbLibLsbLgb
LgbLsbLgbLsbRsRsmbRsbRsLcbRgbLjbRcbLobRsbRhbRhbRcbLcbLcbLcLsmbRsRhbRib
RiRibRebLeLibLgbRgLsbLhbLsbsbLoRsbLhbLibLibLiLsbLgbsbLjbLcbLobLcbRobLc
RsbRebLcbLcLsmbLibLhbLibLibLsbLgbRgRsmbLsRsbLgbLobLhbsbLcbRcbLobLebRob
LcbLcbLibsbLebLiRsbLibLibLibLibLiLsLebLgbLgbLiLibLgbsbRsbLiLsbLibLhbsb
LiRsbLcLsmbLiRsbLcbLibLiLsbLgbLibLhbRgLgbLgbLibsbLgLsbLgLsbLgbLsLsmbLg
LsbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bLsLsmbRjbLsLsmbLgLgLgbLgbRsbRsbLsLsmbRsRsmbLjbRsLibLjbLibsbsbLgbLgbRg
RsmbRgLsbLgLsbLgbRsbLsbLgbLsbRgbLsbLgLsbRsRsRsmmbLsbLsRsbLsbsbLeRiRsRi
RsmmbRhLsRsbRgLsbLcbsbLsRsbRobRebRcbRsbRcRsmbRiRsRgmb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bLhbLgbRibRibRebRgbRebRebRebRebRoLsLibLibRgbLcbLsbLebLsbLgLsLsRgmbLiLs
LsmbLgLsbLhbRsbLjLsmbLiLsLsmbRsRsmbRsRsRsmmbRgbsbRsRsmbsbsbRhbRibLjLgb
RsbLgbRsbRgRsmbRgbLeLsbLibRsbRgbLibsbLhLsbLsbLsbLsbRsbLsbRsRsmbLcbLgLs
bLsLsmbLgbRsbLsbLgbLobLoRsbLgLjbLiLsbLibRjbLsbRebRobsbsbLebLgLsbLgLsbL
ebRgbRibRiRsmbRsbLsbLebLgbLsbRsbRibRsbRibRebLcbLibRsbLjbRcbRgbsbRjbLhb
LcLsmbLjbLhbRcbRibRsbLcbRgRsmbLcbLsbRsRsmbRsbRjbsbsbRsbRibLgLsbLsLsmbR
ebRcbLhbLoLsmbLiLsLgRsRsmbLgLebLibLibRibRgRsRsmmbsbRgRsmbRgbsbRcbRibRi
bRibRiLsbRcbsbRiLsbRgRsRsmmbRiRsmbRgbsbRibRibRgbRibRgbRgbRgRsmbRgbRibs
bRgLsbsbRibRgbRsbRgbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bRcRsmbLibLgLsbLibsbLibRhbLebRhbRebRibLiRcbRhbRibRsbLsbRibRibRgRsmbRgb
RgbRsbRgbRsbRsLjbRoLsbLjbLgbLjLibLjbRibLjbRibRcbRgRgbRsbRgbRgbLsbRgbLj
bRsbsbRgbLsLoRsLsbLiLsbsbLsRsbRsbLebRebLhRsLsRsbRgbRsRiRsLsRsmbReRsRsm
mbLgbLsLsmbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bRcRsRsmmbRobLsbLebRjbLcbRcbLebRjbRcbsbLibRgRsmbRiRsmbRcbLibLhbLcbRcbR
cRsmbRcbRiRsmbRhbLgbLjbLcbRibRebRiRsmbLjbLcbLibLcbLgbRiRsmbRiRsmbRgbRs
RsmbRsbRibRgbLgbRhbLsbLhbRibLjbLhLsbLhLsbRcbRibLjbRhbRiRsmbRibLhbRgRsR
smmbRibLjbRhbRcbReLsbRgbRiRsRsmmbRsbLsbLcbLeLsbRhLsbLibLibRsbLsbRebLjb
LeLsbLcLsmbRebRcbsbRibReRsmbRsbLsbRebLibRibRibLebsbsbsbsbsbsbsbsbsbLcL
smbLgbRsbLgLsbLsbLibsbLibRjbLiLsbLgbRgbRjbLiLsbReLsbRibLgbRsbRgbRiRsmb
LgLsbRsbRhbRebLcbLhLsLsmbLibRjbLsbLibLibRjbLibLiLsbRebRibRibRibLibRibR
gbLjbRsbRibRgRsmbRiRsmbRgRsmbRibRib

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bRsbRjbRcbsbRgRsLsmbRgbRgbRgbRibRgbRgbRgbRgbRgbRgbLobLiRebLobRebRgbRgb
LgbRibRgbRsbRsbLsbRiRsmbRibsbRcbRsRsmbLibLibLiLcLibLhbLhLsLsmbLsbLgbLi
bLgbLgbLgbLgRsbLsbLgRsbLgbLsLgLsLsmbRsbRgbsbLcbRgbLsbLgbRsbLhbLsbRgbLs
LebRibLcLsmbsbLgbLsbRsbRgbRjbLcbLsLsmbLsLgbsbLsLsmbLsRsRsRsLsmmbRsbLsR
sRsmbLsbLsLsmbsbRsbLsLsmbLgbLsbRsbRsLsbsbLcbLcbLsbRsRsmbRibRgbLsRsbLgb
LoLcLsLiLiRgRsmmbRgbRsbRgbRsbRgbRsbRgRsmbLsLsRsmbRsbRgRsmbLsLsmbRibLsb
LsbRgRsmbRgbsbLgbRgbRibRibRgbRgbRsRsmbRgbRgRsmbLsbRsLsRsbRgRsmbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bLsbLiRsbRjbLhbsbLibsbLiRsbLsbRsbLsbLobLcRsbLhbLsbLgRsbsbLsRsbLgbLiLcb
ReLsbLobRibLsbRiLjbRjbRobLsbRsLibLiLsbLgbLoLsmbLsbLjRsbRsbLsbLsbRsLsbR
sbRsbRsbLsbLsbsbLgbLibLcbLcbsbLsbsbLibLsbsbLgbLibLibRsbRsbLiLoRsbLgRsL
sbLsLsmbLgbLgbRsbLsbsbsbsbsbLcbRebRgbLhbRcbRjbRhbRiRsmbRsbRgRsmbRsRsmb
RiRsmbLgbRiRsmbLsbRjbRsbLsbRgLsbLgLsbRcbLsbLgbRgbsbRsbsbRibRsRsRsmmbRs
bLjbRoLsbRsbsbsbLgbRgRsmbLjbLcbLibLibRhbRsLsbLcbLibsbLebLgRsLsbLhbRiRi
bRgbLsbRsbRgbRgRsmbRsbRhRsmbLsbsbLhbsbLcbLsbsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbsbRsbLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bLgbRsLsbLcbLcLsmbLcbLcbRgbRobRobLsbRibRgLsbRsbRibLjbLebsbRsbRobRsbRhb
RcbRibRibLsbLcbLgLsbLsLsmbLgbLsbLgbLoRsbLgbReLsbLcLsmbLcRsbLibLobRsbRe
RsmbLcbRobRoLsbRibLebLsbRebRcbLibLhbRobRobRhLsbRgbRibRgbRhbLjbsbLobLgb
LibLsLsmbLsLsmbLgbLgbLgLsbRoLsbRcbRhbLsbLgLsbRebRebRcbsbLsbRobRgbRobRh
bLgbLgbLcbRiRsmbLsLsLsmmbLiLsbLobLibLcLsmbRsbLsbLsbLsLsLsmmbLibRcbLsRc
bLsbRcbRgbLgbLsbRhbsbsbRsbRhRsmbRsbLobRgbLibLibLsLsmbLgbLibLeLsbRobRcb
RcbRobRsbRobRsbRgbRsbRsbsbRsbsbsbLsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bLhRsbRibLiLsbRsbLibLibLgbLsbLiLsbRgbLsLsmbLibRgbLobRgbLcbRsbRgbLgRsbR
obLsbRsbLsRsbRjbLobsbLoLsmbRsRsmbLgbLsLsmbLsbLobLgLsbLjbLsLebRibRoRsmb
RcbLobRsbRgbLcbLobLjLibsbRsbRibLgbRibLsRsbRgRsmbRjbsbRsbRgbLjbRhbLgbRi
RsmbRgbRebLhbRsbRsbLcbLjLiLsbLcbLcbLsbLgbLgbLgbLsbLgbLgbLsbLsLsmbLsLsm
bLgbLsbLsLsLsRsmmbLsbLsLsmbLsLsmbRsbLibRsbRsbLsbLibRjbLcbLsbRgbLsbLiLs
bLjLsLsmmbRhRsmbLcbLcbLcbRsLsbLcLsmbLebLsbLgRobRcRsmbLjbLgbLsbLsbLsLsL
smmbLgRsbLiLsbLibRsbRiRsmbRsbLgbLcbLsbRsbRcbRibLibLgLsbLsbLgbLsbLgbRsL
sLsmbRiRsmbLhbRsbLebRsbLjbRoLsbRsbRibRsbLsbRhbLjbRsLcLsmbLhbLsbRsRsmbR
gbRsbRjbRibLcLsLimbRobRibRcRsmbLcLsmbLhbLsbsbRgbLibRgbLhbLibRibRebLcbL
eLsbLsbRibLeLsbLhLsbLcbLebRebRcbRsRsmbRhbRsbRgbLsbLibLoLibLibRibRgbRiR
smbRebRibLeLsbLibLcLsmbLcLsmbLsbsbLjLsLsmmbLhb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bLibLjbLhbRsbLhbLibLgbLjLsmbLibRsbRsbLsbLgbLgbLibLgbLhbRsbRsRsRsmmbLsb
LibLsbLsbLsbRsbLcbLhLsbRgbLgbLgbRsbLibLhLsbLibLgbLsbLcbLcbLibLibRsbLgb
RsbRhbLgbLibLgbLgbLsbLgbLgbLgbRgbLcbLibLibRsbLsbLgbLiLsbLgbLsLgbRsbLsb
LgbRjRsmbsbRjbRjbRsLobLsbLgbLgbRsbRsbLsbLsbLibLobRsbRibLibRsbLcbLibRib
LcbLgbRgbLsbLgbLgbLjLsmbLiLsbLhLsbLgbLcLsmbLhbLgbLcbLcbLcbLcbRhbRhLsbL
ibLhbLibLcLsLsmmbLcbLcLsLsmmbLcbLsbLcbRsbLobRsbLsbLsLsmbLsbRsbLgbLsLsm
bRsbLibLobRsbLibLsbLibsbLgbLcLsmbLcbLhbLhbLgbLsbLcbLgbLcLsmbLebLsbLibL
gbLgbLsbLcLsmbsbLcLsmbRsbRobsbRcbLsbLsbLgbRebRiLsbLsbLsLsmbLgbLgbLgLsb
RsbLgbLoLsLsmmbRsbLhbLcbRjbRcbLcbRsbRgRsmbRcbRcbRibLsbLibLsbLgbLsbRsbL
gbsbRcbRcbRcbRcbRcRsRsmmbRgbLsbRgbRgbRibLsbRsLsbLsRsbRebLgbLgLsbRcbRib
RgLsbRgbRsbRiLsbRcbRibRsbLsbLsbRsbRcbRgbRgbRsbRibRsbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bsbRsRsmbRsbRcbRhbRsbLsbLsbRhbRsbRcbRcbRcbRibRsbRgbRsbRobRibRjbRebLsLs
mbLhbRgbRcRsmbLcbLsbLcRsbLibRgbLsbRsbRsbRgbLjbRjLsRsbRhbLcRsbLcLsmbRob
LibRibLsbLgbRgbRgbRoLsbLsbRibRobLibLsbLsbLcbRebRobsbLibRibRsbRgRsmbLoL
smbLhbLsRsbRibLoRsbRgbRsbsbRsbLobLibLibRsbLcbLsbRgbRgbLsbRibLsbLsbRgbR
gbRiRsmbRibRgbRsbRebRjbRsbRsbRgRsmbLgbRiRsmbRsRsmbRebRiLsbRibLjLsmbLeb
LiLsbLsbLjbLibLgbLgbLsbLgRsbLsbLsbLibLibLiRgbLsbRhRsmbLjbRcbLjbRcbLgbR
sRsmbRibRgbRcbRgbRibRcbLobLibLsbLgbLobLsbLsbLjbLhbLsbLgLsLsmbLsbLgLsbR
sLsbLgbLgbLsbLsbLsLsmbLsbLsbLgRsbRsRsmbRcbRebRcbLhbLcbLibLgLsbRsbLgbLs
LsmbLgLsbLgbLsbLsRsbLsbLgbRsbReLsbRibLhbLjbLibsbRcbLjbLibLsbRsbsbRjRsm
bRibLsbRsbRsRsmbLgbLsbRobRhbRcbRcbLsbRiRsmbRsbRiLsbRsbRsbRgbRgbLgbLsbL
cLsRsmbLibRcbRcbLsbLebLobLsbLobLibRsRsmbRgbRibLsRsbRsLsbRsbRsbRgbRgbRs
bRsbRgRsmbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbRi
RgbRhbRcRsmbRibRcbRibRcbLsbLgbLiLsbLgbRsbLgbLcbsbLcbLhbLcbsbRsbLcbLibL
cbLsbLgbLobLsbLgbLgbLsLsRsmbLsbLsbLgbLibRcbsbRcbRsbRobRibLsbLiLsbLgbLg
bLsLsmbLgbRsLsbLibLcLsmbLjLgbLhbLibLgbLgbLgbLgLsbLsLsmbLsRsbLibLsbRjbR
cbRcbRcbLgbLibLgbLgbLgbLgbLsLsmbRgRsmbLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bLsRibRoRsmbRibRcbLsbRcbLsRsRsmbRgbRibRgbRsbRgRsmbRsbRgbRsbRgbRibLcbLc
bLgbRsbLgbLsbLgbLibLsbLsbRsbLgbLibLiLsbLoLiLsbRgbRibLsRsbLsbRibLjbLcbL
gRsbRsbLhbRgbRobRsbLsbLgbRcbRgRibLgbLgbRgbRgbRhbLsbLgbRibLcbRoLsbRiLsb
RhbRibRibLjbLcRsbRibRhbRsbLobLibLsbLsbRsbLcbRibLsbRsbRsbRhRsmbRobRobRs
RsRsmmbLcbLcbRiLsbLsLsmbLibLibLobRsbLgbRsbRibRsbLoRsbLiRsbRgbLgLsbLsLs
mbLobLcbRjRsmbRcbLsbLsbRcbRibLgbLgbRsbRobLsbRoLsbRsbRiRsLsmbRiRsmbRsbR
ibRibRjbLgbLobLjbRgbLibRibRhbLsbLjbLibRgbLsbLcbRjbLcbLgbRgbRobLsbRgbLs
bLjLjbLcLsmbLiRgbLibRsbLhbRsbRsbRebRhbRobLsbRibRsbRsRsmbRhbLobLhbRgbLh
bRjbRobRiLsbLsLsLsmmbLcbLgLsbRjbLjLiRsbLhbRiRsmbLgbLsbRsbRiRsmbLobLcbR
ibRhbLobLoRsbRibRgbRcbLgbLiRsbRjbRebRgRsmbRiLsLsmbRsbRsbRsRgbRgLsbRebL
sbLibLiRsbLiLsbLobRgbRibRibLobLcbRsRsmbRgbLsbRsbLgbLibLcRsbLgbRhbRcbRs
bRgbRgbRgRsmbRgbLsbRjbLsbLsbRgbRgbLgbRcbLibRhbLsRsbRgbRsbsbLobLibLgbRg
bRibRcbRsbRibRgRsmbRgbRgbRgbRgRsLsmbLjbLhLsbLgbLibRibLcbLjbLebRcbRiRsm
bRebRsRibRgRgRsmbRgbRjbRsbLsbLhbLcbRgbLsbLibRibLcbRgbLjbLsbLgbRsbLibLc
bLhLsbLgLsbLibLsbLgLsbLsbLgbLcRsbRibLcbLibRgbLobRsbLjbLgbLgbLiLsbRsbLs
LsmbLhLsbRcbRebRsbRgbRgbRibRebLsbLcbLcbRgbRgbRsbLcbLgLsbLgbLgRsbLoRsbR
sRgbRibRgbRsbLoRsbLiLsbRsbLibLibRgRsmbLcbLiRsLgbLibLgbLgbLsLiLsbLsbLgb
LgbLgbLgbLibRibLgbLcbLsbLcbLiLsbLgbLoLsRsmbRebRiRsmbRgbRgRsmbRgbRsbRib
RibRibRgbLsbRibReLsbRsbLgbRgbRhRsmbRsbRobRibLsbLsbLjbRjbRibRcbLsbRiLsb
LgbRgLsbLobLgbLibRgLsbLcbLsbRgbLcbLgbLiRsbLibLgLgbLibLoLsmbRsRgRsmbRcb
RsbRibRiRobRsbRhLsRsRibLsRiRsRiRsmmbRgbRsbRhbsbLhbRsbLcbRjbRhbRcbsbRcb
LgbLsbRjbRhbLsbRjLsbLiRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bRsRsmbLsbRhbRcLsbLsRsbRgbRgbRjRoLsbRibLsbLjbRgbRoRsmbLcbRgbRiLsbRsbLs
RsbRibLcbRcbRsbLibLsbsbLgbLsbRebRgLsbLjbLiLobLibLsbLsbLibLgbRjbRobLgbR
cbLsbRcLsbRibLsbRgbLsLsmbLibLgbRebRibLsRsbRsbRibLgbRibRcbRcRsRsmmbRcbR
hbRibRsbRhRsRsmmbRcbRgbRibRgRsmbRsLsLsmbRsbsbRibLsbLobLhLsbLgbRjbLsbsb
LsbsbsbRsbRsbRjbRebRibRgbRsbRsbRsbLibRobRibRiRsmbRhRsmbRcbRiRgbLgLsbLs
bLgbRsbsbsbsbLsRsbsbsbLsbRjbRsRsmbRcbLsbRcLsLsLsLsmmmbsbRsbRsLsbLsbLsb
sbsbRsLsbLsbLsbLsbRsbRsLsbsbsbLsbLsbRsbsbRsbLsRsbsbRsLsLsLsmmbRsRsmbsb
LsbLsbRsRsmbLsbsbRsRsmbsbLsRsRsmbRsbRsRsmbLsbsbLsLibsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
bLgbRsbRobLobRoLibLebRsbLgLsbLjbLcbLcLsmbRobsbRcbRibRobLcLsmbRsLsbLiLs
bRsbLcbLoLsmbLcbLjbLcbLobRobRhbLcbLoRsbLsLjbRjRsmbRobLcbRobRsbRobLjbLo
bRebRcbRcLsbRebLgLsbLibLjbLsbLsRsbRcbLobRcbRgbRhLibRibRsbLsbRgRsmbRsbR
gbLsbRsbRgLsbRsbRsRsLsmbRgbRgbRcbRcbRobLhLsbLoLsmbLhLsbLobRcbRebLcLsmb
LeLsbRsbRebRobRjRsmbLsbLsbRcbRhbLsbRebRcbRsbLebLoLsmbRsbRebRobsbLibRob
RhbRebLgbLibLeLsbLgbLobLcbLcbLcbLhbLgbRsbRgbLoLsmbRibLcbRcbRebRcbRibLg
LsbLiRsbLgbLibRsbLgLsbLsbLsbLsbRcbLcbLcLobLibLibLgbLsbLgbLobRebLobLcbL
gbLgbRgLsbRsLsbLibRjbRoLsbLebLhbLibLgbRgLsbLobRsbRsbLobLsLsmbLibLsbLib
RsbLsLsmbLgbLsbLhbRsbRcbRebRcbLsLsmbLgbLiLsbRjbRcbLcbLiLsbLcbLcbRgbRib
RcbLebLgbRcbRibRgbRcbLsbRobLiLsLsmbLiLsbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bLsbLjRsbLsbLsbLgbLibsbRoRsmbRibRibLsbLsbLgbLsbLibLsbLgbLgbLsbsbLgbLgb
LsbLgbRoLsbRhbLsbLsbLcbLgbRcRsmbLgbLhbLgbLibLgbLsbLsbLgbRcRiRsmbRgbRsb
LcbLobLhbLibLcbRcbLobLcbLcbLibRgbRsRgbRsbRsbRsbRsbRsbRobRcRsmbRsLsbRib
LjbRibRsRsmbRsbRsRsmbRsbRsbRgbLsbLcbsbLcRsRsmbRgLsbRjbRibLcLsmbLsbRsbL
ibRiRsmbRgbRsbRsLjbRcbLsbRobRibLgbLgbLgLsbRsLsbLsbLgbLsbLsbLsbLsbLiLsb
LoRsbLibRibRgRsmbsbRsbRsbRsbRgLsbRsbRsbRsbRgRsmbLsbRsRsmbRgbLjbLobLibR
jbRcbLsbRsbRgbRsbRsbRsbRgbRgbRsbRsbRsRsmbRsbRgLsRsbLgLsbRsRgRjLjRgRsmb
RcbLsbRsLsbLobLcbsbRsbRsbRsbRsbLsbRgRsmbLsLsmbRsbRsbRgbRsRsmbRsbRsRsmb
RgbRsRsmbLsLobLgbLgbLgRsLsbLsbLsbLsbLsLsmbsbLgLsbLsbLsbLsbLsbLsLsmbLsb
LsbLsbsbLsLsLsmmbLgbLsbLgRsbLgbLsbLsbLoRsbRebRibRsRsRimbLsbRgbRgbRgbRj
bRsbRibRsbRibRibLgbRgbRsbRgRsmbRgRsLsmbRgbRgbRibRjbRgbRsbRhbRiRgRsRgmb
RgRsRgmbRsLsbRsLobLhLsbLhbLobRibRsbLobLcbLsbRsbLsbRgbRiRgbRibRgRsmbRsR
smbRiRgRsmbRgRsmbRsLsbRsbLcbRsLsbRjbLcbRcbRgbRsbRgbLsbRgbRsbRsRsmbRgbR
gbRsbRgbRgbRcbRcbLiLsbLgbLsbLgRsbLiLsbLgbLsbLibRiRsmbLgbRsLsbRhbRibLsb
LsbRcLsRsbRobRhbRibRcLsbRsRsmbRhbRsRsmbRgbRgbLsRsbRsRsmbRgbLsbLoLsmbRg
bRibLcRsbLgbLibRcbRcbLsbRsbRsbRobRibRibLsbLgbRibLcRsbLsbLsbLgbRsbLgbLs
bRgbRcbRgbRiLsbRgRsmbRgbRgbRobRcbRgbRcRsmbRgRgbRgbRibRgbRsbRgbRsbRsRsm
bRsRsmbRgbRibRhbRibRibRsbLiLsbLiLgRsRsmbLcLiLsbLebLiLsbLibLsLhbLgbLgbL
gbLgbRsRsmbLibLsLsmbRoRsmbRhbRsbRibRgbRhRsmbReReRsRiRimb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bLsbRgbsbRsbLsbLibsbRgbLsbLiRjRgbLcbRsbsbRgbsbLobLhLsLsmbRsbRjbLjbLgLs
bLobRcbLsbRgbRsbRebLgLsLsmbLgLsbLsbRjbRjbLgbLibRsbLgRsbRsbLjbLsLsmbRjL
sbLsRsbLiLsbLcLsmbRibRsbRibLgRsbLcbLsbRcbRcbLobLhbLibRsbRibRsbLibLsLsm
bRjbLiLsbLgbRobRibRgbLjbLibRsbRcbRsbRsRjbRhbLsbLgbLsRibsbRebLsLsmbLsbR
sbRsbRibLsbLsRsbLsbRjLsbRibRsbLsbsbLjbRgbLjbLobLhbLsRsbRiRsmbRibRgbRsb
RsbLsbLjbLibLsbLibLsbLsbLgRsbLsbLsbRsbLsbLsbLsLsLiRgmbRebRgbLsbRebLcbL
oRsbRsbsbsbRibsbRibLsbRsLsbRgbsbRsLsbRsbLsbLiLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bRibLebRjRcRsmbRcbLobLobRsRebLibLsbLsbLgRsbRcRsmbLcbLcRsbRjLebRobRibLc
bLsbRsbLibLibRsRsmbLibLgbRibLibLsbLhLsbLgbLobLsLsmbLhbLsbsbRgRsmbLibLs
bLgbLjRsRsmbLsbLiRsbLhbLsbLibRhbsbLebLibLgbLsbLsLsmbLgbLgRsbLsbLsbLsLs
mbLsLsmbLsbRobRiLsbLgLsbLobLgbRsbLgbLgbLgbRsbLsLsmbLgbLcRsbLgbLobsbsbL
sbRgbLjbLhbLcbsbLcLsmbLhbLibLiRsbRib

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bsbRibRhbRcbRcbRcRsmbRsbRsbRiRsmbRgbRiLsbRiLgbReRiRsmbRgbLsbRgRsRsmmbR
gbRsbRebsbLsLsmbRibRgReRgLsbRjbsbRgbRgbRgbLjLcbLgbRgbLgLsbRsbLsLsmbLgb
LsbLsLsmbLsbLsbLsLsmbLsLsmbLsLsmbLgbLsbLgbLgbLsLsmbLgLsbLsLsmbLsbLsbLg
bLsbLgbLsLsmbLsbLsbRsLsbLsLsmbLgbLgbLgbLgLoLsmbRsbRibLsbRoRsmbRcLsbLgb
RcbLgbRsbRibRebLsbLgLsbLsbLjLsmbLsbRsbLsbRsbLgbLgbRsbLsbLsbLsLsmbLsbLg
LsbLsLsmbLgbLsbLsbLgbLsLsmbLsbRsbLgbRsbLibLoRsbLibRibRibLsbRgbRsbRsReb
RebRsRcbRsbRsbLgbLsbRobsbLibLibRoRsmbLsbRcLsbLgLsbRcbRhLsbLsbLibRcbRhb
RcbRibRcbRibLcbLsbRjbRcbLsbsbRgRgRsmbRcRsmbRibRjRsmbRcRsmbRsbRgLsbLhbR
gbRcbRoLsbLsbRsRebLgLsbRgRsmbRibLobLcLsmbRsbRebRhbRcbLsbLibsbRjLsbRjRs
RsmmbLgRsbRcRsmbRhbRibRibRsbRjbLibLcbLibRgbRcRsmbRgbLjbRcbRibRhbRsbLgb
LsbRcbRibRgLsbRcRsmbRibsbLibLgbLsbLsbLsbRsbLsLsmbLobRgbRgbRsbsbLsbRsbR
sbRgbRcbLgbLgbLgbRobRhRsmbLgbLsbRcbRgbRiRsmbsbLjbRjRsmbRibRibRsbLgbRcb
RhbRiRsmbRsbLgbRcbRebRiLsbRibLsbLibLsbsbLsbRcbRhbRcLsRibRjbRgRsmbRsRjR
smbLsbRcRsRsmmbRgbRoRsmbRgbRcbRsbRibLsbRsbRgbRsbRcbRebRiLsbLibLgbLsbLg
bRgRsLsmbLibLgbLobRibLobLiLsbLcbRjbRoRsmbRgRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bRcLsbLjbLcbLcbLobLjbLgLsbsbLhbLgbLsLsmbRobLsbLcbLoLsmbRgRoLsbRcbLibLs
bLsRsbRsbRjbRcRsmbRgbRoLsbLsbsbRsbLibLgbRsLobLcbLcbLcbRoLsbRiLsbRgbLiL
sbLsbLgLsbRcbRsbRibLcRsbLhbsbsbLcbLsbsbLibLgbLibLobLobLiLsbLsbLibLsRsb
LsbRsbRcbRsbLsbLibsbLcbLiLibLhbRsbLibLsLsmbLsRsbsbLibLcLsmbLcbLhb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 43; Drug: Control Apo 50 然
bRhRsmbRobRsbRobRsbRsbRobRsRsRsmmbRsbRobRibRibLsbRobLsbRoRsmbLgLsbLgbL
sbLcbLsbLobRibRgbRcbRsbLsLobRgbLobRsbLsbLoRsbLobRibRiRsmbRsbRgRsmbRobL
ibLibLsbRoRsmbRhRsmbLsRsbLgbRcbRsbLibRoRsmbRiLsbLsbRjbLjRgbRsbLgRsbLib
LcbLgbLcLsmbReRsmbRibRgbRgbRgbRgbRsbRsbLsbLibLobRoLsRsbRsbRgbRjRsmbRcR
smbRhbRjbRsbRgbRhbRebRcbRsbRcbLsbLibRobRobLgbLibLcbRjbRcbLsLsmbLibLibL
obRgbRibRsLsbRsLsbLsbRjbLobLgbLcbLsbRibRsRgbRcbRsbLgLsbRebLgbLgLsbLsbL
obLcLsLsmmbLsbLsbLgbLhbLobRiLgbLsbLibLgbLsLsmbRebLhbRebRiLsbLjbRobRsRs
mbRsbRcbRjbRsRsmbLgbRibLsbLjbLsbRsbRcbLgbLibLcbLcLsmbRgbRjbRibRgbRobLs
bRjRcbRebLsbLgbLobRgRgbRgbRgbRgbRgbRgbLhLiRsbLibRcbRgbRibRebRcLsbRebRs
RibRibRibLebLibLcbLhbLobLiRsbLjbRsbRebRoLsbLjbRcbLjbLsbRobRsbLibLobRsb
LjbLobRgbLcbLcbRcRsmbRebLibRjbLgLcbLjbRoLsbRcbsbLiLsbLgbRgbLhRsbLsbLob
RebLsbRsbLobRsbLgbRcbRsbRcbLgbLebRobLjbLoRsbRhbRobRibRcLsbLebLiLiLsbLi
bLiLhLibsbLjbLhbLibLgbLiRsbLgbLhbLibLsbLibLsLsmbLobRsbLcbLsbLobRgbRjbR
cbLgbRgbRcbRibRcbRcbRebRibRibReRsmbRiRibRgbRsbLebLgbLgbRgbRibRibLcbLib
LgbLcbLgbLibLcbLibLibLiLebLebLibLiLhbLebLibLibLgbLgbLgbLgbLebLebLibLcb
LsbRcbRcLsRiRsmbRibRgRsmbRsbRsRsmbLsbRsLsbRobRcRcLsbRibRibRcbRcbRibRib
RgbRoRibRcRsmbRcbRhRsLsmbRgbRcbRiRcRsmbRebRibRobLiRsbLobRgRsmbLobLibLe
bLibLgbLgRsbLgLsbRsbRhbRgbLjbLcbLgbLibLgbLibLgbLgbLcbLebLiLsbLibLiLhbL
obLsbLcbLibLibLobRebReRsmbRiRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 44; Drug: Control Apo 50 然
bRjLsbRcRsmbRjbLobLibLibRjbRsRsmbRcbRcbRcbRobRsRsmbRcbRcLsbRsLsRsbRibR
obRsLsbRsLsbRobRcbRibRibRobRsbLsLsmbRjbRhbLgbRhbRsRsmbRgbRsbRobRibsbLi
bRjRobRibRsbRcbRhbRcbRhbRhbRcbRgbRjRsmbRcbRcbRsbRobLsbLsbRcLsbRibLsbRi
bRibLsbRibRgbRgbRgbRibRgRsmbLobRcbRibRibRsbRgLsbRgbRgbRgbRgRsmbRsRgbRg
bRiRsmbRgbRgbRcbRobLibLcbRsbLcLsmbRibRibRcbRsLsbLibRjbRhRsRsmmbLsbRibR
gbRgbRsbRsRsmbRgbRgbRsbRibRcRsmbRcbRjRgbRcbRgbRsRsmbRibRsbRcbLsbRcbRiL
sbRhLsbLsbLgbLoLsmbRebRhLsbRgbRiRiRsmbRgRsmbRibRgbRgbLcbRibRibRgbRsbRg
RsRimbsbRsRgRgbRcLsRcbRhbRsLsbRibRgbLsbRhbRcbLgbLobLibRebLibLobsbLibLe
bRcbRiRsmbRibRsbLsbLgbRiRibRgbRgbRsbRgRsRsmmbRsbRiRiRgRgbRgbLcbLibRcbR
ibRsbRgbRoLsbRcbRgbRibLsLsmbRoRsLsLsLsLgmmmbRhbRcbRiRsmbLgbRgRsmbsbRcb
RcbRsbRcRsmbRhbRsbRgbRsRsmbRgRsLsLsmmbRibRgbRsbRibLsbRibLgRsbRobRcbRib
RibRgbRibRsbRiRsmbLsRgbRgRcbRsbRhbRgbRcRcRsmbRiRsmbRgRsRsmmbRgbRgRsmbR
gRibLsbRsRibRgbRgRsLsmbRgRsRgRgmbRoLsbRcbLobLgbRsbLcLsmbRsRsmbRibLibLi
bLibRsbRibRgbRgRsmbRgRibRsbRibLobLiRsbRjbRhbRiRsRsmmbRgbRgbRgbRibRsbRc
bRobRcbRebRcbRsbRhbRgRsmbRsbRibRgbLsbRsbRibLsbLgbLcbLibRcRsmbRsRsmbLob
LsbRobRibRcbLsbRcRsmbRebsbRcLsbRgbRibRgbRibLsbRcbRebRiRsRgmbRobRiLsbRh
bRcRsRsmmbRgRsmbRhbRibRcbRibLgbLibLgbLsbLibRsbRcbRiRsmbLsRibRibRcbRhbR
hbRsbRiRsmbRsRiRiRsRsmmbRgRsRgmbLobLiLsRsbLgLsbLibLibLibLgbRsbLiRsbRgb
LibLsbLgbLhbLhbLibLcLsmbLibLhbLgLsbLgLsbLsLgbLiRsbLgbLsLgbRsRsmbLgLibL
sbLgbRobRhLsLsmbRibRgbRibLgbRoLsbRcbReRsmbRiRgRhRhReLsbLebLibLobsbLgbR
ibRibLcbRcbRsLsbRcbRcRsmbRebRcbRgbRiRsRgRsmmbRgRsRsmmbRsRsmbRgRsRiRsmm
bRgbRgbRgbLgRsbRibRgbLsbLcbLgbLcbsbRsRcbLibLsbLoRgbLsbRibRgbRibRgbRcbR
cbRsRcbRgRsmbRgRiRebRibRgbLjbRcLsbRibRobRgbRcbRiRsmbRsbRibRibLsRiRibRi
bRsRhbRgbLsbRjRsmbLebLcLsLsmmbLiRsbLibLibLibLgbLhbLgLsLibLiLsbLcLibLiL
sLiLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 45; Drug: Control Apo 50 然
bLgbLcbLibLiLebLiLsbLibLhLsRsLsbLjLibLjbRibLsLsmbLsbLiLsbLgbLsRsbLgbLg
bLibLgLhbLibLjbLibRsbLgLsbLgbLgbLsbLgbRsbLsbRgRsmbRebRibRjRsmbRjbRibRi
RcbRebRibRgRsmbLjbLjRsbLibLjLsmbLhbLibRjRsmbLibLibLjLsLsmmbLibLgbLibLs
bLibLibRsbLcbLibLhbLibRsbRibLsRsbLsRibRibRibLsbRhLsbRibRhbLsbRibLgLsbR
gbRibRibRgLgbRjRiLsbRibLsbLsbRibRgRsmbRsRsmbLjRsbRgbLjbLcbLgLsbLiRsbLc
bRiRsmbRgRsmbRiLsLsmbRiRsmbRgbRsbRgbRsRsmbLsRsbRibRsbRgbRgbLsRebRibLib
LsbLgbLibRcRhbRjRgbRsbRgbLsbRgbRsbRsbLsbLcbLhbLhbLcLibLjbLiRsbRsLibLsb
LibLibLgLsRsbRsbLgbLibLiLsLsmbRsbLcbLsbLsbLcLsmbLsLcLsmbRsLsbRjbRibRiL
sbRsbRibRgbRibLiLsbRgbRcRsRgRsmmbRibRgRsmbRsbRgbRgbRsbRsbRsbRjRsmbLoLc
RsbLsbLebLibLiRsbLgLsbLhbLgLsbLgLgbLsLsmbLgbLsLsmbRjbLibRcRsmbsbReRsmb
Lib

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 46; Drug: Control Apo 50 然
bLobRgbLcbLibLiRsbRsbLgbRcbRibRibRgbLgbRgbLcbLgbLoLsmbRgbRibLibRcbRgbR
gbLsbRsbRobRcbLcbRhbLcbRgbRsRoRsmbRgbRgbRgbRgRsmbRsbRgbRgbRsbRiRsmbRib
RsRsmbLgbRgbRsbRiRsmbRcLsbLgRsbRibRcbLcbRgbLobLgbLcbRgbRgbRebRcbLgbRib
LcbRgbRgbLgbLcbRgbLebRsbRcbRhbRobRcbRgbRibRsbRsbLcbLiRsbLibRibLcbLiLsb
LsbLsbRsbRhbLcbLhbRjbLcbLgbRcbRjbRcbRibLgbRcbLgbRcbLibRcbRcbLebRhbLibL
gbRgbRcbLgbsbRiRsmbLcbRcRsmbLhbLjbLobLgbRibLsbRibLjbLobRjbRebRgbRsbRcb
RsbLibLsbLobRcbRhbRsRsmbRcbLsbLgbRcbRgbRsbRcRsmbLgbLcbLcbLcbLcbLgbRjbR
jbRhbRsbLsbRcbRcbLebRcbLsbRebRcbLsbRgbRgRsmbRibRiRiRsLsmbRsbRsbRsbRsbR
gbRgbRsRsRsmmbRsbRgbRsRsmbRgbRsbRgbRgbRgbRsRsmbRsbRgRsmbRgbRgbRibRibRg
bLsbLgbLcbLgbLiLsbReRsmbLsbRcbRibRibRiRsmbRibRiRsmbRgbRcbLhLsbLcbLhbLi
bLibLeLsbLibLiLsbLgbLgbLgLsbRgbLsbLgbLiLsbLsbRsbRcbRgbRgbLebLgLsbLgbLi
RsbLgLsbLibLibLgbLgbLgbRsRsmbLibLhbRgbLsbLebLgRsbLibLgbLcbRcbRcbRhbRib
RiLsbRibRibRibRgbRgbRsRsmbRsbRsbRsbRsbRsbLcLsmbLsRsbLebLsbLcLhLhbLsbRi
bRibRibRgbRgbRcbRsbRcRsmbRibRcbRiRsRiRsmmbRcLsbRgbRiRsmbRibRgLsbRebRhb
RcbLcbLibLibLhLsbLcLsmbLibLgbLgbLgbLsbLgbLgbRsbLsbRsbLcbLhbLibLgbLibLi
bLiLsbLibLebLebLeLhLhbLibLobLibLibLebLhbReRsmbRgbRgbLsbRgbRsRsmbRgbRsR
smbRsbRsbRgbRsbRsbLgbLcbRsbLgbLibLibLgbLibLibLeLsbLgbLebLhLsbLebLcbLsb
LobRobRcbRibRhbRibRiLsbRcbRgbRsbRhRsmbRgbReRsmbRebRgbRgbRgRsmbRsbRsbRs
bRsbLsRsbRsbRsbLsbRsbRiRsmbRcRsmbRgbRibRiRsmbRibRgRsmbRib

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 47; Drug: Control Apo 50 然
bLcbRgbLibLhbLcbLgbLjbLiLsbLhbLcbRsLhbLjbLhbRcbRibRiLsRsbRiRsmbRsbRsbR
sbRgRsmbRsbRsRibRibRgbRsbRgRsRimbRsRsLsmbRgbRsRsRsmmbRgbRsRiLsbRsRsmbR
gRsRgRsmmbRsbRsRsRsmmbsbRgbLgRsbRhbRcRsmbsbRsbsbRcbRjbLgLjbRobLsbLhbRi
bLebLhbRobRcbLjbRjbLibRhbLiLsbLhLsbRjbRhRsmbRgLsbsbLjbRibLobRjRsmbRgRs
LsRsRiRimbRsRsLsRimbRgbRgLsbRgbRcbRcbLibRsbRcbRjbRjLsLsmbLsbLobLibRgbL
hbRgbLhbRgRsmbLcRsRsmbRgbRsbLibLgLsbRjbRjbRgLsRsbRgbRgRsmbRgRsRgRiRsRs
RsmmmmbRgRsmbRsRsmbRgbRgbLoRsbLibLiRgRsmbLiRgbLgLsbLgbLsLsmbRsbLgbsbLc
RsRiRsmbLibRsRsmbLcbRibLoRsbLgRsLsbLjbsbLgLsbLsbLgLsLiLibLiRsbLhRgRsmb
RgbRibRsbRgLsRiRsmbRgbRgbRsRsmbRiLgLsRsbRcRsmbRgbRibRsbRgbLhLsbLhbRgRs
mbRjbRgbRibRgRsmbRgLsRsbRibRgbRgRsmbRsRsmbRibRgbRgRsmbRiRsRsmmbRibRgRs
RsRimmbRiRsRimbRiRibRgRgRsmbRsbRgRsmbRgRsReRimbRgbLobRobRgbLcRsbLobRhb
LcbRgbLhbRsbLcbLcLsmbRibLhbRsbLhLsLjbLiRsbLibLiRsbLibRcbRibLsbRiLsbRiL
sbRibLsbRiLsbRgbRiLgbRgbRgRgRsmbRibRsLsbRiRsmbRgLsRsLsbRgLsbRibsbRhbLi
bLsbRsbRcbRiLsbLsRsRcbRsbLhbsbRibLibRjbRibRgRsmbRhRgRgRgRsRembRgbRgLsL
gbRibLibRhbRsbRibLgbRgRiRiRsmbRsRgRgbRsbRgRsmbRsbRgRsmbRgRsRsmmbRgRsmb
RsbRgRiRsmbRgRsRsLsmmbRsRsRsmmbRgRsmbRgRgbRgRsmbRgbRsLsbRgbRsRsmbRgRsm
bRibLgbLjbLcbLcbRcRsmbRjRsmbLhbLhbLiRsbRibLhbLhbRsbRgbLibLsbLcbsbRjRsm
bLhbLibRibsbLibRgbLibLibRgbRiLsbLgbLcbLgLsbLjLsmbRgbLsbLsbLsbLibLgbLiR
gbLgRgRsRsmmbLsbLibLibRsbRsbLsbLgbLsbLsbLgLibLsbLgLsRsbLibLibRsbLiRsbR
sRsmbLiRsbsbLibLgbLsbLhbLibLiLsbRiLsbLgbRsbLibLibRsbsbsbsbsbLgbRsbLsbL
iRsbLsbLcRsbLsbRgLsbRhLsbRgbRgRibRiRsmbRsRsmbRgRjRgbRgbRgbRiLsbRiLsbRg
bRsbLgbRcLsbRibRibLsbLsbRgbLsbRsbRibLsLsmbRiLsbRhbRibRcbRgbLgbsbRiLsbR
iLgbRgRsRsmmbRiRsRsmmbRsRsmbRjLsbLsbRibLibsbRhbLsbRibRsLsbRoRsRsmmbLsb
LsbRcbRhRsmbLibRibRjRsmbRiRsmbLsbLsRsbLibRgbRcbLsLsmbsbRjbRjbRjLsbRiRi
RsmbRibLgbLibLgbLsbLgLsbLsbLiLsbLsLsmbLibRgbLgRsbLsLsmbLgLsbRsbLgbLsbL
sbLgbLeLsbRsbLiRsRgLsbLjRsbRgLsbRsbLsbLibRsRsmbRsLsbLibLiRsRsmbRsRsmbL
jLsmbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 120648; End: 121149;
Recording: 1-1; Individual: 48; Drug: Control Apo 50 然
bsbLibRsLgbLgRsbLgbLsbLgRsbRsbLgbLgbLsLsmbLsbLgbLgbLsLgbLhbRsbLgbLibLi
bLgRsLsbRsbLibLsbLgbLibRsbLgbLgbLibLhbLiRsbLhbRiRsmbRhbLibRjRsmbRibRjR
smbRsLsLsmbLcbRsbsbRibRsbRibLiRsbLebLgbLibLgbLcbLiLsbRgbRibRgbLsbLibRi
bRgbLjbsbLcLsmbLibLhLsbLibRsbRsbRgRsmbLjbLgbRibLgbLsLsmbLcbLjbLgbLcbRj
LiLsbLsbRsbRsbsbRibRibRiLsRsbRibLhbLhbsbLcbLgbLibRsLsbRgbRiRsmbRsbRgbL
jbLcbLsLsmbLgbLgbLibLiLiRsbLsbRsbRsbRgbRibRgbLsbRibLibLcbLgLsbLiRsbLib
LgbLgbLgbRgbLibLibLsLsmbLgbLsbLsbLsbLgbLgLsbLgLsbLsbRcLiLsRgbRsbRibRsb
RgbRsbRsbRcRsmbLsbLibLibLibLibRsbRsbLcLsmbLsbLgLsbLsbLsLsmbLsbLgLsbLgb
LgbLgbLgbLgbLibRsLsbRjbRgbRgbRsbLobLhbLjLsmbLjRsbLibRgbRibRgbRgbRgbRsR
sLsmbRsRsmbRcbLibLibLhbRsLibLibLgbLgbLsbLgRsbRsbLgbLgbLgLgLsLgLsbLgbLs
bLsLibLgbLgLsbLibLibLsRsbLibLsbLsLiLebLgLsbLgLsLhLgbLsbLgLgbLgRsbLgbLg
bRsbLibLcbLcbLgbLibLiLsbLibLgbLgbLgLsbLsLsmbLgbLgbLgLsbLgLsbLsbLibLibR
ibLoLsmbRjbRgbRgbRcRsRsmmbRgbRgbRgbRgbRgbRibLjbLcbLiLibLsbLsLsmbRsbLgR
sbLgbLgLsLgbLgbLgbReRiRsRsmmbRgbRibRgbLsLsmbRibRgbLsbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bRsbRgbRgbsbRsbRcbRgLsbLsbRcbRsLsbRgLsbRsbLsbRgRsRsmmbsbRibRsbLsLsmbRg
bRgbRgbLsbLsRsbRgbRsRsmbRgbRsbRsbRsRsmbRsbLsbRgbLsbRgbsbRgbRsbRgbRibRs
bRgLsLjbLobRsRcRgRsmbRgbRoLsbsbsbsbsbLsbLibLsbLsLsLsmmbLgLsbLgbsbLsbRs
bRgbsbLiLsbLsbLgbLsLsmbLibRsbLsRsbsbLsbRgbsbLsLsmbLibLgLsLsRsmbLgLsbLg
bLgbLgbRsbLsbsbsbsbLgLsbLgbLsbRsbLgbLsbLgRsbLgbLsLsmbLsbLsLsmbLgLsbRsL
sbLgLsbLibLgbLgLsbLsbRgbLsbRsbsbsbsbLibLgbLsbLgbRsbLsLsmbLgbLsbLgLsLsm
bLgLsbLgbLsRsbLgLsbLsbLsbLgbLsbLgLsbLsbsbRsbLsLgbsbsbsbLsbLgbLgbLsbLsb
RsbRjbLsLsmbLgLsLsmbLsRsbLsbLibLibLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bsbsbRsbRiRsmbRsRsmbRgbRgbsbLjbRibsbRgLsbRibLjRsbRibRibLsLsmbLsbsbRcbR
hbRhbRiRsLsmbRcbRibRgbLsRcbsbRcbLjbRhbLsRsbLsLsmbRgbsbLgbsbRiLsbLsLsRs
mbLsLsmbRobRhbLcLsmbRcRsmbLgLsbRcbRoRsmbRcbsbsbRcbsbLjLsmbRcbsbRgbRgbs
bRibRgbRgbRgbRgbLsbLsLsmbRsbRgbRiLsbsbLjRsbsbRibsbsbRgbLsLsmbRgLsbRibL
gLsbRsLsbsbsbRibLjLsmbsbsbsbLsbsbLsbLsRsbsbRibRsbsbLsLsmbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bLgbRsbLsbLgbRgbRoRjLsLsmbRgbRsbRgbRsLsbLjbLgbLhLsbLsbRsRsmbRsbsbLsLsm
bRsRsmbLsbsbLiLsbLsbRsbRcbRsbRiRsmbRsbLsLsmbLsbRcLsRcRsmbRibRsbRibsbsb
RsbsbRsLsbRsbRibRsbRgbRsbRsLsbLjbLcLsLsmmbLiLcLsmbRsLobLiLsbLgbLibRjbL
ibLgbLsLsLsmmbRebRibRsRsmbRgLsbRsbRiRsmbRcRibRgbRibRgbRhbLibRcLsbLsbRg
bRhbLibRcRcRibRibRiRsmbRsRsmbRgbRsbLsbRoRibRsbRcbRsbLjbLoLsmbLcbRiLsbL
gbLsLsmbLsbLgbLgbRgbLcbLiLsLiLhRgLsbLsRsbRibsbLhLsbLibLiLsbRibLcLsmbLi
LsbRsbLgbLibLcbLgbLsbLiLsbLsLsmbLsbLgLsbLsbLgbRsbLgbLgbLiLsbLibLiLsbLg
bLibLibLsbRobRsbRiRsmbLsbRcbLgbRgbRiLsbRgbRgbRibRgRgbRcbRibRibRibRibLo
RsRsmbRoLsbLgbLgLsbLgbLgbLsbLgbRsbLgLsbLgbLgbLgbLcbLiLiLiLgbLiLsRsbLib
Lgb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bRsbRibRsRsmbLsbRgbsbRsRsmbLsbRgbRgRsmbLsbRibLibRiRsmbRibRgbRsbLsbRjRs
mbRsbLsbRsRsmbsbRsbsbRsbsbsbsbRsLsRsRsmbLsbsbLsbRsbLsbRgbRsbRgbLibRibR
gbRgbRgbLsbLibLsLsmbLsLsmbLsLsLsmmbLibLgbLgLsbLsbLsLgbLsLsLsmmbLsLsmbL
gbLsLsLsmmbLgLsLsmbLgbRsbLeRsRebsbsbsbLgbLsLsmbLsLsmbLsLsmbLsbLgbRsLib
LebRobRebRsbRgbRgbRgbLsLsRsmbRsRgbRsbRsbRgRsRsmmbRibsbRibRgbRgRsmbLsRs
LsbLsRsLsbLsRsbRibRsbRsRsmbRgbRsbLsLsmbRsRsmbsbRsbsbRsbLsbLgRsbRgbLsRs
bLebLcLcLobRobLhbLgLgbsbLgLgbsbLhbLgLgbLsbLsLsmbLsLsmbLgLsbLgLsbLgLsRs
bLgLsLsmbRsbLsLsLsmmbRsbRebsbRsbRsLsRgbRgRsmbRsbRgbRgbsbLsLsmbRsbLsbRs
bRsRsRsmmbRgbRgbLsbRsbLjbLebLsbLsbLsbLgLsbLgLsbLsbLgbLsbLsbLsRsbLsLsmb
LsLgbRsLsLsLsmmbLsLsmbLsbLgLsbLibsbLgbLsbLibLhLsbRgRsmbLsbsbLsbsbsbLsL
smbLsLgbLsLsLsRsmmbLhLsbLsRsbRcRsmbLsbRsbRiLsbRibsbRsbRgbRsRsmbRgbRgbR
ibRgbsbLsLsmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bLsLsmbRsbLsbRsbLsbLsbRsbLsbRsbLsbRsbRsRsmbRsbLsbRsbRsbLsbRsLsbRsbRsbR
sbLgRsbLgbLsbsbLsLsmbsbLcbsbRsbRibRibRgRebRhbRgRsRiRiRsmmbReRsmbRgRsmb
RgbRiRsmbRgbLsRsbsbRsbsbsbRgbRsbRsbRgbReRsRcLjmbRsbLebRgbLebLgbRebLjbL
jbRcLsbLibsbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bRgbRiLeLiLsbLgbLsLsmbLsLsmbRsbLsbLibLgbRsbRsRsmbLsbLiRsbRsRsmbRjbLibR
jbLhbLibLgbsbRgbLgbLgbLiLsbLsbRsbLsLebLibLeLsbLgLsLsmbsbLsbLgbRsRsmbLg
bRsRsmbLgbLgbLsbLsbLgbsbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bLobLsRsbLsbsbRsbLibLibLgbLiLsbRsbRsbRibsbsbRgbRgRsmbLsLsmbRsbRgbLobLi
bsbRjbRgbRgRsmbRsbRibRsbRsbLsbRobRsRcbRjRsRsmmbRibRibRgbRsbRgRsLsmbLgb
LcbsbLobRibRsRgbLsbLcbRgbLcbLibLibRibRhbRsbLsbRibLebRhbsbRiRsmbRsbRsbR
sbsbRsbRsRsmbRsRsmbRgbRsRsmbRgRsmbRsbLibLsbRibsbRgbRcbRgbRcbRiRsmbRgRs
mbLsbsbRgbLsbRsRsRsmmbRsRsRsmmbRsbRgRsmbRsRsmbRsbRgRsmbRsRsmbRgbRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bLgbLjLsmbLjLsmbLibLgbRhRsRhRsRsmmmbRibRibRibRibRibLibRcbRibRcbRiLgLsb
RibRgRsmbLsRgbRsLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bRcbLcbLibLibLebLjLebLgbRsbRebRiRsmbRiRsmbRsLsbRsLsbsbRsbLsRsbRsRsmbRs
bRsbRsbRsbRsLsLsRsLsLsRsLsmmbRsLsbRsbLsbsbsbsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bLsbRjRgbRiLsbsbLeLsbsbsbsbsbsbLgLcLibRgbsbsbRcbRhbLobLibLsLsmbLibLsbL
gbLgLsbLsbLgbRgbLcbLgbLsbsbsbLibLiLsbLibRiRsmbRcRsmbRobsbRgLsbLjbLibsb
RsbRcbsbsbLsbLsbsbsbsbsbRsbRsbsbsbsbsbsbsbRiRsmbRgbRcbRobRhbRsRhLsbRib
RibRhLsbRibRibRiRgRsmbRcLsRsbLgbLiLsbLiRsbLgbsbLsbLgRsbLsbLgbLgbsbsbLg
bLsRsbRsLsbLgbLsbLgbLgbLsbsbLgbLgbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bLcbLiLgbLoLgLsbRsbLobLgbRhbLibLsbLibLsbLibLgLsbLibLsbRjRsmbRcRgbLhbLs
bLgbLibRsbLsbLgLsLsmbLgbLsbLgbLsbLsbLibLsbLgbLsbLsbLsbLibLgbRsbLsbLibs
bLsRsbLhbLsLsmbReRsRsRgmmbRgbLsbRobLibLibLsLsmbRcbRhbLsbLjbLcbsbLibLgb
LgLsRsbLsLsmbLsLsmbLgLsbRgRsLsmbRobRgbRgbsbRsbRsbsbsbsbLsbsbsbLcLsmbLi
bLebLibLgbLsbLhbLhbLgRsbRsbLhLsbLgLsbLiLsbLgbLibLgbLsbLgLsbLgbRoRibRiR
smbLebsbLjLsLsmmbLsLsmbLcbRiRsmbLhbLsRsbLibsbLibLiLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bRsRsLsmbRsLsbLsbRsbLgbLsLsLsmmbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbsbsbsbsbsbRsbLsRsbLsbLsbsbLsbLsRsbsbsbLsbRsbsbRsbsbRsRsmbLsLsmbLsL
smbRsRsmbRsLsbRsbRsRsmbLsbsbLsLsmbRsLsbsbLeLsbLiLoRsRsmbLcbRibRcbRhRsm
bRobLjLcbLiRsbLeLibLgbLgLsLgbLgbLhRsbLcRsbLgRsRsmbRobLsbRgRsmbRibRhbRg
RsmbLgbLcbLgbLibLibRjbsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bRebRcbRhRobRsRcbLgRsbLgbLsbRsbsbsbsbsbsbRsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bRcbLsLsmbLjLsmbLobLgbLeLsLsmbRgbRhbRibRgbRibRiRibRhbRiLsRsbRsbRibRgbR
oRsmbLsbRcbRhbRiRsLsmbRibRsbRibRgbLsbRibLibLobLgbLoLsmbLibLhbLibLgbLsb
RcbRibRcbLsRsLsbLsbLgbLgbLobLcbLcbRsRsmbRibRebRgLsLsmbRsRcbLgbLcbLcbLj
bLcbRsbRibLjbLobLsbLgbLcbsbRgbRgbRoRgbRibRcbLiLsbRhbRiLsbLsbRcbRsLsbLh
bLoRsbsbLcbsbLcLsmbLcbLibRgbRibRhRsRsmmbRsbLsbRibRsLsbLcLsmbLcLsmbLcbR
sbRgbRcbsbLgbRcbRibRhLgbLcbLsLsmbLibLibRobLsbRsbRiLsRsRsmbRsRsmbRebRsb
RgbLjLsmbsbLcbRsLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bsbLsbsbRsLsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
bRsbLsbLibLgLsbLobRsbRsLebLiLsbLgbLibLhbLgbLibLgbLoRsbRgbRibRibRiRsmbL
cbLibLibLgLsbLoLsmbLcbRgbRobLhLsbLsRsbLcbLgbLcbRgbLeLsbLgbLiLsbLsbLgbL
ibLsbLgbLgbLgbLgbRcRibRsbRobRgbRoLsbRibRibRsbLsbRibRgbRebRcbRgbsbRibRi
bRgbRgbRcbRgbRsbRcLsbRiRsmbRgbRgbRibRibRiRsmbRgbRgbRibRgbRcLsLsmbRsbRi
bRibRgbRgRsLsmbRjbRgbRsbRcbLsbLgbLjRhRsmbLgbLibLibLjbLgbRsbRgbLsbRjbRi
bLcbLcbRsbRsLsbLhbRsbRiRibRjbRibRebRgbRgbRcRsmbRibRjbRobRsbRgbRebRobLs
LsmbLgbLoLsmbLibLgLibLgbLgbLibLgbLgbLsLsmbLiLsbLgbLiLsbLgbLgbLgbLgbLgb
LobLsbLcLsmbLibLgLsbLiLsLsmbLgbRsbRobRiLsbRsbLsLgbLgbRoLsbRgLsbLsbRjbR
ibRcbRgbLibLibLiLsbLibLsbLgbLibRgbLcbLibRgRsmbRgbLgbLgbLcbLgbRgbRgbRhb
RgbRjbRobLsbsbLjbRobLgbRjbLsbLsbLobLjbLhbLiLgbRebLgLsbLobRgRibRibRgbRi
bRsbRgRibRibRibRsbRgbRgbRgRsmbRsbLebLibLgbLebLgbLgbLobRcbLgRsbLiLsbLob
LgbLsbRgbRcLsbRsbRhbRsRsRgmbRgRsmbRgbLsbRsbRsbRsbLsRsbRsLebRcLsbRcbRob
RibLsbLsLobLobLgbLibLcbRiLsbRebRebRcbRobRibReLsbLgbLibLibLgbRgbLsbRcbR
gLsbRcbRibRgbRcbRibRibLsbRobRgbLebLibLgbLhRsbLobLibLgbLibLibRsLjbRobRi
RsmbRibRcLsLsmbRibLgbLibLibsbRsbLibRebLsLcbLoLsmbRcbRobRsbRgbRiRsmbRsR
gbRibRgbRibRgRsRsmmbRsbRcbRibRhbLgLsbRcRsmbRhbRcLsLsmbRsbRcbRsLsbLsbRs
bLibLgbLobLgLsbRcbRibRobRgLsbRjbLgbRibRgbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bLjbLiLsbLoLiLsbRjRoRsmbRhbRobRgbRhbRebRsbRsbRcbRibRibRibRgbRcbRgbRgbR
sRsmbRibRhbRsbRiRsmbRsbRsbRcRsmbRgbRgRsmbRsRsmbLsbRsbRsbRsbRobRgbRibLs
bRibRibRgbRhbLsLsmbLsbLibLibRsbRcbLcbRcbRgbLjbLobLibLibLibLibRsbLiLsbL
gbLiLsbRcbRibRhRsmbRibRibRibRsbRsbRcRsmbRsbRibRgbRhbRgRsmbLcbLibLgLsbL
ibLibRgbLgbLgbLibLhbLcRsbLsbLobLgbLibLgbLgbLcbLcLsmbLiLiRsbLsbLiRsbRsb
LibLgbLgbLibsbLibLsbRsbLgRsbLgbLiLiLsbLgbLcbRibRiRsmbRgbRsbLobsbLibRjb
RsRsmbsbsbsbsbsbsbsbsbsbsbLsbsbsbLsbRcRsmbRiRsRgmbLcbLgbLiRsbLsbRgLsbR
hbLibRgbLhbRsbRsbRcLsRsRgRibRgRsmbRgbRsbRibRgRsRsmmbRiRiRgRiRsRsRgRgRs
mmmbRibRcbLobRsRsmbRibRibRgbRiRsRgmbRibRgRsmbRgbRgbRgbRsbRgRsmbRgLsRgR
smbRgRsmbRgbRcLsbRgbRibRiRsRgRiRsmmbRgRsRsmmbRibRgbRgbRsbRgbRgbLsRsRsm
b

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bLsbRjbRibRsbRcbRoLsbLsbRibRibRgbRcbLsbLsLjLgbLgLsRsbLgLsbLibLgbLsbLcL
smbLgbLiLsbLibLgbLcbsbRsbRgLsbRgbRobRcbRgbReRibRsLsbRgRsmbRgbRiRiRiLsR
sbLcRsbLibLibLhbLibLjbLibLiLhbLgbLgbLgbLibRgbRjbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 19; Drug: Control Apo 50 然
bRjbRebLcLsmbLobRsbLibLgbLgRsbLibLgRsbLsbLhbLibLgbLibLibLgLebLcbLibLoR
ebRebRgRgRiLsRsbRibRgbsbRgbRsbLsbRsbRgbRibLsbRibRhbRhbRibRhbRiRsmbRibR
hbRsRcRiRsmbReRsRembReRsRsmmbRgbRiRsmbLsbRiLsbRibRhbRebRibRhReRebRgbRs
bRibRsbLgbLgbLibLgbLcLsmbLcLgLsbLcbLibLgRsbLhbLhbLiLsbLgbLiLsLhbLebLhL
sbLebLebLcLsRsmbLebLcRsbLcbLeLsbLeLsLgLsbLsbsbRsbsbsbsbsbRsbRsbLsbsbsb
sbRsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 20; Drug: Control Apo 50 然
bLjLsmbRcbRobRcbRgbRebRebRibRibRgRsmbRibRgbRibRiRsmbRsbLebLobsbLjbRcbR
gbRoRsmbRsbLjbLebLhLibLebLsbRibRcbLsbRibRsRebLjbRibRsbRcRsmbRobRsRobRe
RsRsmmbRsbRoLsbLcbsbReRsmbRiLsbRjbRgbRebRgbsbRcbRjbsbRhbReRsmbRebRgLsb
RgLsbRcbRibRhLsbRibRibRcbRibRibLgbLiLsbRsLsLsmbLsLsmbLsLsLsLsmmmbLsLgL
gLibLsRsbRsLsbRcbRcbRibLsbRcRsReRsmmbRgbRcbRobLgbRjbLgbRsbRsbLhbLobLcL
smbLcLiLsbRibLibLsbLsLsmbLobLibLebLibLibRcbRcRsmbRcbRsLsRsbRhbLobLsbLc
RsbRebRgRsmbRebLsbRcLsbRgLsbRibRhbRhbRobRobRobRibRsRibRgbLcRsbLibRsLsb
RgbRoLsbRebRibRgbRibRibRibRibRiLsbRcbLcbRgbLcbLoRsLsbLsRsbRibRsbRibRjb
LsbLgbLsbRsRsRsmmbRsRsRsRsRsRemmmmbRsRgRsmbRsLsLgbLsbLsLsLsLsLsLgmmmmb
RgbLebLibRibLgbLobLobRcbRebRsLsbRsbRsRsRsRsLsRsmmmbRgRsRgmbRgRsRgRsLsm
mbRebRsbLsbRsbLsbRsbRsRsRsRsmmmbRsRsRsRsRsmmmmbRgLsbRhbRgbLjbLcLsmbLib
LsLsLsmmbsbLsLsLsmmbLiLsLsLsLhLsmmbLhbRcbRiLsbLebLiLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 21; Drug: Control Apo 50 然
bLcbsbRoRsmbRgbLobLgbRcRsmbLcRsbLobRsLibRhbRobLhbLibLcbLsbRobRibRibRsR
smbsbLibLcbLgbLibLgbLibLsbLjbLsRgbLsbRsbRsbRebRcLsbRibRjbLibLeRsRsLsmb
LsbLiRsbLhbLiLsbsbLhbLibsbLjbLiRsbRsbRcbRsbRibLjbLcbLgbLibLiRsbsbLsRsb
LcbLcbLcLsmbLibRsbRsbLibLibLjbLobRsbLcbLcLsmbLgbLjLsmbsbLiLsbLgLsbRoLs
bRibRibRhbRhRebRebLgLsbLibRhbLsbRjbRcbRhbRgbsbRgbRsRsmbRsbLibLjbLebLsb
LsbRjbsbLiLsbRcRsRembRgbRhRsRimbRebRebRgbLsbRgLsbRsRsmbRiRsRgmbRgbLsRs
bRcRhRgbRgbRibLjbLhbLcbRsbLsbRcbRgbLcbLibRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 22; Drug: Control Apo 50 然
bsbLsbRsbsbRgRsmbsbLsbRobRobRjbRibRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 23; Drug: Control Apo 50 然
bsbsbsbsbsbsbsbsbsbsbRsRsmbRsbRsbRsbLsRsbsbsbsbLsbLsbsbsbsbsbsbsbsbsbs
bRsbRsLsbLsbLsRsLsbLsRsbLsLsRsLsmbRsRsLsRsmbRsLsLsmbRsLsRsRsmbRsRsLsLs
RsmmbRsbsbRsbLsbRsLsbRsRsmbRsbsbRsbLsbsbRsbRsbsbLsbLsbRsbLsbLsRsLsbLsb
RsLsbRsLsRsLsRsbRsLsbLsLsRsmbsbsbsbRsbLsLsRsLsRsmbsbsbLsbsbsbsbLsbsbsb
sbsbsbsbsbsbsbLsbsbLsbRsRsmbRsLsbRsRsRsmmbLsbRsbLsbRsbLsRsbLsbRsbRsRsR
smmbLsLsmbRsLsbLsbsbsbRsbRsbsbsbsbsbsbsbLsbRsLsbRsbRsbRsLsLsRsmbRsbRsL
sbLsbLsbsbRsRsmbLsLsmbLsbLsbLsbLsbLsbRsLsbRsRsLsmbLsRsbRsLsbRsLsbLsbLs
LsRsmbRsLsLsmbRsbLsbLsbRsRsLsRsLsmbRsLsbsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 24; Drug: Control Apo 50 然
bLgRsLsbLcbLibLgbLebLibLgbLebLebLebLebRsRsRsRsmmmbLhbLgbLsbLjRsbLiLgbL
cbLebLgbLiLebLebLebLeRsbLiRsRibLibLgbLsbLgLsbLgbLgbLgbRsbLgbRibLcbLgbL
gRsbLibLibLcRsbsbLgbLobLobLibLoLeLsLsmbLgbLebLebLebLiLhbLebLeLebLibLiL
ebLgbLibLgRsbLgbLgbRcLsLsmbRjRjRsmbRhRsmbRgbRjRjbRhRsmbsbLcbLcbRcRsmbR
ibRjRsmbRsbRsbRsbRhbRjRgRsmbRgRsmbRiRsRsmmbLsbLjLsmbLjbLsLcbsbRgRgbRgR
smbRsRsmbRjbRhbRcbLcbLjLsmbLcLsmbLjLsLsmmbLhbLjLgbLiLsbLsbRcRsmbLsbRsb
RibRjRsRsmmbRcRsmbLcbRcRsmbLsbsbRcRsmbRsRsmbRibLibsbLhbLoRsbLibLibLobL
cbLeLebLibLebLeRsbLiRebRebLjbLobLgbLiRsbRoRsmbRsbRibLhbLobLcbLibLobLib
LcbLibLgRsbLcbLiLsbLgbLjLsmbLgbLibsbLibRjRsmbRibRcLsRsLsbLibLibLsbLobL
hbLibLcLeLeLebLcbLeLsLebLiLsbLibLibsbRjbsbRhLsbRcbLsbLsRsbRcbLibsbLibR
obRobRhbRibRoLsRgbLoRsbLhbLebLebLcbLebLebLebLibLeLsbLsbLgbLiRsRsmbRsbs
bRjRsmbRobRsRsmbLhbsbLibLsbLjbLgLjLsmbLcLebLgbLgLsbLgbLibLibLibLgLsbLc
bLibLibLiLiLiLhbLibLibLgbLsLsmbRgbLsbLsbRgbRsRsmbRjbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bRgbsbLsbsbRsbsbsbRsbLobLgRsbLoRcRgRsLsmbLgLgLibLgLsbLsLsmbsbRsbsbsbsb
sbRsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bRsRsmbRsbsbRsbsbRcbLsbRibRjRsmbRiLsbRgbLsbRgRsmbRsbRcLsbLobRgbRgbRgbR
gbLsLsmbRhbLobLobsbRsbRgbRibRibRcLsRsbRcRsmbRibRgbRibRsbsbRsbRgbRgRsmb
RebRibRsLsbRiRsmbRiRsmbRiLsbRibRibRgbRgRsLsmbRsbRgbRibRibRibRsbRgbRgRs
mbRgLsRsbRibRibLcbLibRsbLiLsbRibsbRjbsbsbsbsbsbRhbRsbLobLgbLgbRiRsmbRg
bRgRsmbRhbsbRibRiLsbsbsbRsbsbRgbRsbsbRgbLcbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bLiRsbLcLobLibLobLsbRsbsbsbsbsbsbsbRsbLjLsLsmmbLsbRsRjbLhbLoLcbLebRgbR
sRsmbRiRsmbRgRgRsmbRgbRibRiLsRhbRgbRebRsRsLsLsmmbLibRcbsbRhbLjbRebRiRs
mbRgbRsbLsbRsbRsbLcLgbRgbRjRiRsRgRsmmbRcbRcbRsRsRsmmbRibLgbsbLjb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bLibRibsbsbsbsbsbsbRgbRgbRgRsmbLsbRgRsmbRsRsmbRibsbRiRsmbRibRibLcbRgLs
RsbRgbsbRsbsbsbsbsbsbsbsbRgbRiRsmbRgbRibRjRsmbRgbRibRiRsmbRgRsmbRiRsRs
mmbRsbRibRgRsmbLibRsRsRsRsRsmmmmbRgRsmbRgbRgbRgbsbRibRibRibRsbRsRsmbRs
bLsbRsbRgRsRsmmbRgbRibLiLsbLsbRsbRibsbRibLsbRibRibRibLibRgbRibRibRiRsm
bRibsbsbRiRsmbLhLsbRgbRgbLgbRibRiRsmbRgbsbRiRsmbRhRsmbRibsbRjRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bLsbsbRsbRgbLsbLsbsbLsRsbLsbLsbRgRsRsmmbRgbLsLoRsbRgbsbLsbLcbRgbRsbLhb
RsbRsbLiLsbLsLsmbLsbLgbLsbRsbLsLsRsmbLgbRsbRsRsmbRsRsLsmbsbLsbLibLsbRs
bLgLsbLgbLsLsmbLgbLsRsbLiLoLgbLjbLcLsmbLsbLibLgbLgbLgLsbLsbLgbRsLsbLgb
LsbLgLsbsbRgbLhbRgbRsLsbLibRsbsbRsbLsbLgbLsLsmbLsbLsbLsbLsbLgLsLsmbRsb
LsbLibLsLsmbLgbLsbRsbLiLsRsbLsbLsLgbLgbsbRsbRgbLgbLibRsbLsbLsbLibRsLsb
LsbLsbLgbLgbLsbLsRsbLsbLgbLsLsmbLsbLgbLgbLgbLgbLsbLgbLgRsbLgLsbLgbLgbL
gbLgbLgLsbLgbLsbRsbRsbLsLsLsLsmmmbLsbRsbLsbRsRsLsRsRsRsmmmbRsbRsbLebLc
bRsLibRibRgbRgRsmbRsbLsbRgbLsLsmbRgbRibRsbLgLsbRgbRgbRgbRgbLsRsbLgbLsb
RibRsRsmbLgLebsbsbLgbLibLsbRgbLiRsbLsbRsbRsbRsLibLsbRsbRsLsbLgbLgbLsbL
sbLgRsbLgbLgbLsbRgbRsbLiLsbLsLsLsmmbLsbLsLsmbLsbLgbLgRgbsbLiLsbLibLsbR
gbRsbRobLsLsLsmmbRgRsmbRgRsmbRgRsmbRsbRsRsmbsbsbRsbLsbRsbRgbsbLsbRgRsm
bsbLsLsmbsbRsRsmbRsbsbLsbsbRsRibRibRhbRsRsmbRgRsmbLibsbLsLsmbLiLsbLgbL
gLsbLsRsbsbLsbRjbsbRgRsmbLsbsbLsRiRsmbsbLsbRsbRsbRsbRsbRsRsmbRgbLsbRsb
sbRgRsmbRgbLsLsmbRgbsbLsbRgbRgbRibRibRibLsbLsLsmbRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bsbLhbRsLobRgbRgRsmbLgbRsLsbRsLsbRsbRsRsmbRsbLjbLob

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbRibsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bLgbLibRibRibRsLsbRjRsmbsbRibRibRsbRiRsmbLsbLgLsLsmbRhbRibRiRoRibRiRsm
bRiRsmbRsbsbRjRgRsmbRsbRgRsRsRsmmmbRiRsmbRibRiRsmbRcRsmbRiRsmbLsRibRib
sbLebLibLsbLiLsbRsbLibRgbRsbLsbLiLsbLibLsbsbsbLgLsLsmbLsbLsbLibLiLsbLs
bLjLsmbLsLsmbsbLgLsLsmbLibLiLsbLsbLibLiLsbLhLsbLsLgbRjRsmbLsLsmbLjLsLs
LsmmmbsbLiLsbRsbLjLsLgmbRgRsmbRsRsRsmmbLibLgbLhbLiLgLiLiRsbRcRsmbRoRsm
bRiLsbRsRsmbRjRsmbsbRgbRibRhbRiRsRsmmbRiRsmbLjLsmbLeLsbsbLsLsLsmmbLibL
ibsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bRgRsRgmbLgbRgLsbLobRgLsbRobLgbLgbLgLsbLibLsbLiLsbRgbLsLsmbLsbRcbRsRsm
bsbLhbLcLoRsbRobRhbRsbLgbLsbLgLsbsbRcbsbRibRiLsbRhbRjRhbRibLsbRgbRibRi
bRhbRcLsbRibRhLsbRsbRibRsbLgbRsRsmbRgbRibLjbRsLsbRibLsbRgLsbRsRibRsbRi
LsLsmbRhbRibRebRibLsbRhRsmbRibRgbRibRibLibRcRhbLgbLjbLiLsbLsbLibLgLgbL
gRsLsbLoLsmbLgbLobRsbLsbLcLgbLgLsRsLsLhLiLsbLgbLgRsbRgbsbLibLsbLibRgbs
bLgbRsbLgbRsbLoLiLsbLgbLcLsLgLimbRgLsLgLsbLiLsLsLsLsmmmbLgLgbLobRsRgbR
gbLsbRgbRsRsmbRgbLsbRjRebLhbRsbLebLgbLibLcbRiRsmbRebLsLsmbRsbRgbRiLsbR
gbLcbLiLsbLsbLiRsbLgLsLsmbRgbRjLsbRcRsmbRsLsbRsbRebRibRibRsbRibLsLsmbL
obLgbLcbLibLcbLjbLgLsRsbLsRsbRebRjbLsbRgbRsbLsRsLgLgbRiLsbRibRgRsmbRgR
gbRgRsmbRgbRgbLsRsbRgbRsbRibRgLsbRgbRsbsbLcbLsLsmbLcbRibRsbRiLsbRibRib
RibRgbLibLibLcbLiRsbLhLsbLiLsLiLibRsLsbLgbRcbRsRsmbLsbRgbLcbRjbRebRibR
sbsbRibRgbRhbRibRhRsmbLsbRibRsbLjbRcbLgbLjLsmbRgbsbRsbRhbLsbsbRibRsbRi
bRcbRibsbRcbRcbRhbRibLsbRsbRcRsRiRgRsmmbRiRsmbRibRiRsLsmbRgRsLsmbRsbRg
RsmbLsRgbLoLsmbLhbLiLsLsLsmmbLiLsLiLsLebLibLiLsRsbLeRgbLgbLiLsRgbLsRsb
LsbLgbLgLsbLsbLgbRgbLibLcbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bRcbRcbRcbLsbLgbLgbLibLibLiRsbReRsmbLsbLhbLibLobLibLgbLcLgbLgbLgbLgbLs
bLgbLsbLibLiRsbLgbLiLsLibLcLiLsbLibLgLsbLgbLgbLsLsmbLibLcbLibLgbLhLsbL
gLsbLgLsbLgbLgbLgbLhbLibLsbLsbLoRsLibLeLeLeLeLsbLgbLcLsmbRsRgbLibLebLi
bLgbLebLoRsReRsmbRgRsmbRoLsRcbRibRibRsRobLiLsbLhLsbLebLeLeLebLebLeLsbL
ebRsRsRsRsmmmbLebLibLibLibLeLiLsLebLsRsbLobLoRgbLcLebLebLebLebLeLiLsbL
gbsbsbLsbLebRgbLobLeLibLiLsbLebLeLhbLcbLeLsbsbsbLebsbsbLsbLjbRsbRgRsmb
LgbsbLiLsbLibLibLgLibLeLhLiLibLgRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bsbsbRjRgbsbRgbRsbsbLgbRsRsmbsbsbsbsbsbsbsbsbsbsbsbRjbRgbRgbLgbRgbsbsb
LjLsLsmmbsbRgbRgbRsRsmbRjbLsLsmbRsRsRsmmbRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bRgRsRsmmbRsLsLsmbsbLcbRsbLibLsLibLsLcbLobLsbRsbLcbLibLgLsbLsbsbLibRsb
sbsbLgbLibLhbLsbLsLiLsbLgbLebLgbLgbRsbsbRsbLhLsbLcbLiLsbLebLhbLsbLsbRc
bsbLjbLcbsbRsbLsbLsbsbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
bRobRebRobsbLgbRcRsmbRsbLjbRgbRibLgbLebLcbLcbLcbLgbLhLibLgLsbLsbRcbRcb
RcbRcbRhbRebRibReRsmbRibRgbRgbRgbRsbRgbRgLsbLoLobRcbRcRsmbRhbRibLsRsbL
jbRebRiRsmbLsbRiLsbLjbLcLsmbRebRobRcbRibRhbRgbRcRebRobRcbRibRibRebRgRs
mbRibRgbLcbReRsmbLcLsmbRcbRcbRsRsmbRcbRebRgbLsbRsbsbsbLobsbRcbsbLebsbR
cbRcbRibRibRebRcRsmbRibRibLgbRsbLcbLibRebRobLobLobsbLibLiLsbLsbLgbLcLs
mbLiLgbLibLiLsbRobLhbLobLibLibLeLgbLibLebLiLsbLgbLgbLiLsbLobLoLsmbLebL
sLhLsbLebLsbLibRsbLsbLebLsbRobRcRsmbRebRibRebRebRiRsRembRhbRiRsmbRgbRg
bRgRsmbRcbRibRobRcbRibRibRgbRiRsmbRgbRibLsbRoLsbRcbRibRgbRhbRsbRsbRsbL
sbRobRebRebRibRebRibReRibRhRebRibRgRsmbRgRsmbRgbRsbRgbRgbReLsbRgbRoRsm
bReRgbRsRebRebReRsmbReRcbLibsbLsLsmbRcbRiRsmbRgbRsbRebRebRebRebRebRgbR
gbRibRsbRgbRibRhbRhbRebReLsbRebRoReLsbRebRebReLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bRobRibRobRcRsmbRiRsmbRiRibRgbRgbRgbRgbLsbLjbLhbsbLibLcbLhbLiLsbLsbRcR
sLsmbRobRhbReRgRsmbRibRgbRgbRsbRsbRgRsmbRsRsRsRcmmbRobRsRsmbRcLsbRiRsR
gRembRiRsmbRgbRgbRgRsmbRoRsmbRcRcbRiReRhRsReLsmbRibRgbRgbRgbRobRcRsReR
eReRsmmbRgbRgLsbsbLsLsmbsbsbRsbLsbLsbLibLibsbLsLiLsbLiLsbsbsbLhbLibLib
LiLsbRibLobLcbLibLcbLhLiLibLeLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bRibRibRiLsbLsbRsbRibRsbRgbRgbLibLsLsLsmmbRcbRgLsbRhbRibLsLsmbLibLgbRs
bLsbsbRgRsmbLcbRibRibRhbLjbsbLiLsbLibRgRsmbRebLcbRsRsmbRgbRibRsbRgbRsR
smbRsbRgbRiRiLsbRsbLibLsLsmbLsbLsLsmbLgbLsbLsRsbLsbRsbRsLsbLsbLsbLsbLs
bLhLsbRibLibLgbRobRhbRibRsbRsbRgbsbLjbRhbLhbLcbsbLgLsbLibRcbLjLsLsmmbR
ibLibRibLcbLcbLobRgRsmbRgbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bLcbLcbLhbLibLcbLcbLcLsmbRobRobLiLsbLcbLibLibLiLsbLgbsbLibLcbLcbLibLsb
LgbLsbLsbLsbRsbLsbLgbRoLsbLgbLjbLcbLhbsbLcbRgbLcbLcbLhbLobRjbRiRsLsmbL
sbRgbRsRsmbRgbRsbRsbRgbRgbRsbRgbRsbRsbRsbRgLsbRsbRgbRsbRgbLsbRgbRsbRgb
RsbRgLsbLsbRsRsmbRsbRgbLsbRibRsbRcLgbsbRcRsmbLgbLiLsbLsbLsbLgbLsbLgLsb
LsbLsbLgbLsbLsbLsbLsLsmbLgbLsbLcRsbLiRsbLcbLibLcbLobLsbLsbLhbLgbLibRsb
LiRsbRsbRjbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bsbRcbRgbRiRhRsRhRsmmbRsRsmbLsbRiRsmbRgbLobsbRsbLiLsLsmbLsbLsbLgbRcbRg
bRcbLsbRsbRhbRibLgRjbsbRsbRcRebRsbRsbRsbRsbRsRsmbRgRsmbRsbRsbRgbRsbRjb
RhbRibRgbRsbRjbRsbRgbRiRsmbRebRgbLsbRcbRebRgbRiRgbRgbRsbRsbRsbsbRgbRcL
sRsbRibRjbRobLsRsRsRsmmbRgbRgRsmbRgbRebRcbRgLsbLsbRibLebLibLiRsbReRsmb
RgRsmbRgbRgbRgbRgRsmbRibRibLsRgRsLsmbRcbRgbRgRgbRcRhbRcRsmbRgLsbRgRsmb
RgRsmbRgbLsbRobRsbLibLcRsLsRsbLcbLiLsbLsRsbLsbRcbRiLsbRiRgRsRgmbRhRsRg
RiRiLoRombLsRsRebRiRsRgmbLsRiRsmbRibRhbRibRibReReRsReRembRiRibRiLsRiRh
ReRebRobLobLcbLoRsLcbLeLsLibLebLebLibLibLiLsbLgbsbLsbLibRgbLibLjbLibLs
RcbRcLsbLobLoRsbRsLsbLgbLsLsmbLobLcbLcLsmbLgbLgbLgLsbLgbLsbLibLcRibRiR
gRcLsbRgbReRsmbRsRsmbRgRsLsmbRgbRgbRebRgbRcbRibRsbRiRsmbRiRsmbRcLgRsbR
cRsReRhRgRsmmbRgRsmbRgRsmbRgbLjbsbRsbLsRsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bLgbLjLsmbLcbLcbLcRsbRgRsmbRsbLcbLiLibLibRsbRibRhbsbLgbRhbRsbRibRoRsmb
LsLsmbsbRsbsbRgbLjLsmbLcLsmbLgbLsLsLimbLgbLgbLgbsbsbLgLsbLibLgLsbLgbLs
bLsbLgbLgbLibLgLsbLgLsLsmbLibLibLibLjLgbLcbLibLcbLcbLibLsbLoRsbRsbRibs
bsbRsbLsRcbsbRsRsmbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 43; Drug: Control Apo 50 然
bLsbsbRhbsbLibLjbLobLgbLibLibLgbLhbLibLibLgbLiLibLiLsbLebLeLsLeLebRebR
obLgbLsLgbRcbLgbLeLsRebLcbRobRobRibRcbRhbRcRsmbRibRobLibRcbRcRsmbRibRi
RsRsmmbLsLsRsmbRsbRgbRsbRsbRebRcbRibRcbLsbLjbLcLsmbLibLibLgbLhbLhbRgbL
obsbLebLcbRsbRhbLgbLiLsbLibLibLgLsbLgbRsLgbLsbLhbLibLibLsbRgbRobRibRcb
RibRobRibRobReRsRsmmbRgbRobRcbRjbLobLgbLhbLibLgbLiLsbLibLobLsbLhbLibLs
bLibLgbLibRhbRcbRobRibRibRcbsbRibRibRibLibLcbLibLibLgbLgbLibLgbRcbRobR
gbLgbsbRhbRhbLsbLebLibRgbRebRcbRhbRgbLibLibRgbLhbLibLibLgbRgbRhbReRsmb
RhbLgbLgbRcbRhbLgbLhbRgbRcbLibLibRhbLhbLibsbRibLcbLsbLibLgbLibLgLsbLib
RgbRebRibLgbRhbRgbLgLsbRsRsRsmmbRgbReLsbLebLibLibRsLsbLibRgbLhRsbLibLg
bRgbLgbLhbRgbRoRsmbRiRsLsmbLsLsLsmmbRibLiLsbLjbLebRjbLibLibLsbRgRsmbRj
RsmbRcbRsbLibLgbLcbLibLibRsLsbRsbRhbRcRsmbLsLsmbLibRobLibLgbLibLgbLgbL
gbsbRibRcbRibLgRsbLibLibLobsbRsbRhbRcbRibRgRsmbRhbLgbLhbRibLcbRsLsbLiL
sbLibLgbLsbRibRhbRcbLsbRiLsbRgbRgbLgbRhbRhbRcRsmbLsbLibLibLibLgbLgbsbR
gbRibRibRibRgLsLsmbLgbRibRibLcbLcbLibLgbLgLsbLgLsbLebLgbRibRiRsmbRgRsR
smmbRibRhLsbRibRhbLgbLibLhbLgbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 44; Drug: Control Apo 50 然
bLgRsbLgLsbRibLjLsmbRibLcbRcbLhbsbLhbLhbLgbLcbLiLsLsmbLgbLgbLibLcRsbLo
bLgbLgLsbLgbLgbLsbRjbRcLsbRcbRcbRibRcRcRgbRiRsmbRhReRiRsmbRibRoLsbLsRo
bRcbRiRiRsmbRhbLjLiLeLsbLibLibLsLsmbLhbLibLibLsbRcbRiRiRgRiRebRgbRhRiL
sRsbLsbRgbLgLsbRgbRsLhbLibLgbRjbLhLsbRjbRcbsbLcbLcbLibLgbLgbLhLiLiLsLs
mbLiLibLibLgLsbLgbLsbLibLibLhbLhbLeLiLsbLiLhbLgLibLgbLibLiRobReRsReRsm
mbRiRsRsmmbRibsbRiRsmbRibRibRobRhbRcRibRgRgbRibRibRibLsbLcbRsbLibLsbLc
LsmbLibLjbLibLibLgbLibLhRsLibLeLeRsLsLeLhRsbLoRsbRebRoReRsmbRcbRhReRib
LsbsbRsbLgbsbsbLhbRhRsmbRobRcbRibRhbRcRsmbRiRhReReReRsmbRcReLsbReRgbRg
bLsbRobRobRcRebRobRcbRcbRibRibLsbLobLsbLibLgLsbLgbLibLgLsbLiLsLibLcLsm
bLebLhbRibRcLsbRcLsbRibsbsbRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 45; Drug: Control Apo 50 然
bRcbRebRgbRiLsbRjbRhbRebRgbRgRcbRsLsbRsLsbRsLsbsbsbsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 46; Drug: Control Apo 50 然
bLsbLibLebLiLsRsbLeLsbLeLsbLsLsmbLgbLsLsmbLsbLsbsbLibLgLsbRibRcbRsRsRs
mmbRgbRgbRibRhRsmbRebRebRsRiRibRoRibRgbRiRibRoRhbLcLsmbLibLeLcLsmbLgLs
bLibLgbRsbRsbLgbRibRhbReRebReRsmbRebRiRsmbRgbRgRsmbRgbRgbRgRsmbRgRsmbR
cRsmbLibLibLcbLgRsbLcbLiRsLsbLcbLcbLebRsbRsbRgbRsRsmbRgRsRsmmbRgRsmbRg
LsbRiRsmbRgbRgbLsbLeLsbLhLsbLsLibLgRsbLiLibLgbLebLebLiRsbRebReRsmbRcLs
bRobRobRcbRhbRiLsLsmbRjbRebLebLibLgbLibLjbRgbRiRgbRgbRsbsbLsbRsbRsRsmb
RsbRsRsmbLsbLsLebLgRsLsbLsbRsbRsLsRsbLsLgbLgbLgbRsLsbRjbRsbRgbRhbLsbRs
bLsLsmbRebRcbsbLgbLsbLebLibLgLsbLebLgbLcbRsRsmbRiRsmbRsbRebLgbLgbRgbRg
bRjbRgbRgRsmbRibRibRsRsmbLgbLgbLibLsRsbRsbRhLsbRsRsmbLhbRsbRsbRhbRgLsb
LsbReRsmbReRsmbRgbLsLsRsmbLsbLcbsbRsbsbLhbLibLgRsbRibRibRgbLsRsbRebRhb
RebRibRiRsmbRgbRsbRsRsRsmmbLgRsbLebLibLibRsbRcbRibRgbRgbRgbLsRsRsmbRib
LsbLsLebLhbLgbRsbRjbRsRebRibLsbRebRgRsmbRsbLiLsbLhLsbLgbRgbLsbReRsmbLe
bLobLiLsbLgLsbLgbsbReRsmbRhbLsRsRsmbLsRsLsbRhbRgbLgbLsbLhLsbLgLsbLibLg
bRsbRsbRcbRibRgRsRsRsmmmbRiRsmbLgRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 47; Drug: Control Apo 50 然
bLiLgRsbsbRgbsbRhRsmbLsbRgbRgbRgRsmbRsbRsLsLsmbRiRsmbRjbRgbRibLibRebRh
bRibLgRgbRcLsbRibRgLsbLibRjbRibReLsbRgLgbRgbsbLsbRsRibRibRjRsmbRjbRsbR
ibLcbLcbLgbRgbsbRsbLjbLhbLjLsLsmmbLjbLjLsRsmbLjbLjLsmbLsbRgbLsRsbLsbRg
bRgbLsbRgbRgbLsRsbsbRsbRsbRiLsbRcbLjLsLsLsmmmbLcRsbRjbRjbLcbLcbRjbLcLi
RsbRgbRsbLibRibRibRhRsmbLgbLsRsLsbRsbRgbRsbsbRgLsbRsbLsRsbsbRjbRsbRgbL
hbRibRhbRibRjRsmbRiRsmbRibRebLgbRiLsRsbRsbRsRhbRjbRcbRjRjRsRhmbRgbRiRs
mbRgRsmbRgbRgbRsbRsbRsbRsLsRsRsmbRiLsLsmbLsLsmbLsbRhbRiLsbRibRgLjRsbLo
bRsRsmbRibLsbLcRsbRsbLsbLibLibRsRsmbLjbRibRcRhRsmbsbRgbRsbRgRsmbLsbRgb
RgbRiLsLsmbLgbRiRsmbRsbRsRsmbRgbRsbRjLsbLgbRgbRgRsRsLsmmbRgbRibLcbLibR
jbLcbLiRsbLhLsbLhRsbLcbLhbLiRsbsbRsLsbRsbLjLsmbsbLhbRjRsmbLibLcbLibLcb
RgbRibLjbLcbLjLsRsmbLsbLsbLsbLgbLgbLgRsLsbRgbRibRgbRgbRgbRsRgbRsbRsLsb
RgbRsbLcbsbLhbRjbLcRsbLgbLhRsbRsbRgbRgbRgbRgbRgbRsbRgbRgbRsbRgbLsbRibL
gbLcbLsbLhbRjbRjLsbLcbLcbLebLcbRibLcbLhbLjRsbLcbLjLsmbsbLibLhbRsbRsbLg
bLgbLsbLibsbsbRsRsmbRsbRsLsbLsLsmbLibLsRsbLgbLsbLgbLgbLgbLgLsbLgbLsbLg
RsLsbRsbRsbLsRsbLsLiRsbLiRsbLhLsbLcbLobLcbLiLsbLiLsbLcbLhbLcbRsbRgbRgb
RsbRiLsbRsRsmbRgbRibRcbRsbRibRhRsmbLsRsRgRsmbRgbRiRiLsbRgbRsbRgbRobLgb
sbLgbLoRsbRsbLiLsbLoRsbLibLgbLgbLgbLgLsbLsbLgbLoRsRgRsmbLibLsbLibsbsbL
ibLebRsbLiLsbLoRgbRgRgRsmbRgRsmbRgRsmbRgRsmbRibRgbRgbRgbRgbRibsbLcRsbR
ibsbRcbRhRsmbRcb

>ZF Recording 2016-08-24; tW: 300s; Start: 121150; End: 121651;
Recording: 2-1; Individual: 48; Drug: Control Apo 50 然
bLebRhbRibLjbLcbLhbLibLibLgbRsbRgRiLsbRsLcbLibRsbLgbLgbRsbsbLsbLcbLgbL
gbLsbLsLsmbLgbLsbLeLsRsbRsLsbLhbRsbRgbRcbRibRsRcbLgbRsbRcbRiRgbRiRsmbR
gRsmbRgbRgbRgRgbRgbsbLsbRjLsbLsbLsbRgbLcbLibRjbsbLibLhLsbRcRsmbRcbRibR
eRgRsLsRsLsmbLiRsbLsLgLsbLsbLcbLiRsLgbRgbRibRgRgbRiRsRsmmbRcbLsbLsbLgb
LhbLcLsmbLcbLsbRsbsbRgbLhbLcbLibLcbLgbLibLibLgLiLsbLiLiLiLgLgLiLsLsmbL
sbRjbRcbRibRcLsbRoRsmbRsbRibRhbReReRiRebRibRgbRibLjbLhLsbLibLibLgLgLsL
gbLibLcbLebLibLgbLibLsbsbLsLsmbLiRsbLgbLiLsbLgbLcbLgbLhbLeLsLsLimbLibL
gbLeLsLsmbLiLsLgbLibRhbRhLsbsbRcbRibRsRcRsLsmbRibRgRiRiRsReReRsRiRsmmm
bRiLsbRibRgbRgbRgbRsbRsbRibLcbLiLsbRobRsbRibRiRsRimbRgbRcLsRsbRibRsbRg
RsmbRgRsRgRsmmbRsbRgbRsbRgRsmbRgbRgbLsbRgbLcRsbRhbRibLcbLibLcbLcLsRsmb
LgLsbLiRsbLibLiLgbLiLsLgLibLoLiLsLiLhLsLeLebsbLibRsbLgRsbLgLsbLgbLiRsb
LcbLiLsRsbLsbLcbLibLiLibLsbLgLiLsLeLgbLgbLsbLgbRjRhRsmbRgbRgbLjbRcbLsb
LsRgbRgRsRsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bLibLsbsbsbLgbLsbRsbRsbLgbLibRgRsmbLiLsbLgLsbLsLsmbLsbsbsbRsbsbsbsbLiL
sRsbLsLsmbLsbLsbLsLsmbRsbLibLsbLsbRobRiRibLsbLsbLcbRsRsmbsbsbsbsbsbsbL
gLsbLgLsbLsLsmbRsbRgbLcbsbLsLsmbLgbLgLsbLgbsbLgbsbRsbLsLsmbLgLsbLgbLsL
smbLgLsbRsbLibLsbLsbLibRsbLsbLgLsbLsbRsbLgbRsbsbsbLsbLsbLsLsmbsbsbsbLs
bLsRsbLgbRsbLsbsbLsbLhLsbLgbLgbLcLsLsmmbRsbsbsbLgbLgbRsRsmbRcb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bsbLsbsbRibRsRsmbRsRibLsbLjbsbRsbsbRgbRgbLgbsbsbRsbsbLsbsbsbsbLobLoRsb
LobLoLeLsbLgRgbLibRhbRcbLgbRibRgbRsbRibsbRobsbsbRsRsmbRsRhbRsbRsbRsbsb
sbRibRsbsbsbsbsbsbRiLsbLjLsRsmbsbLsbLsbsbRgbsbRiLsbLsLsmbLjbRcbLjLsLsm
mbRibLsbLsbRsbRibRsLsbLsbLsbRiLsbLjbRsbRsLsbLsRsLsbsbLgbsbsbsbsbRjbRgb
sbLjLsmbLsbRibLgLsbRsbRibLsLsmbLsRsbRsbRgbsbRsRsmbRgLsRsbRsRsmbRgLsbRs
bsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bLibRsbLgbRgbLibLsbRsLobLibRiLsbRjRsRsmmbLibLoLsmbLibLsbLsbLgbLsLsmbLi
bLoRsbLibRgbRibRibLcbLibLiLsLsLsmmbLsLsmbLibLgLsLsLsmmbLgbLgbLgbLgbRcb
RsbLsbRoLsLsmbRiRsmbRiLsbRibRiRiRibRgbRiRibRiRgbRiRsmbRgRsmbRsbsbLebLi
LsRsLsbLibLgbLsbLibRsLsbLiLsbLgLsbLsbLibLhLsbLhLibLibLjRsRjbLhbLibLgRs
bLsbLobRebReRsRcLsRsRsmmbRcbRiRebReRsReRsRsmmmbRcRobRobsbsbLebRgLsbRhb
RcbRsRsmbRjbLcbsbsbRsLsbsbLibRsbLsbLsbsbLsbsbsbLsbsbsbsbsbsbsbLsLsmbsb
sbLsbLsbLsbsbRsRsmbsbRobRibLjbLhbRibRibRibRiRgbRsRcRsRgmbRoRgbLiLcLsLg
mbLhbLhLsbLobLsLsmbRgbRgbRgRsmbRsbRgRsRsmmbsbLsbRiRsmbLjbRibLjbLcbLcbL
sLsmbLgbLsbLcLgbLibLgbLiLsLeLgLsRsLiLhLeLeLeLiLsLcLsRsmbRsbLcLsRimbRoR
hbRhLsRibLsbRibRsbRsRsmbsbRgRgbRsbRsbLsbRsLsbLcbLcbRsLsbLsbLgbRsbLibLg
LsbLibLgbLgbLcLgbLiLiLibLsLgLiLiLcLebLebLgbLiLsbLhLobLcLhLsbRobRhbRgRi
LsbRobRsRsmbRcbRcRhbLoLeLeLebLobLebRibRibLgbRsbLsbsbsbLsRsbsbsbLoLsmbs
b

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bRsRsmbLsRsbRgRsmbRsbRgbRsbLsLsmbLgbsbsbRgRsmbRsbLgbRgbRgbRgbRgbLgbRgR
smbLsLsLsRsmmbRgRsmbRgbRsbRgbRsRsmbRgbRsbRgRsmbRsbRsbRgbRgRsmbLjRsbLeb
LebLsbRsbsbLsLsRsmbLsbRsbRsbLgbLgLsLsLsLsmmmbLgbRsbLgLsbLgLsbLsLsmbLhb
RgbRebsbRgbRsbLsbRsbRsbLgbLibLebRsbRjbRibLsbRgbsbRsbLsbRsbLjbsbLibLibL
sLsmbLgLsbLibLcbReLsbLhbLgbLsbRjbRjbLhLsLibLeLebRibRhbRiRsmbRsRsmbRsbR
iRsmbRibRgbRgbsbLsbRibRibsbRsbLgbLsbRsbLjLsmbLgbRsLsbLgbsbRsbLiLsbRsLs
LsLgmbsbLsLsmbLhRsbRsbLsbLiRsLsbLgbLgbLsbLsbLsbLsbLsRsLsbLsLsmbLsLsLsm
mbLsLsmbsbLsLsmbLsbLgbLibLibLibLgbLsbLiRsbLgbLsLsmbLsbsbRsbLgbLgbLibLi
bLsbLibLgbsbLsLsmbLgbLsbLsbLobRgbLibLgLsLsmbRebRiRoRsmbRsLsbLgRsbRgbLs
LsmbLgbsbLibLgbLibLgbLgbRsbLgbLgLsbLgLsbLgbLsLgbLgLsbsbLgbLgbLgbLgbLsb
LgLsbLgbLgbLsbLgbLgbLgbLgLsbLgbLgbLgLsLsmbLgbsbLgLsLsmbLgbLsbLgbRsRsmb
RsbsbsbLsbsbRsLsbRiLobRiRsmbRsbRgRsmbRgbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bRebRcbRgbLobRcbRobRebLsbRebLobLebLibRobRobRobRobRebLsbRgbLhbRcbRcbRob
RobLebRebRobLcbRobRcbRobLebLibRebRobRebRebLobRobRcbLobLcbLebLobRibRobR
ebLibRobLcbLobRcbRobLobRobLobLsbLobRobRebRcbRgbRjbLobRgbRibLgbRobRobRc
bLobLobLobRobLsbRobRgbLcbLhbRhbRcbRsbRobLgbRgbLcbLjbLobLibRobLebRjbLib
RibRobRcbRobRobRobLobRobRcbRobRibRibRebLobRobLcbLsbRcbLobLobRibRobLebL
obRibLobLgbRobRobRgbRobLobRcbRebLobLebLobRcbLobLsbLobRobRobRcbLobRcbRe
bRobLebRobLebRebRobLobLcbLobLobRcbRobRibLebRobLobLobRcbLhbLobRobLebRob
RsbLobRcbRobLebRobRobRcbLcbLebLebLobRebRebRobLhbRebRcbRebRebLebLgbLebR
cbRibRibRibLgbLibRobLjbRebLobRsbRobRobLcbRsbRcbRibRibLobLobRebLebLgbRe
bRobLgbRcbLebLebRebRobRobLhbRgbRsbLcbRobRobRcbLibRibRcbRobRobRebLebLhb
RobLobRobLgbLibRobLhbLobLebLebLebLobLobRobRebLebRebRobLsbLobLobLsbRobR
ebLcbLobRgbLobLobLibRebRobLobLobLibLobLobLobLgbLgbRebRobLobLobRgbLsbLo
bRgbRsbRebRebRebLibRobRgbRobRsbLobRobRebLebRcbRibLobRjbLhbLebRibLcbRob
RebRobRobLibRgbRibLebLebRcbRebLobLhbLebLebLcbRcbRobLebRobLobRcbRcbLcbR
gbLjbRibLcbRebLebLobLobRebRebLebRebLobLgbLebRebLsbRobRcbRobLebRebRobRo
bRobLobLsbRobRcbRjbRcbLebRobLsbRebRobLebLobRebLebRebRibRibRobLobRebLob
RebLibLobRsbRobLebRebLobRobLebLobLobRgbRebLobLebRobLebLcbRobLobLobRebL
obLebRobLjbLgbLobLobRibRcbLhbLibLibRebLebRebRgbLcbLobLobLgbLobLobRobLs
bRobRibRebRibRebRebRebRebLcbRebLsbLcbRcbRgbLebRcbRebLibLobLobRcbRibReb
LobLebLsbRobLobRebRsbLebRcbLjbRgbLobRobLgbLobRhbLobLebLcbRibRgbLobLobR
ebLibLobRobRcbLebRobLebLebLobLcbRobLobRcbLebLibLhbLobRobLobLobRgbRibLo
bLebLebRibLsbLcbLobRgbRgbLebRjbLebRobRebRebRobRibRibLebLobLgbRhbRobLob
LobLebLcbRebLobLobLebLebRcbRebLobLgbLobLobRibRobLibRebLebRebRobRcbLebR
ibRcbLebRobLobRgbLibRobLebRsbLobLobRibRebRebRebRgbLsbLsbRsbRsbLgbRibLc
bRebRebRsbLobRhbLgbLgbRhbRibLebRjbLobLebLjbLcbLibRebLobLobLobLhbLobRsb
RebLsbRobRebLjbLobRcbRhbLgbRsbLebLobLebRebRibRobRhbRebLobRjbLobRebRobR
cbRcbRobLobRebLebLsbLebLibLcbLebLobRgbLobRsbLcbRebRibLgbRobLobRsbRibLo
bRibLgbLibLebRgbLobLgbLobLebLobLebRcbRebLgbLgbRebRgbRebRobLobRibLcbReb
LobRebRobLobLobRobRebRobRebLobLobRebLebLebLobRcbLobLobLebRcbLsbRebLebL
ebRebLgbLebRcbLebLebLebRibLibLcbRobLibRebRebLcbRcbRgbLebLobRobLebRobLe
bLhbLibLgbRsbRobRcbLobRobLebLobRgbRobLebRobLobRgbLobRjbRcbLobLobRcbLob
RebLebRsbRcbLobLgbLibLobLebLcbRebLibRsbRsbRcbLobLebLebLibLibRobRobLibR
obLebRebRobLibLcbRobLobLobRebRgbRgbRobRcbLebLjbLebLebLebRebRcbLebLobLe
bLobRgbRebLobLibLobLsbLebLgbLibLebLebRsbLgbLjbRebLobLgbLebLibLgbRobReb
RobRebRobRsbRsbLebLebRgbLibLgbRcbLobLebRsbRjbLobRebLcbRgbLgbRibLcbLcbL
ebLobLcbLgbRobLgbRebLebRobLebRebLobRgbLobLobLcbLcbLibLobRgbLobRgbLgbLo
bLobLobLobLhbLobLibLgbRobLibRgbRibRobRebRobLobLibRibRobRobRebLobRobRcb
RsbLobLcbLibLebRcbRibLebRebLibRsbLebLobRobRobRebRcbRsbRebLibLgbLibLcbR
obRebLcbRobLcbRobRgbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bLgbLsLsRsmbLgbLcbLcbLhLsLiLsbLgLsbsbLgbLsbLsLsmbLgbRsRsmbLgbLgRsRsmbL
gLsbLiLsbRsbRgRsmbRgbRcRsRembRsRsRcRembRiRsmbRibRsbRibRgbsbRiLsbRgRsRs
RsmmmbRgbRhRsmbLgbRcbLgbRsRsmbRsRjbRiRoLsRcRgRsmbRsbRebLgbRgbLibRcbRcb
sbLgbRsbsbsbLsbsbsbsbsbsbsbRsbRsbRsRsmbRsRsLsmbRsRsmbLjbLjb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bRsRsRsRemmbRhbLsbLibLgLsbRsbLibRcbLcbLsbsbRsbLibsbsbLsLsLsmmbLsLsLsRs
mmbLibLibLcbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbRsbsbLsbsbsbLsRsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bLobRobRobRebLgbLebRebLebLsbRebLcbRobLobLgbLsbRcbRobLibRobRgbRcbLebRob
RobRebRcbRobLobRobRcbRgbRsbRibRobLobRsbLcbRibRebLebRobLobLcbRcbRgbRcbR
obRibLebRcbLsbRcbLcbLobLebRcbRebLobLobRibLgbLebLhbRobRobRgbLcbLobLibLi
bLcbRhbRsbRobLsbLhbRobLcbRebLcbRcbLsbRobRobLobRobLsbLobRobLobLebRobLob
RcbLebRobRobLcbRibRobRobRcbRcbRebRcbRobRibRcbRsbLebRcbLsbRibLibRsbLobR
obLebRobLobLobRebLobLobLobLobLebLobRcbLgbLobLcbLobLgbRibLobRobLsbRobRo
bRcbRobLobRebRebRobLebLobLcbRobRebRibRebLebLobLibLebRebRcbRgbLcbLobLob
RobLibRobRobRcbRobLobRsbLobRebLgbRobRobLebLobRhbRobRibLebLebLebRibRebL
ebRibLebRcbRobLsbLcbRobLgbRcbRobRgbRebLobRibLobLgbLgbLibRebRgbRebRebRe
bRobLobLobRcbLgbRobLobLebLebRobRobLcbLobRsbLcbRcbLcbRobRcbLcbRibLcbLob
RibLebLebRibLcbRgbRobLobRobLobLobLsbLjbRobRebRobRobRsbRgbLobLibRhbLebL
ebLebLebLcbRobLsbRebRebLobLcbRgbLobRobRobRibRobLobRcbRobRibLibRebRsbLc
bLobRcbRebRobLcbRcbLebLcbRgbLcbRobRobLibRobRibRcbLobRsbRobRobLebLcbLob
LobLgbLebLebRebLcbRebRebRebRsbRcbLobRobLcbRcbRebLobLcbLebRebLebRebRcbL
obLcbLebRobRgbRobRgbLebLcbLebRcbLhbLobRcbRgbLobLgbLsbLsbRsbRebLobLgbRs
bRgbLobRibLobLobRsbRebLobLsbRcbLcbLobRcbRobLcbRobRebRcbLibLebLibRebLgb
RgbLobRobLobRgbRjbLebRgbLobRobLebRebLebLobLibLebRebLebRobRgbRobRobLebL
ebLobRobLobLsbRobLobLcbRgbLibLobLobLebRebRobLibLobLebLobRobRobRobLobLs
bLobRibLibLebLobLebLibRcbRobRobLcbRebRgbLobLebLobRjbRobRcbRobLobLcbLcb
RebLobLsbLsbRobRcbLobLsbRobLjbRebLobLebLsbRsbLobRgbRebRobRebLsbLebLebR
ebLjbLobLibRebLibLcbLibRobRobLobLebRebLobLebRebLcbLcbLobLebLebRebLebLi
bRobRjbRjbLobLibRebLobLebLobLobLibRobRebRibLebRebRobLebRobLebLsbLebRjb
RobRebRebRobLobRcbRobRibRebRebLobLobRobRobLibRebLjbRebLebLebRobRobLobL
obLobLcbRjbLobLobRebRebLobRebRcbRjbRobRebRebRobLebLobRjbRebRebRibRcbLe
bLhbRcbLcbLobLobRsbLobLibLjbRobRcbRobRobLobLobRebLobRcbRebRibRebLibRob
RobLobRebLobLobLebLobLcbLobLsbRsbLobRobLobLobRobLsbRcbRjbRcbRebLobRobL
obLobLobRebRobRsbRgbRibRcbRobRsbRobRobRcbRibLobLgbLebLebLobRobRobLobRo
bRcbLebRibRobRobLobRcbRcbRgbRebRobLcbRebRobLsbLobLobRebRsbLebRcbRobLib
LebRcbRsbRebRebLobRobRsbRhbLibRobRcbRsbLhbLobRibRebLobRebRobRobRobRobL
obRebLhbRobRobRebRibLobRcbLhbLobLsbRcbLjbLgbLobRobRcbLebRcbLobLebRebLe
bLcbLobLebRobRebRobLobRebLgbLobLobRobLobLebLgbLibLebLobLcbLjbLobRobRsb
RcbLobLebLobRobRebRebLobLebLobRebLcbLcbLobRibRobLobRibRhbRjbRgbLibLcbR
cbRcbRcbRobRebRjbRcbLobRebLobRebRobLjbRebLobRjbRobLcbRebLobRgbLobRsbLh
bLobRobLcbRobLobLobRebRobLibRjbLcbLobLobLebLobRebRibRcbRobLcbRobLobReb
RobRgbRcbRcbLobRebRobRibRebRebLgbRobRobRobRcbLcbRebRcbLobLhbLjbLobLibL
obRobLebRcbLebRcbRcbLcbLjbLobLobRhbRobRebLibRcbRebRobRebLcbLibLebLobRo
bLobRobLobRcbLobLcbRobLcbLobRibRobRebLebLobLcbLebRcbLebRebLobRobLobLib
LobLcbLobLobRebRcbLsbRobLobRibLebLibLcbRcbRobLobRobRobRebRobLgbRcbLobL
ibLebRobLibLobLcbRobRcbLobLobLcbLibRobLebLcbLebRobRobLobRobRcbLcbRobLe
bLobRjbLebRobRebRobRobLobRobRobLibRebLobLobLsbRobRebRcbRsbLebRobRebLob
RcbLcbLgbRebRobRobLibLjbLjbLebRebLobLobLobRjbRebLebRsbLibRobLobRobRebR
ebLebRobLobRsbRsbRgbLsbLcbRcbRgbRibLibRobRobLebRsbRobRobRobLobRebRjbRo
bRsbLobLebRobRobRebRobLobRobLsbLcbLibLebRobRibRjbLebRebRcbLcbRebLobLcb
RebLobLobRcbLebRebLebLcbLcbRibLgbRobRebLebLobRcbLebLobRcbLobRobRebRcbL
hbLgbLobLebRsbLcbLobLibLcbRcbLgbRobRgbRibLebLobRebLebLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bLibRsbRcbRobRibRcbRiRsmbLsbRcbRcbLhbRhbLsbsbsbLsbsbRoLsbRoRsmbRhbLsRi
bLsRcbRcbRcbRcRsLsmbRsbRsbRsbRibRsbRcbRgbRcRsmbRsbRobRibRobRibRiRsRimb
RhbRhRsRiRsRiRiRsRiReRhRsmmmmbRibLoLiLiLhLsLiLebLibLgbLgbLgbLoRiRsRhRh
ReRembRhbRsReReRebReRsmbRibRhRsmbRhbRgbsbRsbLsbsbLjbsbsbsbsbsbsbsbsbsb
sbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bLhLsbLhbRiRibRibRgRsmbRhLsbLsbRhbLgbRiRsmbsbRsLsbRibsbLsbRibRebLsbRsb
LibLibLsLsmbRsbLsbLhbLgLsbLoRsbLsLgbLiLsbRsbRsbLobLsRsbRibRsbLobLcbLgL
cLiLsLsmbLibLgbLgbLgbLgLsbLgbLgbLgbLsbLgbLgbLgbLgbLgRsbRsLsbLobRibLcbL
cbLibLgbLcbLibLgLsRsbLgbLgbLgbLiLsbLgbLgbLgLsbLgLsbLsLsmbLsbRoRsmbLebL
hbLebRcRsmbRsbRoRcRcLgbLiLsbLgbLsbLgbLgLsbLsLsmbLsRsbLsbLjLsmbLsLsmbLs
bLsLsmbLsLsmbLgbLgbLgbLibRsbLsbLibLsbLsbLcbLcbLiLsbRhRsmbRiRsmbLsbsbsb
sbLcbsbLibRibsbRebRibRibsbRibRibLsbRibRcbRoLsbLsRoRsmbRsbRibLsbLoLsmbL
ibRsbLibLgbLgLsbLgLsbLgbLibRsbLiLsbLgbsbsbLgbLgbLsLsmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bsbLsbLsbRsbsbRsRsmbsbLsbsbsbsbsbsbsbsbRsRsmbsbsbRhRsmbRsLjbRsLcbLibLc
bLoLsmbLgbLibRsbLhbLobLhbLcbLiRsbLsbRsbLgbRsbRibRcLsbLgLsbRhRsmbRobRiR
sRsmmbLgLsbLgbLjbsbsbRhbRhbRsbLcbLiRsbLiLibRsLibLgbLibRsbLiRsbLsLsmbLg
bLsLsLsmmbLgbLsbLgbLgRsbLsbRcbRibRsbRobRibLibLibLiLgbLibLibLhLcbLcbLcL
smbLeLhLeLeLiLsLsmbLgLsbLgLsLibRsLsbRcbLhbRjbLsbRsRebRhbRebRhRcbRibReb
Rcb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbRsbLsRsLsbsbLsbsbLsbRsbRsbRsbRsLsLsmbR
sbLsRsbsbLsLsmbRsLsRsLsRsRsmbLsRsbsbsbsbsbsbRsLsLsmbLsLsRsRsmmbsbRsbRs
RsmbLsbLsbRsbsbsbsbLsbLsbsbsbsbsbsbLsbsbsbsbsbsbsbsbLsbsbsbsbsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bLcbLgbLoRsbLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
bLsbLsbRibLjbLcLsmbLhbLebRcbRibRobReLibRsLsLsmbLgbLibLibRsbLiLsbLibLcb
RgbRibRebLobLgbRgbRibRgbRgbRgbRgbRgLsLsmbRobRjbRgbRibRebRebLgLsbLhbLgb
LsbRebsbRebRgbRgbRgbRhbRebRgbsbLhbLgLsbLcbRsbLsbLcLsmbRgbLgLjbRcRebLgb
LgbRjbRobRiLsbLgbLiLsLsmbLgbLjbLibLcbsbRjbRibRjbLobLgbLcbLobLsbRjbLibL
obRsLsbRgbRibLobsbRcLsbRibReLsbRebRgbRgbRsbRebLgLsbLsLsmbLobLsLsmbLibL
cbRjbRhbRcLsbLgbLgbLgbLjbLhbRgRebRsbsbRibRebLibLibLcbRsbLgLsbLiLsbRibR
gbRjbRgbRibRjbRhbLjbLiLsbLgbLgLgbLobRobRgbRgbRibLiLsbRibLsbRjbRgbRiLsb
LgbRcLsbsbRgRjbRgbRibRibRsbLsbLobLsbLibLcbRiLsbRebRibRgbRiLsbRiRsmbRib
RsbRibRgbLjbLhbLgLsbLobRgbLjbLgbRsbRgbRibRcbLsbRsRjbRsbRgbRsbLibLhLsbL
obRsLsRsbLjbRobRibLgbRcbRsLsbRsbRgbLgbLobLibLibLgbLsbLgbRoLsbRiRsRsmmb
RibRsbRibLcLsmbLgbLeLsLsmbRgbLgbLobRsbLibLibLgbRsbReRsmbRobRibRhbRibRs
LsbLibLsLgbRibLcbLjbRsbLgbsbLobLsbLgbRcRsmbRgbRobRcbRsLgLsbLgbLibRibRe
bRjbLsbRebRobLgLsbLsLsmbRjbRcbLebLgbLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bRgbLsbRibRibRhLgbLsbRebRibRiReRiRebsbLsbLsbRsLsbRsLsbLsRsbRsLsLsLsmmb
LsbRsbRsbLsRsbLsbLsbRsRsmbRsbsbLsbRsbsbsbsbsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bsbLsbsbRsRsmbsbsbRsbsbLsbsbsbsbsbsbsbsbsbsbLsbsbsbLsbsbRhbLcbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 19; Drug: Control Apo 50 然
bsbLsLsLsmmbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 20; Drug: Control Apo 50 然
bLoRibRgRsmbRibRgbRhbLgbRcbRebLibRsbLiLsbLcbLgLsbLjbLhbRobRebLobRgbRgb
RgbRsbRibRcbRibRgbRobRibRcbRjRsmbLjbLibLobLsRsbLjbLcbRiLsbRibRobRobLib
RibRoLsbLsbLobRibLgbRiRsmbLcbLobLebLibLiLsbLiLsbLiLsbRoRsmbRcRsmbRgLsb
RhbRiRsmbRhbRgbRobRcbRoRsmbLcbLebLobRgbRibLsbRsbRsRsRsmmbRgbRgRsRsmmbR
sbRgLsbRiRsmbLsRgLsbRsbRgbLgLsLsmbsbRcbRcbRebLobLobRgbRcbRiRsmbReRhbsb
LjbRiLsbRobRgLsbRcbRibLsbRjbLebLoRsbRibLobLobRibLebRcbRgbRiLsRsbRcLsbL
iLsbRoLsbLibRobLcLhbLebLcbRcbRobLsbRcRsmbRgbRibsbRhbLjbLebRgbRebRiRsRi
mbRiRsmbRgbLsbLeLiLsbLsbLiLgLebLgbLgLgbLsLsLsmmbLsLsLsLsLsLsLsmmmmmmbL
gLsbLsLsLsmmbLgLsLebRgbLeLsbLhLsLsRsmbLsLsLsmmbLeLsbRsbRcLsbLsbLsbLsbL
gbLsbLsLsLsmmbLsLibLiLsbLgLsLsLsLsmmmbLsLsLgLsLgRsmbLgLsLsLsLsmmmbLgLs
LsLsmmbRgLsbLgLsbLsLsLgmbLsLsLsLsLsLsLsmmmmmmbLsLsLsLgLsLsLsLimmmmbLsL
sLsLsLsLsLsLgLsmmmmmmbLsLgLsLsLsmmbLsbLiLgLibLgLgLgLsLsmbsbsbLgLsLsLsL
smmmbLsLsLsLsLsLsLsLsLsmmmmmmmmbRsbRsbLsLsmbLsLsLsLsLsmmmmbLsLgLsLgLsb
LsLsLsmmbLgLsLsmbLsLsLsLsLsLsLsLsLgLgmmmmmmmbLoRsbLcLsmbLgbLsLsLsLsLsL
sLsLsmmmmmmmbLsbLsbLsLsLsmmbLsLgLsLsLsLsLsLgmmmmbLgLsLsRsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 21; Drug: Control Apo 50 然
bRcbRiRsmbRsbRjRibRsRhbReReRsmbRiRebRgRsmbRsRsmbRibRsbRsRsRsRsmmmbRsRs
mbRjRsmbsbLcbLsRsbRcbRhbRibRibRiRsmbRgbRsRsmbsbsbRiRsLsmbLgbLjLgbLhLsb
LcLsmbRgbLobLgbLhbRsLibLgLsbRcbLsRsRsmbLoRsbRgRsmbLobLibLgbLeLsLiLibLh
RsbRgbRiRsmbRsbRsRibLsRobLsRebLeRsLsRsbLsbLsbLibLhRsbLiLiLiLsbRsLibLgb
LsLeLebLibLhbLgbRsbRsRsmbLcbLgbLsbLebLsbLcLsmbLhLiLgLiLgbLobRibRebsbsb
sbRsbsbRsbsbLsbLsbRsbRsbLsbRsRsmbsbsbsbsbRsbRsbsbsbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 22; Drug: Control Apo 50 然
bLsbRhbLibLoLgbLebLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 23; Drug: Control Apo 50 然
bsbsbsbsbsbsbsbsbsbsbRsbRcbRobRhRcRsmbRhbLsbLeLibLsLsLgmbLsbLsbLsLsLsL
sLeLsmmmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 24; Drug: Control Apo 50 然
bRcRsmbRsbRcRsmbsbLgLsbLhLsbLibLcbLhbLibLibLcLsmbLeLebLcbLcLebLeLebLsb
LcbLiLsbLgbLibLoRsbLsbLibLibLibLoLsmbLobLcbLibLhRsbLobLobLobRoLsLsmbRo
bLjbRhbRebRgbRsbRgbRsbRsbRgbRsRsmbRsbRsRsmbRsbLsbsbRsbLgLsbLsRebsbRsbL
ibLhbLcbLiLsbLiLsLsmbLiLsRsbLjbRoRsmbRebRobRjbRgbRibRsbRebLsbLsbLibLib
LcbLgbLibLibLsbLsbLgbLsbLsbsbsbLiLsbRebRsRsmbLhbLibLibLcbLibLebLebLsbL
ebLobRsbRobLobsbRibRibRibRgbsbRgRsRsmmbLcbLcbRsbRiRsmbRsRebRjRsRsmmbRe
RsRsmmbRhbReRsmbRibRsbRgRsLsmbRjbRsbRgbLsbRibLgLsbLsbRhbLgRibRgRsRsmmb
RsbReRsmbRgbRobRjbRcbRsRibLgbRibRiRibRibRiRsmbsbRgRsmbRcRsmbRsbLjbLibL
jLsLsmmbRsRsmbLibLibLsRsbLgbLhLsbLsbLhLsbRsbsbRsRgRsRsmmbRgRsmbRebRiRs
mbRgbRsRsRsRsmmmbLsbLjLsmbLcLsmbLibLibLcbLibLgbLibRibLsLsmbLgbLsbLsRsb
LgbRsbLgLsLsmbLiLsbRjbRcbLjbRiRsmbRiLsbRibRibRebReLsbRgRgRsmbRebRebReb
RhbRibRgbLgbLgbLhbLsbsbRcbRcRsRsmmbLsbLiLsbLibLcbLibLibLeLsLibLcbLeLhL
ibLeLeLsbLebLgbLsbLhbLgLsbLgbLgbLgLsRsbLsRsbLibLsbRiRsRsmmbRsbRibRebRg
RsmbsbLjLsmbLjLsmbLjLsRsmbLiLsRsbLgLsbLibsbLcbLhLsLsmbLibLobLobLhbLiLg
bLsLsLgmbLgLsbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bsbLsbsbRsLsbLsbRsbsbsbsbsbLsbsbsbsbRsbsbsbsbLsbLsLsmbLgbsbRibLcRgbLiR
hLsLsRjmbRgbRibReLsLjbRibLgLsRsLsbLgbLgLsbRsbLsbLgLgLsbLsbsbRiLibRhbRe
bLgLsbLsLsmbRebRsbRsbLsbRsbRjbRebLcLeLsbLobRobLobRsRiLsLsReRhLsmbRgRgR
smbRsbsbsbRsRsmbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbLsbsbsbRsbRsbLsb
Lsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bLsLsmbLhbRhbLsbLcLsmbsbRgLsbLobLgLsbRsbRibRgbLsRsbLsbLsbLsRsbRsLsbLsR
sbsbLsbsbsbsbLsbLsRsbRsLsbLsRsbRsbRsbRsbLsLsmbLsbLsLsmbRsLsRsbRsRsLsmb
RsRsmbLsbLsLsmbRsRsmbLsRsLsbLsbLsRsRsmbLsLsLsmmbsbsbLsRsbLsLsmbLsbLsbR
sbRsLsbRsbsbLsbLgbRcbLibRsLibRsbLcbRsbRsbLiLsbLgbsbLsbRgbLsbLgbRebLsRs
bLgbRcRsmbRibRgbRiRsmbRhbRibLiLsLsmbLsLgLsbLobLibRsbLgLsbLsbRoRiRgRsmb
RgbRgbRibRgbRgbLsLsLsmmbRibRsbRgbLsbRcbRgbRsbLsRsbLoLsmbLibLgbLibLsLsm
bLhLsbLibRgbLgLsbLsbLibLgbRebRsbRgbRsRsRsmmbLjbReRsmbRibRebLgLgbRgLsbL
ibRgbLsbLibRsbLjbRiLsbRibLobLhLgRsRsmbRebRgRsRgmbRobRsbRgbRcbRiRsmbRsb
RgbRiRsRsmmbRgbsbRsbLjbRjbLhbLibLibRsbLobRobLobLgbLgLsbRsbLiLebLeLsbLg
Lsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bLibRjbLsbRsbLsbsbLsLsLsmmbLsLsmbRgbRgbRgRgbRebRhRgRibRibRsLsbRibLgbRi
bLgbRibsbsbsbRgLsbLibRsbsbLjbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bRibRsbsbsbsbRsbsbRibLjbsbRsLsbsbRsLsRsLsLsmbsbsbRibRsbRiLsbRibLibRibL
gbRhRsmbRibLgLsbLibLgbLgbLgbLgbLgbRsbLsLsmbLsbLibLibRgbRgbRsbsbLsbRgbs
bsbRsbLgbLgbLgbLibRsLsbRgbLgLsbLgLsbsbLgbRsbLsLsmbLgbLsbRsbLibRsRsmbRs
bLgbLgbLsbLibLibRjbsbRjbLsbLiLsbRjbLsbsbRoRsRsRsmmmbRgbRsbLsbRgbRsbRgR
smbRsbLsbRgbRgRsRsRsmmmbRsRsRsmmbRsbRiLsLsmbLsbRgbRhbLsbLsbLsbLibLgbRs
bsbsbRsLibLsLsmbLsbsbLibRgbRibRsbRsbsbsbsbLhbsbsbsbLcbRcbRsbRcRsmbRsRs
mbLgbLsbsbRsbsbLjbLibsbLsbRsRjbsbsbsbRebRsbRsRsmbRibRgRsmbRsbLsbLhbRsR
sRsmmbLgbRsbRsbLgbsbsbLsbsbsbRsRsmbsbLgLsbLibLsLsLsmmbsbsbReRsmbRsbsbL
jbLhbRjbLsbsbRsbLsLsmbRcbLsbLhbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bsbLibLgbRsbRsbLsLsmbLsbRsLsRsbLsRjbRebsbsbsbsbsbsbsbsbRsRsmbsbsbRsbsb
sbsbRsLsbsbRgbsbLsbRsRsmbRgRsmbRsRsmbLsLsmbRgbLsbLsbRsbRgbRgbLsLsRsmbR
ibsbsbLsbRibRibLsbLsbLibLcbLgbLgbLgbRsbsbLibLgbLgbLsLsmbLsLsmbLgLsRsbL
iLsbLobLebLiLiLsLibLsbLgbLgbLsbLgLsbLsbLsbLsbLgbRsbLjLsmbLsbRsRsmbRsbL
ibLsLgbLgbsbRsbRgbLebLgLsbLibLgbLsbLsbRgRsmbRhbRgbLsbsbLgbRgbLsbRsbLsb
RgbRsbsbsbsbsbRsbsbRgbRibRcbRgbRgbRjbRibLsRsRsmbRgLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bLsbsbLsLsmbRsRcbLobRsLsbLsbLsbLsbLiLsRsRsmbsbsbRhbLsbLjbRjRsmbRgbReRo
LsbLjbsbLsbLsbLgbLsbLgbLsbRsbsbLsRsLsbLsbLsbRsRsmbsbLsbLsbRsbLsbsbsbsb
sbsbLsLiRsRcRsRsmmbReRhbRsbRgbRgbRgRsRgmbRiLsbRibLsbRibsbRhbLgbLgbsbLg
bRgbRsbRsbRsRgbRgbLsRsLsbRgbsbsbsbsbLsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bLebLibLobRcRiRsmbLcbRiLsbLoLibLoLsLsLgmmbLgbLgbLsbLobLcbLhRsbLgbLgLsb
LsbLgbRsbRobRibRgbRibsbRsbRsbRgbLjLjbRebRobRibRcbRgbLjbLcbLiLsbLsLsmbL
gbLgbLsbRobRhbRibRgLgbLoRsLsbLibLgbRobRibRibRibRgbRcReReRsmbLgLeLsbRcb
RcbReRsReRsRsReRsmmmmbLobLibLoLsmbLhLsLibRcbsbRebRoLsbRibRobRgbRib

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bLhbLjLsLsLsmmmbsbsbsbLibLjLsmbsbsbRiRsmbLgbLibRibLibsbsbLsLsmbLgbRsRs
mbLibsbLjLsLsLsmmmbLjLsLsLsLsmmmmbLhbLsbLibsbLebLgbLsLsmbsbLiRsbLgbLib
LibLhLsbLgbLsbLcbLibLibRsbLgbLibLsbLhbLsLsmbLibLibLibLibRsbRobLgbsbLhb
LhbLibLsbLibLsbRsLsbRsbRsbRsbLhbLgbLibLsbRsRsmbLsbRsbRsRsmbRgRsRsmmbLs
LsmbLjRsbLcbRgbLebLhbsbLibLhbLsbLsbRgbRibsbLiLsbRsbsbLcLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bsbLgbLgLibLibRsbLiRgRsmbLiLgbLgLsbLsbLgbLsbRhbRsbRsLsbsbRgbLsbLsLsmbR
jRsmbLjLsmbLcbRsbLiLsbLebLibLibLsbLibLhLcLcLebReLsRsbRsRsmbRsLsbLsbLib
RsbRsLsbsbRsbRsbLsbRgbRsRibRibRibRibRgbRibRiRsmbRgbRsReRebRibRgbRgbRgb
RsbRgbRcRsmbRgbRgbRhbRibRiLsbRgbRgbReReRebRibRgRsmbRsbRsLsbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bLhbLcbLsbRsbLcLhLeLeLsLsmbLebLeLgbLebRsbsbLsbLsLibReRsmbReRsmbRjbRebR
ibRiRgRsmbRiRsmbRgbRiRgbRibRiRebRjRgbLsRsbLsbRsRsmbRsRsRsRsmmmbRsRsRsR
sRsRsLsmmmmmbRsRsmbRsRsRsmmbRsbRsRsRsmmbsbRibRibReRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bLgRsbLjbLsbRibRsbLsbRsbRoRsmbLsLsmbRsbLobLibRgbRsbRcbRgbRsbRibLobLcbL
gLsbLibRgbLgbLgbLgbLibLcbLgbLeLsLiLiLgLsLiRsbLjLobLhLhbLsRsLeRsbLgbLgb
LgLsbLsLgLiRsLobRgRsmbRgbRgbLcRsbLhbLsbLcbLhLsbLoLsmbLebLsbLgbLsLsmbLg
bLibLcRgbRibRgbRibRibLsbRhbLsLsmbLjbLcLgRsbLgLgLsRsRsmbLgLsbLgbLgbLsLs
RsmbLgbLcLsmbLiRsbRhRhRsLsmbRgbRibReRsmbLsLsmbLjbRjbRiRsmbRgRsmbRibRgb
RgbReLgbsbRgbRcLsbRiRsmbRibRibRgbRcRiReRsRgmbRiRebRoLiLoRsRgbLibLebLsb
LcbsbRebsbRsRsRsRsmmmbRibLjbRsRsmbRsbRgRgRsmbRibLgbLibLobLibLcLibLobLg
LsLcLiLgLiLsLiLsbLgbLgbRsbRgRsmbRgLsbLoLsmbLgbLiRsLsLsmbLgbLsbRsRsLjmb
LiLiLsLgbLjbLsbLobLibLibLsbLgLsLsmbLgLibLibRgRsRsmmbRibLsbRoRsmbRjbRib
RibRsbRcLsbLibRebRibRjbLsbLjbLgRsbRgRsmbRgbRsbRgLsbLsRsbRibRibRsbRgRsm
bRsRsmbRibLsbRobRjRebReb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bLsbRsbsbLsbRsRsmbRsbLgbRebRiRsmbsbRgRsLsmbRjbLgbRgbRjRsLsmbRiLsRgbRob
sbLoLgLsbLgLjbLsRebRgbRsbRgbRsbsbRibRgbRsbRgbRgbRsbRsbRgbRgbRsLsbRobRc
LsbsbRsbRsbRsbRgbRsbRgRsmbRgbRgbsbRgLsbRsbRsbRsbRgbRsbRgbRoLsLsmbRgbRc
bRibsbRsbRibRgbRsbRsLsRsbRibRgbLsbRibRsbRsbRgRsmbRgbLsbRsbRgbRiLsbRibL
gbLgbLibLiLsbLibLebRgbRhRsmbRgbRgbLsbRibRgbRhRsmbRibRgLsbRibRgbRgbRgLs
bRsbRgbRsbRsbRgRsRsLsmmbRsbRsbRsbRgRsmbsbLsbRsbRsbRsRsmbRsLsbRsRsLsmbR
sRsmbRgbRsbRsbRsRsmbRsbRgbRgLsbRsRiLsbLsbRsbRhbRgbRsbRgbRgbRsbRsbRibRs
RgbRobRiRsmbRiRsmbRhRsRsmmbRgRsmbRgbRgbRgbRgbRgbLsbLobRjb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
bRsRsRsLsmmbRebRebRebRibRibRiRsRembRibRibRsbRebRcbRibReRebRgbRibRsbRjb
RcbRibRibRebRhbReRsmbReRsmbRiRsRsmmbRibRsRsmbLsRsbReRsmbRcbRjRsRcmbRib
RhbRebRhbRiRsmbRibRgbRebLobRebRgbRebRsbRobRjbLobRgbRebRsRsmbRgbRsbRgbR
gRjbRcbRebReRsRsmmbRgbRgbRgbLcbLobLobLebLebLsbLsbLcLsLsmmbRjRsmbRebRjb
RcbRgRgbsbLsbRsRsmbRsRsRsRsRgmmmbRibLsbRcbRcbRebRiRsmbRebRibRebRjbLhbR
cRiRsmbLjbLobLobLeLsbLhbLcbLgbLobLobLeLsbLgbRgbRobRebRsbRibRebRgbRcbRj
bRebRoReRebRcRsmbRsbLsbLgbRobLoLsmbRibLgbRobRsbRobLobLgRsbLiLsbLcbLgbL
ebLjbLobRjbRobLcbLebLjbLebRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bsbLsbLgbLibRiRsmbRgbRcbRcLsbRiRsmbReRsmbRiRgRsReRsRiRiRimmbRibRoLsbRj
bRgbRibRgLsbLoRsbRgbsbLsbsbRsbLiLsbLsbLibRhbRebLsbRiRibRibRjbLebRgbReR
smbRsLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bRsbRibLibsbsbRiRsmbRsRsmbLjbRhbLjLsmbLiLsbRibLcbRibLhLsbLhbLsbRcbLsbR
oRsmbRsbsbLjLsLhmbRgbRoRsmbRibRsbRsbRsRoLsLgbsbLibLsbRsbRobRibRsRsmbRg
bRsbRsbRsbRgbRsbRsbRgbRsRsmbRsbRsbRiLsbRoLsbRiRsLsmbLibLibLsbLsRsbRsbL
ebsbRcbRgbRhbRibRiRsmbLjRsbLiLsbRsRsmbLgbLgRsbRsLsbLgbLsbRjbRcbRiRsmbR
hbRsbLsbLibLsbLibLsbLsbLgbLsLsmbLhbLibLgbLhbLibLgbLgLsRsbLgbLgbLgbLibL
iLsLsmbLibLgLsbLgbLsbLiLsbLgbLsLsmbLgbLsLsmbLgbRgbsbLsLsmbRibRiRsmbLsR
sbRiRsLsmbRsLsbRsbRhbRgbRgbRgbRsbRgRsmbRsRsmbRgbRibRiLsLsmbLiRsbLgLsbL
sbLgbLgbLgbLgbLsbRgbLgbRgbLobRgRsmbRibRgbLsRgRsRiRgmbRibRgLsbLibLiLhLs
LebLsRsbRjLsbLsRsLsbLibRsbLsbLgbLsbLsLibRsRibRjbRibRgbRibRsbRgbRsbRsbR
sbRibRiLsRgbLcLsRsmbLsLsmbLsbLgbLgbLgbLsbLgLsbLsLsLsmmbLgbLsbRsbsbsbLs
bLibReRcbRhbRsRsmbRgbRibRsLsbRibRjbLsbRiRgbRobRgbRsbRoLsbRgRsmbRcLsbLh
bLgLsbLgLibsbLsLsmbLgLsbLsLsLsmmbLsbLgbLsRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bLhbLcbLiRsLsRsbLsbRsbRibRibLsbRibLsbRjRsmbRsbLgbRcRsmbLcbLcbsbLeLsbLi
bLibLcbLsbRsbRjbRgbRsbRsRsmbRgbRsbRsbRsbRsbRsbRgRsmbRsbRsbRgbRsRsmbRgb
RsLsbRsbRgbRsbRsbRsbRsbLsRsbRgbLsbRsLsbLsbRgRsmbLgbRgbLcbsbRsbLibLhbLs
bLcbLcbLgbLebLcbLgbRcbLsbRsbRsbRgbRsbRsbRsLsbRsbLsLsmbRsbRsRsmbRsRsmbR
sbRsbRsbRsbRsbRsRsmbRsbRsbRsbRgLsbRsbRgbRsbRgbLsbLsbRibRoRsmbRhbRibRib
RgRsmbRibRsRsmbRgbRgbRibRsRsmbRsbRsbRsLsbRsRsmbRsbRebRcbRibLgbLgbLibLs
RsbLibLibLgbLgbLgbRsRsmbLibLgbLibLgbLsbLgbLibLhbRibRibRgbRsbRgbLcbLgbL
gLsbRsLsbLibLibsbsbLgLsbRgbLgbLgbLsbRjbLibRobRgbRsbRsbLcbLcbRsbLiLsbLg
bLiLsbLgbLsbLgLsbLobRgbRibRgbRsbRgbRgbRsbRsbRsbRgRsmbRgbRsbRgRsmbLsbRs
bRgbRsbRsbRsbRsbRgLsbRsbRgLsbRsbRsbRsbsbRsbsbRgbLgbRcRsmbLgbRobRibRibR
ibRgbRgbRsRsmbRgbRgbRgbRsbRsbRsbRsbRsbRsbRsLsbLobRsLsbRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bLgbLsbRgbsbsbLsLjbRjbLebLsLgLsbLiLsbLibLibLgLcbLibLcbLibLsLcbLsbRibRh
bLsbLcbLibRsLsLsmbLcbLhLgbLhRsbLibRsbLsbLgbLoRsbLhRsbRgbRibRsbRsbRgbRs
RsRsmmbRgbRobRibRiLsbRgRibRsRsmbRsRsmbLsbRsRsmbLsbRcbRiRsmbRsbRibRhRsR
smmbLsbRiLsbRgbRsbRgRsmbRsbRgbRsRsmbRgRsmbRsbRibRgbRgbRsRsmbRsbRsbRjbL
sRsbRjbRsbRjLsRsbLsbRsbRgbLsLsRsmbRgbsbsbRibLcbLibLibRgbLobLoLsLimbRsb
LcbsbRsbLgbRsRsmbLsRsbLhbLcbLiLsbLhRsbRsLsbLibRsLhbsbRoRsmbRibRibRsbRs
bRcRsmbRgbRoLsLgLsRsbLibLgbRobRcRsmbLsbRgbRgbRsbRsbRsbRiLsbLjLsmbRgRsm
bLcbRebRjRsRsmmbRjRsmbRcbRebRcbRhbRibRgbRcbRsbRgbRgbRgRsmbRsbRgRsmbRsb
RsLsbRsbRgbRgLsbRgRsmbRsbRgbRsbRiRsmbRiRsmbRsbRsbRjRsmbRhbRebRhbLibLgb
LibRibLhRsbLiLsbLibLibLcbLibsbLgbLgbLsbLhRsLsbLsbLgRsbRsLsbLgbLsbLsbLs
bLebLhbLsbRiRibRgbRgbRsLgLsbLsLsmbLgbLsLsmbRsbLgRsbLgbLgbLsbLgbLeLhRgR
sRhLombRsRsmbRgbRcRsRimbRgbRgbLjbLsbLibLsLsmbLiLib

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 43; Drug: Control Apo 50 然
bRcRsmbRhbRgRsmbRibsbLibLcbLibLibLibLiLsbRsbRobRibRibRgbRibLibLobRibLi
bRjbRcbRgbRsRsmbRsRsLsmbRgbRgbRcbRibsbLgbLiLsbLibLsRsbRgbLcbRsbLcbLsbL
eLsbLobLibLhbLibLiLsbRgbLibRcbReRsmbRcbLsLsmbLsbRcbRibRebLsbLiLsbLhbLs
bLcbRsbRebRhbLsbLhbLgbLgbLjbLsbRsbLibLgbLsbLjbLibLsbLebRgRsmbRgbRhbRgb
LobLibLibLiLsLiLsbLgLsbLgbLgbRsbRhRsmbRhbRiRsRsmmbRgbLsbRgbRibRsbRibRi
bRibRcRsmbRsbRibRcbRibRsbLiLsbLobRsbLcbLibLibLibLibLhbLibRgbRcbRhbRoRs
mbRibRcbRibLsRsbLcbLibLibLgbLgLibLgLsbLiLhLsLiLsbLibLgLsbReRsmbRobLhbL
ibLiRsbLgRsbLgLsLsmbLgLsbLibLgbLgbLgbsbLgRsbLgbLobRsbRgbLibRibRhRsmbRe
bRsbLgbLibLibRcbRhbRsRsmbRiRsLsmbRsRsmbRibRibRiLsbRsbLiLsbLgbLibRgbLcL
sLsmmbLhbLgbLgbLgbLsbRjbRhbRibRibLsbLgbLiLsLsmbLibLibLibRsbLgbLiLsLsmb
RgbLgbLgbLsbLgLsLsmbRsLsbRgRsLsmbLibLgLsbLiLsLsmbLsbLiLsbLsbRjbRhbRsRs
mbRiRsmbLsbRsbLhbRsbLgLsbLibLibLibRhbRibRgbLsbRiRsmbRiLsbRsbLgbRhbRibR
gRsRgmbRgbRgbRgbRsbLcbLibLgLsbLgbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 44; Drug: Control Apo 50 然
bRjRsRsmmbsbRjbLsbRjRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 45; Drug: Control Apo 50 然
bLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbRjbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 46; Drug: Control Apo 50 然
bRibRebRgbRgRsRsmmbRibReLsbsbRsbLibLiRsbLiLsbLebRsRsmbRibRiRsmbRibRsbR
gbRgRsmbLgbRebRgRsRsmmbRgbRibRibRgbLebLhbRsLsbLibLsbLcbLgbRgbRebLsbRhR
smbRgbRibLsRsRsmbRgRsmbLsbRsRsmbRhbRibLsRsbRjbLibLgbLgbRsbRjRsmbRibRib
RibRgbLjbLgbRsbRcbLgRsbLsbLgLsbLibLgbRsLsLsmbRobRsRsRsRsmmmbRiRsRsmmbL
sRsbRiRsRgmbRgRsmbRgbRgRsmbRsRgbRsbRcbLgLsbLibLsbRebRgRsRsmmbRibRgLsbL
gRsbRsbLeLsbLhbLsbRsRsmbRebRgRsmbRsbRgRsLsmbRgbRiRsmbRsRsRsmmbRsbRjRgR
smbRibRibRgbRgbReRsmbLsbRgRsmbRsRsRsmmbRsbRsbRsRsmbRsLsbReRsmbLgbRiRsm
bRsbReRsmbLobRsbLebLsLsmbRgbRsbRiRsRsmmbRiLsbRgbLsLsRsmbLgbRsRsmbRgRsm
bRgbLsRsbRgRsmbRsRsmbRgbRgbRsbRebLsbLebLibLgRsbLsbRsRsmbLgRsbLsbLsbLiL
sLsmbLgLsbLiLsbLhRsbRsRsRsmmbLebRsbRsRsmbLebLsRsRsmbRibRjRsmbRebRsRsmb
RsbRgbRsRsRsmmbLsbRgRsRsmmbRgRsmbRiRsmbRibRgbRsbRgbRsbRgRsmbRgRsmbRgbR
sRsmbRsRsmbRsRsmbRsbRiRsRsRsmmmbRgRsRsmmbRiRsmbRiRgbRibRgRsmbRsbRgRgbR
gRsmbRsRsmbRgbRgRsmbRgbRsbRgbRsbRgbRgLsbRgRsmbRsbsbRgRsmbRgbRgRsmbRgRs
mb

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 47; Drug: Control Apo 50 然
bLhbRjbRcbRhbRcbsbRcbRcbRgbRibRcbRsbRsbRcbRgRsmbRhbRcLsRsbLhbLgLsRsbLs
RsbLhbLgbLgbLgbRgbLibsbRjbRcbRibLhbLobLcbLcbLcbLcbLcbLibLebsbLsLsmbLcR
sbLsbLibLibLiRgbRiRgRsLsmbRgbRgbRgRsmbRhbRiRhbLiLsbLiRsbLgbLgLgbLibLiL
sbLsbsbLsbLsbRsbLsbsbLsRsLsRsbRsbLsbLcbLiRsbRcbRhbLcbLcbLcLsmbLjLsLsmm
bLcbRsbLeLsbLibLsbLhbLgRsbLgRsbLgbLgbLgLsbRsbRcLsbRcLsLsRsRsmmbRoLsbRe
bRcRiRiReRebsbLgRebRsbRsRsmbRsbsbRob

>ZF Recording 2016-08-24; tW: 300s; Start: 121652; End: 122153;
Recording: 3-1; Individual: 48; Drug: Control Apo 50 然
bRibsbRoRsmbRibRgbLcLsmbLcbLibLiRsLgbLibLgLsbLgbLsRsbLgLsbLeLebLgbLgbL
iRsbLiLgbLiLebLebLibLiLsLiLsLibLgLsbLsLibLibRgbLibLiLsbLibLgbLibLeLsLi
LsLeLhLeLsbLiLeLebLhLsRsLeLebLebRgbsbsbsbRsRsmbsbLsRsbLsbRgbRibReRsmbR
ebRcbRibRebsbsbsbsbsbRjRsRsmmbRsbRsbsbRoLgbLcbRobRoRsmbRcRsmbRibRgbRiR
iRhRsRsmmbRibRsRsmbRgbRgRiLsRsbRgRsmbRgRsmbRobRiRsRsmmbReRiRiRiRebRibR
gRsRsmmbLgLsbRiLsRsLjbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bRgRsmbLsbRibLsRsbLsbRsbsbsbLsbsbsbRsbLsbRiRsmbRsRsmbRsbRgRsmbRobRobRc
bRsbRsbsbRgbRsbRsbRgbRgbRgLsbsbLsbRsbRiRsRsmmbLsbRgRsRsmmbLsRsbRgbRsbR
gbRgbRsbRsbRgbRgbRgRsmbRgRsmbLsbRgRsRsmmbRgbRgbRgbRiRsmbLsbRgbRsbRgbRg
bRgLsbRsbRgbRgbRsbRsLsbLoLsmbLgbRgbLgLsbLsbRsLsbLgbLgbLjLsLsmmbLsbLsLs
mbLgLsbRsbLiLsbLsbLsbLgLsbRsLsbLsLsmbsbLsbLibsbLibLgbsbLsbLsbLibsbRsbs
bLgbLsbLgbLsbLibLsbRsbsbLsbsbLgbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bRgbRgbRiLsLsmbLcbLoRsbLcbRibLibRsbsbLsbsbsbsbsbsbRjLsbsbsbsbLjLsmbRgb
LibsbsbRsRsmbRsRsmbRsLsbLsRsbLjbRgRsmbLibLsLsmbLgbRsbRsbLibRgRsmbLibRs
LsbLcbLhbLcbLhLsbLibsbLsbRjbLsRibRobRcbsbLsLsRsmbRjbRhbsbLibLcbsbRsbRg
bLibLsRsbRjbRebRcbRobLibRibLsbLgbLcbLcbRibsbLcbLsLsmbLgbRgbLibRgbRsbLs
bLsLsRsmbLsbsbsbLgbsbRoRgbRibLgbLibLcbLcLsmbRgbRgbLibLcbLcbLsLiRgbsbRi
bRibsbsbRiRsmbRiRsmbRibLibRibRiLsLsmbLcbRsLsbLiLsbLsbsbRjRjbLoRsbsbReb
LjLsmbLgbRsbRsbsbLgLsbRsbRsbsbsbRsbLibsbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bLsLibLgbRsbRsbRsRsRsmmbsbRsRsmbLsbLsbsbLsbsbsbLsbRsbLsLgbLsbsbsbLsbRg
bLcLsmbLcLsmbsbLiLsbLhbLcbLsbLiLsbLiLgbLgbLcLsmbLiLiLgLcLeLsLiLibLiRcb
RoLsbLhbLibLibLgLsbLibLsLsmbLgLsbLsbLsbLgbLgbLsbLibLibLcLiLeLgbLhRhbLg
LeLeLcLsLeLhLeLsLembLibLhRsbRebLibLgLsbsbLgbLsLsmbLsLsmbRsbLsbLsbLsbLs
LsmbsbLsbLgbLsbLiLsLsLsmmbLgbLiLsRsbLhbLibLhLibRjbLiLiRobRjbRcRsRsmmbL
gbRiRsmbRebRobReRsmbRebsbRsbRsbsbRsRsmbRsLsbsbLsbRsbRsbRsbLsRsbsbRsbRs
RsmbsbsbLsbsbRgbRsRsmbLsbRsbRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bRsRsmbRibLgLsbLcLsmbLgbLsbLsbLgbLgbRsLsbLgbLsLsmbLsbLsLsmbLsbLgbLgbLg
bLgLsbLgLsbLsLsmbLgLsbLgLsbLsbRsbLsLsmbsbRsLsbLsbLgbRsbLgbLgbLgLsLsmbL
gbLgbLgbLgbLgbLsbLgbLgbRsLsbRsbRsLsLsmbReRsmbRsbRgbRsbRsRsmbRibRsbRgRs
mbRgbRsbRibRiRsmbRgbRgbRibRgbRsbRhbLsbRsRhLsLsRsmbLgRgRsmbRgLcLebLebLc
LsmbLeLsbLeLsbLibLgbLgbLsbRebRiRsmbRgRsRsRsmmmbRsRsmbRgRsmbLsbRsRsmbRg
bRgRsmbLsbRgRsmbRsRsmbRgbLsbRgbRgLsbLsbRsRsmbRgRsmbRgRibRgbRiRsmbRsbRs
RsmbRsbRgRsmbRgRsmbRsRsmbRsRsmbRgRsmbRgRiRiRsmbRgRsmbLsRsbRgbLsbRsbLsL
smbRsbRhRsmbLgRsbRsbsbLsbRgbLsbRsRsRsmmbRibRibRgRsRsmmbLeRsbLibRibRobR
oReLsbLiLsbLiLsbRoLebLcLiLcLsmbLeLebLcLsmbLgbLgbLgbsbLsbsbsbLgbLsLgbLg
bLgbLgbLgbLgbLsbRsLsbRsbLsbLsbLgbRsbLsbLsbLsRsbLgbLgbLgLsbLibLibLibLsb
LgbLgLsbLsbRsLsLsmbLgLsbLsbLsbLgLsLsmbLsLsmbLgbLgbLibLgbLgbLgbLgbLiLgL
sbLgbLgLsLsmbLgLsLsmbLgbLgbRsbLgbLibLsbLgbLibLiLsbLibLsbLibLiLsLsmbLgL
sbLibLgbLiRsbLsLsmbRsbRsbLgbLibRsLsbLsbsbLsLgbLsbLgbLgbLgbLgbLgbLgbLgL
sbLgLsbLgLsLsmbRsbLsbRcRsmbRsbRgbRgRsmbRsbRibLgbRiRsmbRsRsmbRsRsmbRsbL
sRsRsmbRsRgbRsbRsbRgbRgbRsRsmbLsbLsbLcbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bRibLobRcbRcbRcbLobRebLobLjbLobLcbLobLobRjbRebLcbLcbRobLobRgbRebLobLob
LebLcbRobRebRebRjbLcbLebLcbRobLcbRebRobRobRobLcbLobLsbLjbLobLobRobRcbL
obRobLobLsbLobLobLcbRebLcbRibLhbLobLcbRcbRobRobRobLcbRjbLjbLobRjbRebRc
bRcbRobLjbRjbRobRcbLobLobLsbLebRobLobLobLebRobLsbLgbLcbLibLebLobRjbLob
RobRobRcbRobRcbRobRsbLjbLobLcbRobLjbRebRobRobLobRcbRobLsbLobRcbRebRebR
obLobRobRhbLsbLebRobLobLebRsbRobLebRobLebLsbLcbLcbLobLjbLjbLobRobLobRo
bLjbLobRobLobRebLobRcbRobLobRebLcbRcbRsbRobRjbRobRcbRjbLcbRebLcbLibReb
RcbRebRcbRobRebRibRcbLobRjbRobRobRobRcbLobRobLobRobLhbLobLobLobLobRibL
jbRebLjbRcbRobRobRcbLhbRjbLjbRjbRobLobLgbLebLobRebRcbRibRobRobLebRcbRo
bRebRebRjbRebRobRobLobLcbRobRebLcbRgbLobLibLobLebRcbLjbRobLcbLjbRebRob
RebLibRebLebRobRjbRcbLjbRjbLobRcbRebLcbLcbLjbLobRcbLobRjbRobRcbRobLobL
ibRobRobLsbRibLobLobLibRobRjbLcbRcbLobLebRjbRobRebRobLjbRebRebRobRobLj
bLobRobRobLcbLebLjbRobRebRcbRebRobLjbLobRcbRobLobRobLjbLobLebLobLjbRjb
RcbLcbRcbRibRcbLebRebRgbLebLebLcbLobLobLcbLjbRcbLsbLcbRsbLcbLebRgbLcbL
jbLsbRobRcbLebLjbLjbLobRjbRobLebRobLcbLcbLcbRcbRcbLebLebLjbLcbRcbLhbLo
bLebRobRibLobLobLobRebLebLebRebLsbLobRobLebRebLobRobLobLobRobRobLebRib
LebLibRebRcbLobRebRobLgbLobLcbLobLobRgbRgbRcbRebRcbRobLobRobRcbLebLebR
cbLibRobLibLobLebRobRibRgbLcbRobLobRsbLsbRibRgbLobRobRgbLgbRcbRgbRgbLi
bLebRgbLcbLobRebLobLjbRebLibLobLebRobLebLcbRcbLebRebRhbLcbRgbRobLobLib
LgbLibRobLcbLibRsbLcbLobLebLobLsbLobRobRibRibLibLsbLobLebLebLobLobRcbR
obRebLibLobRebLhbLebLsbLebRobRebRebLibRebRebLcbRobLgbRjbLgbRebRobLobRo
bLcbLobRebLebLobRebLsbRcbRebLebRobLobRsbLebLobLobRebLgbRibLobRobRibRob
LobRcbRcbRibLebLcbRcbRobLibRobRjbLobLobRibRobLsbRobLobLobRobLebRebLobL
obLobRobLcbLibRobRobLobLgbLobRgbRcbRobRcbRhbRibRebLebRobRgbLobRgbRobRo
bRobRgbLebRibRcbLgbRjbRcbLobLsbRobLibLsbRebRobLgbLcbLobLcbLebRebLibLeb
RebLebRgbLsbRobRebRobRobLobLobLobRobRcbRobRibRcbRcbLebRobLobRobLgbRhbL
ebLgbLobRobRobRjbRobRobRebLsbRibLcbRebLcbLobLobRebLobLobLobLibLsbLobRc
bLebRcbRcbRobLobRobLgbLgbLebRobLsbLsbRobRebRebLobLobLobRebLhbLobRobLeb
RcbLsbLgbRobRcbRobRhbRebLebLobLobLgbLebRibLobRsbRobRgbLebRjbLebRsbLgbR
cbRebRcbRobLgbLebRebRcbRobRgbLebLobRebRebLcbLebLgbLobLebLobLebLobLhbLe
bRobLcbLhbRcbLsbLgbRcbLobLobRobRobRcbLgbRobRobRibRobLgbLebLgbRcbLebReb
LibRobLobLobLebLebLebLebLebRebRsbLobRebRebRebRibRobRjbRcbLebRcbLebLgbR
jbRcbRcbLobLsbRibLgbRobLgbLebRcbRobLgbLcbLobLobRobRsbLsbRibLebLebRobRs
bRibLibLhbRebLcbRibRobRhbLobLebRsbLsbRibRebLobRobRcbLobLobLebLebLebLob
LebRgbRobRcbLobRobLibLobLebRjbLebLobLebRibLobRebLobRobLebRgbRjbRebRebR
obRebLhbRobLobLibLcbRebRobRcbRobLebLobRobLebLobRcbRebRobRcbLobLibLgbRe
bLobRjbRebRcbRibLebLcbLcbRebLgbRibRebLobRebLebRcbRibRobLobLobRobRobRcb
RibRcbLobRgbLcbRibRobLobRobRibLhbLcbRcbLobRgbLebLobRobLebLebRebLebRobL
ibRgbRgbRsbLibLobLebRobRebRibLobRebRobRobRobLcbLsbLobRobRcbRebRcbLobLo
bRebLgbRibLobLobRgbLobLebLobRebRobLobLcbLobLebRobRgbRobLcbRcbRobRcbLob
RebRobLjbRgbLcbRcbLgbLobLibLgbRsbLcbLobRebLcbLobLebRcbRgbLobLcbRibLebR
obRobLobLebLsbLebRibLgbRobLcbLebLebRobRobLibLobLobRebRsbReb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bRiRsmbLsRsRsmbLcbLgbsbsbRsbLsbsbLsLsmbsbLsbRsbLsLsmbsbLgLsbsbsbsbRsbL
sbLgbLibLgbLgRsLsbLsbRsbLoLcLibLhbLiLsbRhbLsbRcRsmbRcRsRsmmbRiRsmbRsRs
RsmmbRobReRcRsRsReReReRsmmmbReRsmbLgRgRsmbRibRgbRgbRsRsmbRiRsRgRsRgmmb
sbRsbLjbRgbLsRsbLjbRibLoLsmbRsRobLcbLcbLiLsLebLsRebRgbReRsmbsbLsbRgbRj
RsmbLcbLcLgbLgbLgLsbLsLsmbLgbLgbLgbsbLsbsbLsbLsbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bLsbLgbsbRibRibRcbRhRsmbRgbRiRsmbRsbRibLgbRobRibRhbRiRgbRcRsmbLsbRgRsm
bRgbLsRsbRgRsmbRsRsmbRsbRgRsRsmmbRibRsbRibRoLsbRgbLsbLibLgLsbLsRsbLsbL
ibRsbRgbLibLibLsbLgbLsbLobLcRsbsbRgbRhbRsbLgbLobsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bLsLsmbsbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bLgbLiLjRsbLsLsmbRebRibRibRgRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bLsbLsbRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bLobLcLsmbLibRjbRcbRibRgbLsbLebLibLgbLgLsLsmbLsbLibLsbLcLsmbLgbLcbLhbL
ibLiLcbLgLeLgbLsLsmbLgRsbLgbsbLgbLobRgLsbRiRsmbRgRsmbRgRsmbRsbRgLsLsmb
RsRsmbRibsbRoLsbRcRiRiReRiRiReRiRsRimbRiReRhRhRsmbRhbRhLsbRhReRebReRsR
embRsbRsbLcbRcbLjbsbsbsbRsRsmbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bLsbRsbLsbLibLsbRcbRcRsmbsbLhbLeLsbLibsbRibRcbLobLibRsLsbRsLsbRsRebLib
RjbLibLebRibLjbLcbLiRsLsbLibLsbLiLsbLcbLibRgbLcLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bsbRcRhbRcRibRibRiLsbRgRsRsmmbRiRsmbRgbRsbLsbLsbRsbLsLsmbLsbRsbLsbLsbR
sLsbRsbRsbLsbRsRsmbRsbLsbRsRsmbRsbLsbLsRsbRsLsbRsbLsbLsLsmbRsbLsbLsbLs
RsbRsbLsbLsbRsLsbLsLsmbRsbLsRsLsRsRsmbRsRsmbLsLsmbRsbRsLsbLsLsRsRsLsRs
LsLsmmmbLsbRsLsRsLsLsmbRsbLsbLsbLsbLsRsLsLsLsRsLsRsRsLsmmmbLsRsbsbsbsb
sbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsb
sbRsbsbsbsbsbsbsbLsbsbsbRsLsbLsbsbRsbsbLsbLsbsbsbsbsbRsbRsRsRsmmbLsbRs
LsLsLsmmbRsbsbsbsbLsbsbRsLsbsbRsbsbRsbLsRsbsbLsbLsbLsRsbsbLsbRsLsbsbsb
sbRsbRsbsbsbLsbRsbsbLsbLsbsbsbsbsbRsbsbsbLsbsbLsbsbsbLsbsbsbsbsbsbsbsb
sbsbRsbLsbsbsbsbsbsbRsbLsbsbsbLsbRsbsbLsbsbsbsbsbsbsbRsbsbRsbsbsbsbRsb
sbLsbsbsbsbRsbLsLsmbLsbsbsbLsRsbsbRsbRsbsbLsbLsbsbsbRsbRsbsbsbsbsbsbsb
sbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbsbsbRsbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
bLgLsbLhbLgbLgbRibLeRebLibRsRebRcbRibLsbsbRiRsmbLgbLgbLibRebRhbLsbRjbR
ebLsbLsbLhLibLcbLibLibLgbRiLsbLhbLjbRibRcLsbRgRgRsmbRhbLobLgbRsbLjbRsb
LgLsbLebRsbRgbLgbLsLcbLiLsbRsbLobLibLoRsbLcLsmbLibLhbLsLsmbLibLibRgbRc
bRibRgRsmbRgRsmbRgLsbRibLsbRibLibLebRsbLibRgRgRsmbsbLhbLiLsbRiRsmbsbRe
RsmbRjbRcbRcbRebLhbLhbLjbRgbLobRiRsmbRibRhbLsbLsLibLibLgbRgbRgbLebLcbL
sRsbRgbRjLsRsbRibRibLibLgLsbLgLsbLcbRgbRibRibRsLsbRsbRjbRebsbRgLsbLsbL
ibLcbLoRsbLibRibRgbLebLibLjbLgbRibRibRibRsLsbLgbLobRibRibLgLsbRsbRsbRs
bRgRgbRibRhbRsbLibLgbLibLsbLibRgRsmbRibLsbLoRsbLgLsbLeLsbLsLsmbLsbRiRs
mbRhbRgbRsbRibRiLsLsmbLsbLibLhLsbLiLsRsbLsbLgbLibRsLsbRebRgbRibRgbRiRs
mbRsbRibRgRsmbRjbLsbRibReRsmbRsbRsbLibLcbLgbRsLsbRhRsmbRsRsRsLsRsRsmmm
bRgRsmbRgbRsbRgbRgRsmbRgbRib

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bLobRobLobRjbLebLobLobLobRhbLgbLebLebRcbRebLobRobLcbRebRebLobLebRcbRob
RobLebLobLobRibRsbRebRgbRibRibLobRobLebLebRcbLcbLcbLebLcbRebLgbRobRcbR
gbLobRobRgbRebLobRebRebRgbRobRibRgbLobLcbRobLebRobLobLobLobLobRebRobRg
bLibLobLebLebRcbLobRobRobLcbRibLgbRebLgbRobRebLobLobRobLebRebLobLobLib
RcbLobRobRobLobLebRcbRcbLsbRibLcbLebRobRobRcbRobLebRobRobRobRcbLobLhbR
sbRebLobRgbLibLebLobRsbRibRibLobLgbRebLibRobLobRibRcbRcbLibRobLobLgbRo
bRebLebLebRobLsbRcbRgbLobLobLebLobLobRobLjbRobLobRcbRcbRebLgbLgbLebLcb
RcbLsbLebLgbRgbLcbRebRebRobRebRobLhbRobLebRibLobLobRcbLobLobRcbRobRobL
cbRgbRobLcbRobRcbLobRebRebRgbLcbRobRobRcbLobLobRobRobRobLebLobRobLobRo
bLobRsbRobRobRcbLcbLibRebRobRobLsbRebRobRobRibLgbLebRobRobRobLobRsbLob
LobLebLebRobRgbRibLobLobRhbRibRibRcbRebLobRobLobLcbLgbRobLgbRobLobRebR
cbLebRebLebLibLobLcbRobLebRobRcbRobRsbLibLobRobRsbLobLobRibRebLobLebRc
bRobLobRobLobRibRebLobLibRebRobRjbRhbLcbRgbLgbRobLobLobRobLobRebRobLob
LobLobRobLobRobLobRjbLobLibLobLcbRobLobRibLobRhbLebRobLhbLobRebRgbLibR
obLcbLobRobLobLobRobLgbRcbRobRcbLebLgbRsbRobRcbLgbLcbLobLhbRcbLobLobLc
bRcbRobLcbRcbLcbLebLebLibRobRebLobLibRobLobRcbRcbRobRibRobLobLcbLgbRcb
RsbLebLobLobLobLebLebRebLobRobLobRobLcbRebRobLebRobRcbRobRgbLobRhbLcbR
ibRebRobLcbRebRebLgbLebRobLebLcbLobLebRebRcbLgbRebLobRibRebLsbLobLobRe
bLobRobLibLibLcbLsbLobLobLibLebLebLobRgbRobRibLcbLcbLebLsbLobRobLebRob
LcbRibLsbLebRebRebRibRcbLobLgbLebRobRgbLcbRobRobRobRsbLebRcbRibLobRobR
gbRcbLebRhbRobRobRobRobLibRsbRebLobLobRebLobRobRobRebLibRibLobRcbLobLo
bLobLobRobRobRobLobLsbRobLcbRobLebRcbLobLobLebLobLcbRobRsbRebRebRebRgb
RobRobRobRebRobLsbLobLgbRgbRcbRebRebRobRebRsbRobRobRebLcbRibLcbLibLgbL
obRgbLebLebRebRgbRcbRobRobLcbLcbLobLjbLebLobRobLobRebLebRebLobRebLebLe
bRgbRebLobLcbRobRobRibRobRobRgbRsbRhbLobLsbLobLibRebRebLobRcbRobRobLcb
LibLobLebRobLcbRobRebLcbLcbRobRobLebRebRobRobRebLobRgbRhbRsbRcbRobRebL
obLobRcbRobLebLibLibLobRgbRobRsbLcbLcbRobRgbLobRobLobLobLibRebLcbRebRe
bLsbLcbRobLebRobLebLobRcbLobRobLobLcbLebRobLobLobLebRgbRobRcbLgbLobRib
RobRibLcbLcbLebRobRobLsbLobRcbLebLobLobRhbLebRcbRebRcbLobRcbRebLebRgbR
ebLobLobRobRebRcbRsbLobLsbLebRobRsbRebLgbLibLebRobRcbRgbRcbRcbRobRebRc
bRobRibLobLgbRobRjbRgbRsbRgbLobRobRhbRibRobRobRobLibRebLobRobRebLobReb
LobRcbLobRgbRsbRobRcbLebLebLcbLcbRebLgbRobRibRobRibRcbRobLcbLibLebLebL
gbRibRobRobLcbLcbLobRebLebRobLobLebLobRebLebLobLcbLgbRobLobRobRhbLobRo
bLobRsbLebLibLsbRobLebRibLhbLobLebRcbRebRobLobRobRhbRobRobRgbLobRgbRob
LobRebRebRobRjbLsbRebLobRibRcbLebRobLibLobLobLebLcbRobRcbLebRhbLobRobR
gbLjbLobRebLjbLobRebLcbLibLobLebRobRebRebRcbLsbRibLibRcbRobRcbLhbRcbRo
bLibRobRobLcbRobLobLcbRibLebLebLobRobRsbLcbLhbRobLobLebLebLebLobLcbRib
LobLebLobRgbLobRobLobLcbLobRobLcbRobRibRobLobLcbRobRsbRobLebLobRhbRobL
ebLebLobRobRobLebLcbLsbRebRobLibRcbRobRobLhbLobRcbRebRcbRobLebRobLobRs
bRobRibLebLcbRobLgbRebRobRcbRobRibRobLobLcbRobRibLhbLobRobLebLcbLobLob
RcbLibLebRobRgbRobLsbLebLebRebLcbLebLcbLibLobLobRobRobLibLobRgbLsbRobL
obLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbLsbsbsbsbsbsbsbRsbs
bRsbsbsbsbRsbLsbsbRsbsbRsbsbsbsbsbRsRsmbsbRsbLsbsbLsbRsbsbLsRsbLsbsbsb
RsLsbRsRsmbsbsbsbsbsbLsbsbsbsbsbsbRsbLsbLsbRsbsbsbLsbLsbsbsbsbRsbRsbLs
bsbLsRsbsbsbRsLsbsbsbsbsbsbsbsbsbsbRsbLsbsbsbsbRsbRsLsbLsRsbRsbRsbLsLs
mbRsbRsRsmbLsRsbsbsbLsbsbLsLsmbLsbLsbsbsbLsbsbsbLsRsLsbRsRsmbRsRsmbLsR
sRsmbLsRsbsbRsbLsbLsbsbRsbRsbRsbRsbRsRsmbRsbRsbLsbRsbsbRsbsbsbsbsbsbsb
sbsbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 19; Drug: Control Apo 50 然
bLjbLsbLjLsLsLsmmmbsbsbLsbLsbRsbsbsbLibLsbRobRhRhRebRibRcRebRcbLiRsRib
RhbRiRebRgbRibLgbRibsbRsRsRsmmbRsbRsLsbLjLcbLhLgLeLiLgLsLebLsRebLeLsLs
mbsbLgbsbLobLhLiLsbLhbLiLeRsLeRsbLhLsbLeLsLebLsLsLsmmbRsbLsLsmbLsLsLsm
mbRsRsRcLsmbRsRhbRcRsmbsbRsRsmbRiRsmbRgbRsRibRsRcRsmbLsbsbsbRcbRhRsmbL
sLobLgLsLsmbLsLsmbLgbLsbsbLsLsmbRsbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 20; Drug: Control Apo 50 然
bLeLsLsLsmmbRsLsbLsLsmbLiLsbLsLsmbLgLsLsmbLsLsLsLsLgmmmbRsLsLsmbRsLsLs
LsmmbLgLsLsLgLsLsLgLsLsLiLsLeLsmmmbLcbRcbRibLhbRcbRgbRgbRhbLibRcbLgbRj
bRobLeLsbLobLgbLcbLoRsbRcRsmbRsRsmbLcRsbLsbRgbLcbRibRsbRiLsbRobRsbLcbR
sbRsbRgRsRsRsRsmmmmbRibRiRsLsmbRsRsRsRsRsRgRsRsmmmmmmbRgRsRsRsLsRsmmmb
RgRsRsRsRemmmbRgRgRsRsmmbLsRsbRgRsmbRgLsbRiRgbRgRsRsRsRsRsmmmmmbsbLebL
cbRibLebLiLsbLjbLiLsbLoLsmbRoLsbRiLcbRiRsRimbLjbRiRgLsbRcbLibLsbRobRcb
LsbLeLsLsmbLiLsbRhbRiRsRsmmbRebLgbLsbLcLsmbLsLjbLcbLsbRibLiLsbLsbRcbRs
bRcbRhbRcbLsLsLiLsmbLgRsbRebRsbLsbRsbRsbRgbRibRiRsRsRgRsmmmbLhLsbLgLsL
eLsLsmbLgLsLgbLsLsLsLsLsLiLsLgLsmmmmbRibLsLsmbLsbLebRiRsRsmmbRiRsRsmmb
RibRsRgbRoLsbRobLhLsbLcbLcLsLsmmbLgbLgLsLgLsLsLsLsLsLsmmmmmbLsLsLgLsLs
LimmbLgLsLgLsLsLsmmbLhLsLiLgLeLhbLsbLsbLgLeLsbLsbRcbRgRsmbRgReRiRebRsb
RgRibRibRgbRibsbRjbLebRebLibLgbRobRcbRhbRhbLsLgLsbRgbLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 21; Drug: Control Apo 50 然
bsbRsbLsRsbLsbLsbsbLsRsbLsLsmbLsRsbLsRsbsbLsbsbRsRsmbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 22; Drug: Control Apo 50 然
bRsbLsbLsbLsbRgbLebLgbLgbRsbLsbLiRsbsbRsbRsbLsbRgbLsbRcRsmbRebRsbRsbRs
bsbsbsbsbsbsbLsbRgbReRsmbRebRgbRsbRibRsbRgbRibRcbRcbRcRsmbReLsRsRgbRib
RsbRgRsRsLsmmbRsbRgRsmbRsbRebRgbRsRsmbRgbRgbRiRsmbRsbRgbRiRsmbRibRibRs
bsbLhbLcLgbLgbLsbLsbLsbLsLsmbLgbLsLsmbLsbLsLibLgbLobLsRgbRgRsmbRgbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 23; Drug: Control Apo 50 然
bsbRcRsmbRhRsRgmbLoLiLsbLibLobRsbLhbLiLsbRibRsbLcbLcbRebRcRiRsmbRebReb
sbsbLsbRsbRsbLibLcbLebLgbRoRsmbRgbRibRcbRebRcRiRsRsmmbRiRsmbLgbRibRoRe
LsbRebRebLeRgbLebRsbRiRsRsmmbLebsbRebRgRgbRgRsReRsmmbRhbRgbRebRcbReLsb
sbRgRgRsmbRgbReReReRcRebLsbLsbRiLjbLcbLcbLgLobLeLsbLebLeRsLebLgLibLiLi
bLibRiLibLobLsbRsLsbLcRibLcbRgbLcbRhbRcbRebLcbLibLjbRebRibLhbRhbRgbRsR
sRsmmbLsRgbRiRsmbLobLhbLcbLibLgbLgbRebLgbRsbRebRibRhbRjbRhbRgbRibRibLi
bLibRgbLgbLjLebRjbLhbLibRcbRiRsmbRgbRhbRiRsmbRibLebRcbRsRebRjRsmbRjbRh
bRibRgbRsRsmbRgRhbRiRsmbLibRgbRibRibRibRgbLsbRsbLsbLgLjbLhbLibRibRjbRi
bRgbRibRibRsRsmbRsRsmbsbsbLsbRebRibLibLibRibRebRcbRgbRibRhbRibRgbRgbRg
bRibLibLcLsmbLcbLgbRibLsbLibRebRgbRibLsbLhbLsbRgbLjLebRibRhbRibRhbRgbR
sRsLsRsmbRsbRsRsmbLcbLsLgbLebLgbLibLgbLsbRebLsbRsRcbRibRgbLgLsbLsbLgbL
gbLebRibRcbRibRhbRibLsLsLsmmbLgbRgRsRsmmbLgbLsbLiLsbLsbLibRgRsmbRsbLsb
LibRgbLgbLsbLibRsbRcbRgbRgbLgbRsbsbRgRgbRibRhbRgbLibLsbLibLhbLibRibRsb
RibLcbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 24; Drug: Control Apo 50 然
bLibLibLibLhbLiLibLibLcbLeLsbLgbLhbLgbRgbRhbsbLsbLiLsbLgbLiLsbLibLhbLi
LsbLcbLiLgbLiLsbLibLsLjLsLsmmbLhbLibLoLsmbLgbRobRsLgbLiLsbLgbRjbRcLsbR
ibRibRsRsmbRsRgbRcbRibRcbRiRsmbRcbRhbRgbRcLsbRgbLibLgbLsLsmbLoLsmbRgRs
RsRsRsRsRsRcmmmmmmbLgbLiLsLsmbsbLjbLobLjRsbLjbLhLsbLhbLgbLibLgbRsbRjRs
RsmmbRgbReRsmbLsbRsRsmbLgLsbLjbRjbRsbRcRsmbsbLgLsbLgbLsbRhRsmbLsLsmbLj
bRsRsRsRsRsRsmmmmmbRsRsRsmmbRsbRsbRsRsmbRsbLhLsbLiLsbLgbLebLsbLiRsbLgR
sLsbLgLsLsmbLgLsbLgbLgLsbLsLsLsLsLsLsmmmmmbLsbRjRsmbRebLgbRiRsRsmmbsbL
sbLsbRgRsmbRsbRgRsRsRsmmmbRsRgbRsRsmbLgbLsbLjRsRsmbLgbLgLsbLsLsLsmmbLs
LsmbRsbLibLibLgRsRsmbLiLsRsbLgLsbLsRsbLibLgbLsbsbLsbLsbRjRsmbLsLsmbLgb
RjRsmbLsbRgRsmbRsbLjbRjRgRsmbLgLsbRsRsmbRhbLgRsbRsbLgbLjLsmbLgbLgLsbLi
bLgbLgLsbLgbLgLsbRcbLhLsLsmbsbLgLsbLgLsbLgLgLsLsLsmmbLiLsLsLgmbLjbLibL
sLsLsLsLsmmmmbLgbLgbLsLgbLgbLjRsbsbLibLsLsmbLgbLgbLgbLgLsbLgLsbLsLsLsm
mbLsLsLsmmbsbLsbLgRsbLsRsbLgbLgRsbLjRsbRjbLiRsbLjLgLsbLibLiLsbLgLsbLib
LgbLgbLsLsmbLsRsbLibLhbLjRsbLsbsbLsbLsbLsbLsRsLsbLjbLgbLgbRsbLjLsmbLsL
sRsmbLgbLsbLgbLiLsbLgbRsbRsbRgbRiRsmbRsRsRsmmbRcbLsbLeLsLsmbLibLiLsLsm
bLgbLsLsmbRgLsLsmbLibLsLsmbLsbLgLgLsbLgLsRsbLgbLgbLgLsbRgLsbRsLsbLgLsb
LiLsLgbLgbLgbRsbLgbRjbLhLsbLgLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bReRsLiRembRsRiLsbRcRiRsmbRsbRhbRsRsLsLsmmbLsbRgbLibsbsbLsLsRsmbLgbRsL
sbsbLsbsbLsRsbRsbsbsbsbLgRsReRcLsLhbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bLsRsbLsbLsbsbsbsbsbRsbLsbsbRsbLiRsbRgbsbRsbsbsbsbLsbsbRsRsmbRsbRgbsbL
sLsmbsbRsLsbRsbsbsbsbRsRsmbsbsbsbRsRsmbsbsbRsLsbRsbLebLgbRebRcbRgLsbRc
LsbLoLsmbRcbRjbRebRebRibRibsbsbRiRsmbRiLsbLsLsmbRsbRsbLcbLcLsmbRgbLcLs
mbRgbLhbLgbLgbsbRgRsmbRjbRhRsmbRibRgbRsbRgbRgRsmbRgbsbLsLsmbRibsbLgbRc
LgLsbLgbRhbRhbRsRgLsbRgbRgbRgRsRsRgmmbRiRsmbRibLsbRgbRgRsmbRsbRgRebRgb
LgbRibRsbsbRsbRibLsbRibRgRsmbRsRsmbRgbRebRiRsmbLgRsbLobLsbRsbLhbLibLib

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bRobLobLsbLoLiLgLiLeLiLgbLsLoLsRgmbRgRsmbLoRgbRobRhbRibRhbRiReRgReReRi
RsReLsmbReRiRsmbLiLcLiLsLiLsbLsbLsLsmbRobLjbsbRsRsmbLebLibRsbRgbLhbLcL
sRsLoLeLsLiLimbLiLcLeLebLiRgRgbLebLsbLsbLibLibRhbRcRcRsRcmbRcbRcRhRcRe
ReReReRcRhRcbRgbRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bsbLsbLgbLibLibLibRgbLiLsbLsbLgbLgbRgbLibLibLibLibLibLgbRsbLibLgbLibRi
bRibRgLsbLsbRsbsbLibsbRsbLibLibLibLibLsLsLsmmbRgbRhbRsbRsLsbRsbRibRsbL
gbLibLibLibLibLibRebRibLibLibLibLiLsbRiRsmbRebRibRsLibLibsbLibLgbLiLsb
RsbLsbsbsbLibLgbRgLsbRcbRhRoRgRsLsmbLgRobsbsbLgbLsbLgbLgRsbReRsmbsbRhb
RhbLgRsbLibLibLibLgRsbLgbRebLcbLibsbRsbReRsmbRiRsmbLgbLjbLhbLibRgbsbRg
bRsbLibLsLibLibRibRibRgbRibLgbRgRsmbRhbLgbLgbLjbRebRibRgbLibLibsbLjbRs
bsbsbLsRsRgbLjbRsbsbLsbRsRsRsLsmmbLsbLsbsbRsbsbsbLgbLibLibRibsbLsLsmbR
sbLgbLgbLsbLiRsbsbLgLgbsbsbLsbRsbLsbLgbLsbLgbRebRibRsbRsbRibLsLsmbRsbR
sbLjbLcbLibsbRsRsmbRsRsmbLgLsLsmbLibRiRsmbRjbLhbLgbLibLhbsbRiLsbLjb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bsbLsbRsRsRsmmbRsRsRombRcbRibRhRiRsRgmbRgbRgRsmbRsRsmbLsLsmbLoLsmbLibL
sbRgRsmbRsbLoRsbLgbRgbRsbLobLgbLsLsmbLcLsmbLgbLgbReRcRsRsRimmbLsRsbRib
RgbRibRsRsmbRgbRgbRgbLsbRibRsRsmbRgbLsLsmbRgbRsbRgbRgbRsRsmbRsRsmbRgbR
sbRsRsRsmmbRibRgRsmbRhRsmbRiRsmbRgbRsbLjbLcbLsbsbRgbLcbLsLsmbRgbLgbRsL
iLsbRgbRsbLiLsbRsbLgbLgbRsbRsbLgLsbLibRsbRgbLiLsbRsbLsbLibRgbLcbLgLsbL
gbRsbLcbLsbRgRsmbRsbLiLsbRsbLibLgLsbLhLsbLsLsmbLsbRibRgbRsbRcRsLsRsmbR
gRsmbRgbRibRiRsmbRibRiRsLsRsmbRibRgbRibRgbRgbsbRgRsRsRgRsmmmbRgRsRsmmb
sbLsbLsLcbLgLiLsbLgbLgbLsbLibLgbLsbLibRsbLgbLgbLgbLgbLgLsbLgbLgbRgbLgb
RibRibRibRsbRgbRgbRgbRgbRgbLoLsmbLibLibLibLibRgbLibLiLsbRgbLibLsRsbLhb
LibLgLgLgbLcLiRsLibLibLsLiLsLgbLgLsbLgLsbLgbLgLsbLibLcbLcRsbLcLsLeLeRs
LhmbLhbLibLgLsbLsbLsbLgbRsbLsbLgbLgbLgbLiLsbLgbLgbLgLsbLgbLgbLgbLsbRsb
LgbLsbLgbLgbRsbRsbLsRsbRebRibsbRibLgbsbLjbRibRgbRiLsbRhbRgbRibRibRsbRg
bRsRsmbRsbsbRgRsmbRgRsmbRsbRsbRgRsRsmmbRgbLebLiLsbLibLsLsmbLsLsmbLgLsb
LgbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bsbRsbRsRsmbLsbLsbRsRsmbRsRsmbLsRsbRsLsbsbRsbLsbLsLsmbRsbRsRibLgbLsRsb
RibLsbRsbLoRiLgbRebLiRsbRgbRgbRgbRibRgbRsbRgRsmbRhbRcRsmbRibLsbRibLibR
ibRsbRsRsmbRsRgRsRsmmbRsRsRsmmbRjbRobLhbLsbLgbLsbLsbLiLhbRsbLibLibRgbL
gbRjbRiRsmbsbsbRsbLsbLsbRsRsRsmmbLsbRsbLsbsbLsbsbsbRsRsmbRsbsbsbsbRgbR
eRsmbLsbRiLsRsbLsbRebLsbLsbRebRcRsRsmmbRiLsRsbLibLibLsbLibLiRsLsbRgbLi
bRjbLiLsbLhLgbRsbLcbLsbLjbRsbRgLsbLsbRsbRiRsRsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bLsbLsLsmbLibLgbLiLsbLsRibRebLobLsbLgbRobLibRoLsbRiLsbRcbRcRsRhReRiReR
sRemmbRiReReRsmbLebRobRjbRobReReRebRebsbRsbsbsbRsLsbLsbLsLsmbRsbRsRsmb
LsbLjbLcLsmbRsbLgbLgbLsbLsbLsbLgbLsbLgbRobRibRsRsmbLsbsbRobRcRsmbRobRi
bRiRsReLsRcLeRsLhLembLsbLsLsmbRsLsbLsbRsbLsLsmbRsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bLibLjLsLsLsmmmbRgRsmbRsRsRsmmbRsbRjRgRsmbLgbRiRsRsmmbRjRgbRjbsbsbsbRs
bRsbLsbReRsmbRjRsmbLebsbRsbRjRsRsmmbRiRsRsmmbRcLsbsbLhLsbLgLsbsbLsRsbs
bRsbLhbLgbLibLeLsbLibLjLgbsbRsbsbRsbsbLjLsmbLsLsLsmmbLsLsmbLjLsmbLibLi
bLibsbLcbLiLsbLgbLsbsbLsLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bRibLsbRjRsRsLsmmbRcbRcbRsbRibRibRgbRiRsRsmmbRsbRoLsRsbRibLsbRiRsLsRgm
bLsbLcLsmbRgbLoLsmbRibRgbLhbsbsbsbsbLsbsbsbsbsbsbsbRsbLsbRsbsbsbsbsbLc
bsbLcLsmbLgLsbLgbRebRcbRibRgLgLsbRcLsbRebRibRiLsbRgbRsbLsbRiLsLsLsmmbL
sLsmbRibRsbsbRgbRgbRibRibLsRsbRcLibLiLsbRgbRibRibRgbRgbRgbRgbRebLibLob
RsbRcbRgbRcLsbRgbRgbRsRebRebRibRgbRsRgRsmbRsbRsLsbRcRsmbRibRebRebRibRs
bLsbRsRsLsmbRibRgRsmbRcbRibRcbRibRibRebRhbRhbRcbRhbRibRcReRebRsRsRsmmb
RsRsmbRsbRsbRsRsRsLsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bRiRibReRsRsmmbsbReLgbLhRsbLgbLebLeLsbLebLgbLibLgbLgbLgbLcbLhbLoLsLiLe
LeLeLhmbsbLsbRibLebLcLsmbLebLhLhbLgbLgLsbLgbLgRsbRsbLebLgbRsbLsbLeLsbL
gLsbLibLsbLgbLsLsmbLsbLcLsLsmmbLebLebLcbLiRsbLebLebReRibRgRsmbRibRiRsm
bRgbRiRsmbRgbLsRsbRsbRsLsbRiLsbRgRsRsRsmmmbRgRsmbRsRsmbRgRsmbRgbRiRsmb
RibRgbsbRiRsRsmmbRgbRsbRsRsmbRsbRgRsmbRgRsRsmmbRiRsRsmmbRibRhbReRsmbRc
bRcbRhbReReRsmbReRsRimbRhbRiRsReRsmmbRgbRsRsmbRsRsmbRgbRgbLgbRsbRgRsmb
RsRsmbRsbLsbRhbRjRgbsbRibRgbRiRsmbRibRiRsLsmbRgRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bRsbRsbRsbRsbRsLsRsRsmbRsbRsbsbsbsbsbsbsbRiRsRsmmbRsRgbsbsbRsRsmbRsRsR
smmbLsbRsbLsbRibLsLsmbRiLsbRobRibRoLsRhRsRcRgRiRsRiLsRsmmbRjbLeLsLcbLe
bLiLsLoRiReRiRsRhRimbRibRibRgbRsbRibRgbRgLsbRsbRibLsbRcbRiRgbReReRcReR
smbRibLobLobRgLgbRgbRibReRebRoRsmbsbsbRsRsmbsbsbRgbRsbRsbRsbRsbRsbRsbR
sbRgbRsbRsbRsbRsRsRsLsmmbRsbRsbRsbRsbRsRsRsmmbRsbRsbLsLsmbRsRsmbRsbRsR
smbRiLsbRibRcbRibRcRibRhReReRcRcRcRsmbRcRcbRcLsbRcRsmbRsbRsRsmbRsRsmbR
sRsmbRsbRsRsmbRsRsmbRsbRgbRiRsmbRgbRibRgRsmbRcbRibRcRebRiRsRembLjbLgLs
LsLsLgmmbLibReRsmbRcbLcbLgbRobRgbRebRebRebRibRob

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bLibLiLsbLsbLsbLsbLsLsmbLgbLibLibRgLsbLeLgbRcLsbLjLsmbLibRsbLibLsLsmbL
sbLgbLsbLgLsbLibLibLiLsbRsLiLsbLcRgLcRsbLiLsbLgLsbLsbLgbLsbLgbLgbLgbLs
bLsbLsbRsbRsbRsbRsRsLsmbsbRsRsLsRsmbLibRjbRsLsbRsRsmbRibsbsbLsbRsbRgbs
bRsLsbLsbRgbRsbLcLsmbLgbLhLsbLiLibRibRibRgbRgbLjbLcbLjLgbLgbLcLsLsmmbL
ibRibRibsbRgbRsbRsbRsLsbRjbRsbRgbRcRiRsmbRibRibRsbRgbRgRsmbRgbLsbsbRgb
RsbLcLiLsbLsbLhRsbLsbLiLsbLsRsbLgbLhbLhLsbRsbLhLsLeLsbLibLiLsbLoRsRibL
ebLeLsbLiLsbLhbLeLsLeLsLcLsmbLibLgbLeLeLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
bLsbLgLgLsbLobLsbRsLsbRobRgbRsRsRhRsmmbRibRgbLsRsbRsbRsLsbLobLsbRebRgR
smbRsRgbRebRebRebRebLsbLobLsLebLebLibLsbRebRcbLsLgbLebLhbLgbLhbLgbRiRs
mbRgLsbLcbLgbLsbLgbLsbLsbLsLsLsLsLgLsmmmbLsbLsbRsLsRsLsLsLsLsLsmmmmbLg
bRsbLsLsmbLsbLsLsmbLsbLibLebLebLsLsmbLibRcbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bRsRsmbLsLsmbsbsbRsbLsbRsbRsbRgbRcRsmbRiRsmbRcbRcb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bLgLsbRsbLgbRcbRcbReRsmbRgbRgbRgRsmbRsbRgbRgbRgbRsbRsbRiRsmbRjbRsbRibR
iReRibRgbRibLsbRhRiRibRgbRhLeLsLeLsbLiLsbLgLsLsmbsbRsbRsbLgbRjbLibLgbL
gRgbLibLgbLcLsmbLibLcbLiLsRsbLiRsbLgbLibLgbLgbLobLeLebLibLgRsbLgbLcLeb
RebLiRsbLibRsbRsbRjbLiLhLsLhbLibLgLsbLsbLibLibRsbRsRoRsRembRebsbRgbRjR
gRsmbRibRsbRgbRibRgRsmbRcbRgbRcLsLebLeLsbsbsbsbLsbLgLsbRjbRoRgbRibLgbL
ebRsbRgRsmbRebRibLsbRoRsRembLsLsmbRsLsbRhRsmbRcbRcRsmbLgbLiLsbLibLgLsb
LibLibLiLsbLoReRebRsReReReLsbRebLjbLsbLibRjbRcbRsbRhbLsbLgbLcLsmbLiLgb
LibsbLebRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bRsbLsbLsbRhbRibRgbLgbRcbRsbRcbRhbRcbLebLeLgbLiLsbLoRsRiRsReRembRibRgb
RgRsRsmmbRsbRgbRsRsmbRgbRsbRgbRsRsmbLsbRgbRgbRgbRsbRgbRsbsbRgbRgbRsbRi
bRhbLgbRsbRsbLsRsLsbRsbRibLsbLsbRsbRsLsbRgbRgbRsbsbsbRsbRsbRgbRsbRsbRs
bRgbRiLsbRibLibRsbRsRsmbLibLcbRcRsmbRcLsbRhbLgRsLsbLgbLibLibLgbLsbLgbL
cbLgRsbLibLeLsbLgbLgRsbLobLiRsbLeRsbLeRsLsbLibLgbLcLeLeLebLhRsLgbLibLe
bLiLsbLsbLsbLgRsbLsbLsbLsbLsbLsbLibLgbLgbLeRsbLgbLsbLgLsbLgLsbLsbLgbLs
bLsbLsbLgbLsbLgbLgbLsbLsbLsbLgbLsbLsbLsbLsbLgbLsbLgbLsbLibLsbLiLsbLcLs
mbLgbLsbLcbRibLhbLibRjbLgbLgRsbLiLsbLgbLgbLsLsmbLgbLgbLsbLibLiRsbLcbLg
bLcLsLgLhLeLeLsmbLibsbLgLsbLgbLgbLibRsbLgbLgbLibLgbLsRsbLiLsbLgbsbLsbL
gbLgbLgbLgbLsbLsbRsLsRsbLgbLgbLsbLgbLgLsbLsbLgbLgbLgbRsbLgbLgbLsbLgbLs
bLgbLsbLsbLsbLsRsbLsbLsbLsbLgbLgbLsbLgbLsbLsbLgbsbLgbLgLsbLgbLsbLsbLgb
LgbLsbLsbLgbsbLcbLoRsbLibLhRsLsbLsbLiLgbLgbLibLsbLibLcbLibLeLebLsLebLe
bLibLoLeLeLsbLeLsbLeLsbLgbRsbRsLgbLgbLsbLsbLsbLgbLsbLsbLsbLsbLsbRsbRsb
LsbLsbLsbLsbLsRsbLsbLsbRsbLsbLsbLsbLsbLsbLsbLsbLsbLgbLsbLsbLsLsmbLgRsb
LsbLsbLsbLsLsmbLsbLsLsLsmmbLsbLsbsbLgbLgbLgbLgbLsLsmbLgbLgbLsbRebRgbRo
bRsbLcLsmbLgbLgbLibLgbLgbLsbLgbRsbLgbLgbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bRsbRebRobRsbLobRjbRebRcbLebLsbLebLebRsbRjbLobRobLebLcbRcbLebRjbLobLsb
LjbLcbRobRebLebRobLobLebLsbRsbLobLobLobRsbLebRsbLobRcbRebLsbRsbLjbRebR
obRebLcbLebRebRobRobRebLebLcbLobRsbRobLobRobLebRobRcbRcbLebLobRcbRobLs
bLsbLebRsbRobRebLjbLsbLebLcbLobRobRebLobRebLobRobLebRobLjbLobRcbRobLeb
RjbRobLcbRebRobLebRobLjbRebLgbRsbRcbLobRsbLebRobLcbLebRobLebRjbLobRobL
ebRjbLobRobLobLebLcbLobLcbLobLibRobLobLobLgbLjbLobRebLobLebRobRsbLobLo
bLebRobLobRjbRebRebLobLobRobRebRcbLobRobLcbRjbLebRobRobRobRjbLobRibRob
LobLjbLcbRobLebLobLobLebLobLcbRebRobLobRjbLobLjbRobLebRjbLobRobRobRebR
cbRobLobLobRobLobLcbRebRcbRobLjbRjbRobLebRebRobLcbLcbLobRjbRsbLebRcbRo
bRobRobRobLjbRsbLobLobRcbLobLobLebLobLjbLcbRebLcbRobRobRobLobRobRobRob
LebLobRobRsbRgbRebLobRobLebLgbLsbLobRobLebLgbLobLebRcbRobRobRsbRobRebL
obRcbRebLcbRebRobLebLobRebRgbLebRibLobLebLebRobLgbLgbLcbRsbRebRcbRobLi
bLobLobRobRibLcbLcbLcbLobLobRgbLobLebRobRcbLobRebRcbLjbRobRebRcbRebLob
LebLobRobRebLgbLebLobRobRcbRobRhbRsbLebRobLhbLgbLgbLcbLobRebRobLobLebL
cbRebRcbLibLobRsbLobLobLjbRobRcbRebRebLsbRcbRobLebRebLobRebLebRjbRebLc
bLcbLobLobRobRobLsbLebLcbRobRebRibLobLobRcbLobRcbLobLibRobRhbLebLcbRjb
LcbRobRobLcbLcbLebRobLcbLibLcbLebRobRebLebLibRobLcbLcbLobRcbRgbRobRibR
cbRibLhbRcbRibLcbLcbRsbLobRcbLcbRibRhbLebLhbLobLgbRibRhbRebLcbLebRcbRc
bRcbLibRibRobLibLobRcbRsbLobLcbLjbRobRobLebRebLebLhbRibLobLsbRcbRobLob
RcbRobRibRsbLjbRobRcbLcbLibRobLobLobLobLebLobRobRobRobRobLobRobRebRsbR
obLjbRobLjbRobLebLobLjbRcbRobRebRobRobLcbRsbLobLjbRsbRebLcbRobRcbRobRe
bLcbRobLcbRjbLcbLjbRcbLjbLcbRobRobRobRibLobLobRjbLjbRobLcbRobLobRcbLob
RcbRebLebRobLobRibLobLobRcbLobRobRobLgbRobLibRobRebLobRobLobRibLobRgbR
obRcbLebRobLobRcbLebRjbRebRebLjbLobRebLebRobRebLebLjbLcbRjbRebLobRcbRe
bRjbRobLobLobRjbRobRebLjbRobRebRjbLebRobRsbLebRebLcbRcbLcbRobRcbLjbLjb
LsbRsbRjbRcbRcbLjbLcbLjbRebLobLjbRobRobRebLebRobLebRcbRjbRcbRebLobRobL
obRobLobLebRcbLobRobLobLobRcbLobRcbRibLobLsbLcbLobLibLobLobLobRebRobRo
bRcbRobLibRebLcbRgbRebRobLcbRjbLcbLobRobLobRcbRobRobRcbRcbRhbLcbRobLob
LobLobLhbRobLobRobLcbRobRcbLebRsbRjbLobRcbLcbRgbRebRobLjbRobRebRebLsbL
obLcbRobLsbLjbLobLobRjbLjbLebRobLebLebLobLcbRobLobRebLobLjbRobLcbRcbRo
bLebLobRobLjbRobRobRcbLobLcbLgbLcbLobLibRebRjbRcbRebLobLhbLsbRcbRobLob
LibRcbLobRcbLsbLobLebRobLobLobLhbLsbLcbRcbLebRgbLcbRgbLobRjbLebLobLhbR
obRgbRebLebRjbLcbLobRobRjbRobRebRobRibRebRibRobRcbLobRobRcbRobLobLibRs
bRebLcbRsbLhbRcbLcbRcbRjbRebRcbLgbLcbLebRcbLebLobRobLgbLobRobRobLebLcb
LobLebRebLobLsbLcbLobLobRgbRobLobRcbLebRebLcbRgbRebRebRebRobRebLebLebL
obLibRebLebLobLobLobRobLobRobRobRcbLobLebRobLobLobLobRobLobRobLcbRjbRc
bRebLgbRsbRcbRcbLobLibLobRobRsbRebRobLebRobLcbRibLhbLibRebRjbRebRebLgb
LobLsbRjbRjbRebLcbLcbLebRibLebRjbRobRebLsbLcbRebRsbRebRcbLebLobLobLibR
jbRsbLcbRebRobLobLebLjbRebRobLcbLebLobRebRcbLobLobRobLobLhbRebLibLebRo
bRcbRcbRobRobRebLebRobLebRobLsbRcbRhbRebLsbRobLobRibLobLobRobLobLobReb
LobRobRobRcbRobLobRcbRobLjbLobLjbRobRcbRsbLibLcbLjbRobLobRgbLsbLebLobL
cbLobRjbRobLcbLobRsbRobRibRobLobLobLebLobLobLobLcbRebLhbLcbLobRebLgbLo
bRobRebLcbRobRgbRobLobLobLebLcbRcbRobRebRobLobLebRcbLjbLcbLobRobLobRob
LsbLsbRcbLsbRjbRhbRebRobRjbLobLobLebLobLcbLcbRcbLobLebLobRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bLebLiLsLeLebLhLsbRiReRsReReRsmmbRiRsmbLebLgbLgbLsbRsRsmbRcbLgLsLsmbLi
LsRsbLsbRobLcLsLsmmbRjbLcbLibRgbRcbRsLsbLcLsmbLibLsLsmbLoRsRsmbLiLcLsL
eLembRgbLgbLsbRobRsRsmbRobRcbReReReRhRsmbRgbRiRgLsbRsbsbsbLsLsmbRsbLcb
LgbsbLiRsbsbRsRsmbLibLsLsmbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 43; Drug: Control Apo 50 然
bRebRcbLsbRsbRiLsbLsbRsbLsbRgLsbRgbRsLsbRsbRsbRsbRsRsmbRgLsRsbRgRsLsmb
RgbRgbRgRsRsmmbRebRsbRibRiRsmbRiRsLsmbRibRgbRibLsbLsbLjbLiLsRsbLibLibL
iLsRsbLgLsbLgbLgLsRsbLibLsbRsbLiLsbsbLgbLgLsbLgLsLsmbLgbLgbRsbLiLsbLgb
LhbRgbLgRsbLgbsbLgbsbLsLibLibLgbLgbLgbLgbLgbRcbRhbRibRibRebRebRgbLgLsb
LibLiLsLsmbLgbRsbLiLsbLibLiLsbLgbLgbLibLibLgbLgbLsbLibLsLsRsmbLgbRsbLi
bRjbRcbRibRibLsbRsbLibLiLsbLgLsbLgLsbLibLiLsbLibLebLsbLsLgbLgbLiLsbRib
RsbLiLsbLgbLgbLibLgRsLebLiLsbRgbLsLsmbLgLsbLgbLgbLebLsLsmbLsbLgbLsbLhb
LebLibRsbRibRiRsmbRgbRsbRhbLsLsLsmmbRsRsLsmbRsRgbRgbLjbRsbReRsmbRgRsRs
mmbRgbRgRsRsmmbRgbLsbLsbRgbRsbRsRsmbRgbRsRsmbRsbRsbsbRgRsmbRsRsmbRsbRs
bRgbLsbsbRgbRgbRsbLjbLgbLiRsbLgLgbLeLgbLsbLgbLgbLcbRsbRibRibLsLgbsbRsb
LiLgbLgbLgbLibLsLsmbLgbLsbLgbLibRgLsLsLsLsmmmbLsLsmbRjbLiLsbLgbLgbLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 44; Drug: Control Apo 50 然
bsbLsLsmbsbRsLsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 45; Drug: Control Apo 50 然
bLjbLsbRsLsbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 46; Drug: Control Apo 50 然
bRsRsmbLsbRgRsRsmmbRgbRgbRgRsmbRgRsRsmmbRsbRsRsRsRsRsRsmmmmmbRsRsmbRiR
smbRsbRsRsRsmmbRsRsRsRsmmmbRsRsmbRgbRgRsmbRsRsRgRsmmbRsbRgbRsbRsbRgbRs
bRgRsmbRgbLibLsbLgbLgbLsLsmbLsLsmbRsbLgbLsLsmbLsbLsbLsbLjLibLjbLebLsbL
gLgbLgbLgLsbLgbLgLsbLibLgbRsbLiLsbLsbLibLsbLsbLgbLgbLsbLibLsbLgbRsbRgb
LsLsmbLsbLsbLsLsRsmbLsbLgLsLsmbLsbLsLsmbLsbLsbLgbLibLiLsbLsbLsbLsLsmbL
sbLgbLgRsbLsbLsbLgbLsbLgbLiLsbLsLsmbLgbLsLsmbRsbLsbLsbLgbLgbLsbLsLgbLg
bLgbLgbLgbLgbLgbLgLsbLsbRebRiRsmbRgRsRsmmbRibRgbRgbsbRsRsRsRsmmmbRgbRg
bRsbRgbRsbRgRsmbRsbRsbRgLsbRsbRsbRsbRgbRgRsmbRsRsmbLsbsbRgRsmbRsbRsbRs
RsmbLsRsbRgRsRsmmbRsRsmbRsbRgbRsbRsLsbRgbRsbRsbRsbRgRsRsmmbRsbRsRsRsmm
bRibRsbRgLsbRsRsmbRsRsmbRgbRsbRgbRsbRsLsbLsbRgbRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 47; Drug: Control Apo 50 然
bRcbsbRcRsmbsbLsRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122154; End: 122655;
Recording: 4-1; Individual: 48; Drug: Control Apo 50 然
bRgbRibRgLsbRibRgRiRsmbRiRsReRiRsRgRsRiReRimmmbRiRsmbRibRgbRgbRgbRgLsb
RcbLibLgbLibLcbLibRsLjLhLeLebRsbLgLsbLgLsbLiLiLcLsLeLhLeLsLimbLibLeLeL
sbLsbsbLsLsmbLgbLsbLsbLsbLgbLgbLsLsmbLiRsbRgRsmbLiLsbLhRsbRsbLgLsbLibL
ibLgLibLeLiLiLiLeLibLibLgbLgbLsbLgRsbRcRhRsmbRiRgRsRimbRgbRgLsbRgbRgbR
sbRgbRsbsbsbLhbLsLgbLsLsmbLsbLgRsbRjbRhbRgRsmbRibRhbRibRhbRgbRhbReRsRh
LiLeLsmbLgLiLibLsbLcbLibLhLoLeLsbRsRsRsmmbLsRsRsmbsbRsLsbsbsbLsbLibRsb
LobLibLibLgbLibLgbLgbLgbLibLgbLibLibLsLsLgmbLhLeLebLgbRcbRgLsbLcLsmbLs
bRjRsmbRsbLsbRsbRsRsmbLsbLsbRgbLsbRsLsLsmbRsRsmbsbsbsbRsbRsbRsLsRsbRsb
RsbLsbsbLsbsbRsLsRsRsRsmmbsbRcbsbRgbLibLcbLobLibLgLiLsLiLiLsbLiLsbLiLi
LibLgbLiLiLeLeLsLebLibLibLgRsbLgbRebRcbRiRsmbRgbRibRiRsmbRibRibRgbRcRs
RiRgRembRhbRgbRgRgbRgRsLsmbRgbRsbRgbRsRsmbsbRsbRcbRcbRgbReRsmbLsbRgRsm
bRgbRgbRgbRgbRgRgbRsRsmbRsbRgRsmbRsbRsbRsbsbLsbRsbLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bLgbLsLsmbLsbLgbLsbLsLsmbRsLsbLsLsmbLgbLsLsmbLgRsbLsbsbsbLsbLgbLgLsbRs
LsbLgbLgbRsbReRsmbRiLsbRibRsbLsbRsbRsLsLsRsmbLsLsRsmbLsbsbLsbRsRsmbRsb
sbsbRcbRsbLsbLsbRibsbRibRsbRibLsbLsbRibLsLsmbLsbRsRsmbRgbRibLsbRibRsbR
sbsbsbRsbRgbLsbRibRgLsbLibRhRsmbLjbRiRsRsmmbLsRsbRgbRgbLsRsbRsRsmbRgbR
gbRsbLsbRibRsbRsbRiRsmbRgbRgbRsbRibRcRsRcmbRobLoRsRsLsRsmbRsbLcLsmbRsb
sbsbLgbLsbLibRsbLgbRsbLgbLgLsbLgLsbLgbLgLsbLsbLibLibsbLiLsbLsLsmbLgbLi
LsbLiLsbLibsbLcbLgbLgLsbLgbLibLgbLgLsbLgLsbLibLsbLgLsbRgbLibLsbLgRsbLg
bLgbLcLsmbsbsbLibLsbsbLgbLsbsbRsbLgLsbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bsbsbLjLsmbLgRsbLsbLibsbsbLgbLsLgLsbRsRsRsmmbLsbsbRsLsLsmbLgRsbLobsbsb
sbsbLibsbLibRjbLcLsmbRsbLiRsbRobLobRcbRcbLibRhbLgRsRsmbsbLgbRibLjbsbRc
RsmbLjbRobRgLsbRcRsmbRibRsbsbRcLsbLsLsmbRibLsRsLsbRibRsRsmbsbsbRibRsbR
sbRsbRibLsbRibRsbRsbLcbRibRgbRibRhbRhbLgbLgbRcRsRhLsRsmbRibRsbsbRsbRiR
smbLsbsbRibLsbRhbRcRsmbRsRibLibRcbLjbRibsbRhbRibLsLsmbLgbLiLsbRcbRiLsb
LgbLoLsmbsbsbRsRsmbsbLibLoLsRsmbsbLgbLcLsmbLgLsLsmbRsbsbLgLsbLsbLoRsbL
sLhRgLjbRcbRiRsmbRibLjbRiRsLgmbLsbRcLsbLgbRibRcLsbsbRibRgbRsbLcbLiLsbR
sbLcbRibLobLiLsbLgbLoRsbRgbRibRgbRiLsbRhbLibRibLebLcbRibsbRoRsLsmbRiRs
RsmmbRebLcbLobsbRcLsLsmbRhbLibRcbLibRebRgbLsbRibLsLsmbRiLsbLgbRiRsmbLg
RsbRibLgbsbRibLjbLcbRsbRgbLhbRjbLcbRjbRjLsbRcbsbLjLsmbLcbRjbLhbLgLsbRg
bRcbLibRjbRibRiRsRsmmbLsbRgRsmbLgRsbRcLsLsmbLcbLcLsmbLsRsRsmbLcbRibRcL
sbLibLiLsbLsLsmbRcbRcb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bRibRsbRgbRsbRsRsmbLibRebRcbRsRsmbRcLsbRcbRhRhRiRsmbRibRcRgbReReRhRebR
jbRcbRgbRebLobLhbRgbLsLhLsbLibRcbLgbRibRsLsbLobLoLibLcbLgbRjbReLgbsbLe
bLsbsbsbLsbLsbLsbLsLgLsbLsbLsLsmbLsbLsLsmbLsbLsbsbLsLgbLsbLsLsmbLgLgbL
sLcLsLsmmbLhbLsbLebLiLsbsbLhbLhbLiLsbLsLsmbLsLsmbLgbLsbLsbLiLsLsmbRsbR
hRsmbRebRiRsmbLsbLebLsLsmbRsLsbLsLsmbRsbLsbLsbRsbsbLgLibLibLhLiLsbsbLi
LsbLgbLgbLiLsbLibLibsbLiLibLiLsbLgbRcbRcbLsbLibLsLsLsLsmmmbLgLsbLsbLgL
sbLiLsbLhLsbLhLsLsmbLibsbLgLsbLiLsbLibLibLhbLibLhbLgbLibLhbLiLhLgRsReR
gRsmbReRsmbRobRcbRobLsLsLcmbLgbRcbRebRhbRgRsmbLibLgLsRsbRsRgRsmbsbRsbL
sbRsbsbRsRsmbsbRsbLsbRsbsbRgLsbRsLsbLsRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bLsbRsLsbRsLsbLsbLsLsmbLsbLsbLsLsRsmbRsbLsbLsLsmbLgbLsbLsLsmbLgLsbLgbL
gbLgbLiLsbsbLibLgLsbRsbLibLibLgbReReLcbLibLiLsbRobLhLsLsLsmmbRsRsmbReR
smbRsbRibRsbRsRsRgmbRsbRgRgbRsRsRsRsmmmbRsRsRsRsRsmmmmbRgbRsRsmbRgbRsb
RgRsmbRsRsmbsbRsRgRsmbRgRsRsmmbRsbRsRsmbRsbRibRsRsmbLsRsbRibLsbLsbLsLg
bLsbRsbRebRgbRsRsmbRgbRsbRsbRgRsmbRgRsmbRsbRsRsmbRgRsmbRsbLsRsbsbRcbLg
bRjbLsbLgLsbLsLeRsReRsReRombRebRiRsRsmmbRebRsRsmbRjRibRhbRibRgLsLebLcb
LiRhRsRgRsmmbReLsbLobRhbsbsbsbRgbLhRsbLgbLibLibLgLsbRsbRsbRgRsmbRiRsRs
RsmmmbRsbRsbRsRsmbRsbRsbRsRsmbRgbRsbRsRsRsmmbRsbRsRsmbRgbRsRsRsmmbRsbR
sbRsbRsbRgbRsRsmbRsbRsbRsbRgbRsbRsRibLsRgbRsbRibRiRebLgLcbLhRsbLeLhLib
LcLeLsbLebLeLsLsmbLhbRsLsLsmbLebLsLsLsmmbLibLcbRcRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bsbsbsbRsbLibLgLsbsbLgLsbLibLgbLcLsLsmmbLsbLgLsLsmbLiLsbLgbLibLhbLibLi
LsbLiLsLsmbLibLgLsLsRsmbsbLgLsbLsbLibRgbLobRgRsmbRibRcRoRoRcRsLembLgbR
cRsmbRcb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bLibLiLsRsbRiRsmbLgbLiRsbRsRibRsbRcbRibRsbRcbRiRsmbLsbRgbRsbRgbRsRsmbR
ibsbRcbRibRcbRgLsbRhRsmbRsbLsbsbLsLsmbRoRsmbLsbsbRhbLsbRcbRsbRhbRgbsbR
cbRibRgbRibLobLobLgRsRgbRgbRgbRgbRgRsmbRsbRgbLsbLjbRibRhbLiRsbRhbRsbRs
RsmbRhbRsbRcbRibRgRiRsmbLsbLhbRibRibRgbRsbRibRsbRgbRsbLsRgRsmbLcbLcRsL
iLsLibLgbLebLcLibLiLsLsLimbLibLhbLhLsbLeLsLeLiLsLsmbLgbLgbLgLsbLsbRcbL
cbRhbLobLobLoRsbLcbLcRsRgbLgbLsbLibLgbLsbLibRgbRsRsmbLibLoRsRsLgmbLiRg
bLoRgbLebLgLsbLsbLgbLgbLobLhLsRsbLebLeLsbLsLebLibLiLsbLgLsLsmbLgLsLsmb
LgbLiRsbLsbLoLsLsLgmmbLcbLeLsbsbLsLsmbLgbLhbLcbLhbRebRhbLobLcbsbLhbLcL
hbLcbLebLibLeLsLeRsbRibRhbLeLebLebLibLcbLgbLcLeLsbLibRcbRib

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bsbLsRsRsmbRsbLsLsmbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bRcbLgbLgbLgbLgbRsLebLsbRcbRgRsmbRcLsbLgbLjbRoRsmbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bLhbRobRobsbRhbRcRgbRobRgbReRsmbRgRgRgRibRibRgRsmbRibLsbLhbLcLsmbLgbLs
RjbRibRgbLgRsRiLcbRiReLsbRebRibRgbRgRsmbRsbRibLcbLobLsLhLibLebLcbLeLsb
RjbLibLsbLgbLibRcRsmbLsbLgLcbLebLoLgLsbLsbLsbLsbsbsbLsbsbLsbsbsbsbsbLj
bLcbLhbLsLsmbLoLibLibLgLebLgLsbLeRsLsbLobRcReRhRsmbRgbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbRiRcbRobLobLobLgbLobLcbLjbLgbLgbLgbLgbLgbLgbLsLhLsbLiLibRsLib
LgbLibLgbLiLsbLgbLiLsbRobRiRsmbRiRsmbRiRsmbRgRsmbLoLsRsmbLgLsbLiRsLgbL
iLsLsmbLiLeLebLebLebRsLsbRsbsbsbsbsbsbsbsbLsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bReRebRebRibRiLsLsLsmmbRiLsbRgLsbRgbRsbRgRsmbRgbRsRsmbRsbRgbRibLgbRibR
gbRsbRsbRsRsmbsbRsbRsbRsbRiRsmbRgbRibRgbsbRibRcRsmbRibRibLgbLcLhRsLiLs
LhLsbLibLhbLibLiRiRebLiLeRebRjbRiRhbRcRiRsmbRebRebRoLsbRcbRebRcbRcbRjb
ReRsmbLcbLhLsbLobLcLgLeLsLeLsLsLeRsLhLeLsmbLeLsLsLembLgbLibRsbLsbsbsbs
bsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bsbsbRsRsRsmmbRgbLcbLhLsLibRsbLibLsbRsbLsbsbLsbRsbRsRsmbLcbLobLhbLoRsL
iRsRsmbRsbLcbLobLiRsbRsbRjLsRsLsLsmbLsbRsbRsbRsbRsbLsbsbsbRsbRsbRsbsbs
bLobsbsbRsbsbsbsbsbRsRsmbLsLsLsmmbReRsmbRhbRhbRsbLobRsbLsbsbLoLsmbLsbL
oLsmbLibLobRsbLobLebLhbLibRsLibLsbLgbLgbLsbLobLcLsmbRhbRgLsbRebLobLcLg
bLiRsbLsLsmbLibLiRsLebRgbLgLsLoRsbRibLsbRsbReRsmbRgbRsRsmbRsRsmbsbRgRs
RsmmbRcbRcLsbRcbRgRsRsmmbRgRsmbRgRibLsbRsRsmbLjbLcbLsbRjbRsbLibRobRhLs
bRiRsmbRgRsRcRgmbReb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bRsbRibRebLebRsbLobLebLebRobLobLobRobLobLebRobLebLebRobRebRobRobLsbLob
LobLcbRebRebRibLcbRgbRobRobLhbLobLobLgbRobRobLobLibLobLobRobLobLobLgbL
cbRebLobRobRebLgbRgbRobRjbRcbLobRsbLcbLcbRhbLcbRobLgbRgbLobRobLibRibRg
bLcbRgbRobLsbLjbRhbLcbRcbLebLcbRebRobRcbRebLebRsbLebRobLobRebRcbLobRcb
RebLobLobLhbRobLcbLcbLsbLcbRibRebRebLgbLebLebRobLobRcbRobRobLobLobRsbL
cbLobLebRobRobRobRobLebLcbLobLebLobLebLibRhbLobRcbRobLcbRibRibRibLebRi
bRjbRobLgbRobLibRebLcbRebRebRibRibLsbRsbRcbRcbLobLcbLcbRebRebLebRcbRcb
RobLibRebRobLobRobRobRebRebRcbRebLebRcbRobLobRobRobRobRibLobRebLcbRobR
ibLobLobLcbRobLibLgbLobLgbLobRobRobRobLobRgbRobRcbRobRibLebLobRhbRebLo
bLcbRebLcbRobLgbLcbLobLibLobLobRebLibRobLobLobLobLobLcbRhbLcbRobRcbLob
RobLebLsbLibLobLgbRebLebRcbLebLobLgbRcbRobRgbLcbRebLsbLebRebRobRobRobL
obRsbLhbLobLebRibLobLebRgbRobLibRebRsbRebRobLebRhbLcbLibLebLobRibLgbRo
bRobLebRebLobRjbLobRebRobRobRcbLgbRcbLobLobRebLibLebLobLgbRebRebRebLib
LebLgbLebLobLcbLcbLcbRcbRgbRebLebLebRobRebRebLobRgbLebRobLcbRebLgbRobL
obLebRcbRcbRobLobLcbRobRobRcbLobRgbRobLobLobLebRobRobLcbRobLibLcbRcbRo
bLgbRobLjbRcbLobLcbLobRobLibLobRgbLebLibLebRcbRhbLgbRobRobRobRcbRebLsb
LobLobRobLobLsbLcbLsbRebRobRobRcbRgbLcbLcbLobLebRobRebLcbLcbLobLobLobR
ibLobLebLobLobLobLgbLobLobRsbLobLebRsbRobLsbRcbLobLcbRsbLebRibLibRcbRi
bRobLebRibRibLobRobRobRobLcbLgbLobRobRobRcbRcbLobRebLibLobRcbRebLobReb
LebRebRsbLsbLobRobLebRebLebRobLebLebLebLibRobRebRebLobRebLgbLibRcbRsbR
obLcbRobRgbLcbLobLebLsbLsbRobLsbLebRobRobRibRcbRebRebRebLobLobLobRobRe
bRobLobRobRebLobLobRgbRobLsbRgbLebLobLibRobLobRobRcbLobLobLcbLobLebLsb
LebRebLibRebLgbLibRhbLobLobLcbLobLhbLhbRobRebRobRobLobRcbLibLobLobLobL
obRobLsbRebRcbRcbRobRebLobRobLhbRebLibRcbRobRibLgbLobLobLobRobLebRcbLo
bLobLgbRcbLhbRebLobRebRebRobRebRcbRebLgbLebRobLcbLibLobRibRgbLcbLobLeb
RcbRobRebRibLobRcbRebRcbRobLobLhbRebRjbRcbRcbRibLobLibLobRebRjbRgbLebR
ebRcbLcbLjbLcbLcbRebLobLobLobRibLibRobRcbRobRebRcbLobRobRebRobRcbLcbLc
bLcbLebRobRebRebLcbLobLcbLebLebRebLibRsbRcbLobRobRobLobRebLcbRobRobLob
RobLebRibLcbLobRobLcbLibLebLgbRebLcbLgbLobRobRsbRobRobRjbRebLebRobLebR
cbRcbLobRobRcbRcbLobLebLgbRgbRobLcbLibLobRobRebLebRebRobRgbRcbRobLebRe
bLcbLhbLobRebLobLibRibLobLobRebLobLobRebLebLebLjbLobRcbRobLobRibRjbLeb
RobRobRibRobRcbLcbLobRobLebLobRsbLobLobRobLobLibLsbRebLcbLcbRgbRcbRcbL
obRobRcbLobRobLcbLcbLgbRebRobRobRcbRobLobRebLobRebLobRgbRobRobLebRebLc
bLobRobRcbRobRgbRgbLobRobLebLobRobLgbRebLebRebRobLjbLsbLobRobLgbLsbLob
LgbRibRobRobRcbRebRcbLobLebLebRobLobLjbLobLobLobLcbLobLibRcbLobLibRobL
cbLgbRobLsbLebLobRhbLgbLobLobRobRebLcbRobLebLobLobLcbRcbLgbLebLcbLobLe
bLobLhbLobLebLcbRobLobLobLebLobRobLobRobLobRcbLebRcbRebLobLcbLobRcbLsb
RcbRcbLobLebLcbRcbLobLobRhbLebLebRsbRibRobRobRibRsbRebRobRobLcbLibLobL
obRobRsbLgbRebLebLobLcbLsbLcbRobLcbLsbLsbLcbLebLebRcbLobLobLebRobLobRo
bLobRobRebLebLobRebRsbLebRcbRgbLsbRebRcbLobLebRcbRjbLibLhbLhbRebRebReb
LobRcbLgbLobLibLobLobLobLobRobLebRebLibRebLibLebLebLgbRobLobLcbLebRobR
ebLebRebLcbRobRsbRgbLsbRobLebLcbRibRebLibRcbLcbRebLcbRobRebRcbLjbLobLo
bRjbLibLebRobRcbRobRobRebLcbLobRobLobLobLcbRsbLibLgbRsbRobRobRebRebRob
LibLcbRebRobRgbRcbRobRcbLobRjbRebLgbRobLobRsbRebRsbLobLebLgbLibLebLobL
ibLebRobLebRobRobRobLcbLebLobRcbLobLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbRsRsmbsbsbRsRsmbsbRsbRsbLjLgLsbLcRsbLgbRibsbRibRcbRibRgRsmbRsbR
sRsmbRgRsmbRsRsmbsbRsbRsRsmbRsbRgbRgbRibsbRiRsmbRgbRgbRcRgbRhRsmbRgRiR
sRiRsRiRiRsRimmmbRgbRgbRsbRsbRibRsRsmbRsbRgbRiLsRiRsmbRgbRsRgbLsRiRiRi
RgRsRsRsRsRsmmmmmbRgRgRsmbRgRsRsRsmmmbRsRsmbRgRsmbRgbRsbRgbLiLgbLobLsL
smbLgLsbLgbsbRsbRsRsmbRsLsbRsLsbLsbLjLsRsmbRsbLgbLsbRsRsmbRcbRhbRibRgb
RiLsRhRsRiRsmmbRgbRgbRgbRgRsmbRsbRsRsmbRgRsmbRsbRsbRgbRsbRsbRsbRsRsmbR
gbRsLsRsbRhbRibRiRsmbRjbRibRibRgbRgRgRsRiRgmbRibRgRsmbRgbRgbRgbRsbRiRs
mbRsbRibLobLcbLhRsbLiLsbLiLsbLoLibLgbLsbLoRsLgbLiLsLiLgLsbLgbLgbLiLsbL
gbLsbLgLsbRgbLeRsbsbRgbLsbLobLhLsbLsbRoLsbRibRsRiLsbRsRsmbRgbRiRsmbRgR
gRsmbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
bLgbLgbLgbLcbLhbLiLsbRgbRibLsLsmbRsbLsbLsbRgbRibLsRsRsmbRgbLobLjbRsbRg
RsRgmbRgRsRsmmbRgbLebReLsbLiLsLsmbLgbLgbLoRsRsmbRibRibRgRsmbRsRsmbRsRs
RsmmbRgbRgbRsbRsRsRsmmbLsbRsbLjbLibRsbLibLgbLiLsbLgbLibLebRibLsbRsbLiL
sbLibLgbLgbLsbLsLsmbLgbLgbLgbLgbRibsbLhLsbLgbRsRsRsmmbLgbLgLsLibLebLgL
iLgbLibLsbLsbRgbRgbRibRibRebRgbRcbLsbLsbLebLibLsbRsbRgbRsbLibLcbRsbLib
LgLsbLgbRsbLgbLgbLgbLgbLsbLgbsbRibRgbLhbRjbRcbLsbRsbRgbRgbRgbRsbRgbRgb
LsbRgbLsbRgbRgRsmbRsbRgbRgbLjbRcbRgbLsbLsbRgLsbRgbRibRsbRiLsbLiLgbLebL
sbLgbLsbLgbLgLsbLsbLgLsLibLgbLsbLgbRsbsbRsbRgbRgbRibRgbRgbRgbRsbRsbRgb
RsbRsbRsbRibRsbRsbRgbRsbRsbRsRsmbRgbRjbRgbRibRgbRsbRsbRsbRgbRgbRobLhbL
gLsbLsbRsbRsbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bRcbLsbLebRobRjbRjbRjbLjbRobLebRobRebLobRsbLebRobLebLobLebLobLebLobRjb
RibRcbLobRebLsbRjbRobLebRebLjbLobLjbRsbRcbRobLobRebRobRjbLjbRobRobLobR
cbRobLebRobLobLobLobRjbRobLjbLobLjbLcbLobLjbRobRobLobLobRebRebLcbRobRj
bLjbRebLobRsbRobRjbRobLcbRcbLobLebLebRcbLjbLobRcbRjbLjbLobRjbLobLjbRsb
RjbRobLobLsbRjbRjbLobRjbLjbRsbLobRebRobLobLebRebLobLcbLsbLobLebRobRjbR
ebLebLobRobLcbLcbLobRcbLebLsbLobRcbLcbRobLebLcbRobLebRsbRobLcbRebRcbLc
bRebRibRobLebRcbRebRebLibRobRcbRibRebLobLobRebLobLebRobRebRobRobRebLgb
RobLcbRobLebLobLobLgbLibLobLebLcbRebLibRobLobRgbRebRhbRobLibLobLobRebL
cbRibRobRibRebLobLebLobRobRebRsbLebRebLcbLebLebLcbLobLcbLobLebLobLcbLo
bLobRgbLebRobRibLebLebLobLobLobLgbLebRebRcbRebRobRsbLobLebLcbRebLgbRob
LobLebLebLobLhbLobRsbLobLobLebLobRjbRebRsbLgbRebRcbRobRebLobRobLobRobR
ebRibRobLebLebRobLebRhbRcbRjbLibLobRobLcbRobRobLobLcbLobRobRcbRjbLobRo
bRobLobRib

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 19; Drug: Control Apo 50 然
bLgbLiLsbsbLibLsbLobLibLgbLebLebLobRibRobRgbRibRibsbRiRhbRiRhReRsRembR
gRsmbLgbLebLibLgLsbLebLebRebRebRgLsbRgRsmbRcbRebRebRsbRibRgRsmbRsRgReR
smbRsbRsRsRsmmbLsRsRsRsmmbRsRsmbsbRsRsmbRsRsmbRsbRsRsLsmbRsRsmbRibRgbR
gRsRsmmbsbRsbRsbRsbRsbRsbRibsbRiRsmbRibRgbRibRiRsmbRsbRebRibRsRsmbRebL
sbLjbLcLsmbLiLsLsmbLibRsbReRsRsmmbRhbRebsbRoLsbRcRsRsmmbsbRsLsbRsbRsRs
LsmbRsRsmbsbLjbRhbsbRibReRsRhLsRsmbRjbRiRsmbRiRsRsmmbRebRibLibLibLebLe
LsbLsbLeLsLsmbLsbLcbLcbLibLibRsbsbLiLsbLebLsbRsRsmbRgRsmbRsbRsRsRsmmbR
iRsmbRsbRcbRhbRibRsbRgRsRsmmbRsRsmbLobsbLhLsbsbLiLsbLcRsbLebLgbLgbLsbL
ibLgbLsbLsLgLgLsbLcbLgbsbLjbLibLhbLhbLsLsmbRsbRibRiRsmbLsRsbRsRsmbRsRs
mbRebRhRibRibRgbRiRsmbRhRsmbRibRgRsLsmbRibsbRiRsmbLgbRcRsmbRcRsRsmmbRi
bRiRsRsmmbRibRsbLjbLcbsbLeLsbLcbLjLgbRibRebRhbRibRibReRiRsmbRgbRgbRibR
hRhbRebRebRsbRsbRsRgRsRembRsbRsbRsRsRgRgRsmmbRsbRgbRgbRsLsbLsbRibRibRs
bRsbRgbRsRsmbRibRibRgLsbRebRiRsmbLibLhbLeLsbLcbLeLeLiLgLibLcbLiLibLgLs
LsLsmmbLsbLhbLcRsbLobLibLcRsLsRsbLibLibLgRsbLcbLcbLebLebLebLcbRgbRcRsm
bLcRsRsmbLcbRcbRibRgbRjbRsbReRsmbRebLgbLibLiRobRibRoLsbRobRobRibRobReb
RiRsmbRhbLhbLebLebLebLcLibLobLhbLhbLeLsbLebLcbLcbLibLhbRobRiRebRiRsmbR
jRibRobLobLhbLibLhbLibRibRibRcbRibRiLsbRibRgbRibLibLiLsbLebLeLsbLibLib
LibLgLsbLhbLibLeLsbLibLibLgbLsbRiRsmbRjbRiRsmbLgbsbRjRsmbRsbsbRsRsmbRg
bRibRhRsmbRibRibRjbRibRgbRsbRiRsmbLeLsbLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 20; Drug: Control Apo 50 然
bLibRibRsbRiRsRsmmbsbLsbReLsbRgbRobRgLsbRcbLeLsLsmbLebLibLgbLebLsLgbLs
LsLsLsmmmbLebRcRsmbRgRsmbRgRsmbLebLhbLhbLgbLsbLsLsLsLsmmmbLsLsmbLibLsb
LsLgbLsbLgLsLsmbRsRebLebLsLsmbLebsbLebRsbRsLsbLsbLsLsmbLsbLsbLsLsLhmbL
sLsLsLsmmmbLsbLsbRsLsLsmbRebLebLibLsLsLgLsLsLhmmbLsRsbLgbLsLsLsmmbLibL
gbLgbLsbLsLibLibRibLiLsRsbLiLsbLebLgbLibLsLhbLgbLibLsbLsbRsLhbLgbLsLsL
sLsLsmmmmbLsbLsLsLsLemmbLhbRibRgRsmbRgRsRsmmbRiRsmbLsRsRsRembRgbRsRsRs
mmbRsRgbRsRgLsbRiRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 21; Drug: Control Apo 50 然
bRgbLhRsbLsRgbsbLsbLobLibRsbLibsbLoRsbRsbRgbLcbLgRsRsRsmmbLibRgLsbRobR
ebRibLibLjbRsbLgbLsbLibLeLsbRgbRobRebRibRgbRebLiRsbRcbRibReRsmbRhLsbRi
bLgRsbRgbRgRsmbRoRsmbRgbRoRsLsmbRebRiRgRsRsmmbRibLgRsbRsbsbRhbRebRebLi
bLhbLcbRhbRibRjbReRibRebRibRgbLgbLibLsbLsbLgbLhbRgbReRsmbRhRsmbRhRsmbR
jbRiRsmbLcLhbLibRebRibRibRobRgbLeLsbLcRsRsmbLgbLibLgLsRsLibLgRsbLibRcb
RoLsbRiRsRimbsbRhbRhbLsbRhbRebRsLsRsbsbLiLsbLgbLgbLsbsbsbLhbLibLsbLhbL
ibLgLsbLgLsbLgLsbLgbLgbLgLsbLcRsbLibRgLcbLhRsRsmbRgRsmbLcbRsbLgLsbLgLs
bLgRsbLibLgbLibRcbRjbRcRsmbRhRsmbRibRibRhbRjbLgbRjbRsbRebRsbRsbRsbRsbL
gRsbReRsmbRgbRibsbLebRobRibRhRsmbLcbLibLobRcRsmbRjRsLsmbLsLsmbLcLsmbLs
bLsLsmbLibLgbLcLsmbLebLiLsbLsbLgbLsbRebRhbRibRibRsbLgbLhbRsbLcbRobRiLg
bRibRhRsmbsbRgbLcLsmbLibRgbLsbRsbLibsbsbLsLsRsLsLsRsRsLsRsRsRsRsRsLsmm
mmmmmbLsbsbsbLsbLsLsLsLsLsLsLsmmmmmmbLsLsmbLsLsmbLsLsLsLsLsLsLsLsLgLsL
smmmmmmmmbLsbLsbLsbsbLsLsLsLsLsLsLsLgmmmmmmbLsLsLsRsmmbLsbLsLsmbLsRsbL
sLsLsLsLsLsmmmmmbLsLsLgLsLsLsLsLsmmmmmbLsLsLsLsLsLsLsLgmmmmmmbLsbLsbLg
LsLsLsLsLsLsLsLsLsLsLgLgLsmmmmmmmmmbRsLsbLgRsbLhbLobLibRcRsmbRgbRsRsmb
RoRsRsmmbLcLsmbLiRsbRgbRhbRhRsmbLsbRcbRiLsbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 22; Drug: Control Apo 50 然
bsbRiLsbLsbLgbRiRsmbRcbRsLsbRibLcLsmbLsbLcLebLiLgbLiLsLgbLgbRsbRebsbRs
bRsbRiRsmbRgbRsbRsbRibsbRsbRsbRibLgbLibLsbLgbRsbLgbLgLsbLgbLgLsbLsLsmb
LgbLgbLgbLiLhLibLsbLgbLibLiLsbLibLsLiLcLeLhLiLeLsLgLhLeLeLsLeLebLebLiL
sbLibsbLjLsmbLiLsLsmbRgbRcbRgbRhRcRibRebReReRebRebsbRgLsbRibRgbReRhbRi
bRsbRcReRsmbRebRiRsmbRiLsbRiRsRsmmbRhbReRsmbLcLsmbLebLibLebLebRsLsbsbR
gbLsbRgbRobRebRebReRsLjmbLsbLebRsbLsbsbRsbLgbLibLsRiLebLeLcbLeLsbLebLg
b

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 23; Drug: Control Apo 50 然
bRsRibLsLsmbLsbRsbRsbRsbRgbLebLgbLsLsmbLsbLsbLgbRsbLsLsmbRsbLsLsmbLibL
ibRsbRobRhbRgLsbRgbRibRhbRibRgbRgbLsbLibLsLgLsbLsbLibRibRcbRcbRsRsmbRi
bRgbRibLsRgbRibRsRibRibRsbRhbRiRsmbRgbLsbLibLcbLsRsbLibRgbRsbRgRgbRebR
sRgbRibRsbLgbLsbLsbLsbLibLsbRgbRebRgbLgbLebRsbLhLsbLibRibRgbRcbRebRsLs
bLjLebLebLebLgbLeLsbLibLsbLsbLsRsbRgbReRsmbRsbRsRsmbRsRsmbsbRsbRsRsRsm
mbRsbRgRsRsRgmmbRsRgRsmbRiRsmbRebRgbLiLiLsbRgbLgLsbLsLsmbLsLsLiLsmbLcb
RebRibReRsmbRsLsbRibRhbRibRibLibLgbLiLsbLsbLebRgbRibRiRsmbRgRsmbRgRsmb
sbRsRsmbRsRsmbRgbRsbRsbLsRsbLsbRiRebRgbRhRgRgRsRsmmbRsRsmbRgbRibRsRgbR
eRsmbLsLgRsbRcbRsRsRsmmbLebLhbLgbLiLgbLsbLgbRsRsmbRsbLeLebRebRgRsmbRiR
gbRibRibRgRebRsbsbLsRsbLsRsLsbRsbLsbLsbLebLsbLiLsLsLgmbLcLsmbRebRebReb
RebRebLsLsLembLsLsmbLeLsbLsLsmbLgbLeLsbRibRibLcbLebLeRsbRsLsRsbLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 24; Drug: Control Apo 50 然
bRiRsmbLsLsLgmbRsbRgRsRsmmbRsRsRsLsmmbRibRibLsbLiLsRsbLibLgbLgLsLsmbLs
LsLsLsmmmbLgLsLsLsLsLsLsRsmmmmmbLsLgbLgLgLsbLsLsmbLsLsmbLgLsbLiLsLiLhL
ibLgLsbLgLsbLgbLibRgRgRsmbLsbLgbLsLsmbLsbLgLsLsLsmmbLiLsLsLsmmbLsLsLgL
smbLgbLibRiRsRsRsRsLsLsLsmmmmmmbLgbLsLsLsLsLsmmmmbLgbLsRsLgLsLsLsmmbsb
LsLgLsLsmbLsLsLsLsLsLsLgLsLsmmmmmmbLsLsLsLsLsLsLsLsmmmmmmmbLgbLsLsmbRs
LsRsLgbLebRjRsmbRgbLibLsLsmbLsRsbLsLgLsLsLsLsmmmbLsLsmbRsLsLsLiLsLsLsL
sLsLgLsLsmmmmmmbLsLsRsmbLsLsLsLsLsLsLgmmmmmbLgbLgbRjRsmbsbLsLsRsLsmbLs
LibRsbsbLsbRsbLsbLsbLgLiLgLgLgLgbLgbLsLsmbsbLsLsmbLsLgbLsLsLiLgLsLsLsR
sLsLgmmmbLsLsmbLgLsLsRsmbLsbLgbLsLsmbLsLsLsmmbLibLgLsLsLsLgLsLsLgmmmbs
bLsLsmbLsLsLgLsLsLsLgLgmmmbLgLsLsLsmmbLsbLsLsLsLsmmmbLgLsbRsbLgbLsLsmb
LsbRsbLsLgbLiLgRsbLgLsbRsbLsLsLsLsLiLgLgLsLimmmbLsbLsbLiLsLebLib

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bLibRgbLsRsbRiLsbRgLsbLgbLjbLcbLsbLgbLsLsmbLgLsbLgLsbLsbLsbLsbLhbLgbRs
RsmbRgbLiLsbLibLsbLgbRsLsbLsbLibLgbRgbLgbLibLgbLgbRebRcbRcbRiRibRgRsRc
RsmmbRsbRibRibRgRsmbRgbRgbRiLsbLgLgbLjbRsbLgbLsbLibRgbRcbRgbRgLsbLgLgb
RibRibRsRsmbRgbRgRsRsRsRsmmmmbRgbRibLgbRsbsbRiRsmbLgbRsRsmbRsbReRsmbLj
RsLsbLgRibReRebRebLoLsmbLiLeRhRsRimbRjbLgbRebReRiRsmbRcbLcRsLibLgLcbLe
bRiLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bsbLsbRhbRsbLsbRiRsmbLjbLcLsmbRsbLhbRsRsLsmbRsbLibLibLsbRsbLcRsbRsLsbR
ibsbsbRibRgbLsbRhRsmbLcbLsbLcLsLsmmbLgbLhbLibRsbRgbRibLsbRsbRibRsRebRg
bsbRsbRsRsmbRcbLsbLsLgbLibRcbRibRsRsmbRsbRsRsRsmmbRibRsRsRsmmbRgbRsbRs
RsRsLsmmbRgRsmbRsbRgRsmbRsRsmbsbRibLjbLjbsbLsLeLsbRgRsmbRcbRibLgbRhRsm
bRibLsbRsbLsLsmbLgbRiRsRsmmbRgbRgRsRgmbRgRsmbRibLsLsmbRhbLgbRiLsbRsRsR
smmbRiRsmbRsLsbsbRiRsRsmmbRgbRgbLjbRibLsRsbRsRibLgbLeLsbLsRgLsbRebRiRs
mbLsbRsRsmbRgbRhbRgbRibRsRsRsmmbRgbRsbRgRsmbRgbRibLgRsbLsRsbRgRsmbRibR
gbReRsmbsbRgRsRsmmbLsRsRsmbRsbRsbsbRsRsmbsbRsRgRsmbRsbRgbRsbRgbLsRsRsm
bLsbLcLsmbLibRgbsbRebRibLsRsbRcbLgbLjbRcRsmbRgbLsRsbRsbRhRsRsmmbLjRsbR
hLhLsLsLsmmbLsLsLsLsmmmbLeLsRsbRobLeLcLeLsbLebLhLsbRsLsbLsbLgLsbsbsbLs
LsmbRsbLsLsLimbLgbLebLibRcbRiRsRsmmbRgLsbsbRsRgRsReRsmmbRjRsmbLgRsbLeL
sbLeLsbRgRsmbRsbLsbRsbRsRsmbRsbRsbRsRsmbRsRsmbRsLsbRsRsRsRsRsRsmmmmmbR
sb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bsbsbsbLcLsmbRiRsmbRgbRgbRiRsmbRibRiRoReRsRcRsRhRiRiReReReRsReReLsReRe
RsmmmmbLjRebRhbLibLsLibLeLhbLcbLibLhbLibLibLgbLiLsRsRsmbRibLebReRsmbLe
LcLeLeLeLhLeLeLsbLhLibLiLsbRoLsbLobLsbLiRib

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bLibLsLsmbRsbLgRsbLsLsmbLsbRsRsLsmbLgbLiRsbsbRibLebLebLhbRgbRsbRibRsRs
mbRcRjRsRiRombReRsRembRgRsmbRhbRibLjbLibLibLibRiRsmbRibsbRjRsmbLsLjbRc
bRgbRhbLiLsbLiLsbLgbLibLgLsLsmbLgbLgbLgLsbLsbRsbRcbLsbRgbRebReRsmbLiLs
bLibsbLgbLsbRiRsmbRiLsbRsRsmbLsbRjRgbRibReRsmbRibLiLsbLgbLgbRgbLibLgbR
ibLgRsbLibRjbsbLgLsbRsbsbsbRjbRhRsmbRsRsRsmmbRibLjbRgRsmbRgbRsLsbLsbRg
RsRsmmbRsRsmbRgbsbRsRsmbLsbsbRgbLjbLsbLsbLsRsbsbRsbLsbsbLsbRsbsbRsbRsb
sbLjbsbReRsmbLhbLjbsbsbLsbsbLsbsbsbsbsbsbsbLsRsbLsbLsRsLsbLsRsRsmbLsRs
LsLsmbRsLsRsbLsRsRsLsmbRsRsmbRsLsbRsbLsRsLsbLsRsRsmbLsbRsLsbRgbRsbRsbL
gbsbLsbsbsbRsbsbLsbLsbLsbLsRsLsRsRsmbLsbsbsbsbsbsbsbsbLsbsbLibLgLsbLsR
sLsbRsbLsbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bLsbLsbLsbLsRsbRsbLibsbLsbRsbRsRsmbRcbRcbRiRsmbRgbRgbRgbRibRibRgbRsRsm
bRsRgbRgbLsbsbLsbRgbRsbLobLibRgbLsbLsRsbLsbLibRsbLsbLsbRsbLibLsLsLsmmb
LgLsbLsbRsbRsbRebRgRsmbRgRsRsmmbRsRsmbRgbRsbLsbRsbRgbRgbLiLsbsbRsbRiRs
mbRibRgbLsLsmbLsbLgbRibRgRsmbsbLsRsbRgbRgRsmbRgbRibRiRsmbRibRsbRibRibR
sbRgbRsbRgRsmbRgRsmbRgbRgbRgRsmbRhbRgbLsbLhLsbLiLsbLhLsRsbLgbLsbRgbRsb
RgRsmbRiRsmbRibRgRsmbLsbRibRsbLsbLcbLsbLgLsbLsbLgLsbLsLsLsmmbLgLsbLgbL
gbLgbLsbsbLgbLsbLgLsbLgbLsbLgbRcLsLsmbRiRsmbRgbRiRsmbRgRsRsmmbLsRsbRib
RgbRgRsmbsbRgbRsRsmbRiRsRsRsmmmbRsbRibRsbRgbRsbRgbRgRsmbRsbRgbRsbRgbLs
RgbRgbRgbRsbRibRgbRgRsmbRibRgbLgbRsbsbLsbsbLcLsmbLibRsbRgRsmbRibRibRgR
smbLsbRgbLsbRgbLsRsbRgbRgbRsbLoLsmbLgbLsbRsbLibRsbLsbLgbLibLsRsbLgbLgb
LgbLsbLibLgbRgbRcbRiRsmbRgbRgbLsbRgbRsbRsbRibsbRsRsmbLsbRibsbRsbRgbRgb
RgRsmbRgbRgRsRsRsmmmbRsRsmbRgbLsbRiRsmbRgRsmbLsbRhbRsbLsbRgbRibRgRsmbR
gRsmbRgRsmbRsbRcRsRsmmbRibRcReRsmbRiRsmbRgRsmbRgbRgbRibRgRsmbRgbRgbRgb
RgRsmbRiRsmbRgRsmbRgbRgbRgRsRsRgmmbRgbRgbRgLsbRsRsmbRgbRgRsmbLsRsbRgRs
mbRibRsRsmbRgbRgbRgRsmbRgRsmbRgRsRsmmbRsRsmbRgbRgbRgbRgRsmbRsbRgRsmbRg
RsmbRsbRsbsbsbLsbRgbRgRsRsmmbLsbRsRsmbRibRgbRsbRiRsmbRgbRgRsmbRsRsmbRg
RsmbRsbRsbRsbsbRsRsRsmmbRgbRsbRgbLsbLebRsbRsbLibRsbLsRsbLgbRgbRebRibRg
bLsbLsbLsRsbRsbRgbRgbsbRsRsmbRgbRsbRgbRsbRibRibRsbLsbRgbRibRgbRgbRgbRg
bRgbRgbRgRsmbRgbRgbRgRsmbRsRsmbsbRsbRgbsbRgbRgRsmbRsbRsbLsLsRsmbLeLsbR
gbLhLsbLiRsLsbLsbRgRsmbLibLebLsbRgbRgbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bRiRsmbRibLibLgbLjbLiRsbRjbRibRjbsbLjbRgbLsLsmbLgbLebRsbLsbLsbsbsbLibL
gbRsRsRsmmbsbRjbRjbRhbLibsbRsRsLsRsmbsbRsbRsLsLsmbsbRsLsbLibLibRgbRgbL
sbLsbRsLsLsmbLsLsLsLsmmmbLibLsbLsbLgbLgRsbLhLsbLsbRsbsbRsbsbsbsbsbLsbL
gbLgbRsbRgbRsLcbRgbLhbRsbRsbLgLsbLhLsbLsbRgRsmbLoRsRsLsmbLiLsbLjbLgbLi
bLjbRsbLsbLsbLgbLjbRgbLibRhRsmbRibRsRgbRgbRibLsbRgRiLsRsbLsbLsbLsbLhRs
bLsbRcbRibRibRsbRsbRgbRgRsLsmbRibsbLibLcLsmbLiLsbRgbRsRebLgbRsRgbRibLs
bRibRibRsbLgbLgLsbRebLsLsmbRsbRsbLebLibRiRsmbRgbRgRsmbsbsbsbRsbsbRsbRs
bRobLcLhLsbLcRsLhbLeRgbLebLeLeLsbLibLcLgbLcLebLebLcRsbRgbLsbsbLsbRsbLs
bsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bLsLsmbLsLsmbLgLsRsbLsbLgRsbLgbLgbLebRcbRobRgbRcRsmbRiRsLeLeLhmbLeLeLe
bLeLsLsmbLeLsbLsbLsLsLsLsmmmbLsbLsbRsLsbLsbLsbLsLsmbRsbLsbLsbLsbLsbLsb
LsbLsbLsbLsbsbLsbLsbLsbLsbLsbLsLsmbLgLsbsbRcbRibRhRebRcbRebRsRcbLeLeLs
bLobReRsmbLcbLcbLiLsbLgbLgbLgbLgbLgLsbLgbLsLsmbLsbLsbRsbLsbLsbLsbLsbLs
LsmbLsbLsbLsbLsLsLsmmbLsLsmbLsbRsLsLsmbLsbLsbLgbLsbLgbLgLsbLgbLgbLsbLs
bLsbLsbLsbLsbLsbLsbRgRsmbRsbRibReRsmbRcbRhbRibRhbRcbRebRibRibRgbRgbRgb
RsRsmbRsbRsbRsRsmbRsbRsbLsLsRsmbRsLsbsbLsbsbLsbRsRsmbLsbRsbsbRsbLsRsbL
sbsbsbRsbLsRsbRsbLsbRsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bRgRsRsmmbLcLsmbsbsbLibLgLsbsbsbRjLsbLiLsbLcRsRsmbLcbLiLsbLibRiRsmbLhb
LhLsbLhbLibLsbLibLibRsbRgbLhLsbLiLsbRsbRsbRsbLsbLiLsbLibRgbLsbLibRgbLg
bsbLsbLgbRsLsbRsbLhbsbRsLsRsbLhLsbLhbLhbLsbLibLcLsmbRsbLibRsbRjRsmbLgb
LibLgbRjRibRibRgRsRsRsmmmbsbRgRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bLsbRibRibLcbRobRcRibRsbRcbsbRsbLgbRsRcbRhbRcbRcbLsbRcbRibRibRgbRsbRib
RhbRhbRibRiRiRebRgRsmbLsbsbRgbRgbRsbRgbRsRiRsmbRiRsmbRhbRcRsmbRibRibLs
bRgRsmbRibRgRsmbRsbRibRibRibLsbRibRibRsLsRiRebRebRsRsmbRhbLhbRiRsmbRiR
smbRhbRibRgbLibLgbLgLsbRsLsbRjbRoLsbRibRsbRsRibLsbLcbLcLsmbLcbRsbRgRsm
bLcbLsbsbRibRibsbRgbRhbRibRgbRhbRcbRibRsRsRsRsmmmbRsRsmbRsRsmbRsRsmbRs
bRsRsmbLsRsRsmbRsLsbRsbsbsbsbsbsbLsbRsRsmbsbRsbRsbRsLsbLsRsbLsLsmbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bLgRgbRibRgbRgbRiRsmbReRsmbRiRgbRcbRebRebReRsmbRibRsRsmbRjRibRibRibRiR
smbRibRgbRsRsmbRsbRsRsmbRsRsmbRsRsmbRibRsbReRsmbRibRgbRsbRibRgbRgbRgbR
gbRgRsmbRgbRgbRgRsRsRsRsRsmmmmmbRsRsmbRsbRsRsRsmmbRsRsLsmbLsbRsbRsRgbR
sbLsLcLebLibLcbLibLeLiLsLsmbLibLebLgLsbLsLsLsLsmmmbsbLeLsbLcbLebLebLgb
RsLebLebLgbLiRsbLgbLobRgbRgbRibRibRibRgbRhbRgbLsbRgbLibLgLsbLgbLgbRsLs
LsmbLgbLibLibLgbLgbLsbsbLsbLsLsmbRsbLsbRsLsRsbLsLsLsmmbLsbLsbRsbLsbLgb
RhbRhRsmbRhbRiRsmbRibRhLsbReRebRebReRgbRebRebRibReRgRsmbRhb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bLebLsbRsLsbLsLsmbLgbLsbLsLsmbLsLsLsLsmmmbLsLsmbLgbLsLsmbLsbLsLsLgLsmb
LgLsbLsLsLsmmbLsLsLsmmbLsLsmbLsbLsbLsLsLsmmbLsbLsLsmbLsbLsbLsLsLsmmbLs
LsmbLsbLsLsmbRsbLsLibRsbLsbRgbLsLsmbLsbLgLsbLgbLsbLsLsmbLgbLsbLsLsLsmm
bLsbLsLsLsmmbLsLsLsmmbRsRsmbLsbLsLsmbLsLsmbLsLsLsmmbRsRsmbLgbLsLsmbLiL
sLsmbRsbRcbRobLcLsmbLiLsbLobLsbRcbRgLsbRgLsbRgbRcbRsbRibRoRgbReRsRgmbR
iRsmbLjbReLibLgbLibLgbLsbLgbsbLgbLgbRcbRiRsmbRibRibLgbLgbLgbLgbLcbRsRs
mbsbRsbRsRsmbRgbRsbRsRsmbRsRsmbRsRsmbRsbLcRsbLebLsLeLsbLcbLcLsmbLibLhb
LhbLoLhLiLiLsLiRibRebRoLsRsbLgLoLsmbRsbRebRobRebRibReRibRebRgbRsRsmbRs
RsmbsbRsRsRsmmbRsRsmbRsbRsRsmbRsbRsRsmbLebLgLsbRsbRsbRsbRsRsmbRsbRsRsm
bRcRsmbRhbRhbRjbRcRibLjbRibRebRoLsbLgbRiRsmbRcbRibLcbRcRgbRiRibRiLsLhL
sbRibLcbLsRsbRcbsbRcLsRsbsbsbsbsbLsbLsLsmbLsbLsLsLsmmbLsLsLsLsmmmbLsLs
LsLsRsLsmmmbLsLsmbsbLsLsmbLgbLsLsLsmmbLsLsLsmmbLsLsLsmmbLsLsmbLsLsmbsb
LsLsLsmmbLsLsLsmmbLsLsLsmmbLsLsmbLsLsmbsbLsbLgbLgbLsbLgbRsbLsLsmbLsbsb
LgbLgbLsRsbLsbLgbLsbLsLsmbLsLsLsLsLsmmmmbLsLsLsmmbLsLsLsLsmmmbLsLsLsmm
bLsLsLsLsLsmmmmbLsRsRsmbLsLsLsLsmmmbLsLsmbLsLsRsmbLjbRjbRgbLjbLobsbLsb
LsbLsLsmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bLsbLsbLsbRsbsbLsbLsbRsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
bLsbLsLsLsmmbLsbLsbRiRgbsbRgbReRibRsbLgbLsLgRsbLgbLgbLsbRsbLgbLsbLgbLs
bLgbLsbLsbLsbLsbLsLsLgmbLsLsmbLsLsmbLsLsmbLsLsmbLgbLsbLgbLsbLgbLsLsmbL
gbLsLsmbLsbLsLsmbLgbLgbLgbLsbRsbRsbLsbRsLsLsmbLsLsmbLgbLsLsLgmbLsLsmbL
sbLgbLsbLsbLsbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bRsbLsbRcbRsbRibRcRibRiRsmbLsRgbRgbRoLibLiLiLsLebLsRsRsmbsbRjbRsbRsRsm
bsbRgbRcbLobLibRsbRsbRsLhbLebLebLeLsbLibLiLsLebLoLsmbLoLsmbLiLsbLobLiL
iLiLeLeLsLeRsLebLhbReRsReRsReReReRsmmmbRcRibRoReRibLsRsbLibLibLibLhbLo
RcRebRebRebLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bLsbRsbRsbLsbLsLsLsLsmmmbRobRhbRhbRibRgRiRsmbReRsmbRhbRgbRsRsmbRsbRsbs
bRsbRiRsRsRgmmbRibRibRgLsRgRebRsbRsbsbRgbRsbRgRsmbRiRsmbRgRsmbRgRsmbLs
bRsLsbLjbReRsmbRiRsmbLsbRcbLsbRgRsmbRgRsmbRsRsLsmbRsbLsRsbLsRsbLjbsbRg
RgbsbsbRsbRsbLsbLsLsLsLsmmmbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bLgbLcLhLsbLiLebLebLhRsbReLsbRebRiRsmbRjbLgLsbRobLgbLgLsLsmbLsbLgbLgbL
gLsbLgLsbLsLsmbLsbLsbLsbLgbLgbLgbLsLsmbLsbLsbLsbLgLsbLsbLsbLsbLsbLgbRg
bLsbLgbLsLsmbLsLsLsmmbLsbLsbLgbLsbLsbRsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLsb
LsbLsbLiLsRsLsbLobRgbRebRgbLcLsmbLcbLhbLgbLiLsbLibLhLgLsbLibLibLoRsbLo
bLcLsLeLeLsLembLhLsbLibLibLgbLgbLcbLobRsbLcLebLibLibLgLsbLjbRcbLeLsbLi
bLibLgbsbLsbLgbLgbLgbLsbLgbLgLsbLgbLsbRsLsRsbLsbLgRsbLsbLsbLsLsLsmmbLg
bRsbLsbLgbLgbLsLsmbLsbLsbLsbsbLsbLgbLsbLsbLsbLsbLsbRsbLsbLgbLsbLsbLsbR
sLsbLsbLibLsbLiLsbLsRsbRcRsmbRoRsmbLgbLcbLcbLgRsbLgLsbLgbLgbRsRcLsbLjb
RebRhbRgbRibRhbLgbLgbLgbLsbRgbRcbRgRsmbsbRgbLgbRgbLsbRsbRsRsmbRsbRgbRg
bRgbRsbLsbRsbsbsbLjbLcbsbReRsmbRgbRiRsmbRgbRibRhbRgLsbRebRiRsmbRhRsmbR
gbRcRsmbRsbLsbRobLgbLjbRoLsbsbRgbRsbRcbRiRsRsmmbRiRsmbRiRgbRgRsmbRgbRg
bRgbRsbRgbRgbRsRsmbRgRsmbRgRsmbRsbRsbRgbRgbRsbRsbRgbRsRsmbRsbRgRsmbRgb
LgbLsbLsbLsbLsbRhbsbRsbLsLsmbLsLsmbLgbRhbRiRsmbLsbLjLgLsbLgbLgbLsbLsbs
bLsLsmbLsbLsLsmbLsbLsLsmbLsbLsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bRsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsLsLsmmbLsLsmbsbLsRsbLhb
sbLhbLsLcbRsRsmbLjbRibRjRcLsbLsbRcRsmbLgbLhLsbRsLsbRsLsbLcLsmbLsbLibLg
bLgbLibLoRsbLsbLcbLiLsLeLgLibLgRsbLiLhRsbLibLgbLgbRcbRgRsmbRgbRgLobRcR
sRgRsReRsReRsReRsRemmmmmbRibRebRgRsmbRgbRibRibRibRgbRgbRsbRiLsRiRhRsRc
mbRiRsReRsmmbRiRsmbRibRiRsLsmbRibRgbRgbRsRsmbRsbLgRsbRsLgLeLgbsbLgLiLs
bsbLgLobLcLsmbLcbLeRsbLsLsmbLsLsmbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 43; Drug: Control Apo 50 然
bLsbLgbLgbLgbLibLsbLibLsbLjLsmbLebLgbLgLsbLiLgbLgbLgLsbLgLgbsbRgbLebLs
bLiLsLsLimbLgbLibLgbLsbLibLhbLgLsbRsbRsbLhbsbRgbLgLsLsmbLgbLgbLgbLgbLg
LsbLsLsmbLebLgbLibLsbLgbLebLgLsbRibRsbLiRsbLiLsbLgLsLsLsLsLsLsmmmmmbLg
LsLsmbLsbLsbLsbLibLiLgRsbLibLgbLibLsbLgbLgbLibLgbLgbLiLsbLibLibLgbLsLs
mbLibLgbLibLsbLsbLhbLsbLsbLgbLgLsbLibLgbLibLibLibRsbLiLeLhLgRsbLgbLgLg
bLibLibLgbLgbLsLsmbLgbLibLsbLgbLgbLgbLsbLsLsmbLibLibLsLsRsmbLsbLgbLsbL
sbLebLgbLsbLgbLsbLgbLsbLsLgRsbLgLsbLsLsmbLgLsbRgbRibLibLgbLgbLibLgLsbL
gbLibLsbLgbLibLsLibRsbLibLiLsbLsbLgbRsLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 44; Drug: Control Apo 50 然
bLsbLcLsmbsbLcbLibLcLgbLebLoLgbLoLsmbRgbRcbRiLsbRibRebRsbRgRsmbRobLgbR
oRsmbRcRsRiRsmmbRgRsLsmbRsbRiLsLsRsmbRhRsmbRiRsmbRgbRgbRgbRgbLsbRoRgbR
cReRsRiReRimbRsbsbRgLsbRsbRsbLsbLoLhbLiLsLgLeLsLeLsLeLebLhbLoLsRsLsRsR
smmbLgbLgRsbLibLibLgLsbLobLsLeLsLeLebLiLsLebRsLebLhLsLsmbRobReRsmbRibR
sRsmbsbRsbRsbsbRsbRgLsbRcbRcLgbRobRiRhRcRsmbRib

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 45; Drug: Control Apo 50 然
bRgRsRsmmbRjbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 46; Drug: Control Apo 50 然
bRgbRsbRsbRsRsmbLsRsbRgRsmbRsRsRsmmbRsbRgRsmbRsRsmbRsRsRsmmbRgbRgbRsbR
sbRgbRsbRsbRgbRgbRgbRgbRsRsRsmmbLsLsRsmbRsRsmbRsbLsbRsLsbRsRgbRsRgbRsb
RsbRsbRsbRsLsbRsbLsRsbRsRsRsmmbRsbRsbRsbRsbRsLsbLsbRsbRsLsbLsbRgbRsbLs
bRsLsbRgbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 47; Drug: Control Apo 50 然
bsbsbLcbRcbLhbLsRsbsbRgRsmbRcbRcbRcLsRsbLsRcRhbsbLsbRibRcbRhRsmbRsbRib
RgbRibRhLsbRgRhRsRcmbRgbRibRiRsLsmbRgRoLsRgRsmbReReRsmbRibLoLeLebLebLi
bRcbRcbRobLibLhLsbLjbRibLibRibRjbRcbRibsbRgbRcbLibLhbLhbLhbRhbLibLhLsb
RsLibLibLiLeLsLeLiLsLiLsLsmbRsLgbsbLgRsbLgRsbLoRsLiLcLgLiRsbLiLsbLgbLi
RsbLoRibLoLhLcLeRsbRgbRhRsRiRsmmbRibReRsRsRsmmmbRsbsbsbsbsbsbsbsbsbRsb
sbsbRibLoLsmbLcbLcbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 122657; End: 123158;
Recording: 5-1; Individual: 48; Drug: Control Apo 50 然
bLgbLcbLhRsLsbLibLiLsbLgbLgLiLiLeLsLsLhLsmbLhLsLiLsLibLgLiLiLsbLeLebLi
bLiLsbLibRcRiRsRgRiRsRgmmbLsbRebRgRsmbLsbRsbRsbRsRsmbRsRsmbRsRsmbsbRsL
sRsbRsRsmbRsbLjbLcbLibRsbLsbRsbRgbLibLgbLgbRgbLgbRsbRsbRsLgbRsRsmbRsLs
bRsbRgbLgbRsLsbLcbLsbLibLsLsmbRiRsmbLsRsbRiRsmbRsRcRsmbRibRcbRiRsmbRgb
RgRsRsRcRgLsmmbRiRcRgbLsLeLebLiRsRebRcRgbLcLcLeLeLebLebRebRibRsbRsRsmb
RsRsmbRsbRsRsRsRsRsRsRgRsmmmmmmbRsbRsLibLjbLibLgLsRsbRsbLsbLcLsmbLiLsR
sbLibLcbLibLibLgbLiLsbLsLgbLcbLibLiRsbLgbLibLsLibLgbLgLsbLgLsbLsLiRsbL
sLsmbRgbLgbLsbsbsbRsbLsLsmbLsLsRsmbsbLsbLsbLsbLibRsbRsbRsbRhRgRsmbRebR
gbLsbLgbLibLhbLibLibLibLiLibLiLsLiLiRsLsbLeLeLsLibLgbRiRsmbRcRsLsRgRsR
iRimmbRibRoRebRoRiRsmbRibRebRsbRsbRsbRsbRsRsmbRsRsRsRsRsLgmmmmbLsRsbRs
bRsbRgbRgbLsbRgbLsbRsbRsbRsbRsbRsbRsRsmbsbRsRsLgmbsbLcbLibLsbLcLsmbLib
LibLhbLibLiLsbLgLsbLhLsLgbLcbLiLiLhLeLebLiRsbReRebRibRiRgRoRsmbRhbRebL
jbRsLsbLibsbRebLibRibRibRobRgLsbRhRsmbRibsbRgbRibRibRiRsmbRgbLsbLibLsb
LsbLsbLgbLjLsmbLgbLgbLjLjbLibRsbRsRgRsmbRsbRsbRsbRibRsLsLsRsmbRsRsmbRs
bRsbRsbRsbRsRsmbRsLgbRsRsmbRgbRsbRsRsRsLsmmbLsLsLsmmbRsRsmbRsRsLsmbRsb
RsRsmbRsRgRsmbRgbRsbRsRsRsmmbRsbRsRsRgmbsbRsRsRsRsmmmbRsbRsRsmbRsRsmbR
sRsRsRsRsLsmmmmbRsbRsRsRsmmbRsbRsRsRsmmbRsbRsbRsbRsbLsLsLsmmbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bLgbLgbLgbLgbLgLsbLsbLsbLiLsLsmbLsbRsbLgLsbLibLgbLgbLsbsbLgLsbLsbLgLsb
LsbsbsbLgLsbLsbRsbLsbLcbLgbLgLsbLeLsbLgbLsbsbLsbLsLsmbLgbLgRsbLsLsmbLg
RsbLsLiLsRsbLibLgbsbLsbLhbRsRsmbLgbLgbLsbLibLgbRsRsmbRobRgbRgbRiLsbRsb
RsbRibRgRsmbRibLibsbLobLiLsbLsLsmbLsLeRsRsmbsbLsbLeLsbLgbsbRsbRcbRiRsm
bRibRgRsmbRgRsmbRsbRiLsbLgbRibRsRsmbRgbRsbRgbRgbRgbRsbRgRsmbRgbRgbRsbR
gbRgbLhbRgbsbLgbLibRjbsbRobRcbRsbLebRsbLsbLibLiLsbLsbLiLsbLsLsmbLibLsb
LgLsbLgbLgbLgbLgbLgbLsbLibLsbLibRsbLsbLgbRsbLibLgbLgbLgbLgLsLsmbLgbLgL
sbLgLsLsmbLsLsmbsbRsbLgbLsLsmbLgbLgbRsbRsRsmbRsbLibRsbLiLsbsbLgbLgbLgL
sbLgbLgLsLsLsmmbsbRsbLgbLsbLgLsbLsLsmbLsbLiLsbLgbLgbLsbRsRsmbLsRsbsbLg
LsbLgbLsbsbsbLgLsbLibsbLsbLgLsLsmbLgbRsRsLsmbLiLsLgbLsbLgbLsLsLsmmbLsb
LgLsbLsbLgLsbLgLsbLsLsmbRgbLebsbLsbsbLgLsbLgbLgbLsbLsLsmbLhbLgbLiLiLib
RgLsLcbLobRcbReLeLsLsLsLsLsLsLsmmmmmmbsbLsRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bLjbRcbLgbRhbRibLjLsmbLsbRiRsmbsbsbRibRibRsRsmbRsbLsLsmbRgbRsRsmbLgbLc
bLiLsbRsbRjRsmbLjbRjbLjbRcRsmbRcRsmbRobsbRibRiRsmbRgLsbRiLsbsbRibRcbRg
bLsRsLsbRibRgbRsRsmbRgbRsbRgRgbRgRsmbRoLsRibRibRhbLjbRcRsmbLsbRibLsbsb
RsbLjbLsbRhLsbLsRsLsbRsRsRsmmbRgRsmbRsbsbRiRsmbLsbLobLibRgbLibLgLsbsbR
jbRjbRcbRibLgLsbLcbLhbLsbRiRsmbRibRgLgbRiRsmbRiRsRgmbRoRiRsmbRsbRibRib
RoLgRiRcbRibRgbRgRsRgRsmmbRgbLobLoLsmbLcRsLsbLcbLibLcbRsbsbRcbRsbRcbsb
RcbsbRcRsmbRiRsmbRgbRgbLsRsbsbRibRibRgbRgRsmbRgRsRsmmbRiRgbRgRsmbRobRc
RsmbRgbLsbLgbLiLgLsbLjbRoLibLiRsbLoLsLcmbLcRsLsbLiLeLiLsLsLimbLgbLcbLe
LeLeLeRcLsRebRibRiRebLsReb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bLsRsbRsLsbRsRsRsRsLsmmmbRgRsmbRebRsRsmbLcbLebLhbLobLeLibLiLibLcbLcLsm
bLcLhLcbLhbLcRsbLcbRobsbRebLoLsmbLsLgLsLsmbLsbLsbsbsbsbsbsbsbsbsbsbsbs
bsbLsbLiLsLsmbRjbLibLhbLjbLcbLobLcLsmbLobRhbRhbRsbLobRiRobLcLibLgbRsLs
LsRsmbLibRsRsRimbLsbRsbRsbRsRsmbLcbLobLhbLcLobLobLcbRgbLjbLsbRsbLoRgRs
mbRsbRoLsbRsbsbRsLsRibRsRgbRsbRgbRsbRsRsRsmmbRibRsbLebRgbLcbLcbLsbLoRo
LsbRoLsbRiLsbLjbLgLsbLiLsbLhRsbLcbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bRebLgLsbLebLgLgLoLhLgLsbRjbLebRibRgbRsLobRgRsmbLgbRebRsRgbRibLiRcbRcb
LibRcRebRebRgRsmbRsbRgRsmbLoLgbRibLgLsbLgLsLsmbRsbLsLsmbRsbLsLsmbLsbsb
LgbLsbRsLsLsmbLsLsmbLsLsmbLgbLsbLsbLsbLsbLsbLgLsbLgbLgbLsLsmbLsbLsbLsL
smbsbLgbLsLsmbLgbLsLsmbRsRsLsmbLsLsmbLsbLgbLgbsbRsRsmbRhbLsbLsRsbLcRsb
LgLsbRsbLiLsLsmbLibLibLeLsbLsRsRsmbRebRiRsmbRibRgbRoRjbLoRsbRiRsmbLsLs
mbLebLsbLiLsLgLgRibRsRsmbRsbRib

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bLgbRsLsbLsbsbLsbRcRibLcbRsLsLiLoLiLsLsmbLgbLgbLgLsbLgLsbRsbLibRcbLiLs
bRcbRgbLibLsbLgRsLgbRiLsRibRgbRsbRgRgbRgbRgRsmbRsbLsLsLsmmbsbRsbRsLsbL
gbRibsbLgbLsbLsbLgLsbLsbLgbLibLsRsbLibLgLsLsmbsbLobRobReRsRsRiRsLsmmmb
RiRsmbRhbRiRebRsRoLsReReReRsRcmbRiRsmbRcbRobReRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bLebRsRsmbLgbRibRiRcbRibLibRebRobLgbRiRgbRobLcLsmbRsLhLsbLcbLsbRsbReLs
bRiRsmbsbRibReRsRsRhRimmbRcbRgbRiRsRhRsRcRcRemmbLobRobRobLhLobRgbLsbLc
bLebLsbLsbRcbRjbLcLsmbLcbRoLsbRcbLgRsLsbLjbRebRib

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bLgbLcbLeLsLeLhbLebLebLiLebLcLgRsbLibsbRebRsRsRsmmbsbLsRsRibRsbLsRsbRg
bRebRhbRiRgbRgRsRsmmbRhReRsRgmbRebRebsbLsbsbRibRcbRhbRibRcbLobLcbLibLe
bLeLsbLsbRcbRgRsmbRsbsbRsbRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bRsbLcbRobLhbRoRsmbRebRobLiLsbLgbLgbLibRobRobLsLsmbRobRhbRcLsbLsbLgbRi
bRibRibLsbRcbsbRcbLcbLobLibLobRhRsmbRhRsmbRcLsbLsRsbLhbLobLsbLsbLoRsRs
mbLhbLibLiRsbLiLsbLsbLgLsbLsLsmbsbLgbRoRsmbRibRibRsbRiRsRsmmbRsbRibLgb
RhRsmbRcbsbRhbRhRsmbRibLsRsbRgRsLsmbRgbRsbRgRsmbRsbLsbRgbRgbRgbLsRsRsm
bRibLsbLjbRibRibRcbRibRsRgbRhRsRiRsmmbRgbRgLsRsbRsLsbRibRibLjbsbRibLjL
smbLgbLibLcbLsLobLhbLhbLibLibLgLsbLsbLebRebRhRsLsmbRibRcLsRhRiRiRhRhbR
gbRhbRhReReReReReRsReRsmmbRgLsbLoLebLcbLhbLobLeRsbLiLsLsmbLibRcbRcbLsb
LjbLsLcRsbRcbRiRsmbLsbRsbRibLsRsbRibRgLsbRgLsRsbLjLsRsmbRhbRcRsmbRcRsm
bRcLsbRsbRibRhLsRsRiRiRibRiRsmbRoLsLsRsmbRoRsmbRebReRebRebRgbRsbRhbRgb
RgbRgbRgbRsbRgbRgRsRsLgRsmmbRsRsmbLeRsbLobLibLoLibLcbLcRsbLeLhbLebLhbL
gLsbLiLsbLsbRcbRobRiLsbRcRsmbReRsmbReRebRgRsmbsbLsRibsbsbsbsbLibRibRib
LsRoRibRcRiRcRiRsmbRebRgRsmbRsbLcbRhbRgLsRsRsLjmbRsRsmbRcbRcbRiRcRsRsR
iRcRemmbRebRhbLeLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbLobRgbLobRoRsmbRcbRhRsRiRsReReRsReReReReReRsmmmmbLsbRsbRsbLgb
LobLcbLcLobLeLibRobLeLsLebLebLgbLibRjbRebRoRsmbLobRgbsbRhRsmbRgbRgbRib
RoRsmbLsbLibRoRebLgLeLgbLibLcbLebLeLebRibRebRiLsLsmbLobRibLsbsbLsLsmbL
sbRsbRsbsbRsRsLsmbRsbRsbRsbRsbRsbRsRsmbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bRsbRgbLiLsbLibLibLgbLibLoRsbRiRsmbRibRsbRibRgRibRiReRiRiReRsReReReRsm
mbReRsmbRebRibRhRsmbReRsReRsmmbRiRsRcReReRcReRcReReRcmbRebRsbRsbsbRsbs
bRgbRcbLoLsmbsbLcbsbLobLcbLiRsbLgLsbLiLsLgLsbLiLiLgLiLsLebLiLsbLibLibL
ibRsLibLiLsbLhbLhLebLcbLebLgbLebLsbLgLsbLibLiLsbsbLibLibLibLcbLibLeLsL
hbLebLeLsbLibLiLsLgbLebLebLebLjbLcbLobRgRsmbRsbRcbLcbsbRebRjbLcLsmbLcb
LjLiLsbLcbLibRjbRgbReRsmbRebLeLibLgbLibLobLsRsLeLsbLeLsLsmbLeLsbLgLsbL
gLsbRjRcRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRgbRsLcLsLsmmbRsbRsLcbLcbLebLiLcbLgbLo
bLiLiLgLiLcbLgRjbLcRgRibLhbLcbRcLebLhRsbLibLsRsbRebRibRgRsmbRobRcRiRgR
ibReRsRembLeLsbRoRsmbRsLsbLiLgbRsRsmbLgbLobLgbLgbsbsbLsbRsRsmbRsRsRsRs
RsmmmmbRsRsRsRsmmmbRsbRsRsmbRsbRsRsmbLsbRsLsbRsbLsbsbLsLsmbRsRsRsmmbLc
bLgbRgRgbLiLsbRsRsmbLsbLibLibLibsbLcbLibLcbLhbLcbLiLobLibLgLeLeLsLgLsL
hLibLiLsLgbLsLibLhbLoRebReLsLgbLibLibLgLsbRjbRibLsLsmbRsLsbLsLsmbLgbLs
bRibRgRsmbLsbLjbLsRsbLcbLcbLhbLibLiLgbLcbLeLibLoLibLgLsbLiLsbLhLsbRsLs
bLeRsbRiRsmbRiRsRgmbRcbRcbRobRebLobLsLiRsbLhbLcRsbLibLobRjbLcbLcbLsbRi
bLibLoLsmbRgbRjbRhbRebRjbRebRibRjRsmbRibRhbRibLgbLjLsmbLiLib

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bLebLsLsmbLibRcbRiRiRsmbRhbRgRsRsmmbRsRcbRgbLgbsbsbRsRsmbRibRhRhbsbLgb
LiLsbLgLgbLsLsLsmmbLibRsbRoRsmbRiRsmbRiRsmbRibLsbLsbLgbLiLsbLsLsmbRcbR
hbLgbRcRsmbRgbRoRgbRiRcReReRiRsRimbRobRobLsRcbLjbLiLsRsbLibLgbLgbLibLi
bLsRebRoLeLsLsmbLeLsbLsbLsLsLsmmbRsbLsLcLsLsLsLiLiLsmmmbLiLiLsRsLsbLhL
ibLsbRsbLobLcLsmbLsRsbLcbLibLibLibLibLibLgbLgLsRsbLiLsbLiLsLsmbLiLibLs
bRsLsbRcRsRsmmbRcbRcbRcRsmbRsRibRgLsbRgRsmbRibRgbRsRsmbRibRcbRiRhRsmbL
gbLeLsbLgLsbLgbLgbLsbLibLcbLgbRiLsbLobLgbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bRcbRjbRsbLobLobRobRobLebLobLsbLebLobLcbRobLebRebRobLobLebRsbRobRobRjb
RjbRcbLebRebLjbLebLcbLjbRobRjbLobLobRjbLjbRcbRebLjbRobRjbLsbLcbRebLebL
ebLjbRjbLobRjbRebLjbRobRobLjbLebRcbRobRobLebRobLebRjbLobLobRcbLobLobLo
bLgbLobLobRibRebRebRibLcbLobLebRobRobLcbRobLobLobRebLebLobRjbRebLobLgb
LjbLcbLhbLcbRebLobRcbLcbLjbLcbRebLsbRibLobLcbLebRebRobRebRgbLobRcbRebL
hbLgbRobLobRobLobLebRobRcbRobLobLebLebLebRobRebLobLsbLibLobLobLobLobRh
bRcbLcbLebRcbLgbLobLibRebRcbRibLobLobRebRebRobLcbRcbLobLobRsbRgbRgbRob
RebRcbLebRebRobRcbRebLobRebRebRebRobRgbRobRibRsbLgbLebLhbRcbLobLhbLobR
ibRebRcbLobRebLobLobLobRobLgbLebRgbLcbRcbLobLobRsbLcbRebLsbRsbLobLibRs
bLibLcbRcbLebRhbRibLcbRebRobLgbRobRobLobLebLcbRebLobLcbLebRebLobLcbLeb
LobRobRebRcbRobLobLebRsbLebLgbLobLebLhbLcbRobLobRebRcbRcbLobRgbRebRsbL
ebRebRebLobRobLjbRcbLcbRobRcbRobRobLcbRcbLobLobRobLcbRsbLobRebLgbLebLe
bRebRebRebRebRobLobLcbLebLobRobRobLebLebLgbLjbRobRibLsbLobLebLobRibRcb
RibRcbLebLebRgbRobRobRgbLebRebRebLgbLibRebLebRhbLgbRebLobLgbRcbRebRebL
ebLebLobRgbLcbLebRobLebLsbRcbLobLobLibLobLobLobRcbRcbRebRebLobRobRcbRs
bRgbLebRobRebRcbRibLcbLobLobLobLebLebLobLcbRibRhbLobLgbRgbLobLobLobRob
RgbRobRcbRobLobLsbLcbLibLobLobLcbLobLsbRebLobRobRobLebRobLibLebLebRgbL
gbLcbLsbRobLobLgbLobRobRobLcbLobLobLobRebLobLcbLobRebRebLcbLhbRibLcbLe
bLcbRcbRcbLobLobRobLcbRebLsbRsbLibLebLhbRebRcbLibLcbRgbLhbLobRebLobLib
RebRobLebRebLebRebRcbLobRsbLebRibLobLcbRgbRcbLebRobLebRcbRobLobRobLcbL
obLebRebRobRobLebLcbLebRjbRobRobLobRebRobRebRobLebLibRibLhbLobLobLebRe
bRcbLgbRcbLebRobRobLibLebRhbRobRcbRgbRobRobRgbRebLgbLobLibRobLobRebRhb
RobLobLibLcbLobLobRobRobLebLobLebRobLobLobRibRibLcbLobLebRsbRobLgbLhbL
obRobRobRsbRcbLcbRcbRjbLebLebLobLobLobRhbLgbRebLobLjbRobLebRgbLobLobRc
bRebRobRobLobLebRobRebRsbRibRgbLebLebLcbLcbLobLebRebLibRobLcbLobRhbLcb
LobRgbLgbRobLcbLobRobRobLobLobRobLcbRgbLobLsbLobLgbRebLobRebLebRibRobR
obRebRebRcbLobRsbRjbLobLobRobRebRobLcbRibRcbLebLobLsbLebRebRcbRobLobRo
bLebLjbRobRobLobLebRcbRobLcbRobLebLcbRcbLobRsbLebLebRsbRebRebRebRebLeb
LcbRobLebRobRibRhbRobRebRobLobLcbLgbRobRobRsbRebLibRobLebLebLebRebRebL
cbLjbLjbLobRebRebLobRcbLcbRcbRobRobLebRcbLobRobLjbLgbRcbLobLebLebRobLo
bRobRebLcbRobLebRibLobLobLebLobRcbLobRcbRcbLcbLebLcbLebRgbRhbLcbRibReb
RobLgbLobLebLobRobLobRcbLibRobRobLobRebRhbLsbRobRibRobRobLobRcbRcbLcbR
obLhbRjbRobRebRebRibRcbLjbRobLebLebLcbLobRebLibLcbLobLobLcbLobLobRcbRo
bLcbLobRsbRibRobLobLebLobRobLibRobLobRobLebLgbRebLobLebLgbRebLobRobReb
LobLgbLobLebRcbRebRebLcbLebRobRhbLebLgbRhbLebLhbLcbRobLobRobLjbRobLgbR
obRebRhbRobLobLcbLebLibRebLobRibLobRcbLibLcbRobRcbRebLcbRobLobLebRobRe
bLsbLobRcbLebLobRobLebRcbLobLobLsbRobLobRobLcbLebRobLibRobLobRcbLgbRob
RobLhbLebRsbRobLebRibLibRobLobRobRebRobRobLhbLebLobRibRobRobLebLobLobR
obRcbRobRebLebRobLsbRibLebLcbRobLobRcbLobRcbLcbRsbRobLobRobRobLebRobRo
bLobRobLebLebRebRebLobLebLebLobRobLobRebRcbRibLobLcbRcbRebLgbLobRobLob
LcbRibRebRcbRebRebLhbRgbLcbRcbLebRobLobLgbLebRobRobRcbLobRobRgbLsbRcbR
obLsbRobRobLcbLebLebLcbRobLhbRobLobLobRcbRobLobLsbRebRsbRobLobLcbLcbRe
bLsbRsbLobRobRcbRibLebRibLgbLob

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bRsbLsbRobRhRcRsmbRhRsRgRsmmbRibRsbRiRsRsmmbRgbRgbRgbRgbRgbRgbRsbRgbRi
bRibRcbRiRsmbRcRgbRibRgRsRiRgmbsbRgbRoRibRcRebLeLebLeLebLsbLoLhbLcLsLs
LiLsLemmbLgbLsbLgLsbLsbLgbLgbRsbLsLcbRiRiRsRgmbLgLeLeLeLeLsbLebLsbsbLg
bsbsbRibLiRsbLobLcLsmbLcLiRsbLiLiLibLcLeLiLsLebLgbLsLeLebRoLsbReRsRsmm
bRhbRgRsmbsbLcbsbsbsbRcbLobLgbLiLsbLsLcRsRgRjbRebRgLsbReRsmbRgbRgRsmbR
ibRgbRebRgRsmbRgbRgRsmbRgRsmbsbRibRsbRebRcbLcLsmbLiRsbLgLhLeLsLiLeLibL
hRsLhbLeLeLebLhLiLcLsLcLeLsmbLebLebLsbRgbRsLgLsbsbLgbRibRsLsbRgLsbRgLs
bsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
bRsbRsbRgbRsbRgbRsbRsbRgbLsbLsbLsbLsbLsbLsbLsbLsbLsbLjRgRsmbLsbLsbRsbL
sbLsbLsbRsbRsbLsbLsbLjbRgLsLibsbRsRsmbsbLgbLsbLsbRsbLsbLsbRsbLsbLsbLsb
RsbRsbLsbRsbLsbRsbRsbLsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bRsbRsLsbLsbLsRsbRsLsbRsbsbRsbsbRsbLsbRsbRsbRsbLsbRsbLsLsmbLsbRsbLsbRs
bRsbLsbLsRsbLsbLsLsmbRsbLsbRsbRsbLsbRsbRsbRsbLsbLsbRsbLsbRsbLsbLsbLsbs
bLsbLsbRsbRsRsmbLsbLsbRsbLsRsbRsbLsbRsbRsRsLsmbLsbLsbRsbRsbLsbRsbRsbRs
bRsbLsbRsbLsbRsbLsRsbRsbRsbRsbLsbRsbRsbLsbsbRsbsbLsbLsbLsbLsbRsbRsbRsb
LsbRsbRsbRsbLsbRsbLsbsbRsbLsbRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbLsbLsbsbsbsbsbsbsbsbRsbRcLsbR
obRhbRibRibRebLgbRsbRobRsbRiLsRsRibRiRsLsmbRsbRiLsLsmbLsbLcbLibLsRsLsL
iLibLgLsLgRsLiLgLeLsLeLsbLiLsbRsLsbLibLobLgLgLeLsLebLibLibLibLibLeLeLs
bLeRsbLcbLeLsbLebLgbLsbLibLibRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 19; Drug: Control Apo 50 然
bLsbLgbRibLebRhbRgbRibRgbLgLsbLjbLhbLgbLgLsbRsRgRsmbRjbRibRgbRibLgbLib
LsRsbLgbLibLebReRgbRibRibLgLsbRsLsLsmbLsbRiRsmbLebLsbRibRhbLsRgbLsLsmb
LsbLhbLgbLsbRsbLhbLobLibLibRobRibLeLsbLgbLgbLibRsLsbRhbRiRibRibRibRgbL
ebLebRhbRiRsmbRibLsbRibLebLebLhLsbLibRebRibRibRgbRhbLibLsbLcbLgbLsbsbR
iRsmbLibLibLsLsmbLcbRsLsbLgbLjbLsRsbRsbLsbLsbLsLsmbLsbLsbLsbRsbRsLsbLg
bLgbLibLgbRhbRebRibRsbRjRibLsLsmbLibLsRsbRsbRsLsRsRsmbRgbLebLibLsRsRsm
bRcRsmbLgLsbLiLsLsmbRsLsRsbLsLsmbLsRsRsLsLsmmbLgRsbsbsbLsbLsbLsRsbLsLs
mbLgbRsRgbRcRsmbRhbLjbLcbLiLsbLiLsbLcbRcRsmbLhLsbLgLsLsmbRsbRebRcbsbRe
bRiRsRsRsRemmmbRibRhbRsbRgLsbRcRsmbRobLebRhbLsbLjbLjbsbsbRiRgbRsRsRemb
RsbRgbRhLsbRibLib

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 20; Drug: Control Apo 50 然
bRsRebRebRsRsmbRibRgbRebRgbLsbLjbRcbsbLsLsmbRsRgbRsRsmbRgbRibRibRgbRsb
LsRiRsmbRsbRgbRsRsmbRibRgRsRsmmbRgRgbRsRgbRibLsbRibRsbRgbRgbRgbRsbRobR
obRsbLsLsmbLgbLsbRsbLgbRgbRhbLsbLsLgbLebLibLgbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 21; Drug: Control Apo 50 然
bRibRcRsmbRgLsbRgbRgRsmbRobLsRsbLsbLoLsmbLcbLgLsbLibLibLibLhRsbLgbLsbR
iRsmbRgbRibRiRsmbRgbLsbRebLebRcbRjbsbRebRgRsmbRiRsmbRgbLjbLjLcbRgbRibR
gbRiRsmbRgbRgbRsRsLsmbRgbRsRsmbLsLsLsLsRsLsmmmbRsbRsRgbRsRsRsRsmmmbRgR
sRsRsRsmmmmbRsRsRsRsmmmbRsRsmbRsRsRsmmbRsbRobRiRsRsmmbRsbRcbsbRsRsmbLs
bRjRsRsmmbRsRsmbRcbsbRebRiRsmbReLsRibRgbRcRsmbRgbRsbLsbLiLsbRsLsbLsLsm
bLsLsLsmmbLsbLsbLsLsLsLsLsLsLsLsLgLsmmmmmmmbRsbLsLsmbsbRsLsLsLsLsLsmmm
mbLsbLsLsRsLsLsLsRsLsLsLsmmmmmbLsLsLsLgLgmmbLsLsmbsbsbLsLsmbLsbLsLsLsm
mbsbLsLsLsLsLgLgLsRsmmmbLsbLsbRsRjbRcbRibRibRebRgbRhbRibRgbRsbRsRsRsmm
bRsbRsRsRsRsRsRsmmmmmbRsRsRsRgmmbRsbRsbRsRsRsmmbLebRhbRsbReRsRsmmbRgLs
bsbRsbLgbLcbLsLsLsmmbLsLsLsLsmmmbLsLsLgmbLgbRsLsbLsLsLsmmbLsLsLsLsLsLs
LgLsLsRsmmmmmmbRsRsmbLsLsLsLsmmmbLsbLsLsLsmmbLobLgbLjbLcbRebRjbRcbRibR
ibRcbRebRibRgbRsRsmbLsRsbLsRsbsbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRsbRhbLc
bLiLsbLgLsbLiRsbLsLsLsLsLsLsLsmmmmmmbsbLsbLgbLsLsmbLsLsLsLsmmmbLsbRsbs
bLsbReRsmbLobLcbRsLsbRibRgRsmbLjbRsbLsLgLsLsmbLgLsLsLsLsLsLsLsLsLsLsLs
LsLsLsLsmmmmmmmmmmmmmmbRsbLsLsmbRebRobLcLsmbLibLiLsbsbLgbLiRsbLsbRcRsm
bRcRsmbRcRsmbRiLsbRgbRgbRsbLsRgbLgLsbsbLsbRsRsmbRibLsLsmbLsLsLsRsLsRsm
mbRsbRsRebRcRsmbRjbRgbRhbRgbRjbRgRebRiRsmbLebLgbRsbLcbLgLgbLibRsLsbRib
RgbLjbLsbLsLsmbRsbLsbsbLsbLjRsbsbLcbLgLsbLibLhRsbLsRsRsRsmmbLjbRgbLibR
ibLcRsbRebLobRgbLsRjbLiLsbLhLsbRsLsbRobRgbRjRsmbLgbReRsmbRebRgbLjbRsbR
sbRsLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 22; Drug: Control Apo 50 然
bLobLcbRcbRibRibLibLibLcbLiLeLcLsLembLcRebLebLgLhLebLebLebLeLjbLebLoLs
LgLsmbLeLsLsmbLebLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 23; Drug: Control Apo 50 然
bLhbLebRobRobLsLgbLsReRhbRgbReRsRsRgmmbRibRebRsbRsRhbRsRsRimbRgRsmbReb
RgRsmbRsbRsbRsRsRsRgmmbRsRibRsRiRgbRgbRhbRibRibRibRsbRsRsmbRsbRgbRgbLs
bRsbRgbRgbRsbRsbRgbRsbRsLsbLsRsRibRgbRibRgbRgbLsRsRsmbRebRgbRsbRsbRibR
sbRgbRsbRibRsbRsbRgbRgbRgbRgbRgbRsbRsbRgbRgRsmbRsbRiRsmbRsbRgbRgRgbRgb
RsbRgbRsbRgbRsbRsbRsbRsbRgbRgbRsbRsbRsbLsbRsbLsbRsbRsbRsbLsbRsbRsbRsbR
sbRsbLsbRsbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 24; Drug: Control Apo 50 然
bRsbLgLibLgbLgbsbRsbRsbLgbLiLeLiLsLsmbsbLgLsLhbLgbLsLgLsbLsbLsbLsbLsbR
sLsLsLsLsLsLsmmmmmbLeLibLsbLsbLsbsbLsLgLgLsbLsLsLsLgLsLsmmmbLsLsmbRsLs
bsbLsLsLiLiRsLgmbsbLsbLsbLeRsbsbLgLsLsLsmmbsbRgbRsbRgbRsbRsRsRsmmbRsbR
sRsmbRsRsRgRsRsRsmmmmbRsbRsbRsRsmbRsbRsRsRsRsmmmbRsRsRsmmbRgbRsRsRsLsR
sRsRsRgRgmmmmbRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bLsbRsbLjbLjbLibLeLeLeLsLcbLeRibLebRebLgbLsbsbLsbsbsbRsbsbRsRsmbsbsbRs
RsLsmbsbLsbRsbLgbLgRsbLsLsLsmmbLsLsmbsbLsLsmbLibLibLhbLibLcbLibLgRsbLs
LsmbLiLsbLsbLibLgbLgbLgbLiRsbRgbReRiRgRsmbRibRibRcbRcbLibLibLeLoLeLobL
oRsbLiRsbLjRsLsLsmbsbLsLgLsbLsLgRsRsLsmbLgLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bsbRsLsbRsbRsbRsbRsRsmbRsbLsbRgRsmbRsbRsbRsbRgbRgRsmbRgRsmbLsbRsLsbsbR
gbRgbRsbRgbRsbLsbRsbRsbRsRsRsmmbRgbLsLsmbRsRsRsmmbRsRsRsmmbRsbRiLsbRhb
RiRsmbRsbRebRoLsLsmbRibRiLsRsbRiRsmbRibsbRsRsmbLsbsbLsRsbLsRsbRsbRsbRi
bLjbLsbLcLsLsmmbLcbLhRgbRcLebRsbLjbReRibRsRsmbsbRgRsmbsbRsbRsRsmbsbsbR
sbsbLsbsbsbsbRsbRsbLibLcbLcLsmbLiLsbLcbRobLhbLebLgbLgLibLebRgRsLsmbLiL
sLsmbLiLsbRsLsLgLsLsmbLsLsLsmmbLsbsbLsbRsLsLsmbLsLsmbsbLsbLsbLsLsmbLsb
sbRsbLgLsbRsLsLsmbRsRsRsmmbRsRsmbsbLsRsbLibRgbRsbRsRsRembRsbRsbLsbRgbR
sbRsbRiRsmbRibRgRsRsmmbRsLob

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bRgbLiLsbLsbLibLsbLsbRsLsLsmbsbsbLsRsbsbsbRsbsbLgbLcRsRsmbRcbRcRsmbRcb
RibRcReReReReRcReRebRcbReReRhRsmbRgRsmbRebsbsbRcRsmbRiRsmbRcbRhbLebReb
LsbRgbRcbRsbRcbLgbLgbsbRibLibRibLsbRjbRiRsmbsbsbsbRibLjRebRebLgLiLsbLe
LcLebLcLcbLcLsLsmmbLgLsbRibRebRgbLiLsbsbLsLibLiLsbLiLsbRsRsmbsbLsLsRsm
bsbsbLsbRsbsbsbsbRsbRsbLsbLsRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bLsbsbLsbsbRsLsbLgbLsbLsbLsbLgbLgbLgbRsbLgbLgbLgbRsbsbLgbsbsbRsLsbLgbR
sLsbLsbLgbLgbLgbLgRsbLgbLsbLgbLgbRiRsRsmmbLgbLgbLsbsbLgbRsbLgbLgRsbsbR
jbsbLgbLgbLgbLsbRsbRjRsmbLibLgRsbRebRcbRhRsmbRcbRgbRhbRiRsmbRibRsbRibs
bRsbRiRsmbLsbRcLsbsbLgbLcLsmbLibLgbLsLgbRsbLiLsLsmbRebRgRsmbRibRgRgLsb
LibLibLgbRibRcbRiRsmbRibRgbRgRsmbRgRgbRibRsbRibLgbLcbsbsbLibRsbLiLsbLs
bLibRgbLibLsLsmbLibRjbLebsbLhbLibLgLsbReRsmbRibsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bsbRjbRhbRsbLsbsbsbRgRsmbRgbLsbRgLsRsbRsbLsbRsbRsbLsbRgbRgbLsRsbLsbRsb
RsbLsbLsbRsbRgbRsbRgbRgbRsRsmbRibRgRsmbRiRiRsmbRgRsmbRsbRgbLsRsbLeLcbL
sbLsbLiLsRsbLsbLsbLsLsmbLgbLgbLgbLgbRsRsmbRsbLsbRsbLcbLgbRsbRiRsmbRsbL
ibLibLgLsbLsbLgbLgbLsLsmbRsbLgbLgbLgbLgbLgbLsbLgbLgbLgLsbLgbLgLsbLgRsb
LgbLibLibLeLeLebLoLeLsbLoLsmbLsRebLsRsbLsLsLsmmbRgbLsRsbRibRgRsmbLsbRs
bRgRsmbRsbLsRsbRsbsbRsRsmbRgbRgbLsRsbLsbRgRsmbRgbLsbRsRsmbRsbRgbRsRsmb
RsbLsbRgbRgRsLsmbRsbLsbRsRsmbRgbRsbRgRsRsRsmmmbRibRibRiRsRsRsmmmbRiRsm
bRgbsbRgbLsRsbLsbRsbRsbRsbRsRsmbRsbRsbRsbRsbRgbRgbRgbRiRsmbRibRgbRgRsm
bRgbRsbRsbRgbRgRsmbRsLsbRgbRsbLgbsbLebLibLsLsmbRsbLiLsbLsRsbLgLgbLeLsb
LgbLsbLibLgbLgbLgbLiLsbLsbLgbLgbLsbLgbLsRsbRsbsbLsbLgbLgbLibLsLsmbRsbL
ibLgbLgbLgbLsbLsLsmbLgbLsbLsLsmbLsbLsbLgbLibLsbLsbLsbLgbLgbLgLsbLsbLsb
LsbLgbLgbLgbsbLgbLgbLgRsbLgbLgbLgbLgbLsbLsLsmbLsLsLsmmbLgbLgbLsRsbLsbL
sbLibLgLsbRsbLsbLsbLsLsmbLsbLgbLgLsbLgbsbLsLsLsmmbLsbLsbRsbLibLsLsmbLs
bLgbLgbLgbLgbLsbLsbLgLsbLgLsbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgLsbLgbLsb
LgbLgbLgbLgbLsLsmbLgbLgbLgbLgbsbLgbLsLsLsmmbLgbLsRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bsbLsbsbsbRsbsbsbsbsbLsLcbLebLcLsmbLhLsbLhLebLeLgbLobLgbLibLgbLiRsLsbL
ebLeLsbRcRsmbRsbRsbLsRsbLsbLsbLsbLsbsbLsbLsLsmbRsbLsbRsbLsbLsbRsbsbLsb
sbLsbLibLgbRsbRsbLsLsmbRcbRcReRsRembRebRebRebReRsmbRibRgbRobLibRgLebLe
bLibLjbLeLsbLcbLebRoLcbRsLsRsbRsRsRhmbRhbLsLsmbRibRsRsmbLsbLsLsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bLsbsbLsLsRsmbRsbRsRsRsmmbRsRsRsmmbRsbRsRsRsmmbRsbRsLsbRsRsmbRsLsbRsbR
sRsmbRsbRsRsmbRsLsbLsbLsbLsLsmbLsbRsbLsRsbLsLsmbLsbRiRsmbRsbLsRsbLsbLs
LsLsmmbRsbLsLgLgLsLsmbLsLsmbLsbLsbLsLsmbRsLsbLsbLsbLsLsmbLsbLsbRsbLsbL
sLsmbsbLsbLgbLgbLsbsbRebRsbRibRsbRgbRgbRgbRebRiRsmbRibRibRgbRcRibRebRi
RebRhbRibRobRgbRsbLgbLgLoRsbRebLobLobLhbLhbLgbLhbLcbLeRsbLiLsbLsLsmbRs
bLhbRsbLibLibLsbLsbRsbLsbLsbLsLsmbRsbLsbLgbLsbLsbLsbLsbRsLsbLsbLsLsmbL
sbLsLsmbLsLsmbLsbLsLsmbLsbLsbLsbLgRsbLsbLsbLsbLsbLsbLsbLsbsbLeLsbLhLsb
LebLebLibLhbLhbLebLcLsmbLcbLcbRgbLhbLobLobLobLobLcLsmbLhbLobLjbLhLsbRc
bLgLsbLjbLibRebLibLhLsbLsRsbLgLsbLsLsLsmmbsbRoLsbLsRsbLebLhbLeLsbLgbLs
RsLsbLgbRsbLsbLsbLsbLsbLsbLsLsmbLsLsmbLsbLsbLgbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bsbRjRgRsRsmmbLjLgbLjbsbsbLiLsbLhLsbRsRsRgmbRsLsbLgbLiLsbsbsbLibLiLsbL
ibLgbsbLebLcbLebRiRsmbLsbLsLsmbLibsbLcLsmbLhbLgbRsbRgRsmbRhbLcLibLhLsb
RsbRgbLcbRsbRgbLcbRsbLsbLgbRsbLsbLhRsbRsbLsbLibRsbRjbLiLsbRsbLibLcbLgb
LsbLsbRsbLhbRgbLibLgbLsLsmbLsbLsLsmbLsbsbRsLsbLiLsbRsbRgbLgbLgbLibRsbR
sRsLsmbLiLsLsmbLgbRsbLsLsmbLgbLsbLsbLgRsbLsbRsLsbRsbLiLsbRsLsbLsLsmbLi
RsbRsbRgbLibLsbLsbLibLsbRibLsbLibLjLsLsmmbRsRsLsmbLibRsbRgbLibLsbLcbRg
bRsbRsbLhbRsbLsLsmbLgbLsbLgbLsbRsbLibLsbLsbLsbLsbLsbLiLsRsbRsbLiLsbRsb
RsbRcbRibLsbRcbRsRhbRsbLsRsLsbRoRsmbLcLsmbLcRsbLcbLsbLsbLgRsbLibsbLibR
sbLsbLgbLsbLgbLsbLsLsmbLgbRsbRobRibRsbRiRsmbRgbRsbRiRsmbRsbRibRsbRiLsb
LsRsbRiRsmbRsRsmbRibRgLsbRsLsbRibLgRsbRcbRibRiRsmbLgbLcRsbLsbLibRgLsbR
cbRcbRiRsmbRibRibRgLsRsbRiLsbRiRcbRhbRibRibRibRhbRgRsmbRgbRjRgbLsRsbRg
bLgbRib

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bsbsbRjbsbsbLiLsbLibLoLsmbsbRibRcRsmbRibRgbLhbLibLobLobLcbLibRsbRibRcR
smbRcLsbRhbRgbLcLsmbLobLibLcbRsbRjbLsbLobLibLgbLibLcbLcLiLhbLeLsbLibLe
bRgbRcbRgbRcbLibLoRsbRsbLibRobRgbRgbLjbLibRjRsmbsbsbsbRsRsmbsbsbRsbRsb
RsbLsRsbsbLebRcbRsbRebRebRgbLiLsbLibLibLiLsLsLsmmbLcbLebLcbLibLibLeLeL
sbRcbRibRgLsLsmbLsbLjbLiRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbRsRgbRebLgbRsbLcbLgLsbLgLsbLgbLgLsLsmbLgLsbLgbLgbRsbsbRsRsmbR
cRsmbRhbRcbReRgRsRembRebRiRsmbRsbRsRhbLgbLeLsbLhLsbLibLibLgbLebRgbLcLe
bLeRsbLibLgbLcbLebLcRsbLibLibLiLsbLebLibLibLobLoLgbLcbLebLgLsbLsRibRiR
smbLiLsLcbRcLsbRebLsbRibRgbsbRibRgbRebLsbRgbRsRsRgmbLibRsRsmbLcbLgbLgL
sbLibLibLibLsRsbRibRiRebRibReRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bRsLgbRsbLgRsRsmbLsLgLsLsmbLgLsbLsLsLsmmbLsLsLsmmbLsLsLsmmbLsLsmbLsLsL
smmbLsbLgbLgbLsbLsLsmbLsLsLsLsLsmmmmbLsLsmbLsLsmbLgbLsLsmbLsbLsLsLsLsm
mmbRsbLsLsmbLsLsLsLsLsmmmmbsbLsLsmbLsbLsbLsLsLsmmbLsLsmbsbRsLsLgbRsRsm
bLsLsLsLsmmmbLsLsmbLgbLgLsbLsLsmbLsbLsLsmbLsbLsbLsLsLsmmbLsbRsbLgbLgbL
gbLsLsmbLsLsmbLsbLsLsmbLsLsmbLsLsLsmmbLsLsmbLsbLsLsmbLsLsLsLsmmmbLsLsL
sLsLsmmmmbLsLsLsmmbLgLsLsRsmbLsLsmbLsbRsRsmbLsbLgRsbLgbLsRsbLsbLsbLsLs
mbLsbLsLsLsmmbLsbLsLsmbLsLsLsmmbLsRsbLgLsbLsLsLsLsLsLgmmmmbLsLsmbLsLsm
bLsLsmbLsbLsbLsLsLsLsmmmbLsLsLsLsmmmbLsLsLsmmbLsLsmbLsLsLsLsmmmbLsLsLs
mmbLsLsmbLsLsmbLsbLgbLsbLsLsmbLsbLgbLsLsmbLsbLsLsLsmmbLsLsLsmmbLsbLsbL
sbLsLsmbsbLgbLsLsmbLsLsLsLsmmmbLsLsLsLsmmmbLhLsbLsbRhRsmbRcbRoRsmbRsbR
iRsmbRgbRsRgbLcLsmbLcbLcLsLsmmbLhbLsLhbLibLobLeLoRgbRibLobRgbRhLsbRiRs
mbRgbRgLsbRoLsbLsbsbRsRebRsbLobLcbLibLhbLsbLoLgbLibLcbRibRjRcRsmbReRhR
sRsmmbRgLsbReRgRsmbRibRgbRebLsLsLsmmbLsbLsbsbLsbLgbLsbLsLsmbLsbLsLsmbL
sbLsLsmbLsLsmbLsLsmbLsLsLsmmbLsLsLsmmbLsLsmbLgbLsLsLsmmbLsbLsLsmbRsbRs
bLsbLsbLsLgbRsbRsbRsbLsLsLsmmbLsbsbLsbLsbLsbRsbLgbsbLsRsbLsLsmbsbsbLsb
sbsbsbsbsbLsbLsLsmbLsRsbRsRsmbRsLsbLsLsLsLsRsmmmbLsbLsLsLgLsmbsbsbLsbL
sbLsbLsbLsRgbRhRsmbLjbLcbLibLsLcbLsbLibLsbLiLibRhbRibRiLob

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbsbLobLcLsmbRsbLoLsLsmmbLsbLsbLcLsRgmbLiLsbLgLsbLsLsmbLgbLgbLc
bLiRgbRiRsLsmbReLsbRhbRibRgRsmbRibRibRgbRcbRiLgLsbRebReReRebRebRebRobR
ebRsRsmbRebRgRsmbRgbLobRhbRsRsLsmbRgbRsLsbRsbRsLsbLobLiLsbLeLsbLeLsbLe
bLgbLeLsLsLsmmbLebLeLsbLiLsLebLiLsLebLeLsbLeLsbsbLsbsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
bLsbLibLsbRsbLgLgbLsLsmbRsbLibRsbLiLsbLsbLibLsbLibLgbLgbLgbLgbLgbLsbLs
bLibRsbLibLgRsbLgbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bRgbRsbLjbLcbLcbLhbReRsmbRhbReRsmbRebRgbLsbLsLsmbLsLsmbLsbLsLsmbRsbsbL
sbLhbLebLgbRcbRoRcbLcbReRsmbRgbsbRsbLsbsbsbsbsbRsbRcbRebRcbRibLcbRebRi
bRcbRhbRcbRhbLibLgbLhbsbLgLsbRsRebLeLsbRgbRcbRobRgbLcLsmbLebRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bLiLsbRsLsbLsbRiLsbRjbRibRcbRcbLsbLsRsbRibRhbRibRoLsLsLsmmbLeLsbLebLgb
LebRsbLgbsbsbsbsbRsbLsLsmbLsLsmbLsbRsLsbLgLsbLgbLgLsLsmbLgLsbLibLgbLgb
RsbLjbLjbsbLibLcLebLeLebLibLgLebLsbLjbRcbRebRiRsmbRsRsmbLsRcLsbRcbLeLs
LsmbLcbRgbRebRsbRsRsRsRsRsRsmmmmmbRsbRgRsmbRsRsmbRsbRsRsRsmmbRsRsmbRib
RsbLeLsbLcLsmbLgLsbLgbLiLsbLhLsbLhLsbLgbLcLsLembRsbLobLsbRobRcbRgbRibs
b

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bRcRsmbRhbRibRhLsbRibLsbLibLgbLiLsbLsbReRhbLsLsmbLjbRibRsbRsRibRsbRiRs
mbRgbRcbRibRcLsbRibRibRebRgbRgRsmbRsLcbLhLsbLibLgbLibLoLsLsmmbLgbLeLsb
LebLeLgbLgLsbLhbLcRsLibReRsmbRibRgbLgLsbLcbLebLgRebRsbsbsbsbsbsbLebRib
LiLsbLobLgbLibLgbLsbLsbLsbLsbLsbLsbLsbLsLsLsmmbLgbLsbLsLsmbLsbsbLsbsbs
bLsLsmbLsLsmbLsbLsLgLsbLsbLsbRebReRsmbRiRsmbLgbLiLsbRgbLgLsbLiLsbLhbLc
LsmbLcbLhbLcbLobLhbLcLsLsLiLsLsLiRsmmmbLibLiLsbLiLsbLibLgbLgbLibRibLcb
LjbLeLsbLebLsLsmbLibLgbLibLgbLsbLsLsmbLsLsmbLsLsmbLsbLsLsLsmmbLsbLsbLg
bLsbLsbLsbLsbLsbLsbRjbLgLsbLsLsmbLgbRibRsbLsLsmbLsbLgbRgbRcLsbLgLsbLgb
LsLsmbRjbLibLsLsmbLgLgLsbRjbsbsbRebRgRsmbRcRsmbRsRsmbRsbRibRibLsbRgbRs
bRsbRgRsmbRsbsbRsRgbRiRsmbRcbRgbRiRsmbRgbRebRgbRebRgbLobLsbLibRcRsmbsb
RibLhLsbRobRebRcbRiRsmbRsbRsLsbLobRibLibLgLsbLsbLsbLsbLsLsmbLgLsbRebRi
bLgLsbLhb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bRsbRsbsbRiLsbRsbRobLsbRobRcRsmbRibRiRsmbRebLsbRhRsmbRiRiLsLsmbRcbRsbR
ibLsbRcRgLsRsLsRgRhRsRimbRgbRsbRsbRiLsbRcRgbReRiReRsReReRsmmbRiRsmbRhb
RgbRsLcLhLgLeLsLeLiLiLsbLeLsbLebLsLsmbLcLhRgbLebLebLebLcLsmbLibLebLcbL
gbRsbRcLsbLcbLgbLibLobLcbLeLsbLiLsbLibLsbLsbLsbLsbsbLsbLsbLsbLsRsbLsbR
sbLsbLsbLsbLsbLsbLsbLsbLsbRsbLsbRsbLsLsmbLsbLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bsbLsLsmbLsbLibRcbRcRsmbLhbRobRiLsReRebRebRebRibRsbLebLeRebLcbLsbLsbsb
LsLsmbLsbLsbLcbLibRcRsmbRebRoRsmbRhbRhRsRhRsReReRsRsmmmmbRiRsmbLsbLsbR
gRsmbRsbRhbLibLcbLibLibLcbLebLebRobLebLobRibLobLcbLibLsbLsbsbLsLsLsmmb
LsbsbLsLsLsLsmmmbRsLsLsmbLsbRsLsLsmbLsbLsLgbRgbRsbRoRsRsmmbRcbRibLsReR
ebRibRebRobRobRsRsmbRhRsmbRibLebLebLeLsbLeLsbLsLsLsmmbLsLsmbLsLsLsmmbL
sLsLsmmbRsRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 43; Drug: Control Apo 50 然
bLgLsLsmbLibLsbLgbLsbLgbLsbLgbLibLgLgbLgRsbLgbLebLibLgbLsbLgLsbLgLsbLs
LsmbLibLsbLsbRsbLsLgbLsbLibLsbLsbLgbLgbLgbLsbLibLgbLsbLgbLibLsbLgbRsbL
gbLsbLsbLgLsbLgLsbLgbLhbLsbLsbLgbLgbLibLgbLsbLsLsmbLgbLsbLsbLibLgbsbLg
bLibLgLsbLsbLgbLgRsbLibLgbLsbLsbLgbLibLsLsmbLgbLgbLsbLgbLsbLibLsbLsbLs
bLgbLgbLibLgbRsbLgbLsbLgbLgbLibLgbLsbLgLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 44; Drug: Control Apo 50 然
bRhLsbLcbLibRsbLcbLibLcLeLeRsbRiRhReRsLsmbRsbsbRgbRsbRsbRiLsbLgbLsLjLe
bLibLcbLgbLibLoRgReRiReRhbRgbLeLcLsLeRgmbLebLgbLsLebLeLsLsmbRcbRebLebR
gbLcbLgLsbLgbLcbLoRsbRhbRibRiRsmbRgLsbRsbRsbRsbLcbLhbLiLcbLcLsmbLiLsbL
iLsbLibLcbLibLoLsLimbLiLsbLgbRsbLsbLhbLibLgbLgbRcbRebRiRsmbRhbRgRsmbRo
RsRimbRibRibRiRcbRhbRhLsbRcRhRsmbRhLsbRibRcbRibRibReRsmbRobRgbRibRiRsm
bRibRsLsbRibRhLsbRibRcbRjRsRsmmbRibRiRsmbRoLsbRgbLhbLcbLibLibLcbRibRcb
RoLsbRgbRibRiRsmbRjRgbRiRsmbRiLsbRibRhbRibLebLcbRgbRibLgLgbLibRibRgbLi
LsbLibRgbLsRsbLsRsbRsbLsRsbLgbLsbLibRsbRsLsbRsbRsbLsLsmbLsbLsLsLsLgmmb
RebLgbLjbsbLsbRcRsRsmmbLsLsRsmbLebRgbLgLsLsmbRjbRcbRhRsmbRobRhbRcbLibR
obRgbRibRcbRcRsmbLibLcbLcbLiLsbLiLsbRcbRjRsmbRobRibLebLeRsbRibRgbLoLsm
bLibLibRgbLibLcbLcbRsbRibRibRibRibRcbRibRjRsmbRhbRsRsmbLiLsbLcbRibLcbL
ibLcbLibLibRiRsmbRibRsRsRembRibLsbLiLsbLiLsbRgbLsbLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 45; Drug: Control Apo 50 然
bsbsbsbsbLsbsbLgLsbsbRcbRcbRibRiRiRsRsmmbReRsRsRsmmmbLsbRiRsmbRsLsbRib
RibReRiRsmbRiRsmbRiRgbRgbRiRibRcbReLsReRsRsmmbRiRsmbRgRsRsmmbRiRsmbReR
smbRcLsbReRhRsRsRiRimmbRibRsRiRsLsmbRiRsmbRebRiRsRembReRiRebLeLsbLeLsb
LibRibLobLhLsLiLeLeLeRsLibLgLcRsLcLebLibLebRhLgbReRsmbRibRsbsbsbRibRib
RcRsRcReRsLimmbLibRibReRsmbsbLiRsbRcbRiRiRsReRsReRsRimmmbRhRibRiLsbRhb
LsRsbReRsmbRoLsbLibLsLgLsbLgbRcbRibRcbRcRcbRiLsbRiRsmbRebRcLsRcbRcbRcb
RcbRiRsRgRsRsRsmmmmbRsRsmbLsbsbsbRiRsmbLsLiRsRsLgLsmbLoRsbRsRsmbRgRsRs
mmbRsRsmbRebRcRsmbRiRsmbLibLgRsbRsbRjbRcbLsRsbRgRsRsmmbRobRcbRibRibRiR
gRsmbRcRiRsRimbRcRgbRcRebLsRibRiRgbRgbLeLsLhLsRsbLsbRcbLcbLsbLsbRgbLib
LgbLsbLibsbLcbLcbLibLibLgbLibLiLsLgbLebLgRsbLsbLgbLob

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 46; Drug: Control Apo 50 然
bRgRsmbRgbRgbRsRgbRgbRgbRsbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 47; Drug: Control Apo 50 然
bLibLhbLcLsRsmbLibsbLiRsRgbRibRsbRgbsbRhbRobRgbReRsmbLsRsbRibRsRsRgmbR
ibRobLibRcRsRiRsRhmmbRiRoLgRebRgbRgbLibsbLsLsLsmmbsbsbsbRcbLcbsbLsLoLs
mbLcbLcbRibLhbsbRcbLcbLcRsbRcRsmbRcbLcLsmbLjLsmbLcbRgbLeLsbLhbLsbLhLiL
iRgRsmbRibRiRsRhRsRsLsmmmbReLebLsLsmbRobRiLsbRgRsRsRsmmmbRibRsLsRsbsbR
sRsRsmmbRsRsmbRsLsbRsbLhbRcbRsbLcLsmbLcbsbLcbRsRibRhbLcbsbLcbLcLsmbLhb
LhbLibLjLgLgbLcRsbLibRhbRgRsmbRgRhLsbRgRsmbRibRsbRibRgLsbRcRsmbLsbRibR
hLsbRhbRiLsbRiRibLsbRgbRsRsRsmmbsbRgRsmbRsRsmbRsbRgLsLsmbsbRgbRgbRibLc
bLibLhbLsLcbLibLhLsbLcbLsbRsRcbRcLsRhRgbRibRibLsbLcbLibLiLobRgRsmbRibR
gbRcbLgLsLsmbLebLgLibRcLsRsbRibRhRsmbRsbLibRjRsRcLsLsmmbLjbRgbLsLsLsmm
bLebRsLsbRcbRcLsbLsLsmbRoLsbRcbRcbRibRsbRibLsbRibRsbRibRgLsbRibRibRiRs
mbRhRibsbRsLsbRgbRgbRiRsmbRgbRgbRgbRibRibRhRsmbRcRiRiRibRoLsbLsLgbLsbL
sLsmbsbRebRibsbRibLibRhbRgbRibRibRsbLgLsLibLgLsbLgLsLibRsbLibLcbLibRib
RgRsmbRsbRcbLsbRjbLcLsmbLoLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123159; End: 123700;
Recording: 6-1; Individual: 48; Drug: Control Apo 50 然
bRsbLgbLcLsmbLjLibRjRjRjbRcbRibRibRcbRibRiLsRsbRgbRibRgReLsRgbRebRiRsR
sReRgmmbRiRsRsmmbRsRebRgbLgbLsbRsbRsbRsRsmbRsbRsRsmbRsRsmbRsbLsRsbLhLs
LsmbLsbRebRibRhbRiRsmbRibRiRsmbRibRibRgLsbRibRgRsmbRgRsmbReRsRhRhmbReR
ebRebRibRgbRgbRsbRsbRsbRsbLebLhLiLsbLgbLiLsbLcbLgbLibLibLgbLgbLibLiLiL
eLebLgbsbLsbLsbLgbLgLsbLibLgbsbRsbLgbLgLsbLcRsbLibLibLgbLiLsbLibLibRsb
LibLibLgbLsRsbLibLiLsbLgLsbRsbLgbLgLsbLsLsmbLsLsLsLsmmmbLsLsmbLibLgbLi
bLsLsmbRsbRgbRgbRgbLiLsbLgLsbLgbLgbLsLsLsmmbLsbLsLsmbLsbLsLgbLsbLsbLsL
smbLsLsmbsbLibRsbRsbRibRibRebRibLsbLcLsLsmmbLibLibLgbLcRsbLsRsLibLibLg
LsbRsbLsbLsLsmbLsbLsLsLsmmbLsLsLsmmbLsLsmbLsbLsbLsLsLsLsLsLsLsmmmmmmbL
gbLsLhbLsbsbRsbRsbRebRhbRiLsRsbRsbLcbLiRsbLibLibLgLsbRhbReRsmbRibRcbRi
RsmbRibRgbRgbRgbRjRibRjbRhbRhbLhbLibLibRjRsmbLiLsbLiLsbLsRsbLeLsbLgbLi
bRgbRjRsmbRiRsmbRsbRgbRiRsmbRgLsbRsbLgbLgLsbsbLsbLsbLsLsLsLsmmmbRsLgbR
sbsbLibLiLsbLsbLibLiLsLgLsbRsbRsbLgLsbLibLsbRsbLgLgbLsLsLsLsLsLsLsmmmm
mmbLsLsLsmmbLsbLjbLgLeLsbRsLsRsRsRsLsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bsbsbLsbLgbRgbRgbLobLgbLgLsLsmbLgbRsbLgLsLsmbLiLsLsLsmmbLiLsLsLsmmbLib
LsbLgbLgbLgLsbLsbLibLcbLibLibLebLiLebLsLebLebLiLsbRsbLsLgLsbRgLsbLibLg
bLibLgbLibLibLibLibLibLhbLcLoLobRebRcbRibRiLgbRhbsbsbsbsbLsbRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bLebLoLcbLcLsmbLcRsbLebLoLsRgmbLoLsLsmmbLiRgbLhLsbLsbLoLsLsRsmmbRsbLob
RebRebRcbReRibRcRsmbLsbRsbLgbLcbLsRsbRcbLebRhRebRgReRsRgmbRobRebRhbRcR
obReLsbLgbLoRsbRcbLgbRsLsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bsbLsRsbsbsbsbLsLsRsmbsbsbsbsbsbsbsbLsbsbsbsbsbsbsbLsLsLsmmbLsLsmbLhbL
ebRibRgbLjbLhbLobLcLsmbRibRoRsRembRcLsbRcbRobRcRsmbRibRcbRcbRebLsbRgbR
obLibLjbLebRebLsLebLcbRobRibLsbLsbLsbRsbRsRsmbRsbLhbLgbRsbLgRsbLibLobL
cbRibLobLibLibRebRoLsbRobRcbRcbRebReRgbRobRiLsbLcLsmbLsLcLsmbLgRsbRgbR
sbsbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bsbsbRgbRsRsmbRsRsmbsbRsbRsbsbRsRsmbRsbLsRsbsbLsbRsbLsbRgRsmbRebRgRsmb
RibRebLsLoRsbRebRgbLsbRibRjbLobsbRsbLsbRibRsbsbRgbRsRsmbRgRsmbRgbRsbsb
LsbLsLsmbLsbLsLsmbRsbLsbLsbRsLsbRsbsbsbsbsbsbRsRsmbsbRsLsbRsLsbRsRsmbR
sbRsLgRsbRsLsbLjbReLsLsmbLjbLoLsmbLcbLgLgbRsbLsbRobRoRsLsmbRobLibLiLoR
obLoLsmbRsRgbLcbLgbRibsbRgbLsbsbRsRsmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bRebLsbLsbLsbRsbRsbRsRsmbRebLiLsLjbReRebsbsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bRebLeRiRsmbRjRsRsmmbLgRebRobRebRebRcRsmbLsRsbRgRsmbLeLgLsbRsbLhbLjbLs
bLgLebLsbRsbRibRebLjbRsRsmbRsbRcbReRsmbRjbRobRsbRebRcbRsbRcRoRsLiLsmbR
ebRobLsLsLsLsLsLsmmmmmbLiRsbLibLsbLsLsmbRsRsLsmbRsbRgLsRhbRgbLebRoRjbL
sbLjbLobsbLibLgLsbLsLsmbLsbRgbsbLsLsmbRibRsRebRibsbLsbRobLobLiLsbLgbLi
RjbLgbLsLobLobLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bRsRsmbLoRsbLgbLsbLsbRcbLcbLsbRsbsbLsRsbsbsbLsbRsbLcLsmbLibLibRsbLgbLe
LsbLcbLcbLcLeLsLsLsmmbLsLsRsLsRsLsmbLsbLsbRsbLsRsbLsLsLsLsLsRsmmmmbLeb
LcLsmbLeLsbLeLsLiLgbLebLiLsbLiLsbLgbLhbLgbLsLhbLiLsbLhbLcbLcLsmbLebLeb
LsbsbLsLsLsLsLsLsmmmmmbLsLsLsmmbLsLsLsLsLsmmmmbLsLsLsLsLsLsLsmmmmmmbLs
LsLsLsRgmmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bsbRcbLhbLobLcLibLhLsbLcLcLcLeLsLiLsLiLgLsbLibLgLsbLgLsLsmbLsLibRcbRcb
sbLjLobLgLsbLibLoLcbLcbLebLibsbLeRsLoRgRsmbRhRsmbRsLsbRiLsbLsbLcbRebRc
bRcbRoLsbLsRhbRiRsmbRoRgbRhbRgRsmbLgLgbLsbLjbRebRcRsmbRcRsmbRiLsbLgRsb
RobRhbRhLsbLhLsbLoLibLebLcbRjbRobRibRcbRjbLsbsbRgbLcbLcbLsLsmbLcRsbLib
LjbLgbRibLsbLgLsbLsLsmbLsbLsbsbRcbReRsmbRcbRjbRhbRibRsRoLsbRibRjRcbLob
LobRgbRiRsmbRibRgbRsbRsbLsbsbLgbLsLsmbRsbRoRsmbRcbRibRcbRiRsmbRcLsbRib
RhbRiLsLsmbRiRsmbLobLcbLhLsbLcbLebRsbLibLobLibLebLobLcbLcbLibRgbLgbLib
LgbLsbLsbRjbsbsbLsLsmbLibLgLsLsmbLgbLebLsLgbLsbRiRsmbRcLsRsbLiRhbLhbRo
bRibRobLsbRcLsbRobLgLsLsmbLob

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bRgbRsLjbLsbLebLiLsbLgbLeLsbLebLiRsbLibLiLsLsmbLgbLcLgLibLcLsLeLeLsLcL
iLeLeLeLembLeLsbLebRebRebRebRhbRgbRoLebLsbLsLsmbsbLsLsmbsbsbLsLsmbLsRs
LsbLsbLsbLsLsLsmmbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bRebRsbLeLsbRgbLgLgbLebRsRsmbRcRsRembRgRsmbRiRsmbRiRsRsmmbRgbLoLsmbRjb
LobLobLgRjbLoRebRjbRgRsmbRebLgbRobRobRebRoRsRsRiRimmbRcRsmbLibLcRsRsRg
RsRsmmmbRiRibRibRsRiRsRsRgRsmmmbRcbRhbLcbLoRsbLiRsbRjbLcLsLsmmbRsbLibL
gbLsbLobLiRsbRsbLgbRibReRsmbLoRsbLhLsbLcbLobRgbLobLeLsLsmbRibRebLcbRcR
sRsmmbRsRsmbRebsbsbLsLhbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bsbRsRsmbRsRsmbRsbRsbRsbsbsbRsRhbLcbLcbLiLsLsmbLcbLgbLibLibRjbLcbLeLsb
LhLsbLiLsbLiLsbsbLiLsbLgbLibLiLsLsmbLiRsbLgbLcLsmbRsbLoLsmbLsbLcLsmbLi
bLibLiLsbLiLsbLiLsbLiLsbLgLsbRcbRobLsLsmbRhLsRsbLcbLcbRobLjLjLsLsmmbLe
bLcLsmbsbLeLsbLcbLcbLeLsbLeLsbReRsRsmmbRcRsRsmmbRibLsbLcbLcbLiLsbLgbLs
RsbLiLsbRsbLibLgLsbLiRsbRsbRcbRcbRhbRhbLsbLiLibLgLsbLgLsbLgbLgbLsbLsLs
mbRsbLibLgbLsbLgbLgbLibLhbLiRsbLcbLibLebLibLgLsbLibLibLibLiLsbLibRgbRc
bRcLiRsbLeLsbLgbLsbLgbLibLsbLgbLsLsmbLsbsbLsbLsbLsLsmbLsbLsLsmbLsLsmbL
sbLsLsmbLibRsbsbRjRsRsRsRjRsRsmmmmmbRcbRcRsRsmmbRcLsbLiLsbLhbLcbLibLgb
LibLiLsbLhRsbLcbLibLiRsbLhLsbLibLgbLgLsLsmbLgbLgbRibRobRcbRibRhbRebRgb
RiRsmbRibRgLsbRebRhbRcRsmbRcbRiRsmbRgbRgRsmbRgRsRsRsLsmmmbLsRsbRsbsbRs
bLsbRsbRsRsRsmmbRsbRsRhbLcLsmbsbsbLeLsLsmbLhLsbLcbLcbLcbLiLsbLeLsbLcbL
ibLhLsLsmbLgbLibLiRsbLibLgLsLgLsLsLcLeLembLebLebLibsbsbsbsbsbsbsbsbsbs
bsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bLhbRsLebRjbRsbLsbLiLsLiLsbLsbLsbLsbLgbLsbLsLsmbRsbRsbLgbLsbsbsbRsbsbR
sbsbLsLsmbLsLsLsmmbLsLsmbsbLobRobLibLcbLhbLhb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bRsLibLibLibLhLsbLiLsLgbLgLsbLoLsRsmbLibLgbLgbRobLsbLsRgbLobsbRsbLgLib
RsbRsRgLsbsbsbsbLebLebLhbLibLcbLiLsLibLgbLgLcLsmbLebLebLhbLibRsRsLsmbL
gbsbLsRsLsbsbLeLcLsmbLibLhLeLsbLibLgLsbLiLsbLiLsbLsLgbLibLibLibLhbLibL
hbLebLibLgbLibLsLsLgmbRsbsbsbsbsbsbRsbsbLhLsLsmbLcbLiLcbLgLibLsbLibLib
LebLsbLcbLoLsLgLsmbLiLsbLgbLgbLibLgbLcLsmbLibRjbRjRsmbRibRjRgbRiLsbLgb
RebRgRsmbRsbLsbLgbRsbLsRsLsRsbRsLsbRibRiRjbRebRibRebRhbReRcRsmbLhbLoLs
mbLibRiLsbRsbLibRebLgbRsRhbRcbLgLsLsLsmmbRsbLsbRjbLcRsbLobRsRsmbRgbReb
RibRgbRcbRgbRiRsRsmmbRcbRibRibRgRsmbRibLibLcbLcbLgbLebLeLsbLebRibLibRe
bRobLjbLsLsmbLsLgbRgbLebLcbLibRsLsbLjLsmbLhLsRsbLgbLibLgbLgRsRsmbLiLsb
LgLsbLibLgbRgbRibRcbRgbReLsbRibRibLgbRibRsRhRsRsmmbRsbReRsRembLobRsbRe
bRgLsbRjLsbLsRcLoLsmbRgbRibRebRibRebRebLsRibRibRgbRibRibRibRgRsmbRgbRh
bRhbRjRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bsbLsbsbLsbsbsbsbsbsbsbLsbRsbLsbLsbRsbRsbsbsbsbRsbLsbRsbsbsbsbRsbRsbLs
bsbsbsbLsbsbsbsbLsbsbLsbsbRsbRsbsbsbsbRsbsbsbLsbsbsbRsbsbLsbsbsbsbRsbs
bLsbsbRsbLsbsbsbsbsbLsbsbsbLsbRsbRsbsbsbsbsbsbsbsbsbRsbRsbsbRsbsbsbReb
LjbLcbRsbLibLcbLgLgbLibLsbLibLgLsbLibLoRsbLobLhbLibLiLsbLsLebLgbLhbRgR
smbLsbLeRsLiLsbRcbRgRsmbLsbRgbRsbLsbRsbRibRsbRibLcLsLsRimmbRebRobRgLsb
RhRebRebRibRoRsmbLsbRcbRcbsbRcbLsbsbsbRsLsbLobLebLgbLhbLiLsbLsbLobLcLs
mbLcLsLgmbLcbLiLsbLgbLsbLibsbRgbRcRsmbRiRsLsmbRibRoLsLgbRoLsbRebLsbLsR
sLsbLsRsLsLsmbRsbLsbRsRsmbRsRsmbRjbLoLjbLebLobLoLeLiLeLsbLebLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bRjRgRsRsmmbRjRsmbRcbRibRiRsmbRibRcbRcbRcbRgbRcRsmbRgRsmbRiRsmbRgRsmbR
ibRcbRcbRcRibRiLsReRsmbRsbLebLhLsbLhbLibLgbLgLsbLhLsRsbRgbLhLibLibRsbL
gLhLsbLeLsbLebLiLhbLgbLhLgbLgbRsbRjbLsbLsLhbLibRobLjbsbLebLcbLcbLsLgLs
bRcbRcRsmbsbRcbRcRsRsRsmmmbRcbRcbsbLjLsmbLhbLiLsLsmbLgbsbLgbLiLsbRsbLg
LsLsmbLgbLgbLgLsRsLsbLsbLsbLsLsmbLsbRsLsbLsLsmbLibLiRibRibRibLgRsbRcRs
mbRiRsRiRsRimmbRsRiRsRsmmbRcbRibRibRhRiRsmbRhRsmbRibRgbRgRgRsmbRgbRsRs
mbLjbLibRiRsmbLhbRsbRgbRibRcbRibsbRsbRibRgRsmbRsbRsRsmbsbRgbLgbLhbLiLs
bLibLsbLsbRibRebLiLsbLjLsLsmmbLsbLibRjRsmbRibRibRcRsmbRjRgbRcRsRsmmbRi
bRiRsmbRgLsRsbRgbRsRsmbRebLeLsbRgbLhbLibLjLibLcbLiLsbLsbRibRsRsRgmbRcb
RhRsRsmmbRiRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
bsbLsbLsbLsbLsbsbLsLsLsmmbLsbLsbLgbLebLcbRsbRsbRsbRsbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bLsbLsbLsbRsRsmbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bRgbRhLsbRcRsmbsbRhLsbRobRcLsbRcbRiRsRimbRcbsbRsLsLsmbRcbLoLsmbLcLsmbL
iLibLhbLibLgLsbLibLiLiLsLeLeLcbLibLcbRebRebRebsbsbsbRsbRsbsbsbLibRsbRs
LsLsmbLsRsbsbRsbLsLcLsmbLgbLobLcLsmbLibLibLiLsLsmbLeLeLebRebRhbLcbLgbL
gbLgLsRsLcbLobReRsmbRhRsLsmbRiLsbLcbLobRibsbsbRsbRsbRgbLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 19; Drug: Control Apo 50 然
bRiRsmbRgRgbRiRsLsmbRibLsbRiRsmbLsLsRgRsRsmmmbRebRgbRsLsbLgbRiRsmbRsRs
RimbRiRsmbLsbLsLsRembLsbRsbRibRsRsmbRgbRiRsmbLsRsbRgRsmbRsRsmbRhbRgbRs
RsmbRibRgbRgbLsbRgbLsRsbRgbRgbRsLsbRsRhbRsRibRgbRsRsmbRgRsmbRsbRsRhbRs
bLsRsbLsRsRebRgbLobLsLsmbRibRibRiRsmbLsbRgRebLsbRsbRgbLsbRgbLsbRibLsbL
sbLsbRgRibRibRsRgbRsbRgReRsmbRsbRhbRsbRgbRsRsRsmmbRsRsRsmmbRgRgRsmbRsR
gbsbLsRsbRsRsmbLsbRsbLgbLsbRsRsmbRsbRsbsbsbLsRsbRsRsRsRsmmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 20; Drug: Control Apo 50 然
bLgbLsbLsLsLsmmbsbsbsbsbLsbLsbRsLsRsbLgbLgbRhbLibLjbRgbRsbRgbRgbRgbRgb
RsbRgbLsbRsbRsbRgbLsbRsbRsbRsRsRsmmbRsbRsRsmbRsbLsRsbRsRsRsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 21; Drug: Control Apo 50 然
bLsbLgLsLgLsLsLsLsLsLemmmmbsbLibLgLsbsbLsLsLsLsmmmbLgbLiLsLgLgbLsLsLsL
sLsmmmmbLsbLsLsmbLsLsmbLsLsmbLsbLsbLsLsmbLibLsLsLsLsmmmbLsRsRsmbLsRsLs
bLsbLsLsmbLsLsLsLsmmmbLsLgLsbLgLsbLibLsLgbLsbsbRgLsbRiRsmbLebLeLsbsbRs
LsLsmbLiLsbLgbLgLsLsmbLsbLsLsmbLgLsLsLsLsLsLsLsmmmmmmbLibLiLsbLsbLgLsb
RibRiRsmbRgRsLsLsRsLsmmbRsbLsLsmbLsbRcRsmbRhbRsbRsRsRgmbRsRsmbRsbRsbRg
LsbRsRsmbReRsmbLiLsLsmbLibRebRgbRobRjbRgReRsmbRjbLgLsLsmbLgbLsRsbLibLj
bLgbLgbLibLibRhbRjLsLsmbRjbRibLgbRhbLjbLsbRibRgRsmbRiRsmbRsRsRsLsmmbRs
bRsRsmbLsbRjbRebRhRsmbLiLsbLgbRsbLibRsRebLibRebRsbLsRsLsRsbRsbRsRibReR
gbLgLgbRsbLsLgLeLsbsbLebLebLgLgLebLsbRsLsbLsbLeLsbLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 22; Drug: Control Apo 50 然
bLobLiLsLsmbLibLeLsbLibLiRsbLcLibLgbLgbLsLebLiRsbRibRhRsmbRhRgbLeLibLi
bLiLoRsRsmbLobLebLobLebLobLgbRobRhbLjbsbLjLcLsmbRsbLiLsbLibLjbRsbLjbLg
bLibLibLibLcbRcRsmbRebLibRsbRobLobLsLsLsmmbLiLsbRsRsmbLsbLibLsLsmbLsLs
mbLsbLsbLsLsLsLhmmbLjbLsbRsLsbRsbRjRebRsbLjbReRsmbLjbRgbRsRebRibRsbsbL
ibLibLsbLsLibLgLgbLibRiRsRsLsmmbLgbLjbRiRgbRebRsbRsLsbRcbLgLsLsmbLibRs
bRsbRibsbRsbRsbRsRsRsmmbRsbRjbRobsbLeLsbLsLsmbLsLsmbLgLsbLsbLsLsLsLsLs
LsmmmmmbLsLsLsLsmmmbLgbRsLsLsLsLgmmbRsRcbLsbLgbRjbRiRsRsmmbRibLsbLsLsL
smmbLsbRsbRjRcbLsLsLsLsmmmbReRsmbLgbRsbLsRsRsRsRsRsRsRsRsRsRsRsmmmmmmm
mmmbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 23; Drug: Control Apo 50 然
bRsbsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 24; Drug: Control Apo 50 然
bRsbRsRsRsRsRsRsRsRgRsmmmmmmmbRgRsRsRsmmmbRsbRsRsmbRsbRsRsmbRsRsRsmmbR
gRsRgRgmbRsRsmbRsRsLsmbRsRsmbRsRsRgRsRsmmmbRsRsLsmbRgbRsbRgbRsRsmbRsRs
mbLsbLsbRsbRiRsmbRsLsbRsbRsLsRsbRsRgRsRsRgmmbLsbRsRsmbRsbRsRsRsRsmmmbR
sbRsRsmbRsRsRsRgmmbRsbRsLsbRsRsRsmmbRsRgRsmbRsbLsbRsbRsRsRsmmbRsRsRgRs
mmbRsbRjRsmbRsbRsbRgbRsbRsbRibLsbLgbRsbRsbRsbLsbRsbRgbLsbRsRsRsRsmmmbL
sRsbRsbRibRsbLsRsbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bLsbLsLsLsRsmmbLsbLsbLsbLgbRsbRjRsmbLobRcbLjbLcLgLiLsLebLsbLeLiLebLsbR
hRobLjbRsbsbsbRsRsLsmbLsbLsbRsbRsbsbRsRsmbsbsbsbsbsbsbsbsbsbsbsbsbRsRs
mbRsbReRsmbLsLsLsmmbLiLsLgbLiLsbLiLsbLibLiLsbLiLsbLgbRsbLhbLiLsbLiLsbR
sbRcbRiRsmbLibRcRsRcmbLjbLcReRiLsRebRhbRibLsLjbRgbRcbRjbRcLsbLjbRsLsbL
hbLcbRgbRobLobRiRsRsmmbRsLgbLcbsbLsbRibRcbLsRobLebLibRebLsbRsbsbsbRsbs
bLsbsbsbsbsbLsbsbLsbLsRsbLsLsmbLsbLsbLsbLsRsbRsLsbsbsbLsbRsbsbsbsbsbsb
LsbsbsbsbsbLsbsbsbsbsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bRsRsRsRsmmmbRsRsmbRsRsRsmmbRsbRsRsRsmmbRsbRsbRsRsRgmbRsRsmbsbLsbRsbRs
bRsbLsbRsbLsbRsbRsbLsRsbRsRgbLsLsmbRhbRgRsmbRsRsmbRhbLsbLsbsbLsbLsLsLs
LgLsLsmmmbsbsbLsbRsbLsRsbRsRsRsmmbRsbsbLsbRsbLsbsbLsLsLsmmbsbsbsbLsbLs
bLsbLsLsmbLsbsbLsLsmbLsbLsbLsLhbReLsRsbLibLiLsbLibLiLsbLgbLeLsbLhLsbLi
LsLsmbLobRoRsRiRsRemmbLoLsmbsbLsLsLsLsLgmmmbsbRsbLsLsmbsbRsRsmbLsbLsbL
sbLsbsbLsRsbLsbLsbLsLsmbLsbLsbLsbsbLsbLsbLsLsmbRsbRcLsbRhbRibRibRibRcb
RgbLebLgbLsLiLsbLobLcRobRobRibRiLcLgLibLiRsbLsRebLhRiLsLsRoLsmbLcRsReb
LgbRebRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bLsRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbLeRsbRsbRibLgbRcbLobLiLeLsbLibL
ibLeLsbRcbLoLsmbLoRsbLiLsRsbLgbLobRsbLcbLcLsmbLcbLcLsmbRgbRjbRhbRhbRcb
RcbRcRsmbRcbRcRsmbLiRsbLebRgbRgbLebLsLobRgbLgbLsLsRsRimbRjbLibLebLibRs
bRsbRsbLsbRsLsbLsLsmbLebRcbRjbLgbLjbLoRcRsmbRiRcbLgbLibLhLebLhbLibLibL
ibLsLsmbRjbRobLhLsLsmbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bRiRsRsmmbRgbLibLebsbLsLsmbLcbLibLgLsbLgbRibLsbRibRiRsmbRsbRibLgbsbRib
LgbRcbRgbLgbLiLsbLcbLcbLibLgbLcLeLebLhbLgLsbLgbLgLsbRsbLgLsbLgLsbLgbRs
LsbRsLsbLiLsLsmbLsbLibLibLibLiLsbLibLebLgbRgLsbRgbLgbRibLsbRgbsbRgbRsb
RgbLsbsbRgbRibLjbRibRgRsLsmbLgbLhbsbsbRsLsbRjbLsbLsbRsLsbLsRsLsbLsLhbL
iLsbRsbLgbLibLsLgbLsbRebRiRsRsmmbRebRibLibLgLsbRsbsbReRsmbRiRsmbLsbRib
LsbsbRgRsmbLsbRgbRsbsbLsRsRsmbLeLsbLsLsmbRjbLsbLsRsbsbRjbRcLsbLebLiLsL
smbLgbRsbLsbsbLsbLsbsbRibRsbRibRiRsmbRiRsRsmmbLebsbLcbLgLsbRsbLibRgbLi
bLsLsmbLsbLgLgRsbLibRsbRibRcbRibRgbRgbRibsbLsbLsbLhbRjbRibRsbRibRibsbL
iRsbsbRibRiLsbRgRsmbRsRsRsmmbRgRsmbRsRgbRsLsbRgRsmbRiLsbRibRiLsbLibLib
RsbRcbRgRsmbLgbRgRsRsmmbLsLsmbRibRibRhbLibRsbRibRgbRsRsmbRgbRgRsmbRgbL
sbRgRsmbRgbLgLsbRgbRsbRgLsbLgbRiRsmbRiRsmbLebRgbRhbRgbRgRsRsRsmmmbLsbR
sbLsRsbsbRgRsmbRsbRibRibLibLgbRibRibRsRsmbRibRgRsmbsbRgbLsbRibRgbRibRe
bLgbLsbRhRsmbRibRsbRiRsmbRiRsmbsbRhbRhbLiLsbLebLhbLhLsbRgbRjbsbRsRsLsm
bRibLgbLjbsbsbRiRsmbLsbRhbLjbsbsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bLgbLsbLsbLsbLgbLsbLsLsmbLsbLsbLsbRsbRsbLiLsbLgbLgbLgbsbLsbLsbLgbLgLsb
LgbLsbLgbLgbLgbLsbLsbLsbLgbLsbLsbLsbLsLsmbLgbLgbLgbsbLgbLgbLgbLgbLsbLs
LsmbLgbLgbLgbLgbLsbsbRsLsRsbLgbLgbLgbLgbLgbLsbLgbLgbLsbLsbLgLsbLgbLsbL
gbLgbLgbLgbLgbLsbLibLgbLsbLgbLgbLgbLsbRcbRsLsbsbsbRsbRgbRgbLsLsmbRsRsm
bRsRsmbLjbLibRsbLsbRsLsbLibsbLsRsbLsbLsbLgbRsbLsRsbsbLsbLsLsLsmmbLsLsL
smmbLsLsLsmmbLsLsmbLsLsLsmmbLsRsLgbLsbLsbLsLsmbLgbLibLsbLiRsbLebLiLsbL
eLsRsRsmbLebRcbRcRoRsmbRgbRhbLiLsbReRsmbRcRsRsmmbRhbRiRsRsmmbRsbLcbLib
RsbLsbLsbLsRsbLsbRobLsbLeLjbLhbLibRebRebReRsmbRobRcRsmbLiRgLebRebRgRsm
bRibRsRsmbRgRsmbLsLsmbRsRsmbRsbLsbRsbRsbRsbsbRgbRsRsRsRsmmmbRgbRsRsmbR
gRsmbRsbLjbRsLcbLibLsRsbLibLibLsbLhbLgbLgLsbLgLsbLgbLsbLgbLiLsbLsLsmbR
obRiRsmbLsbRgbRsbLsbsbLsbRsbsbRsbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bRsbRsbRsbRsbRsbRobRoRsmbRjbRcLcRsLeRibRgbRiRhbLebRiLsbLsLsLsmmbLsLsLs
mmbLsLsmbsbsbLsbLsbRsbRsbsbsbsbsbLsbRgRebRsbRsbRsbRsRsRgRgRgRsRsRommmb
RgRsRsmmbRiRsmbRobLgbRobLgbRebLcbLgLsRsbRgbLob

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bLsLsLgLsmbRsLsLsLsmmbRsLsbLsLsRsmbLsbLgbLsLsLsLsmmmbLsLsLsmmbLsbLsLsL
sLsLsRsLsmmmmbLsLsLsmmbLsLsLsLsmmmbLsLsLsmmbLsLsLsmmbLsbRsLsbRsLsbRsbR
ebRsbRgLsbRsbRsbRsbRsbRsRsLsmbRsbRsRsLsmbRsRsmbLgbLobLcbLiLsbLeLsLsmbL
iLsLsmbLhLsbLibLibLgbLsbLsbLsbLsLsmbLgbLsbLsLsRsmbLsLsmbLsbLsLsLsLsmmm
bLsbLsbLsbLsbRsLsLsmbLsbLsbLsLsLsLsLsmmmmbLsLsmbsbRsbLsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bRsbRgRsmbLibLebLcbLibLgLibLiLsbLibLsbLsbLibRsbLsbLibLgbLsbLiLsbLoLiLs
LsLeLsLiLiLimbLibLgLsRsLsbLgbLibLibRsRsmbLobRobsbLibRsbRjbRgRsmbRoLsbR
cbRgReRsmbReRebRebRebRobRcRsmbRgRcLsbRobRhbRhbLsRsbRibRgbLsbRobRgbLsRg
bRsbRcRsRgmbRgbRsRsmbRgbRsbRgbRibRiRsRiLsRsmbRhRsmbRgRsRhRsmmbRiReReRc
ReReReReReRsmbRebRcRsRsmmbRebRcb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bLhbLeLsLsmbLibLoLsmbLhbLeLsbLeLebsbsbRsbRsbRsbLcLsmbRibLcLsLsmmbLcbLe
bLebLgLsbLcRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bRobLsRsbRsRgbRsRebsbRsRsmbLsbsbLsbRgRsmbReRsmbRibLebLeLcbLeLsLsmbLiLs
LsmbLgLsbLibLiLiLsLsmbLsLsmbLsLsRsmbLsLsmbLsbLsbRsRjbLibLobLjbLeLsbLsb
RsLsbLsRsLsbLsbRgbRsbsbsbRibRgbRebRibRebRhbRgbRebRibLjbRibLsbRsbRcbReb
RhRsRcmbRgRgbRibRhRsmbRiRsRsmmbLhbLsbLebRgRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bRsbLgbLcbLgbLgbLsbLsLsmbLsLsmbLsbLsLsmbLsLsmbRsbLibRobRobLsbRgbRhbRib
RsbRgbRsRsmbRibLhbLsbLcbsbLcbLjbLcbLibRgbsbRcbRobRobLjbLibLsbLoRiRsmbR
gbRibLgbRoLsbRibLsLsmbLcbLsbLobLibLjLsLsmmbLibLiLgbLcbLcbRibLcbRgbRgbL
gbLcRsbLgbLsbRgbReRsmbRhbLobRoRsmbRibRjbRsbRobLsLcbLibLsLsmbLobRgRsmbR
sbRsbRibLsbRsbRsbRsbRsbLsbRsRsRsmmbRsbRsLsLsmbRgbsbRsbRsbRsbLsbLsbRsbs
bRsbRsbLobLhbRsbRsbRcRsmbRebRhbRibRibRibRsbLcRsbLobRibLobRsbRgbLebLobR
sbRgbRiRsRimbRjbLebRibRcbLcRsRsmbRjRsLsmbRgbRgRsmbLcbRhbRjbLibLsRibLjL
smbRebLibLebLibLsRiRsmbLsbLcLsmbLoLsmbLcbLibRgbLibLibRsbRibLhbLcbRsbLc
LsmbLebRsRsmbRebRebRgRhbLgbLgbLsLibRsbLebLsbRsbsbsbLsbRsbLsLsmbLsbLsbs
bLsLsmbLsbLsLsmbLsbRsbLsbLsbLcbRobRobRsbLsbLsLsmbRsbLsLsLsRsLsmmbLsbLs
LsmbLsLsLsLsmmmbRsLsLsLsmmbLsLsLsmmbLsLsmbLsLsLsmmbLsLsLsLsLsLsLsLsRsL
smmmmmmmbLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbLsbLsLsLsRsmmbLsLsLsmmbRjbRibLs
bLsLsmbLsbLsLsLsRsLsLsLsmmmmbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLgLsbLsLsLsL
smmmbLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbLsLsLsLsmmmbLsLsmbLsLsmbsbLsLsLsLsL
smmmmbsbLsLgLsbLsLsmbRgLsbLsLsLsLsLgmmmbLsLsLsLsLsLsmmmmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bLsbLsbLsbLeRsLiRsLibLgbLgbLgbLgLsbLgLsbLgLsbLgLsbRsLsbLgbRsLsLsmbLsbL
gLsbLsbLsbLiLsbLsRsbLgRsbLibLibsbLsbLibLgbLsLsLsRsLsmmbLsbsbLibLibLcRs
RsLgmbLibLibLiLsbLsLgRsbLiRsbLgbsbRsbLjbLibLsLsmbLgbLsLgbLgRsRsRsmmbRs
bLsRsbLgbLibLgbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
bLsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bLsbLsLsmbsbsbsbRsLsLsLsLsLsLsLgLiLsmmmmmbLsbRsbLsbRsbLibLsbLiRsLsLiLs
LsmbLsLiRsLsRsLsLsmbLsLiLsbLgbLiLsbsbLsbLsLsmbLjRsbLsLsLsmmbLiLsLsmbLc
LsLsLsLhmmmbLiLsLsmbLsLsLsmmbLiLsbLsbRsRsLsLsmmbsbRsLsbRobRhbRibRebLgL
sLgLgLcbRibLobLsbLjbLibRebLcRsLsbRhbLsbLgbRebRoRsmbLoLsLsmmbLsRhRsmbRc
bLcbRhbRobRcbRsRsmbRcbLeLsLsmbLjLiLsbLobRgbRoLsbRjbLibLcbLibLibsbLiLsb
Lgb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bRsbsbsbRsbRcbRibRoRsmbRibRcbRibReRebRcRsmbsbRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bLgLsbLsLsmbLsbLsbsbLsLsmbLsbLsLsLsmmbLsbLsLsLsLsmmmbLsLsmbLsLsmbLsLsL
sLsLsmmmmbLsLsLsmmbLsLsmbLsLsmbLsLsLsmmbsbLebRsRobRcbRgLsbRgbRgRsmbRsR
sRsmmbRgbRgbLgbLhbLiLsbLgbLibRibRcbRiRsmbRebRebRebRiLsbRcbRibReLsRsbRe
bRibLsbLcbRsbsbLsbLsbRsLsLsLsLsLsmmmmbRjbLgbLeLsbLcLsmbLcbLobLibLebLib
LsbRcRsReRsRsmmmbLsLjbLhbLgLsbsbLgLsbRgbLcbLcLsLsmmbRgbRgbRgbRgbRgbLsb
RsbRebsbRsbLsLsRsmbsbRsRsmbRebLcbRjbsbLcbLcbRgRsmbRgRsmbLcLsmbLeLsbLcb
LcLsmbLcbLebLebRgRsmbRibRgRsmbRiRsmbRgbRsbLcbLobLsLsmbLsLsLsLsLiLsmmmb
LgbLgbLsbLsLsmbsbLsbLsbLsbRsRsmbRjbRibRebRebRiRsmbRgLsbRiRsmbLjbLeLsbL
obLobLebRsbLebLeLsbLsLsLsmmbLsbLsLsLsLsLsmmmmbLsLgbLibRgbRobRcRsmbRsRi
bLsRcRsmbRgbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bLgbLcbLhLsbLcbLibLhbLsLeLeLeLebLeLsbLcbLeLsbLoRsbLobLibRibLeRsbLhbsbL
sLsmbRsLsbRsbLsbLsbLsbLsbLsLsmbsbRsLsbLsLsmbLsLsmbLsbLsbLsbLsRsbLsbLsb
RsbsbLsbLgRsbLsLcbLeLsbLcLsmbLgLsLiLsLibLiLeLcLeLsbLcLebLsbLsRsbRobLjb
LcbLcbLhbLhbRibLsLsmbRobsbLgRsbLgbLibLebLsLsmbLobLjbLhbLhLsbRsbLebLobR
ibLibLiLsLsLembLoRsLsbRhbRsbLebLebLgbLsLsLsmmbLgbLgbRjRsmbRcRsmbRibRib
sbRebRsbLibRcRsmbRgbRiRsRsmmbRgbLsbRsbLebRebReRsmbRhbRibRjbRjRebRgbRib
LgbRhbRibRibRiLsbRibRibRibRiLsbRcbRibRjbRsbRjRcbLgRsbRsRobRsRsmbRibReL
sbLibLibLsRsbLobLoLsmbRgbRebLibLcbLsLcbLobLgbRgRsmbRjRebRgbRibRobRebLg
bRcbLjbLcbLeLsbLiLsbLebLcbLiLsbLibLiLsbRsRsmbLjbLcbRebRhbRebRibRibRebR
sbRjRjRhbsbLsbRsbsbLcbLhbRsLsbRhbRibRgbRcbRgbLibRcbRobRsbRibRgRgbRebRg
bLgbLgbLcbLhbLsbLebLcbLgbRgLsbLebLobRibRgbRebRebRgbRcbRcbRsbReRsmbRgRs
mbRibRebLgbRebLjbLcbLgbLcbsbRsbRjRebRibRebRgbRjRgbRhbRgbLgLsbLsbRebsbL
ebLcbRsbRgRsmbLgLgbLsLcbLhbLcbLibLhbLsbLgRsbLebRgbRgbRibRebLgbLibLibLi
bRgbLibRgbLebLobRgbRebRgbRibRebRgbRsbRebsbRhbLjLsmbsbLibLobLibRsbRsbRj
RcbRsLsRibRgbRobRgbLsbLibRsRcbLjbLibRsLoLsmbLcLsmbRoRsmbRebRebLgbRsbRg
RsmbRgbLcLsmbRebLhLsbRgRsmbRcLsbRebRgbLibLeRsbLiLsbLeLsbLhLsRsbLcbLgbL
ebRsLsbsbLebRgbRgRsmbRgRibRebRgbLibRgbRjRibLgbLsLeLsbLeLsbRsRsmbRcbRiR
smbLgbsbLhLsbRjRgRsmbRgRsmbRcbRgbRsbRcbRcbLgbLsLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bRsbsbRsbsbsbRsbsbsbsbsbLsLsmbRsbRsReRsRsmmbLsbLoLsmbRiRsmbReRsmbRcbRc
bRhRsRembReRsmbRiRsmbRsbRcLsbLgRcLhbLsbRebReLsbRebLeRsbLobLobLcbLibLoR
ebRsLibLobReRsmbRcbLgbRcLsbRibRebRibRcbRibLsRobLoRibLcbLsRsbLobRgbLibL
ibLgbLobLiLsbLobLibRibLcbsbLjbLgbRsRsmbLobRhbRsRsmbLjLsmbLsbLgLsLsmbLi
bLiRsLsbLsbLsbRsRsRsmmbRsbRgbRgbRibRsRsRsRsRsRimmmmbRsRsRgRsmmbRgRsRgL
smbRsRsRsRsmmmbRsRsmbRgbRsRsmbRsRsRsmmbRsRsRsRsRgRsmmmmbRgRsmbRsRsRsRs
mmmbRsRsRsRsRsRsmmmmmbRsRsRsRsmmmbRsRgRsRsmmbRsbLsRsbRgRsRsmmbRgbLsRsR
sRsRsmmmbRsRsRsRsRsmmmmbRgRsRsmmbRsRsRsRsRsRgRsmmmmmbRsRsRsRsmmmbRsRgR
smbsbRsRsRgRsRsRsmmmmbRsRsRsmmbRsRsRsRsmmmbRsRsRsRsRsmmmmbRsRgRsmbRsRs
RsRsmmmbLsLgbLsRsRsmbLsbRgbsbRsLsbRsbLsbRsRsmbRsbsbRsRsRsmmbRsRsRsmmbR
sbRsRsRsmmbsbRsbRsRsRsRsmmmbRsRsmbRsRsRsRsmmmbRsRsRsRsRsmmmmbRgbRgRsRs
mmbRsRsmbRsRsRsmmbRsRsRsRsRsLsmmmmbRsRsRsmmbRsRsRsRsRsRsRsRsmmmmmmmbRs
RsmbRsRsRsRsRsLsRsRsmmmmmbRsbRsRsRsmmbRsRsRsRsmmmbRsRsmbRsRsmbRsRsmbRs
RsRsmmbRsRsmbRsRsRsRsRsRsmmmmmbRsRsRsRsRsmmmmbRsRsmbRgRsLsmbRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 43; Drug: Control Apo 50 然
bLgbLgbLgbLsbLsbLibLgbLgbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLgbLgbLsbLsbLsb
sbLsbRsLsbLgbLibLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 44; Drug: Control Apo 50 然
bLsLsLsLsLemmmbLgbsbRsLsLsLsmmbLgLsbRcbRcbRcLsbRhbRhbRjbRcbLhbLiLsLsmb
RjbRebRhbRcbRcbRhbLebLiLsbLgbLibLgbLebLgbLsLsLsLsLgLiLsmmmbLiLsbLeLsbL
cLsmbLebLgbLsbRobRcbRhbLgbRsRsRsmmbRsbRsbRsRiRsmbRsRgbsbLsbRsLsbRgbRsR
sLsmbRsbRsRsRsmmbRsRsmbRsRsmbRsbRsRsmbRsbRsbRsbLsbRsbRsRsmbRsbRgRsmbRs
RsmbRsRsmbRsbsbRsbRgbRsLsbLsLsmbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 45; Drug: Control Apo 50 然
bRsbLebLibLiLebRcRibLsRsbRcbRhbRibRcbRcbRiLsbLsbRgbRiRibRibRibRibRgbRc
bRcLsRcReRsRiRsmmbRcRsmbRibRiRsmbRsRcbRiReRibRgbRhbRobLibLhbRjbLsbLjLg
bRsbRcRsmbRebRcbRgbRsRcbRibRgbRgRsmbRgbRjbRibLgbLgbLiRsbRgbsbLjLsmbLcb
LgRsbLebLibLhbLcLsmbRgbRibLsbRgbLsbLsbRsbLgbRsbRsbsbReRsmbRhbLsbLsLebL
hLsbLgLsbLibLgbLsbRsbLgLsbLsLgbLgbRhRsmbRcbRcbRcbRiRsmbRibRibRgRsmbRgL
sbRsbRgLsRsbRibRhbRibRibRibRebRgbRgbRsbRgLsbLjLsmbRibLgbRibRcRsmbRibRc
bsbRibRsbRibsbRgbRhbRgbRgbRhLsRsbLhbLibLibRsLsbLsbLgLsbRsLsLgbLibLsLsm
bLsLsmbLsLsLsmmbRjbLsLjLibLcbLsLsmbLjLobLibRjRsmbRjRgbRibLsbLsbRibLjLs
mbLjLsmbReRsmbRcRsmbRhRsmbRibRgbRibRibLsbRhbRibRgbRibRgbRebRcbRibRgLsb
RgbRgbRsbRgbRsbRsbRsLsbRsbLsRsbRsbRsbRsRsmbRgbRjRibRcRsmbRhbRgbLsbLgLs
bLgbLgbLgRsLsbRjbRgbRgbLjbLcbRsLcLsmbLgLsbLgbLhbLibLcbLcbLibLiLsLsmbLc
bLjLsLsLjmmbLibRjbRjbRcRsmbRgbRibRcbRgbLsbRgbRsRsmbRgbRsRsmbRgbRsbRsbs
bRsRsmbLsbRsbRsbRsRsmbRcRsmbRcbRebRgbRcbRcbRibRibRibRhbRibRibRgbRibsbL
ebLcbsbLebLibLgbLibLsbLgbLebLjLibRibLhLsRsbLibLgbRgbLebRibRhbRibRjRsmb
LgLjLgLsbLsLgRsbLsLsmbLhbRsRsmbRjbRgRsmbReRsmbRibReRsmbRgbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 46; Drug: Control Apo 50 然
bRsbLebsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 47; Drug: Control Apo 50 然
bRsbLsbRibRobRibRoRsLsmbLgbLebLiLsbLsLsmbLsbLsLsmbLsLsmbLsLsLsLsmmmbLs
LsLsLsmmmbLsLsLsLsLsLsLsLsLsLsLsRgmmmmmmmmmmbLsLsLsmmbLsLsLsRgmmbRsbRs
bLsRsbRsbLsbRsbLsbLsbRsbRsbLeLsbLsbRsbRsbLsbLsbLsbLcLsmbRsbRsbLhbLcbRg
bRgbsbsbLsbRebRcbLsbLhLsLsmbRsbsbsbLsbLsbLcLsmbLebLibRjbRiRibRgRsmbRsR
sRsRsLsRsLsmmmbLsbLcLsRsmbRsbsbLsbsbsbRgbLsbLsbLcbLcLsmbLcLsmbLibLibLi
bLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmbLsLsLsLsmmmbLsRcbLcLsLsmmbLhLs
bLcbLcbLiLsbLiLsbLeLsLebLiLsbLhbLebLgbLgLsbRsLiLsbRhbRcbRibsbRsbsbRsRs
RsRsRsmmmmbRsbRibRcbRibRcRsmbRcRgReRsReRgRembRebRhRsmbRibRsRgbLsRsLsbR
sRiRsmbRsRsRsRsRsRsmmmmmbRsRgRsRgmbsbRsRsRsRsLsRsRsRsRsRsRsRsmmmmmmmmm
bRibRsRcbRjbRcbRsbRibRibRgLsbRcRsmbLgbLhLsbLiRsLgLibLgbLebLibLebRgbLgb
LjbRsbLcLsmbRcbRibsbLsRebRcbRebRiLsbLgbLcbLgbLcbLgLsbRibLoRsbLgLsbLibL
hbRcbLhLsbLiRsbLiLsbLgRsbRsbRjbLobRsbRhbRhbRiRsmbsbLibRibLibLibLibsbRs
LsLsLsLsRsRsRsLsmmmmmbReb

>ZF Recording 2016-08-24; tW: 300s; Start: 123701; End: 124202;
Recording: 7-1; Individual: 48; Drug: Control Apo 50 然
bRsLsLsmbRsRsmbLsbRsbRsRsmbRsLsbsbLjbsbRsRsmbRebRsLsRsbRsbRsbRsbReRsRs
mmbRgLsbRsRsmbRsRsLsmbRjRsmbRsbRhRsmbsbRgRsmbLibLebLiLsbLhbRsRsRsRsRsm
mmmbRsbRsRsRsmmbRsRsmbRsbLsbRsbRsLsRsbRsRsRsmmbReRsRsmmbRsbLgLsLsLsmmb
LsbRsLsbLsbLgLsbLsLsLsmmbLsbLsLsLsLsLsmmmmbLsbLsLsLsLsLsLsLsLsLsLsLsmm
mmmmmmmmbLsbRsLsLsLsmmbLsbLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLsLsLsLgmmb
LgbLsbsbLsLsmbLsLsLsLsmmmbLsLsLsmmbLsbLsLsmbLsLsmbLsLsmbLgbLsbLsbLsbLs
bLsLsLsLsLsLsLsmmmmmmbLsLsmbLsLsLsmmbLsbLsLsmbLsLsmbLsLsLsLsmmmbLsLsmb
Lsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bLsbRiRsLsmbRsLsbLeLsbLiLsLsmbLibLgbLibLiRsLeLoRsRjbRhRgbLgbRebRiRsRiR
gReLcLsmmbRcbRobRobRebsbsbsbsbsbRsbsbsbLsRsbsbRsLsRsbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbRsbsbLsbsbLsbsbsbsbsbsbsbsb
sbsbsbsbsbsbRsLsLsLsmmbsbLsbLsLsmbLsLsmbRsLsbLsRsRsLsRsLsLsmmbLsbRsbsb
sbLibsbLsbRebRibRhRsRsRsRhRsmmmmbRcRsRiRsRiReReRoLsmmbLsLhbRebRebLsbLs
RgRsRsRsLoLsLcmmmmbRcbLebLgbsbsbLoLiLgLsLsmbLsRsLsbLgRibRebRgbLsbLsbLs
bLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bLsbLsbLsbLsbLsbRsbLsbRsbsbRsRsmbRsbRsbLsbRsbRsbRgRsmbRcbLibLobRgLsbLc
bLsLgbRcbRgbRibRibRiLsbRibRiLsbRobLcbLgbLibLibLcRsbLcbLiRsbLcbLsRcbLgb
sbRsRsmbRsLsbsbLibRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bsbsbsbsbsbsbRsRsmbLsbsbLsbRsLsbsbRsbsbsbsbsbRsbLsRsbLsLsRsmbRsRsRsmmb
RsbRsRsmbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bsbsbsbsbsbsbsbRsLsbLsLsmbRsbRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bRjLsLsLsmmbRebLgRsbLsbLsbRsbLsbRsbLeLsbLebLiLgbLebRgbLgbsbRcbRhLsbRgR
smbRsbLjbLobRgbLiLsLsmbLsRsbLeLsbLebLibLsLsLsmmbLgbRsbRsbsbsbLgLsLsmbL
sLsLsLsmmmbLgbLsbRsLsbLsbLiLsbRebLgLsLsmbsbLgbLgLsLsmbLsLsmbLsLsmbRsbL
gbLgbLsLsLsmmbLsbLsbLsbLsbLsLsmbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bsbLsLsmbLsbLsbsbsbLsLsmbLsLsmbLsbRsLsbsbLsLsmbLsbLgbLsRsLsbRsbLhbLiLs
LsmbLjLeLsbLsLgLsbLebLibLibRhbReRsRgmbRhRsRsRsLsmmmbLsRsRsRsRsmmmbRsRs
mbRsbRsRsRsmmbRsRsmbRsRsRsRsmmmbsbRsbRsbsbRsbsbRsRsRsRgRsRsmmmmbRsRsmb
RgRsRsRsmmmbRsRibRcRgRsRgmbRsbLgLsbLjLhbsbsbsbLsRsbsbLgLsbLsLsRsLsmbLs
LsLsmmbLgLsbLgLsLsLsmmbLiLsLsmbLcLsmbLeLsbLeLsbLeLsLsmbLibLeLgbLeLsbLe
bLibLsbRsRsmbsbRsRsmbLsbLsbLsbRsRsmbRsbLsbRsbLsRsbLsLsRsLsLsmmbLjLgbLh
bLgbLhbLeLsLsmbLiLsbLiLsbLcbLibLiLsbLibLeLsLsLsmmbLgRsbLobLsLsLsLsLsRs
mmmmbLsLsmbLsLsmbLsLsLsLsRsmmmbsbRsbsbsbLeLsLsmbLiLsbLeLsbLhbLgLgLsLsm
bLibsbLsRsLsLsmbLsbLgLsLsmbLsbRsbRsbLeLsbRjRgbRgRcRsRsmmbReRsmbReRsRsm
mbReRsmbsbRsbsbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bLibLibLgbsbRcbRibRgRsRsLsmmbRebRgRsmbsbRoRsLsmbRobsbRcbRcRsmbRcbRibRo
bLcbLiLsbLeLiLsbLiRsbRsLcbLjbLibRobLhbRiRsRsmmbRsbReRsRsmmbLsRsbRsRcbR
cLsbRcbsbRhbRhbRobLibLobLcbLiLsbLoLsmbRsbRjLsbRcbsbRcbRebRcbRiRsmbRebR
hbLibLebLcbLcbLibLiLsbLhbLsbRibRhbRibRibRibLgbReLgbRebLsbLcbRcbLsbsbLi
bLiLsbLcbLcbLcbLsLjLsmbLeLsbLibRobLgbLibRibRibRhRsmbRgbLjLsmbReRsmbLib
RsRsmbLibRcb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bLoLibLcLcLeLeLibLcLeLeLsLebLhLsbLebLibLgbLhLsbLoLgbReRgbsbLsbRsRsRsRi
RgmmbRsLsbRsbRsbRsRsmbRsRsmbRsbRsRsRsRsRsRsRsmmmmmmbRsbRsRsRsmmbRsRsmb
RsRsmbRsRsmbRsbRsbRsRsmbRsRsmbRsbLsbLsbsbRoRsmbRcbReRsmbRcRsmbRgLsRgRi
ReReRsReRgmbRcbRhLsbLgbLjbRebLgbLgbLcRsbRibsbLsRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bsbRsbsbLsbsbsbsbsbsbLsLsmbsbRsbLsbsbLsbsbRsRsLsmbsbLsbRsbLsbLsbRsbRsb
LsLsmbLsbLsbRsbRsLsbRsRsmbLsRsbLsbRsbRsbLsbsbRsbsbsbsbsbLsLsLsmmbLiLib
LobRsLcbLcbsbLiLsbLcbLcLsmbLcbLcbLsLiRsRsLsRsmbLobLcLeLsLsLiLiLsLeLeLs
LiLiRhmbLoRsbRcbRibRebReRsRsmmbReRibRsbRgbRhbLsbRcbRcRsmbRoRsRombRebLc
bRjbReLsbLoRsbRcbRhbLobLobLiLsbRcLsbRhLsLsLsLsmmmbRsbRsbsbsbLsbRsRsmbR
sb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbRoRsmbsbRcRsmbRobRcbsbLsLcLsLsmm
bLcLsmbLiRsRsmbLibLoLsmbLibLibLcRsbLiRsRsRsmmbLibLiLsbLobLibLcLsmbLibL
iLsbLgbLgLsLgbLhbLhbLsLgbLcbLgLsbLeLsLsmbLebLebLgbLibRhRgbLcbRiRsmbRiL
sbRiRsRgmbRcRsmbRgRsmbRhbRiRsmbRjbLobRgRsmbRibRobLibRsLiLsbLhLsbLhbsbL
hbLcbLibLibLibLiLsbLcbLiRsLsbRoRcbRobLibRebLebRibsbRgRsmbRebLsbRsbRebL
cLsRsmbLebLcbLiLsLsmbLgbLcRsbLjbRsRsmbRgRsLgLombRhRsmbLiRsbLeLsbRcbLsb
RibRoRsRsRsmmmbRhRsmbRibLebRibLoRsbRsbLsRsLsLsmbLsbsbsbLsLsmbRjbRobsbs
bsbLsbsbsbsbsbLsbRsbLsbLsLsLsmmbLsRsbLsbsbsbsbLsbLsLsLsmmbLsRsLsbRsbsb
sbsbLsRsRsmbLsLsmbLsLsmbLebRcbRcLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bRhRsRsRsmmmbRoRobRhRcRhbRgRgRsmbRcRiReRhbLeLsbLgLibLibLiRgbRcbRgRsmbR
obLiLsLibLibLgbLiLgbLiLsbLgLgbLeLsbLgLsLsmbLsLsLsmmbLibLgbLsbLobLcLcbL
cLsmbRgbLeLsLsmbLebLeLsLcbLhLcbLcRsbLoRsbLibRhbLebRgbRibRebRcRibRobRib
RobRiLsbRsbRiRsmbRgbRjLgbRibRcbRsRsRsmmbRjbRcbRcbRibLhLsbRsbsbLgbRhRsm
bLsbRsbRgbRgbsbsbsbsbRsRsRsRgRsRsRsRsRsRgRgmmmmmmmbRibsbsbsbsbsbsbRsLs
LsmbRsbsbRsRsRsRsRsRsRsmmmmmmbRgRsRsRsLsmmmbLsbRsRgRgbRgbRgbRebRsRsmbR
sRcbRjbRcRsmbRgbReRsmbRjbLoRsbLibLhLiLcbLibLhbLibLiLhRsLsbLibLcbLebLcb
LcLsmbRgbLcLsmbRibRcRsmbRsbRibReRsRsRsmmmbRgRsmbRibRsbRsRsmbRsRsmbRgbR
gRsRsmmbRgbsbRsRsmbRsRsmbRsRsmbRgRsmbRibRsRcbRcbRgbRhRsmbRiRsLsmbRibsb
RgbRibRcbRgbLjLcbLcLsmbLcbLhbLcbLcbLgLsbLiLsbLgbLgbLgbLgbLebLgbLgLsbLs
LsmbLgLsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bRsbsbRgRgbRgRsLsmbLsLsmbLcbLhLsbLcRsbRsRcbLsRsbRjbRoRsRsmmbRcRsmbRibR
ibRhbRibRebLgbLiRsLsbLibLcbLibLobRsRsmbLcLsmbRcRsmbRgRsmbLebLibLebLcbL
hbRsbRcbLebLeLsLhbLgbsbLgbRsRsmbRgRsRsmmbRsRsRsmmbLsbLsbRgbRcbRebRiRsm
bRiRsmbRibRgbLsbLibLibLhbLibLibLiLsbLeLsbLibLibLibLhbLgLsbLcLsmbLibLeb
LibLhbLgbRsbRiLsbRsbRgbsbLjLebLebLebLgbLebLgLsbLgLhLsbLgLcRsbLiRsbLibL
hbLibLibLeLsLsLsmmbRhbReRsmbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bLiLsbRebLgbRhbReLibLeLsbLoLsLcLcmbLeLsbRoRsRsRsmmmbRibRsbRgbLsbRgbReb
RcbRcbLcbLebLeLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bLjbsbRebRebsbRsRcbRibRgbRsRibLoLsmbLgbLiLsbLsbRjbRoRibRgRibRhRsmbRiRh
RhbRiRsRgmbRgbRgbRsbRiRsmbRsRsmbRsRgbRibRoRcbRoRsmbRgbReRsRimbRgbRgbRi
RsmbRgLsbRgbRgbLgRsbRsbRgRsmbRsRsmbLebLhbLsLjbLhbLcLsLsmmbLeLsbLcbLcbL
cbLibLgLgLsbLgLsLgLsbLgLsbLgLsbLgLsLsRsmbRsbLibRgbLgbLsbLgbLgbLsLsmbRs
bRsRsmbLjLsLsmmbLgbLibLgLsbLcLsmbLcbLibLgbLebLibLjLibLibLgbLgLsbLgbLgR
sLsbLgbLsbLgLsLsmbLgbLsbLsbLgRsbLgLsbLgbLsbLsbLsbLsLsmbLsLsmbLsbLgbsbs
bLebLcbLebLobLibLobLibLhLiLsbLiLsLiLsLgbLibLibLcbRgRsmbRebRhbRhbRgbRob
RcRebsbLsbRcbLobLcbLhbLgRsbLibLgbLgbLgbLibLgLsbLgLsbLgbReRsmbRcbRebRhR
smbRcRsmbRhLsbLgbRjbRcbRibRibRcRsmbRibRiLsRsbRiLsbLgbRebsbRcLsbLcbLobL
cbLcbLiRsRsmbLebLcRsbReRsmbLobRsbLobLobLcbLibRebRcbRhRsmbRibLgbLibLsbL
gLsbRsbRebRhRsmbRcRsRsmmbRcbRiRsmbRgbRjLsbLjbLjLhbLobLcbLebLhbLibLebLs
bLsbLhbRgRsmbRjRcRsmbRgRsRsRsmmmbRgRsmbRsbRsRsmbRgbsbRhRsmbLcbsbLhbRcR
smbRebRobRhbRibRgbRiRgbRibRhbLgbRcbRhbsbRgbRcbRebRcbRhbLiLgbLgLsRsbLgb
LibLgLsLsmbLsbRcbRsbsbsbRsbLsbLsbRsbRsbsbRsRsRsLsmmbLsbsbRsLsRsbRsbsbL
sRsRsmbsbRsbRsLsbsbRsRsRsmmbRsbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
bLsbLsbRsbLsbLsbLsRsbRsbLsRsbRsbRsbLsbLsRsbLsLsmbRsbRsLsbRsbLsbRsbLsRs
bLsbRsbRsbLsLsmbLsLsmbLsbLsbLsbRsbRsRsmbRsRsLsmbLsbLsbsbLsLsRsmbRsbRsR
smbRsRsmbLsLsmbLsRsbRsbLsLsRsmbLsbRsLsRsRsLsmbsbLsRsbRsbRsRsmbLsbRsbRs
bRsbRsbRsbLcbRsbRsbRsbRsRsLsmbLsbLsbLsbLsbsbLsbRsbLsbRsbLsbLsbRsbRsbLs
bLsbLsbRsRsLsmbRsbLsbLobRobLsbRebLsbLobRsbLsbLsbLcbLcbLsbLsLsmbRebRsbL
ebLobRsbLobLsbLsbRsbRsLsbLsLsmbRsbLsLsmbsbsbRsbsbsbsbLsbsbsbsbsbsbsbsb
sbsbsbRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bRsbLsbLsRsbRsbLsbLsbLsbLsbsbLsbLsbLsbLsbsbLsbRsbRsLsbsbLsLsmbLsbsbRsL
sbLsbRsbsbsbsbLibRcbReRsmbRibRibRsbRobRibRhbRgbRhbRsbRsbRcRsRhRhLsRsRg
RembRoLsbRibRcRsRiReRiRsmmbRhbRhLsLjbRoRsRhRsRsmmmbRsbRoRsmbRcbRcbRiRs
ReLsRsmbLiLiLebLgbLgbRebRgRcbLcLgbsbRcRibRgLsbRgRhRsRsmmbRiLsRsbRhRiRc
RsRiReRsRsmmmbRiRsmbRhbReRebRiRsReRhRsRiRsmmmbRgRsmbRibRcRsRgmbRibRibR
sReReRsRsmmbLgbLcLcRsLgbLgbLgbLobLibLiLsbLibLibLobLobLcbLoRcbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bLsbsbsbRsRsmbLsRsbLsbLsRsLsbLsbRsbRsbRibRoLsbRobRobRcbRgbRibRsbRibRoR
smbRgbLhbLobLhbLibsbLiLsLsLimbLibLiLsbLiLsbLibLsRsRsmbRibRhbRcbRhbRhbR
cbRibRhbRcLobRobLiLsbLsbLobRgbLgLsLgbLiRsbLjbRgbRibLibRiRhRsmbRoRgRsmb
LobLobRobRobRcbLcbRcbRgbRiLsbLiLsLsmbRibRibRgbLsbRibLjbRhbLcbLgbsbLsLs
mbRgbLebLgbLcbRjbRcbRcbRcbRhLsbRibRibRcbRhbRjbRcbRjbLibLiLsLsmbLiLsbLi
bLgbRobRibLjbRcbRcbLgbRcbRcbRgbRsbRibRgLsbLjbLgbLsbsbsbLsbRsLsbRsbRsLs
bRsRsmbRsRsmbRsRsmbsbRsbsbRsbsbsbRibsbRgbRgbLjb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 19; Drug: Control Apo 50 然
bRsbRsbLjbRsbLsbRsbRsbLsbRgRsRgmbRsbRsbRsbRsbRgbRsbLsbRsbRsbRsbLsbRsbR
sbRsbRsbRsbLeRsbRsbRsbLgbRsbRsbLsbsbsbLsbRsbRsbLobLgRsbLibLcbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 20; Drug: Control Apo 50 然
bsbsbLsbRsbLsbRsbLsbRsLsbsbRsbRsbRsbsbsbsbsbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 21; Drug: Control Apo 50 然
bLsbLgLsbLgLsLsLsLgLsmmbLebRgRsLgmbRjbRcbsbLsbLsRsbsbRsbLgbLsbLsLeLsbL
sbLsLsmbLgLgLsLsmbLgLgLsbLiLsbLsbsbRsbLsbLebLsLsmbLsLsmbLsbLgbLsbLsLgL
gLsbLgbsbsbLsLgbLsbLsLgLibLiLgLsLsLsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 22; Drug: Control Apo 50 然
bLsbRsbRcbLsbLsbLsbLsLiLsbsbRsLsLsLgLgLhLsmbLsLgLiLsLsLgRsLsLsmmbRsLgL
sLsLiLgLsLsLgLsmmbLgbLgLgLiLsLsmbLsLiLsLsLsLiLsLsmmmbLiLsLsLgLsLgRsLgL
smbLsLgLsbLgbRsRsLsLsmmbLgbLiLgLgLsLsLgLsLsLgLhmmbLsLgLsLsLgLsLgmbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 23; Drug: Control Apo 50 然
bsbLsRsbRsRsmbRsbLsbLsbLsLsRsmbRsRsmbsbRsRsLsmbsbLsbLsbRsRsmbsbLsbRsLs
bRsbsbsbLsRsbLsbLsbRsLsbsbLsRsbRsbLgLsbLsbLsbRsbRsbsbsbLsRsbRsbLsRsbLs
RsLsLsLsmmbLsRsLsbLsRsRsLsRsmbRsbLsbRsbLsbsbRsbRsbLsbRsbLsbLsbLsbRsbRs
bRsbsbRsLsbRsbLsbRsbLsbLsbLsbsbRsbsbLsbLsbsbsbRsbRsbsbRsbLsbLsbLsbLsbR
sLsbRsbRsbLsbLgbLsbRsLsLoRsRebLsbLjbLcbRebRobRobLobLebLobRcbRibLobRobR
obLobLebLsbRsbLsbLobRobLsbRebRobRsbRcbRcbLobRebLgbRsbRobRcbRcbRcbRebLj
bLebRobRebRobLobRobRobRcbRebLobLobLobLobRobLebRebLsbRobLjbLobRsbLobLeb
LeLjbLebRsbLcbLibLobRebLsbRibRobLobLobLgbRsbLebRobLsbLobRibRobLobRebLo
bRobLobRebRobRsbLebRgbLjbLobLobRobLobRobLobLsbRobLobLhbRobRebLsbRcbRob
RobRsRebLobLsbLebRobLcbLobLcbLjbRoRibLsbLobRebLobLjbLsbLgbRjbRsRjbRjbR
cbLobRobRobLjbRjbRjbLobRobRobLobRjbLjbLsbLobRobLobRobLsbLebRjbRebLobLs
bLobRebLjbRjbLobLebLobRcbLjbRobLebLobLjbLsbRebRjbRebRcbRobLobLobRebRjb
RcbRcbRebLebLjbRobRebRobLobLobLobLcbLobLobLjbLebRobLobLobLsbLobRobLsbR
sbRjbLobRebRjbRobLjbLjbRsbRobRobLsbLobLobLobRobLobRcbRobRsbLsbRobRjbLe
bRebRobRebLebRsbLjbRebLcbRobLsbRobLebRobRsbRobRsbLobRobRebLsbRjbLjbRob
RobLebRebLobRobRjbLobLobRobLobLobRebLobLebRobLobLebRobRobLobRebRebRebR
obLobLjbLsbRjbRebLjbLobLobRobRobRobLebLebLebRobLcbRjbLobLebRibLobRibRg
bLebRjbRebRjbRobLgbLobLgbRjbLebLebLebRobRcbLebRobLsbRobLgbLebRobRgbLob
RebLobRjbRebRcbRcbLobLobRebRgbRobRebRobLobRobLobRebRcbRebLobLobLobLjbR
obLjbRebLobLebRobRebRobRobRcbRebRobRobRcbRobLgbLcbLcbLgbLebLebLcbRebRo
bLcbLjbRgbRhbRobLebRobRjbLjbLobRebLobRebLcbLebRhbLobLcbRjbRebLsbLobRob
LebRebRobLjbLcbRsbRcbLobRobLobRcbLobRobLobRgbRsbLobRcbRebRgbRobLgbRsbR
obLobRobRebRebLibRobLebLobRebLobLobRobLobRobRcbLebRobLobLebRobRebRobRo
bLobLebLebRobRcbLcbLobLsbRsbLgbRebLhbLjbLcbRobLebRobRebLobRebRobLobRob
RobLebRobRebRobLcbLebRebLobLebRobRobRsbLobLobRgbRgbLobLcbLobLebLebLibL
sbRsbRebRsbLsbRebLobRcbLebLsbRobRebLhbRsbLobLobRibRobLgbLobRobRobLsbLo
bLebRobLobRcbLebRobLebLobLobLobLobRebRobRebLsbRsbLebRobRcbRobRobRjbLob
RgbLebLebLsbRobRebRobRebRebRsbLebLobLobRgbLjbRobLobLcbLhbRgbLebLobLgbL
ebRobLobRobLobRobLobLebRobRsbLsbLsbLobLcbRebRebLsbLobRsbRjbLsbRobRsbLs
bRebLsbLebRebRsbLcbLobLjbRsbRebLjbRsbLebRebRjbRsbLobRgbLsbLjbLjbLsbRsb
RjbRjbLsbRsbLsbLsbLsbLobRebRsbLobRobLsbLsbLebLsbLsbLsbLsbRsbRjbRsbLjbR
obRsbRobRsbLjbLsbLsbRsbRobRsbRgbLsbRsbLsbLsbLsbRsbLsbRsbLobRsbRsbRsbLs
bLsbRsbLebLsbLsbRibLsbRsbRsbLsbRsbLsbLsbRsbLsbRsbRsbRsbLsbRgbRsbLsLsLs
RsmmbLsbRsbLsbRsbRsbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 24; Drug: Control Apo 50 然
bRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bLsbLsLsmbRsbLsbsbLsLsLsmmbLsbsbLsbLsbRsbsbRsLsbRsbLsbLsbsbRsbRsbLsRsL
sRsbLsRsbLsRsbLsRsbsbsbsbsbLsbsbRsbRsLsbRsbsbLsbRsLsRsbLsLsmbsbsbsbsbs
bsbsbRsbsbRobRgbRobRebLgLsbLsbReRebRiRsRgmbReRgbLgbRsLsbLgbLgbLgbLgLsb
LgbsbLsLsmbLibLebLgbRcbLsbsbRgLsbRsbLgLhbsbLsLsmbLibLsbLibLibRebRiLsbL
eLsbRiRhbsbRebRibLjbLgbRgbLibLgbRsLsbLgbLsbLgLsbLgLsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bsbRsbsbsbsbRebRsLhbRoLsLcbLgLcLsLsRommbRsLsLsmbLibLhbRiLsbLiLsbLsbsbs
bLsbLsbLsbLsLgLsLgbLsLsmbRebLsbRsbLsbRibLsLsmbRsbRsbsbsbsbsbsbsbsbRsbR
sLsbsbsbRsRsmbsbsbsbsbsbsbsbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bLeLsbRjRebLgLsbLeLsbRsbLsbRhbReRsmbRgbRsbRibLgbLsbLcbRhbLiRsbRsbsbLcb
LsbLsbRhbLsbsbRhbLsbRsbRsbsbRsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bRgRsmbLsbRgRsmbRsbLgbRgbsbsbRiLsbsbRsbRgRsmbLsRsbRsbRgbRibRhbRibLibRs
LiLsbLgbLgbRsbLsbRsLsbLgbLgbLibRsbRsbRsbLiRsbLibLibRgbLsbLsbRsbLiLsbLs
LsmbLsbLsbLsbLsLsmbRgbLsLsmbsbsbLgbLsbLsbRgLsbLibLgbLsLsmbRibRsbsbsbRs
LsbsbLgbLiLsbLgbLsbLgbLgbLsbLsbsbLgbRsLsbsbsbLgbLgLsbLgbLiLsbLibLsbLsb
RgbLjbLsbLsbLsbRsbLhbLgLsLsmbLgbLsLsmbRsbRsbLhbRibRsRsmbLsbRsbRgbRcRsm
bLibsbLcLsmbLsbLsbLgbLgRsbLsbLibRsbLsbLsbRsRsmbLsLsmbLgbLebLibLsbLibRs
bLsbLgbLsLsmbLgbRsbRsRsmbLibLsbRsRsmbLsbLsbLsbLsbLsbRsbLgRsbLgbLsbsbsb
sbRcbRibLsRsbReRsmbRhbRebLsbsbLjbLsbsbLsbLibLibLiLsbLgbRgbRibRiRsmbRgb
RsbLsbLsbRsbRebLibLjbsbsbRsbRebRgbLsbLjbRsRgbRgbRibLsRsbLjbLjb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bsbRsbRsRsmbsbsbRsRsmbRgRsRsmmbsbRsbRsbLjbRcRsmbsbRibsbRibRibRibRiRsRc
RsRsRsmmmmbRgbRhbRgbRsRsmbRiRsmbRibRiRsLsmbRhbRibRgbReLsbRgbRsbLsbLobL
hLsbLiLsbLebLgbLcRsLsLjbReRsRembRcbRiLoRsLsRhbRgbLjbsbRsLsbsbsbsbRsLsR
sbRsRsmbsbsbLsbLsbLgLgbLsLsmbLiLsbLeLibRebRebLibRjbLebLhbLsbLebLiLsbsb
RsbRebRgbRgRsmbRgRsmbRsbRsbRgbRsbLsbRgbsbRsbsbLsbsbRsbRgbLsRsLsbLsbRsb
RsbsbRgbRsbRibRibRiRsmbRhbRgbRsbRibsbsbLcbLgbLgLsbLiLsbLgbLsbLsbLgbLsL
smbLsbLsbLoLsLsmmbLcbLoRsbLsRsbLgbLgbLobLgbRiRsmbLobRgLsbLgbLibRcRsmbR
sLibLoRsLsbsbsbLsLsLsmmbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bRsbLsbLsbRsbRsbLsbRsbLsRsbsbLsLsRsmbLsLsmbLsbRcbRiRsmbRcRsmbRjbRcbRsR
cbRgReLoLobLgbRsLgbRibRoLsLsmbsbsbsbsbRsbLsbLsbsbsbsbRsbRsbLsbsbsbsbRs
RsmbsbLsbsbsbsbRsbRsbLsLsRsmbRsLsbRsbRsbRsbLsbLsbLsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bLsLsmbLsLsmbLgbLgLsbLsLsmbLsLsmbsbLobLebLcbLiLsLsmbLiLsbLibLibLgLsLsm
bLsbLsLsLsmmbLsbLsLgLsbLgLsbLsLsmbsbsbLeLsbLgLsLsmbLcbsbLebLibLibLsLib
LsLsmbLeLsbLibRebsbRsbsbLsLsLsmmbLcLsmbLebLebLibLibLiLsbLsLsmbLsbLebLh
bLsbsbLibLgbRsLsLsmbRsLsbLsLgbLgbRibRsRhRsmbRsbRsbLebRcbRibRebLgbLibLc
RsbLcbLhRsbLibLgbLgbLibLebLsbRgbLsbRsbLsbRjbRiRsmbLsbLjbLibLsLsmbRjbRs
bLebLsbsbRiRsmbLgbRsbRjbRebLgbLebLcbLcRsbLibLibLgbLibLgbLiLsbRgbRobRsR
smbLibLibRsbRjbRjbRcbRgbRsRobLjbRsRsmbLebLcbLebRjRgbLjbLhbLibReLsbLsbR
jRhbRgbsbRsbRcbRcbRhbRsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bRiLsbLsbRiRsmbLcbLcbLgLsbLgLsLsmbsbLgbLgbLiLsbLsbLcbLgbLeLsbLgbLiLsLe
bLibLgbLiLsbLgbRobRiRebLebLobLoLsmbLebsbsbsbLebLsbLjbRcRsmbRcRsmbRhbLo
bLobLibLgRsbRjRsmbRebRebRibLiRcReRsRsmmbRobLhbLcLsLsmmbLcLsLsmmbLcbRhb
RebRjbRgbLsLhbReRsmbLcbRgbRebRobRjbRjbLgbRobRiRsmbRgbLgLsLsmbLobLcbRhb
RjbRibRsbRobRebLgRsbLobRebLgbRgbRgbRebLcbLobLsLsmbLoLsmbLgbRsbLgRsbReb
RsRgbLsbsbRsbRsbRsbRsRsmbRsRsRsmmbRsbRsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbRsbLcLsLsmmbLcLsmbLibLcLsLsmmbLcLsmbLiLiLcbRhLsRcbLobLjbsbsbs
bsbsbLsbsbLsbRsbRsLsbsbsbsbRcbRjRsmbRjRibRhbRebRhLsbReRsmbRibLiLsbsbRs
ReReLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bLsLsLsLsLsmmmmbLgLsLsLsLsmmmbLgLsbLsLsRsLsmbRsLsLsLsLsLsLsmmmmmbsbLsL
sLsLsLsmmmmbLsbLsLsmbLsbLsbRiLsbLgLsbLsLsLsLsLsmmmmbsbLsLsLsLsmmmbLsLs
LsmmbLsLsmbLsLsLgmbRsLsLsLsLsLsmmmmbLsLsmbLsLsLsLsLsmmmmbLsLsRsmbLsLsm
bsbsbLsbLsLsLsmmbLgLsLsmbLsLsmbLgbLsbLsLsLsmmbRsRsLsmbLgLsbLsLsLsLsLsL
sLsLgmmmmmmbLsbLgbLsLsmbLsbRsLgbLsLsLsmmbLsLsLsmmbLsLsLsmmbLsLsLsmmbsb
LgLsbLsLsmbLsLsLsmmbLsLsmbLsLsmbRsRsmbLgbLsLsLsmmbLsLsmbLsbLsLsLsLsLsm
mmmbLsLsRsmbLsbLsLsmbLsLsmbLsbLsLsmbLsbLebLgbLobLiLsLsLcmbLiLebLiRsLsb
LhLoRsbReRsRgmbRebsbRcRsmbReRsmbRcbLgRgbLhbLcbLjbLcbLgbRibRebRcbLsbLsL
smbRcbLgbLsRsbRiRsRsmmbRcbRsbRibRgbLsbRsbLcbLcbsbLebLhbLiLsbLsbRiRsmbR
ibRhbRibRebRiLsbRhbRjbRhbRgbRibRsbRgbRsbRcbRebRcbLsbLjLsmbLcbRgLsbRebL
iRsbLjRsLcbLjRsLsbLgLsLsmbLiLsbsbLgbLgbLibRsbLcbLcRsbRsbRsbsbLsRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bsbsbLsbLsbsbRsbsbRsbRsbRsbsbsbsbsbsbRsbsbsbsbsbsbsbsbLsLsmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
bLsbLsbRsbRsbLobRsbReRebLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bRsRcRsRsmmbLsbLsRsbLibLibLgbRsLsbRibLibsbLibRsbRjRsRsmmbLgbLiLsbLsLgb
LsLsmbLsLsmbLgbLibLjLsmbLibLgLsbRsbLgbLgbRsbRhbLobLsbRibRcbRsbLjbRsbRi
bLgbLjbLgbLsbLsLsmbLgbLsLsmbLsbsbLsLgLsLsLsLsmmmbLsLsLsLsLsmmmmbLsLsLs
LsLsLsmmmmmbLsLsLsLgRsLsmmbLsLsLsmmbLsLsmbLsbLgbRsbLgbRjbRgbRcbsbsbRsb
LsLgLsbLsLsLsLsLsmmmmbLgbLsLsLsmmbLsLsLsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbLgbRsbLsLsmbRsbRsbRsbLjbLobLgbRcRsmbLjbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbsbsbLjbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbs
bsbsbsbsbsbsbsbsbLjbRsbLgbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bRiRsmbsbRsRsRsmmbRsbRsRsRsRgmmbsbRsRsmbRsbRsbsbLsbsbLsbRsbRsbRsRsmbRi
bRibLgLcbLcbLgbLibLsLsLsmmbLiLsbRsRsmbLsbLsbRsbLsbLsbLsbLsLsmbLibLcbLc
bLcbLgLsLsmbLgbLcbLhbLcbLsbLsRsbLiLsbLjbRebRebRcbLsbRoRsRsmmbLebLibLcL
smbsbsbLsLsmbRsLsLsLsmmbLsLsRsmbRebsbRcbRibRhbRiRsmbsbRibRgRsRsmmbsbRs
RsRsRsRsRsmmmmmbRsRsRsRsRsRgRgRsRsmmmmmmbRsRsRsRsRsRsmmmmmbRsRsRsRsRsR
smmmmmbRsRsLsRsmbReRsmbRjRcbRebLsLsLsLsmmmbLsLsLsmmbLsLsmbLsbLsbRcbRob
RcbRebRiLsbLeLsbLcLsmbRsRsmbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bLsLibLeLsbRgbRcbRsRgbRibLibLebRsbLcbLgLsbLcbLhLsLsmbsbLiLsbRgRsRsmmbR
ebRhRsmbRsbRcbRibRcbRsbRebRhbRhbRhLsbRibLgLsLsmbLsLgbLibLsbLsLsmbLcbRs
RcbRcbLibRibRebLgbLsLsmbLebRsRsmbRebRgRsmbRgRcbRhbRhbRcbLibLgbLibLobRc
bsbRcbLibLhbLibLgbLobLebLcbLibLibRcbRcbRgbRgbRsRgRsmbRgRsmbRiRsmbRiLsb
RsbLgbRcbRcbRibRibRhbRibLsbRcbRibRibRibRjRebRibRhbRibLgLsbRobLgbLsbLib
LhbLebLcbLebRebRhbRgRsmbRsbLsbRsbLiLsLsmbLgLsLsmbLiLsLsmbRcbRebRgbRcbs
bRiLsbRgbRebsbRsbRhbLsbsbRsRsLsmbRibLsbLjLsmbLebRgbRcbLibRjRcLsbRsbLeL
sbRgbRsRoRsmbReRsmbLgbRcbRgRsmbRebLjLsmbRibRibRibRebLiLsbsbLsLsmbRibRe
RsmbLgLsbLcbRjbRcbRibLeLsbLobRsbRiRsmbRsbRsbRjRgbLsbRsbsbLcLsmbRsRsmbs
bRgRjRcbRsbsbLgbRjRebRsLsbLsbRsRsRsmmbRiRsmbRebRhbRebRcbRebLgLsbLiLsbR
cLsbRcbRsbRcRsmbRhbRcbRibRcbRebRiRsmbRgbRebLsbRsbLsbRsLsbRibRebRsbsbLe
LsbsbRcbRcLsbRibRiRsmbRgbRgRsRsmmbRcRsmbLgbRgbReRsmbRgbRsReRsmbLsLsmbR
gbRcbRibLsLsmbLgbLsLsLsmmbsbRhbRsLsLsLsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bRsRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsbRsRsmbRsRsmbRsRsmbRsRsmbsbRsRsRsRsRs
RsmmmmmbRsbRsRsRsRsmmmbRsRsRsmmbRsRsmbLsRsRsRsmmbRsRsRsRsRsRsmmmmmbRsR
sRsmmbRsRsRsRsRsmmmmbRsRsRsRsRsmmmmbLsRsRsRsRsmmmbRgRsRsmmbRsRsRsmmbRs
RsmbsbRsRsRsRsRsRsmmmmmbRsRsRsRsmmmbRiRsmbRsbRiRsRsmmbReRsRsRsmmmbReRs
mbRcRsmbRcbRcbRcbRibLhbLgLsLcLsLsmmbLeLsbLcbLgbLiLsbLibLibLcbLibLcbLcb
RsbLebLcbLibLgLsLsmbLobLgbLcbRhRsmbRiRsmbRjbLgbRsbReRsmbRobLiLsbLsbLhb
LsbLoLobLcbRgbsbLoLsmbLobLobRcbRgbRobLcbLgbRjbRoRsmbRibRjRebRcRsmbReRs
mbRsbReRsmbRgbRebRsbRiRsmbRjbLsbLsLsRsmbLjbLoLgLsbLiRsbLebRiRsmbRsLsbR
jRgRsmbRgRsRsmmbRsRsmbRiRsmbLgbRsbsbLcbLgLibsbsbLsbLsRsRsRsmmbRsRsmbRs
RsmbsbRiRsRsRsRsmmmmbsbLibLsbLsbLebLcbLsRsLsbLsRsLsLsmbsbRsLsRsRsmbRsb
RibRhRsmbsbRsbLsLsLsLsLsmmmmbLsbLsLsmbRsbRsRsmbRebRgbRhbReRsmbLsLsmbLg
bLgbLgbLsLibLgbLibLebLsLsRsRsmmbLsLsLsRsmmbLsbLsLsLsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 43; Drug: Control Apo 50 然
bLgbLjbLiRsbRhLsLgLsbRsbLsbLsLsmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 44; Drug: Control Apo 50 然
bLsLsRsmbLsbRsRsRsRsmmmbRsbRgbsbRsbRsRsRsRsmmmbRsRsmbLsbRsRsmbRsbRsbRs
bRsbRsbRsRsmbRsbRsRsmbLsRsRsRsRsRsRsRsmmmmmmbRsbRsRsmbRgbRsbRsbRsbLsRs
RsRsmmbRsRsRsRsmmmbRsbRsbRsRsmbRsbRsLsbRsRsRsmmbRsRsRsmmbRsRsmbRsbRsRs
RsRsRsRsmmmmmbRsbRsRsRsmmbRsRgLsRsbRsRsmbRsRsmbRsRsmbRsbsbRsRsRsRsmmmb
RsRsRsmmbRsRsRsmmbsbRsRibRsRsmbRsbRsbRebRgRsmbRsRsRsRsRsmmmmbRsRgRsRgR
sRgRsmmmbRgRsRsRsmmmbsbLebLobRcLsbRcbRcbRibRibRcbLsbRgbRgbLebRobLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 45; Drug: Control Apo 50 然
bsbLsbLsbLibLiLsbsbRsLsbLcLsmbLjLgRsbLgLgbLgbLsbLiLsbLsLebLjbLjLjLsmbs
bRiRsmbReRsmbLibsbLebRsRsRsRsmmmbRsbRhbRcbRgbRibRibRcbRibRibsbLsbRsbLs
bLsLsLsmmbLsLsmbLsbLsRsbLsLsLsLsLsmmmmbLsLsmbLsbLsbsbLsLsmbLsRsbsbLsbL
sLsLsLsLsmmmmbsbLsbLsbLsRsLsbLsbLsLsLsLsmmmbLsLsRsmbLsbLjbLsLsLsLsLsmm
mmbLsLsmbRsLsbLsLsmbLsbLsLsLsmmbLsLsLsLsLsmmmmbLsbLsLsLsmmbLsLsRsmbLsb
LsLsmbLsLsLsmmbLsbLsLsLsLsLsLsmmmmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 46; Drug: Control Apo 50 然
bLjbLjbRcbRebRebRjb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 47; Drug: Control Apo 50 然
bRsbRsLsLsmbsbLsbRjbLsLsLsRsRsRsmmmmbRsRsmbRsRsRsRsRsRsRsLsRsRsLsmmmmm
mmbRsRsmbRsbRsbRsRsmbsbsbRsRsmbLsbLsbLsLsLsLsmmmbLsLsLsLgLsLsLsLsLsLsL
gmmmmmmmbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLgLsLsLsLsmmmbLsLsLsLsLsLsLsmmm
mmmbLsLsLsmmbLsLsLsLsLsmmmmbLsLsLsLsLgLsLsLsLsLsLsmmmmmmmmbLiLsLgLsLsm
bLgLsLsLsLsLsLgLeLsmmmmbLiLsLsmbRsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLsL
sLsLsLsLsLsLsLsLsLsLsLgmmmmmmmmmmmbLsLsLsLsLsLgLsLgLsLsLsLsLsLsLsLsLsL
sLsLgmmmmmmmmmmmmmmbLsbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 124203; End: 124704;
Recording: 8-1; Individual: 48; Drug: Control Apo 50 然
bRsLgbLsLsmbLsLgLsLsmbLgbLsLsmbLsLsmbsbLsRsLsbRsLsLsLsmmbLsLsmbLsLsLsm
mbLsLsmbLsLsmbLsbLgLsbsbLsLsLsLsLsmmmmbLsLsLsmmbLsLsLsmmbLsLsLsLsmmmbL
sLsmbLgLsLsRsmbLsLsmbLsbRsLsLsLsLsmmmbLsbLsLsmbLsRsbLgLsLsmbRsLsLsLsmm
bRsLsLsLsmmbLsLsLsLsmmmbLsLsLsmmbLsbLsbsbLgbLsLsLsmmbsbsbLsLsLsLsLsLsm
mmmmbLgLsLsmbLsLsLsLsLsLsLsmmmmmmbLsLsmbLsbLsLsLsmmbLsLsLsmmbRsbLsLsmb
LsLsmbLsLsLsmmbLsbsbLsLsmbLgLsLsmbLsbLgLsLsLsmmbLsLsLsLsLsLsmmmmmbLgLg
bRsLsLsLsmmbLsbRsLsLsLsRsLsmmbRsbRsLsLsLsmmbLsLsRsmbLsLsmbLsLsmbRsLsbL
sLsRsmbLsLsmbLsLsLsmmbsbsbsbLsLsLsmmbLsLsLsLsmmmbLgLsLsmbRsLsLsLsmmbLs
bLsLsmbLgbLsLsLsLsLsmmmmbLsbLsLsLsmmbLsLsmbLsLsmbLsLsmbLsLsmbLsLsLsLsL
smmmmbLsLsmbRsbsbLsLsmbLsbLsLsLsLsmmmbLsLsRsmbsbLsLsLsmmbLsLsLsmmbLsLs
LsLsmmmbRsLsLsmbLsLsmbLsLsLsmmbLsbLsLsLsmmbLsbsbLsbLsLsmbLsbLsLsmbLgLs
bLsLsLsmmbLsLsLsLsmmmbRsbLsLsLsmmbLsRsbLsLsLsmmbLsLsmbLsbLsLsmbLsLsRsm
bRsLsLsLsmmbLsLsmbLsbLsRsbLsLgLsLsmbLsLsLsmmbLsbLsRsLsbLsbLsbLsLsLsLsm
mmbLsLsRsmbLsLgbRjbsbsbRsLsbLsLsLsLsmmmbLsLsLsLsLsmmmmbLsbLgRsbLsbRjbR
cbRibRebRcbsbRcbLcbLsLiLsbLibRcbReb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bLsLsmbLsbsbLgLibLhbLiLsbLeLsbLsbLeLsbLibLibLibLiLsbLhRgbRoRiRsmbReLib
RsRsRimbLiLsLibLoLcbLsbLgRebLhbRgbsbRsRsmbLgbRsbRgbLgbLjbLsRcbLoLiLsRs
LjLobLiLoLoLsmbLeRsbRgRgbLobRiRsLhmbRgbRibLhbRgbRgbLgbRgbLoRsLsbLibRob
LobLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bLsbLsbRsbLsLsLsLsmmmbRsbLsLsmbLsLsmbLebLgbRibRebLsbReRgbLgbRoRsmbLebR
cbLsbRhbRhRcbLcbLjbLsRobRsRsRsmmbRcbLobLeReRsmbRjbReRibLobsbLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bLsbRsbLsbLsLsmbLgLgbLsbsbLsbLsbLsLgbLgLsbLsbLgbLsbLsbLibLgbLgbRgLsbRs
bRsRgbLjbLgbsbLsbsbLgbLgRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bLcbRsLsbRsbsbRsLsRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bsbsbsbsbsbsbsbRsRsRgRsmmbLebRebsbRoLcbRebReRiRiRebRcbReRsmbRcbRebLcLs
mbLcLsLsLsLsRommmmbLcbLiLsbLiLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bRsbLsbLsLsmbsbsbLgbRsbLsbRsbLsRsbRsbsbsbsbsbLsbsbsbRsLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bRsRsRgRsmmbRsbRsRsRsmmbRsbRsbsbRsRsRsRsmmmbRiRsRsRsRsReRsmmmmmbRsReRg
RsRsmmbsbReRsRsRsmmmbReRsRsRgRsmmmbRsRiRgRsRsmmbRsRgRgRsRsmmbRsRsRsRsm
mmbLiLsbLiLsbLsLsLsmmbLgbLhLsbLsbsbRsbRsbsbLsLsLsLsmmmbLsLsmbLsLsLsLgm
mbLsLgLsLsmbRgRsRsRsmmmbRsbRhRiRhRsRsmmbReRsmbRhRsRsRsmmmbRgRsRsRsRsmm
mmbRgbRsLsbsbsbLsbsbLgLsLsmbLsbLgLsbLsLsLsLsLsLsmmmmmbRsbRcRsRsmmbReRs
RsRgmmbReRsRgRgmbRgRsRsRsmmmbRgbLsbLcbLeLsbLeLsLsmbLgLsbLibLiLsLsLsmmb
LhLsbLeLsLsmbLiLsbLiLsbLgLsLsLsLgLsmmbLibLgLsbLgbLgLiLsbsbRgRsRsRsmmmb
RsRsRsmmbsbRgRgbRcRsmbRoRsmbLgbLsLsmbLgbLgLsLsmbLsLgbLgRsbLhbLiLsLsmbL
cbLiLsLsmbLhLeLsLebLiLsbLibRsbRcRgRsmbsbRgbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bRsbLsRsRsmbRsbLsRsbRsRsmbRsbRsbRcRsRsRsmmmbRebLebLgbLgbLcbLibRhRsRsmm
bRebRgLsbRcRsmbRhbRiRsmbLobLeLsbRcbLcbLsbLsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bRsbLsbLsbLebLcbLibLcbLeLibRsLebLeLsLibLcLsLeLsmbLeLsbRgbRobLjRcRsRsmm
bRibLsbRcRsLsmbRgbRsRsRsmmbsbsbRsbRsbLsbLsbsbRsbRsbRsbLsbRsbRsbRsbsbsb
LsbRsRsmbRsbsbRsbLsbsbsbsbsbRsLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bRsRgRsRsRsmmmbLsbLsbLsLsRsRsRsmmmbRsRgRsRgmbLsLsRsRsmmbLjbLjbLobLjbLc
LsmbLcbLcbRsbLcbLcbRebReRsRcRsRsmmmbRoRsmbRcbRhbRcbReRsmbRiLsRsbRibRcb
sbRcbRobRcbRcbRebRjRjbRhRsmbLgRsbRsLsbRsbLoLsmbLsbLsbRsbRsRsRsmmbRebRj
bRsbsbLsLsmbRsRsmbRsbLsbLsbsbRsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbs
bsbsbsbRsbsbsbLsbsbsbsbsbsbsbsbsbsbLsRsbLsbsbsbsbRsbRsbLsbsbsbLsbsbLsb
LsLsmbLsbRsbsbLsbsbsbsbsbLsbsbsbsbRsbLsbsbRsbsbsbsbRsRsmbsbRsRsmbRsbRc
bLsLjbLobLcLsmbLeLsLsmbLibLsbLsbLsLsLsmmbLsbLsLsmbsbsbLsLsLsLsmmmbRsLs
bsbLsbsbLsLsmbsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bLsbLsbsbsbsbsbsbsbRsbLsRsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbRsRsmbRgbR
ebRobRsRoLsRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbsbsbLsLsLsmmbLsRsbLsLgLsLsLsLsLsLsLsLsRsmmmmmmmbLgbLsLsmbsbLs
LsmbLsLsLsLsLsmmmmbLsLsmbLsbLsLsLsLsLsmmmmbLsbLsLsmbRsbsbLsLsLsmmbRsLs
bLsbsbsbsbRsLsbRsLsLsmbLsLsLsmmbLsLsmbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bLsLgLsLsmbLebLebLhbRgbRebRgbLebLibRiRsmbRgRsRsmmbRibRcRsmbRhRsmbsbRiR
smbRsRsmbRebRcbRebRebRgbLgbRsbLebLhbLibsbRsbLsbLiLsbLgLsLsmbLgLsLsmbLg
LsbLgbLsLsmbLsbLiLsbLcbLebLgLsbLebLgbLgLgbLgbRibsbRjbLsRsbRgRsmbRsbRsb
RgbRsbLcLsmbLiLsbLebsbLgbRsbRiRsmbRjRsmbRgLsbRiRsRsRsmmmbsbRebLjLsLgmb
LibLibLibLgbLgLsbRhbRsbRgbRibLjLsmbLibLgbsbLibLgLsbLibLsbRgbRebRgRibRi
bRsbRiRsmbRiRsRsmmbRebLiLsbLjbLsLibLgbsbRgbLhbLgLsbLgbRsRsmbLsbLeLsbRs
bRjbRebLsbsbsbsbsbsbLsbsbsbsbRgbLcbRebRebRhbRibRsbReRsRsmmbRebReRsRsmm
bRibRebRiRsmbRiRsmbRsbReRsmbRibRebLcLcbLjLsLeLsmbLebLibRsRsmbLibLibLgb
LgLsbLeLsbLgbRsLsbRgbReRsmbRcbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bsbRsbLoLsmbLeLsbLobLobLebRgbRsbLcbReRsmbRgbRebRibRoLsLsmbLobRibLsbRsb
LsbRobRsLobLgRsbLcbsbsbLsbsbLsRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bRsbRsRsmbRsbsbsbsbsbsbsbLsRsRsmbRsbLsbsbRsRsmbsbRsRsmbRsRsmbRsbRsRsRs
RsmmmbRsbsbLcbRcbReRsmbRoRgbRcRsmbReRsRsmmbRebRibRhbReRsmbRsLsbRcRsmbs
bLsRsbLjbRibRgRsmbRiRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
bLsLsmbRsbRsRsmbLsbLsLsmbRsbLsbLsRsRsmbRsbsbLcLsLsLsmmmbRibLsbRsRsLsLs
mmbLsbLsRsLsbLsbLsLsmbLsbLsbRsRsLsRsLsRsLoRsLsmbRsRsLsLsmmbLsLsmbLsbLs
bRsLjbLsLsLsmmbLsbLsRsbRsLsLsmbRsLsbLsbLsLsmbLsRsbLsbRsbsbRsLsLsmbLsLo
bRsLsRsLsbRsbRsbRsbRsLoLsmbLsRsRebLsLsmbRsbLsRsLsbRsLsLcbLoRsRsmbRebLs
RsLsRsbLobRsbLsLsmbLoLsRsRimbReRsLsmbLebLsRsLsRsRsmbLsRsbRoRsmbLobLoLs
mbLsbLebRsbLcRebRobLobRsbLsbLebRobLebRobRobLsbRebRsbLsbLebRobRebRjLsbL
sbRobLebLebRebRcbRebRobLobRobLebLobRebRobLebLobRsbLobRsbLgbLsbLobRebLo
bRcbRgbLobLsbRebRobLobLebLobLobLcbLjbRgbLobLjbRebLebLobLebRobLobLebRsb
LobLjbRobRhbLibLobLsbRobRobLsbLibRobRebLjbRebRjbLcbRgbLjbRcbRobRobLjbL
jbLobRibRebLebLebRobLjbRsbRsbRsbRobRebLsbRsbLebRebRobLsbRobLebRobLobRs
bRebLebRsbRebRobLsbLcbRobRsbLebLobLebRcbRcbRebRobLobRebLobRebLsbRobLib
LebRjbRcbLcbLgbRcbLsbLsbLcbLebRsbLcbLsbRgbLjbRobRobRobRebRcbLsbLobRobL
sbRebLobRobLebLcbRobLibRebLebLobLibRgbLsbRebRsbRobRibRebRobLobLobRobRg
bRgbRebLobLebLebRobLcbRgbRsbRebLcbRgbLobLobRobLobRobRsbLgbLgbLobRibLob
LsbLcbRcbRebLobLcbRcbRgbRcbLibLibLcbRibLcbLcbLebLgbLcbLebRobLobRibRobR
obLobRobRebLobLsbLebLhbLebRebRibRobLobRebRobRobRibRebRebLibLobRobRcbLo
bLebRcbRebRebRcbLobLebLcbLibLibLebLebRobRebRcbLobRcbRibRibLebRobLcbLcb
RgbRgbLebLobRibLobRebLobLhbRebLobLobLibLcbRobRobRgbRcbLibRibRsbLgbLobR
ebRcbLobLebRcbLobLebLhbLobLobLibRobRobRebRobLebLobRobRobLobLsbRobRobRc
bLgbLcbLibRhbLobRebLebLobRebRebRobLobLcbLibRcbRobRjbRobRobLjbRobRobRgb
RcbRebLcbLobRobRsbLebRobRgbLebLobRobLibLebRebLebRibRcbRobRobRebLobRcbR
sbLobRibLebRgbLcbLcbRebRsbRobRebLobLebLsbLcbLgbRgbRobLebLcbRibRcbRobLe
bRcbRobLebLibRobRobRobLobRobLcbRobLebRobLcbLcbLcbLebRobRobRcbRcbRobLob
LcbLebLobLobLobLcbLcbLobLobRgbLebRjbLcbLcbLcbRcbRsbRibRcbRebLebLcbLebR
cbLobLebLibLobRobRobLobRobLobLobLibLobRobRcbLobRcbLibLebLobRebRibLobRi
bLcbRsbRebRobLcbLebLobRobRobLebLebLobLobRgbRibLjbRobRebLobLibRobRobLcb
RebLsbRcbRobLebLobRobRcbLcbRobLobRobLobLobLcbLibLgbLebLebRgbLobRobLobL
gbRibLebRobRebLebLebRobLcbRsbRebLcbLcbLebLobRobLcbLjbLibRebLobRcbRebLi
bLobLobLobLobLcbLcbLcbRsbLcbRebLcbRcbLcbLebRebLebRebLobLobRcbLibLobLgb
RibRobLebRhbRcbLobRebRobRobLobRcbLobRcbRibLobRjbLcbLebLobRebLobRobRcbR
obRcbRgbLcbLcbRebRobRobLcbRcbLebRcbRobRebLobRcbLobLcbRebLobLgbRcbRobRo
bLobLobLobLibLobLgbRobLebLobLcbRobRgbRebRobLgbRobRcbRhbRebLobLsbRcbLob
LebLobLobLobRebLobLebRcbRibRebRcbRebLsbRobLebRobRcbLsbLibLobLebLgbLebL
obLebLsbLgbLgbRsbRobLobRcbRobRgbRcbLjbLobRebRibRebLcbLobRobLobRobRobLc
bLobRebLobRgbRobLjbRebLcbLobRhbLebRobRobRebLobLsbLcbRobRsbRebLcbLibLeb
LebRobRobLhbRgbLcbRcbLebRibRobLobRobLgbRobRjbLobLcbLobRgbRobRsbRcbRobL
cbRobRgbRhbRcbLobLobLgbLcbRobRibRobRobLcbRebRobLcbRebRobRebRsbLibLobRe
bLobRobRobLcbLjbRobLobLobLibRjbRebRcbLobLibRebLobLobLebRobRsbLsbRobLob
RibRsbLjbRebRobRsbLgbRjbLibRobLobLjbRcbLebRgbLobLcbLobRobLibLobLobRsbR
obRobRebRobRobRobRjbRsbLibRobRobLebLcbLebRobRebLsbLcbRobLebRebLobLobLe
bLobRobRobRgbRobLobRobRobRebRobLobLobLobRobRebLobRobRebRobRebLobLebRob
LobLebRobRsbLobRebRibLobRebLobRobLobLsbLebLebRobLobLjbRebRsbLobRobLcbR
ibLebRgbLebLgbRobLibLobLobLebRgbRjbRsbLjbRobLobRoLebRobLebLsbLebRsbRob
RgbLibRjbLobRsbLjbRobLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bLsRsLsbLgbRjRjbLsbRjbLiLsRsbLcbLobLibLibLsRsbLibLhbRsbRjRsmbRhbRjbRob
LibLjbRhRsmbRibRibRjRsmbRcbLcbLhbLcbLcbRjRsmbLcbRgbRgbRibRcbsbLjbLcbLj
LjbLjbLcbLebLibRjbRhbRjbLsbLjbLjLsmbLcLsmbRebRebRibRsbLcbLibLsLcbLibRc
RsmbRcbRibRhbRcbRcbLjLsmbLibLcbLsbLibLcbLsLebLcbRibRcbReRsmbLgbLgbLibR
ibRebRhbRibRibLibLhbLibLibLibLsLsmbLgbRibRhRsmbRcbLsLsmbLibLjLhLsbLsRs
bLsLsLsLgmmbRgRsmbLiLsbRsbLgbLibsbRsLsLsmbLsbsbLsRsbsbsbRsbsbsbsbsbsbs
bsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bRgbRsbRgbLsbLsbRsbLsbRsbLsbLsbRsbRsbRsbRsbsbsbRsLsbsbsbsbLsRsbLsbsbsb
sbLsbRsLsRsRsmbRsbsbLsbsbRsRsmbLsbsbRsbRsbLsbLsbRsbRsbRsLjbLsbsbsbsbRs
RsmbsbsbsbsbLsRsbRgbRsRsmbRsbRsRsLsRsmbLsbLgRsRsmbsbLsbsbRsbRsbsbLsRsb
LsbLjbsbsbsbsbsbRsRsmbRsRsmbRsbRsbRsbRsbRsbsbsbsbsbsbsbLsbLsRsbRsbRsbR
sLgbLgbLgbRsbRsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 19; Drug: Control Apo 50 然
bLsbLjbLcbRiRibLobsbLobRgRsmbLiRsbLgbLgLiLsbLoRsbRgbRobRsbsbLobLobLcbL
sbRsRsmbsbRsbsbLsLsRsmbRsLsLsmbLebRcbRgRsRsRsmmmbLsRsRsmbRob

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 20; Drug: Control Apo 50 然
bRoLsbRjbLebRcbLsbLgRsbLjbLsbLsbRsbLjbLsRsbRebLsbRsbLsbLsRsbRsbRjbRsbR
sbLsbRsbLjbLjbRsbLjbRsbRjbLsbLsbRsbRjbRsbLjbRsbRsbLsbLsRsbLsbRsbRsbRsb
LjLsmbLsbRsRsmbRsbRsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 21; Drug: Control Apo 50 然
bLgbsbLgbLsbLiLsLsmbLsLsmbLsbRsLsbLiRsbRsbLsbRsbLsbLsbRsbLsLsmbRsbLsbL
gbLsbLsRsbLsbLsbLsbLcbRsbLsbRsbRsbRebLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 22; Drug: Control Apo 50 然
bLgbRsLgbRjbRebRsRsRsmmbRgRgRsRgRgRsRsRsmmmmbRgRiRsmbRsRgbRcbLgLsbLeLs
bLsbRjRsmbLgLgLsLsLeLgLgLembLeLsbLebLiLsbRsLsbLsLgLsLgLgLgbLeLsbLsLsLs
LemmbLeLiLsbLebLhRsbLsLeLibsbLhbLsbRsLsbLsRsbRsLsLsLsmmbLhbRibLiLsLsLg
LiLsmbLgLgbLsbLiLibLeLsLebLebRsbLsLeLsLebLebLsbsbRsbLsLhbLebLcLsmbLcbL
sRsbRebRsRibLsRgRgbRsLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 23; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 24; Drug: Control Apo 50 然
bRsbLcbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bRsRsmbLgbsbLsLsmbRsbLsbLhbRsLsbsbsbRsbLsRsbLsbRsbRsbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bRobLobRhbRsRsRimbLsLgbLsLsmbLiLsbLgbLgbRobLcbRobRsbLibRobLeRsbLgbRgbs
bRsbLsLsmbRsRsmbRsbsbsbsbsbsbsbsbsbsbRsRsmbsbsbsbRsbLsRsbRsbRsbRsRsLsm
bLsbRsRsmbRsRsmbRiRsmbRiLsbRiRsmbRgbRgbRebRiLsbRgRobRibRgbLhRsbRcbReLs
RsbLsbLibLsLsLsLsmmmbsbsbLsLsmbRsLsbsbsbsbsbLsbsbLsLsmbRsbRsbsbRsbRsbR
sLsRsbRsRsLsmbLsbLgbLsbRsbRsbLsLsLsmmbLsbLsbLsLsmbLgRsLsLgbLoRsLsbRsLi
bLgLsLsLsmmbLsbRsLcbLiLsLsmbLsLgbLsbLgLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bsbsbLsRsbsbLobRgbRgbLobLobRcbRsbLiLsbRebLibLiRoLsbLsLgbRsRsRsmmbsbRgb
RsbLsRsbLjRsbRsLsbLebLsLsmbLibLjbsbLsbsbsbRsbLebLsRsbsbRsbsbsbsbsbRsRs
RsmmbRsbRsbLsLsmbRsbRsbRsbLsLsmbRsRsmbRsbLsRsbRsbLsbLsRsbLsbsbRsRsmbLs
bRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bsbsbLgbRsbLgbLsbLsbLibLsLiRsbLeRgLebRsLgbRsbLsLsLsmmbRsbRsbRsbLsLsmbL
sLsmbLsbRsLsbRsbRsbsbRsRsmbRsbLsbsbRsbsbLsRsbLsbRibRgbRebRcLsRsLjLcbLe
bRibReRhbRobRobLobRhbRsRsmbRsLsbRcbRoRoRgbRjbRgRibLgbRsRsmbLebRcbRebRs
bLebLebLeLsbLsbLsLsmbLgLsbLsbLsbRsbLsLsmbLgbsbsbRsbRsbsbLsLsmbsbsbsbRs
bLsbLsbRsbsbsbsbLsbsbsbRsbsbLsbRsbLsLsmbRsLsbLsbsbLsLsmbLsLsLsmmbLsRsb
sbLsbLsbRsbsbRcbReRsmbReRsmbRibRhbsbLgbLibLgLsbLiLsbLcbRebsbRcRsmbRobs
bLeLsLsmbLcLsLsmmbLcbLcLsmbLob

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bsbsbLsLsmbRsbLsLsLsLsmmmbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbsbsbs
bLsbRsbsbsbsbRgbRsbRebLebLibLibRsLsbRebRgRebRhbLibLjbRiLobRgLiRsLcLsLs
LimmbRoLsbLsbRsbRsRsmbRgbRgRsmbRgbRgbsbRgbRgbRgRsmbRsLsbRsbRgRsRsmmbsb
RsLsbRsRsmbRsbsbsbRsbsbRsbRsRgLsbLsbLgLsbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bLsbsbsbsbRgbLgbRcbRebLsRsbRibRsbRobLobRibRoLoLeLoLsmbLsLibLsbLgLsLsLo
mbRsRsRsmmbLsLsmbRsbLebsbsbsbLsbsbRsbRsbRsbsbsbsbRsbRsLsbsbsbRsbsbLsRs
bsbRsLsbLsbLsbLsbLsbLsbLsLsmbRsRsmbLsbRsbRsRsRsmmbRsLsbLsRsbRsbRsbsbsb
LsLsmbRsbLsbsbRsbLsbsbsbsbRoLsbsbsbsbsbRibRebRcbLcRsbLjbRcbLibLgbLsLsm
bLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bRsbRsLsbsbsbsbsbRsRsmbLsLsmbRsbsbRsRsRsmmbRsRsLsmbRobRsbRsRsmbRcbsbRs
RibRsReRsmbReRsmbRebRgRsmbLsRsLsLsmbRsLsLsmbLsLsLsmmbRib

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsLsmbRsbsbsbRjbR
sLoLoRsRsmbRiRsRsmmbRcRsRsLsmmbRcRsmbsbRcRsmbLcbLcLsLsLsmmmbLcLsRsLiLs
mbLhLsLsmbLebLeLsbLhbLcbLibLibLibRcLsReRsmbRcbRgbRibRcbRiRgbRibRgRsRsR
sRsmmmmbRgRsRgmbRgbRsRsRsRsRsmmmmbLgbRibRjRsmbRhbLgLgbLibLibLsLibLhbLi
LsbLgbRjRsRsmmbLiLsbLjLsLsmmbLibsbRsRhbLcbLcbLiLsLsLgmbLiLsbLibLibLibL
iLsLsmbLiLsbLgbLgLsbLibLgbLsbLgbRsRsRsRsmmmbRsRsmbRsRsmbLibRjRsRsRsRsR
smmmmmbRgRsLsmbLsbLcLsmbsbsbsbLgbsbsbLsRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bsbsbLsLsRsRsmmbsbRsbRsbLsbLsbLsbLsbRsRsmbRsRsmbsbRgRsmbLsbsbRsbRsbRsb
LhbLjLsLsmmbLhLsbLeLsLsmbLibLiLsbLibLcbLebLeLsbLeRsLebLeLeLsbLoLsmbLcR
gbRibRoLsbsbLhbRoRsRsLsmmbRgbReRsLsLsmmbRcbLoLsLsmmbsbLsReb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bRsbRsbRsbRsbLsbRsbRsbRcbLoLsmbLsbsbsbsbLsbRsbLsLsmbLgbLsbLsbLsbLsbLsb
RsLsbLsbLsbLsLsmbLsbLobLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bRsbRsbRgbsbRsRgbRsbRgRsRhRsmmbRsbRsRsmbRgbRsRsRsmmbRsbLebsbRsbRsLsbsb
LsRsLsbRsbLsRiRhbLcLgbLcLsmbLibLoRsbLibLsbLhbRibRsRgbRcbRcbRibLsLibLjL
gbRjbRebLsbRsRsLsmbRsRsmbsbsbsbsbLsbsbRsbRsbRgRsmbsbRebRgbRsReRsmbRsbs
bsbsbRsbRsRsRimbsbRsbRsbRgbRsRsmbLeLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bRsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bLsLsLgLsmbLsLgbLsbLsbLgbLgbLsLsmbLsLsLsmmbLsLsLsLsLsmmmmbLgbLsbsbLsbL
gbLsLsmbLsbLsLsmbLsLsLsmmbLsbLgLsbLsbLgbLgbLsLsmbLsbLsbLgbLgbLsbLsbsbL
sbLsbLsLsmbLsRsLsbLsLsmbLsbsbLsRsLsbLsRsbLsbLsbLsbLsRsbLsbLsbsbsbLsbLs
bLsLsmbLsLsLsmmbLsLsmbLsLsmbLsbLsbLsLsmbLsLsmbRsLsRsbRsLsbLsbLsbLsbLsL
smbLsbLsbLsbRsLsbsbRsbsbLsbRsRsmbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bRsbsbRsbRsbsbsbLsbsbRsbLsbsbsbRsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bLsbRsbRebLgRhRsmbRsRcbRcbLhbsbLsLsmbLhLsLeLsbLebsbLeLsbLiRsbRsLsbLgLs
LiLsbLsLsmbLsbLsbLsRsbLsbLgbLsbLeLsLsmbLeLsbLcbLebRcbRjbRebRebRsRsmbLg
LsLsmbLibRgLsbsbRsRsmbLgbLsbsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bRsRsmbsbRsRsmbRsRsmbRsRsmbRhbRsbRsLsLsmbLsbRsLsRsRsRsmmbRebRebsbRcbLi
LsbRsRsmbLsbLgLsbRebRgRsmbRgLsbRgbRsbRsRsmbRsbLsRsRsmbRsRsRsRsmmmbRsbR
gbRgbRgbRsbRgbRgbRebRcbRcbRsLsbLgRsbLebLobRsRsmbRgbsbRgbRibRjRebRgRsmb
RcbRebRgbRsLsbRsLsbLsRsbRsbRsRsmbRsRsRsmmbRgRsmbRgbRhbRiLsLsmbLsLsLsmm
bRgLsbLgLsbRiRsmbRsbRsRsmbRsbRsRsmbRjRibLsRsLsbLsLsmbRsLsbLsRsbRgRsmbR
sRsRsLsmmbLjbLsbLsbLsbLsLsmbLsbsbsbLsLsLsLsLsmmmmbLgbLsLsLsLsmmmbLsLsm
bLsLsmbLsbRsLsLsmbRiLsbRgbRcbRsbLsLsmbLsbLsbRsLsbLsbLsbLsbLsLsmbLsbRsb
LsLsLsLsmmmbLsLsLsLsLsmmmmbLsLsLsmmbLsLsLsLsLsLsLsLsmmmmmmmbLsLsmbLsbL
gLsbLsLsLsRsmmbReRsmbRcbRcbRhbRibRcbRgbsbLgbRsbsbsbRjbRgLsbRsRsmbRiRsm
bRebRcbRhbRibRhRsmbRibRgbRebRibLsbLiLsbLgbLgbLgLsbLsLsmbRsbLsLsLsLsmmm
bLsLsLsLsmmmbLsbRsLsLsLsmmbLsRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bLsbLibLsLsmbLsLsmbLsbLebLsLsmbLsLsLsLsLsLsmmmmmbLsLsmbLsLsmbLsLsLsLsm
mmbLgbLebRsRsmbLsLsmbLsbLibsbLeLsbLsbLsbLsRsbLsLsmbLibLsbLsRsLsbLsLsmb
RsbRsbLebRgbRsLsbsbsbRsbLsRsbLsLgbLsLibLsRsbsbLsbLsLsmbLsbLsbLgbLebRgb
RebRebRebLsbRsbRibLsbLhbRsbLsbRsbRsbRsbLsbRsbRsbRsbRsbLgbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 43; Drug: Control Apo 50 然
bLsbsbsbsbRsbsbsbsbLsbsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbLsbsbsbLsRsbsbsbs
bsbLsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbsbsbLsbsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbLsbRsbsbLsbsbsbsbRsbsbRs
bLsLsmbLsbRsLsbRsbLsbLsbsbLsbRsLsbRsbLjbLsRsbLjbRgLjbLsbLjLjbsbsbRgRgb
RsbRjbRsbRibLgbRibRjb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 44; Drug: Control Apo 50 然
bLeLsbLsLsLsLgLsmmbLsLsLsmmbLsLibLsLsLsLsLsLsLsmmmmmmbLsLsmbLsLsLsLsLs
LsLiLsLsmmmmmmbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsLsmmmmbRsLsbLsLsLsLsLsmmmm
bLsLsmbLsLsLsmmbLsLsLsLsLsLsmmmmmbLiLgLibsbLsLsLembLgLsLsLsLsLiLgLeLsm
mmbLsbLibLibLsbLsLsLsmmbLsLsLsLsmmmbLsLsLsLsLsLsLsRsmmmmmmbLsLsLsLsmmm
bLsLsLsLhLsmmbLeLsbLsLsmbLsLsLsLsmmmbLsLsmbLsLsmbLsLsmbLsLsLsmmbLsbLiL
ibLiLsLsLsLsLsmmmmbLsLsmbLsLsmbLgLsRsLsLsmbLsLsLsLsLsmmmmbsbLsLsLsmmbR
sbLsbLsLiLsbLsLsLsmmbLsLsLsLsmmmbLsLsmbLsLsLsmmbLsLsmbLibLsbLhLsbLsLsL
sLgmmbLsbLgbLsbLsLsmbLiLsLsmbLgLsLsmbRsLsLsmbLsLsLsRsLemmbLsLsmbLiLsbL
obLcbLiLsbRebLibRobRcbRebRjRcLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 45; Drug: Control Apo 50 然
bLgbLsbRsbRhRsmbRsbLsbLsbRibRibRsbRsLsbLsbLsbLsLsmbLsbLsbLsRsLsLsLsmmb
LsbLsbRsbsbRsRsmbLsbLsbLsbLsLsLsmmbLsbLsbLsbLsLsmbRsRsmbLsbLsbLsRsLsLs
mbLsLgLsbLsbRgbRebLsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 46; Drug: Control Apo 50 然
bLsbsbsbsbRsbsbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 47; Drug: Control Apo 50 然
bLsLsLsLgLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmbLsbLsLsLsLgLsLsLsLsLsLs
LsLsmmmmmmmmmbLsLgLsLsLsmmbLsbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLsLsLiLsLsL
emmmbLoLsmbLibLgbLsLiLsbLgLsbLibRsbLibLsbRsbLsLgLsLsLsLsLsmmmmbLsLsLsL
sLgLsLsLsLsLsLgLsLsLsLsLsLsLgLgLsLsLsLgLsLgLsLsLsLsLsLsLgLsLsmmmmmmmmm
mmmmmmmmmmmbsbsbsbLsLgLsLgLsLsLsLsLsLsLsLsLsLsLsLhLsmmmmmmmmmmbLsLsLsL
sLsLhmmmmbRsLsLsLsmmbLeRsRsLsmbLebRsLsLsLsLsLsLsLsLsLsLsLsLsLsLgLgLgLs
LsLgLsLsmmmmmmmmmmmmmmbLgbLgLibLcLsmbLebLibLebRsLsLsLgLsLsLsLsLsLsLsLs
LsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmmmbsbLgLgLsbLsLsLsLsLgLsL
sLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgLgLsLgLsLsLgLsLsLsLsmmmmmmmmmmm
mmmmmmmmmmmmmmmbRsLsLsLsLgLsLsLsLsLgLsLsLsLsLsmmmmmmmmmbLsLsLsLsLsLsLg
LsLsLsLsLsLsRsLsLsLgLsLsLsLiLsmmmmmmmmmmmmmbLsLsLiLgLsLsLsmmmbLgLsLsLs
LgmmbLsLsLsLsLsLsLsLsLsLsLsLgLsLsLsLsLsmmmmmmmmmmmmmmbsbLsLsLsLsLsLsLi
LsLsLsLsLsLsLsLsLsLsLsLgLsLsLsLsmmmmmmmmmmmmmmmmmmbLgLsbLcLsLcRsmbLsLg
LsLsLsRsmmbLcLsmbLcbLgLsbLgbLeLsLsmbRsLgLsLgLsLsLsLsLgLsLsLimmmmbsbLsL
sLsLsLsLsLsLsLsLiLsLgLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmbLsLsLgLsLsLsLsLsL
sLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmbLgLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 124705; End: 125206;
Recording: 9-1; Individual: 48; Drug: Control Apo 50 然
bRsbRsbLsbLsLsmbLgLsbLsLsLsmmbLsLsmbLsbLgLsbLsbLsLsmbLsLsLsmmbLsbLsLsm
bLgbLsbLsbLsbLsLsmbRsLsLsLsLsmmmbLsbLsLsLsmmbLebRcbRibRebRoRsmbRebRebR
ebLiLsLsmbLebLibLibLsbLibLgLebRibRebRibRibRibLgLsbRiRibRsbRsRgbRgbRsbR
gRsmbRgRsLsmbLgbRgbRgRsmbRsRsRsmmbRsRsRsmmbRsRsmbRsbRsLsbRsbRsbsbRgbRs
bLsRsRsmbsbsbLsRsbRsRsmbRsRsmbRsRsmbLsbRsbRsbLsbRsRsmbRsbRsRsmbRsRsmbL
sRsbRsRsmbRsbRgbRgbRsbRsbRibLjbRcbRobLcbLjbLsbLibsbRibRsbLgbLsbRib

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bLobRsbLsbLiRsbRcbRoLeLgbRiLgbLgbRgRcbLcbLsLsmbLgbLsbRsLeLsLsmbLibLgbL
gLsbLgbRsRsmbLibLibLebLobLibRcbLsbRiRsRoRsRsLemmmbLsLsmbRjbLebLgLsbLsb
LsLsmbLsLsLsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bsbLebsbLiLcLsLsmmbLebLobLcLeLsRibRiRebRebLsRgLsbRcbRebLibLsbRebsbsbLs
bRsbRsbRjbRibRsLsbLcLsmbRsRjbRsLhRibLeRsbRsLcLgbRgbLoLsmbLsRsbRsbLsRsR
smbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bLsbLsbLsbsbRsLsbLsRsbsbLsbsbsbsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bRsbLsbLjbRsbRsbLsbLjbLsbRsbRsbRsbRsLsbRsbRsbLsbRsbLsbLsbRobsbLjbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bLeLsLsmbRgLsbRibsbReRsmbRibRcReReRsmbRebRebRhReRsmbRcLibRgbLibLibRgRs
mbLobRibRcRgbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bsbLsbsbRsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bLsbLsbsbsbLsLsmbsbLsbLgbLgRsbLgbLsLgbLgLsbLibRsbLhLsbLgLsLsmbLiLgbLgb
RsRsmbLsLsRsLsmbLsbsbLsbRsbLsbRsbLiRsbLibLgLiLsLsLsmmbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bLsbLibRsRsmbLsbRsbRsbLsbLsLsLsmmbRsbLsbLsLsmbLsbLsbsbLsLsmbLgbLsLsmbL
sbLsbLsbLsLsmbLsLsLsmmbLgbLgbLibLebLiLsLibLibRcbLgLsLsmbRcRsmbLjbLjLib
LsbLsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bRsRsmbRsbRsbRsbRsbRsRgbsbRsbRsRsmbRsRsmbReRsmbsbRsRgRsmbRsRsmbRsbRgRs
RsmmbRsRhbRgRsmbRsRsmbRsRsmbRsbRsRsRsmmbRsRsRsmmbRsLsRsbRsRsmbsbRsLsbR
sRsmbsbRsRsRsRsRsRsRsRsLsRsmmmmmmmbRsbRsRsRsRsRsRsRsmmmmmmbRsRsmbRsRsR
sRsmmmbRsbLsRsbRsRsRsmmbRsRsmbLsRsRsmbRsbRsRsRsRsmmmbRsRsmbLsbRsbRsRsm
bLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bLsLsLsmmbLebRsbRcbRoRsmbRcRsmbRebRiRsmbRebRebReRsmbRebsbRhbLjLgLgLsbL
ibLiLibLgbLgLsLsmbRsLgbRsbsbsbRsbsbLsLsmbRsbLsbRsbRsLsRsLsbsbRsLsRsbLs
bLsbLobLcRjbLiLcRsbLcbLgbLgbLgRsbRhRsmbRcbRcbRcbLsbsbsbRebRhRsmbReRsmb
sbRsbLsbRsLsbRsLsbLgLsbLsbLgbLsbLsLsmbLgbLgbLsLsmbLjRsbRgRsRsmmbRgbLcR
sbReRsmbReRsmbsbRgbReRsmbRgRsRsmmbRgRsmbRcRsRsmmbReRsmbRibReRsmbLsbLsb
LsLsmbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bsbsbRebRibRjbRobRcLsbRcbRcLsbReRibRgbRhbRhbRsRsmbRibRcLsbRcRobLsbLobR
iLsbLibRgbRobsbRsRsRsmmbsbsbRsRsRsRsmmmbRebRcbRcbRoLsbRjbRobRhbRcbLsbR
cbRcLsbLobsbsbLgLsbLgLgbsbLsLibLgbLobLgbLcbLcRsbLebLeLsbLcbLebLhbRibRc
bsbLiLsbRgRsmbRgbLgbRob

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bLsLsmbLsbsbLsLsLsmmbLsbLsbLsbLsLsLsmmbLsRsLsRsLsbLsbLsLsmbsbsbRsLsLsR
sLsLsLsLsLsLsmmmmmmbLsLsmbsbsbLsbLsbRsLsLsLsmmbRsLsLsmbLsRsLsbRsRsRsmm
bLsLsLsLsLsmmmmbsbLsRsbLsbRsLsLsLsmmbLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbLsb
LgLsbLsLsmbLgbLsRsLsLsLsmmbLgbLebLebLcbRsbRgbRcRsmbRsbRhRsmbRcLsbRsRsR
smmbRebRibRiRebRibRgRsmbRsbRgRsmbRsRsmbRgRibRiRsmbRiRsmbRgRsmbsbRjRhRs
RgmbRcbRiRsRgmbRsbRgbLgbRjbLgbRsbsbLcbRcbLcbLebLibLjbLcbRgbRibRgbRgRsm
bRibRibReRsRsRgRsmmmbReRibRsbsbsbsbsbRsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bRsbRsbRsbRsbRgbRsRsmbLebLsbLgbRjLsbRiRsmbRibLsbRgRsmbsbsbRibLcbLsbsbs
bLgbRsbLgRsbLgbLgbLibLgbLiRsbLsbLsbLsbLgLsbLsbRjbRgbRsbLsbRsRsmbRsRsmb
RgbRsbRsbLcbsbLgbLgbLsbLsLsLsLsLsLsmmmmmbLebLgbLgbRsbLsbRsbLgLibLsbLgb
LsbLgbLgbLgbLgbsbsbRsbLobLobsbLjbLsbRgbRgbsbRjbRjbRebsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bLgRsbLgLsLsmbLsLobLcLsLsmmbLiLsLsLsmmbLibLgbReRsmbRiRsLsRimbReRsmbRgR
smbsbRiRsmbRsbLoLsmbRcbRcRsRsmmbLgLsbLcLsmbsbLoLsmbLebLibRjbRcRsmbRebR
iRgRsRsmmbRibRibRgRgRsRgmbRgRsRsRsmmmbRsRsLsmbRibRob

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bRsRsRsRsmmmbRibRsRsRsRsmmmbRsRsRsRsRsmmmmbRcbRsRsmbLsRsbsbRsRsmbReRsm
bRcRsmbsbReRsmbsbRibRebRiRsmbRcbRebRgbRebLibRebReRsmbsbLsbLjbRgRsmbsbR
cbsbsbReRsmbsbLsbRgbRsbRgbRsRsRsmmbRsbLsRsRsRsmmbsbRsbRsRsmbRsRsmbRsRs
RsmmbRsRsmbsbRsRsRsRsRsRsmmmmmbLsRsbRsbRsRsRsmmbRsRsRsRsRsLsmmmmbRiRsm
bReRsRsmmbReRsmbRiRsRsmmbRgbRsRsRsmmbLsRsRsmbRsRsRsmmbRsRsRsmmbRsbRsRs
mbRsRsRsRsRsLsRsmmmmbRsRsmbsbLsbRsRsmbRsbRsRsRsRsmmmbRsRsmbRsRsmbsbRsb
RsRsRsmmbRsbRsRsRsmmbLsRsbRsbRsRsRsmmbsbRsRsRsRsmmmbRsRsRsRsmmmbRsRsmb
RsRsRsRsRsRgmmmmbRsRsRsRsRsLsRsRsRsmmmmmmbRsRsmbRsRsRsRsRsmmmmbRsRsmbR
sRsRsmmbRsbRsRsRsRsRsRsmmmmmbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbLsRsRsmbRsR
gRsRsRsmmmbRsbRsRsRsRsRsRsLsRsLsmmmmmbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsRsR
smmbRsbRsRsmbRsLsRsbRsRsRsRsRsmmmmbRsRsRsRsmmmbLsRsbRsRsRsRsRsRsRsRsRs
LsmmmmmmmmbsbRsLsbLsLsmbsbsbsbsbRsbRsRcRsRsmmbRiRcRsmbRcRsmbReRsmbReRs
mbRebRgRiRsLsRsmbRgbRiRsmbRgbLsRsbRsRsmbRsbRgbRgRsmbsbRgRsmbRgRsmbRibR
gbLsbRgRsmbRsbRiRsmbRgRsmbRebLiLsLsmbLebLibLeLsLsmbLiLcbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
bLsbLsbLsbLsbLsbLsbRoLsbLsbLsbLsbRsbRsbRsbLsbRjbRobRsbRsbRsbRsbRgbRsbL
sbRsbRsbLsbRsbLobLsbRsbRsbLsbRobLsbRjbLsbLobLobRsLsbRgbRobRsbRebLobLsb
LsbRobRsbRsbRsbReLsbRebRsbRsbLcbRsbLsbRebRsbLsbRsbLsbRsbLebRsbLjbRobRo
bLobRsbRsbRsbLobRsbLjbLobRcbRobRsbLsbRsbLobLebRobLobRebRebRobLobRcbLjb
RsbRsbRebLobLjbRobLcbLsbRobRsbLsbLsbLebLobRebRebLsbLobLebRobRsbRjbLcbL
obLsbRobRsbLsbLgbLobRebRcbRhbRcbRjbRebRobLcbRsbRobLobLobLsbLoLsmbRcbLo
bRebRobLebLobRobRobLjbRsbLobRcbLobRsbLobLebLsbLobRcbLobRjbLobRhbLobLjb
LobRebRobLobLobLobLcbLobRsbRsbLsbRobLjbLobLobLebLobRebRcbLobRcbRcbRobR
obLjbLobRcbRobLobLebLsbRgbRebLebLebLgbLobLebRsbLjbRebLjbRobLobLgbRgbRc
bLobLcbRobRsbLebLsbLebLobRjbRobLsbLobRsbRjbLebLjbLjbLjbRobLjbRebLjbRob
RobLsbLjbRobRebLjbLobLsbLebRebLjbRebRsbLjbRsbLobRjbLebRobRebRjbLgbRcbR
obLebLebRobLibRobLobLobLobRobRsbLobLsbLsbLobRobRobRobLsbLjbRebLobRcbLs
bRebLebLobLcbLobLebRobLebRgbLsbRobLobRobRobRobRebRsbLobLsbLsbRobLobRob
RebRebRsbLebRebRebLobLsbRsbRgbLobRobRsbRebLobRobRobLobLobRobLcbLobRhbR
sbRhbRobLobLcbRebLebLcbLobRjbLcbRibLebLgbLobLobLsbRobLcbLobLobLibLobRc
bLgbRsbLcbRebLobLcbRobRcbLobLobLobLobRcbRcbRebRibRobRhbRebRobRebLcbLsb
LebLobLobLgbRobRsbRibRhbRobRgbLcbLgbRgbLibLobRobLebLobRcbRebLjbRsbLobR
obLobRobRgbLcbRhbRobRobLobLcbRebLobRobRcbLcbRcbRgbRcbLhbLcbRobLebLobRe
bLobLobLcbLcbRebLebRibLebRobRcbRcbLobRebRobLsbLobLebLebLsbLobRobLibRob
RebRgbLobRebLebRgbLebRebRobRobRebLcbLhbLebRebRgbRebRcbLobLibRebRebLsbL
cbLcbLcbRebRebRebRebRgbRobLebRsbRobRobRebRobLgbRobRcbRebRobLobLcbLobRc
bLobLcbRobLcbRcbLobLcbRobRobRgbRcbLgbLebLcbLobLcbRebRobLibRobRobRobLob
LgbRebRobRobRhbLobLibRebLobLebLobLobLebRobRobRebLcbRibRebLhbLcbLhbRsbR
ebLebRcbLibLgbRobRgbLcbRobRobLcbRobLebRobLibRsbRobRobRobLobLgbLebLcbRe
bRcbLcbLebLobLebRebLebRebRobRebRcbRsbRcbLobLobRobRcbRebRobRobLibLobLib
LcbLcbLobRobRcbLcbRobLobRgbLcbRobRcbRobLcbRobRobLobLhbRobRcbLsbRobLebR
ibRhbRsbRsbLibLebLcbLobLobRobRebRobLobRebLgbRsbRcbRjbLobRobRobRobLibRo
bRsbLcbRobLsbRgbLcbRebLibRcbLobLebLobLcbLsbLcbLobRobLsbLebLibLibLgbLob
RebLobRebRibRcbRibRobLgbLebLsbLhbRgbRcbRobLebLobLibLobRgbRgbRcbLibRgbR
ibLjbLgbLcbLebRobLebLcbRobRebRobRobLebLcbRebRgbRcbLobLcbLebLebLobLobLe
bRgbRgbLobRhbRobLcbRobLobLebLobRobLcbLebRebLobRebLebRibRebLebLcbRibRib
LcbRcbRobLebLebLibRcbLobLgbRobLgbLcbLcbLebLcbRebLobLgbLebRgbRobRobRsbL
ebRgbLobLobRobRobRobRcbRobRobRibLebLgbLobLcbLcbRebRebRsbRcbRobRobLebLo
bRebRobRebLebLibRobLcbRobLgbLcbRibLobRgbLibRebRobRsbLobRobRebRebRobReb
RebLebRobLebRibRobLcbRebLibRibLobLobLebLcbRgbRebRibLcbRjbRcbRcbLebLebL
gbRobLobLobLobLibLcbLcbLcbLcbLobRobRjbRobLobLebRebLobLcbLibRobLcbLebRc
bLgbRibRebLebLobRebLobRebLibLcbLgbLobRobRjbRobRjbLjbLjbRgbRebRibLjbRob
LibRobLobLebLobRsbRgbLsbLobRobLebLebRhbRcbRobLibLebRebLobRebRcbLjbLebR
cbRobRgbLhbRobLebLcbLibLcbRobRebRobLobLobRsbRebLobLobRobRibLgbLcbRobLo
bLobLobLebLobLobRebRcbLibRebLebRobLobRcbLobLobLcbLibLjbLobLobRebLobLeb
LobRobLebLebLgbLobLobLsbLcbLebLgbRebLebLobLebLjbLobLobRsbRobLebRobLcbL
obRcbRebRobLgbLcbLobLebLsbRibLebLobRebLobRobLobRcbLobLebRobLcbRobRibLs
bRsbRcbLobLobRcbLobRobLibRebRebRebLgbLcbRobRobRebRobLobLobRebRsbRobLob
RobLebLobLebLebLobLobRgbRebRsbLobRobLobRobRgbRebLebRobLcbRobLsbLobRibR
obLgbRobRobRobLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bRobLobLobLsbLcbRobRibLobRjbRcbRebRobLebRcbRobLobRcbRcbLobLjbRcbLsbRjb
RobLobRebRsbLjbRsbRobRobRobRobLcbRobLobLobRjbLobLobRsbLobRobRebRobLebR
obRcbRebLsbLobRcbLobRobLcbRebRsbLsbLebLobRcbLjbRebRobLobRsbLobLobLgbLe
bLcbRjbLobRobLsbLjbLobLcbRsbLcbLobRebLsbLobRobLjbLebLobLsbLsbLebLobLcb
RobLcbLobRobLcbLsbLobRobLobLsbLebLhbRebLobRebLebLobRjbRjbLsbLsbLobRjbR
obRjbRobLobRjbLibRjbRjbLebRobLjbLobLebLobLobRebRobLebLjbRobLebRobRcbLj
bRjbLcbRobLebRibRobLobRjbLibRsbRcbLobRobLjbLobRjbRibRobLebLobRjbLibRjb
LjbRobRgbLobRcbRobRobLibRjbLcbRjbRsbLcbLobLcbRobLhbRebLibLobLobLobLcbR
jbRobLobLhbLobRobRhbLobRibRcbLcbRcbLobLsbRsbLobRsbRobLobRsbRobLobLobLj
bRcbRcbLobRgbRobRobLebRobRobRobRebLobRobRjbLobRebLjbRjbRebLcbLjbRebRib
RjbRcbLobLgbRobLcbLobLjbRobRjbRobLebRebLobRobLjbLobLsbLobRobRebRobRobR
ibLobLobLsbRobLobRobLobLebRsbLobRebLcbRobRebLobLcbLobRobLebRobRebRobLs
bLobLebRjbRjbLgbLebLsbRobLcbLsbRebRebRobLobLobRobLobRjbLsbLjbLcbRobReb
RjbRcbRjbRgbRobRebLobLobLobLebLsbRobLsbLcbRebLjbLcbRobRebRebRobLobLobL
ibRobLobLjbLebLobRobRobRebRebLsbRcbRebRjbLebRobLsbRobLobRcbLcbLebRsbRo
bLebLobRgbRebLjbRcbRjbLobLebLjbLsbLobRsbRebLjbLebLebRcbLcbLebLobRebLeb
RibLjbRgbRcbRcbLibRsbLebRobRobLobLobLebRsbLobRebRobRebLsbRebRibLjbRjbR
obLibLobLjbRibRjbRjbRebLsbLebRebLjbRebRjbLjbRobRsbLsbRjbRobRjbLobLjbLe
bRobLebRobRobRsbLebLobLebLobRebLobRobRsbLsbRjbLjbLobRebLobRebLebLcbRcb
RhbRjbRjbRcbRebLjbLebLcbRcbLibLcbRobRobLjbRobRcbLjbRjbLebRcbLebRsbRobL
ebLjbLjbRsbRobLjbLebLebRobLcbLsbRsbRjbRobLebLobLjbRobRjbRebRjbLebLsbRs
bRobLobLjbRobLobLsbRsbLjbRcbRsbLebRebRcbRcbRobRobLobLjbRcbLebRcbLobLjb
RebRebRobLebLobLebRebRobRibRobRobRebRobLebLobRsbLsbLobLobRjbLobLcbRobR
sbRobLsbRjbLcbLebRobRobLobRebLobRobLobRobRobLcbRibRebLebLobRjbLjbRobLe
bLobLobLobLobRebRobLebRobRsbRgbLjbRebRebRebRebRobRcbRsbRjbRjbRobLobLjb
LsbLobLobRebRobLebRsbLjbLcbRebLjbLcbRobRobRebRobRhbRobRebLsbRcbLobLobR
obLobLobLjbLobRobRebRebRjbLjbRjbRebRcbRobRebRobRobRobRobRjbLobLgbLobLo
bLjbRobLebLobLebLjbRebRgbRsbRobRcbLobLobLsbLebRebRobRcbRcbRebRjbRobRob
RebRebRobRebLebLebLebRebRebLcbLcbLebRobRobLobRebRsbLobLcbLebRcbLobRobL
obLcbRibLsbRjbRobLebRsbRobRobRobRcbRjbLobLobRebRjbRibLobRcbLobLjbRobRe
bLobRcbRobRebRcbRebLjbLebLebRobRobLobRobLsbRobLebRjbRobRcbRsbRobRjbRob
RobLebLhbLebRjbRobLobRobLobRsbLcbRobRjbRjbRobRjbRobLibRebRobRebLcbRobR
ibRobLebLcbLebLobLobLebRobRobRobRobLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bsbsbRsbsbsbsbRsbsbRsbLsbRsbLsbRsbsbsbRsbsbsbRsbsbsbLsbsbRsbLsLsmbLsRs
LsbRsRsRsmmbRsLsbLsbRsbRsbLsRsbRsbRsbLsbRsbsbsbRsLsbLsbsbsbRsRsmbsbLsR
sbLsbLsbsbLsbsbRsRsmbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsRsmbsbsbsbsbRsbsbR
sbRsbRsbRsLsbLsbRsbRsLsRsbsbsbsbsbsbLsbLsRsbRsbRsbLsbLsbLsbsbRsLsbLsbR
sbLsLsRsmbRsbRsbsbLsbRsbRsbsbLsbRsLsbRsbRsbRsLsbsbsbsbsbsbsbLsbRsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbLsbRsbLsLsmbsbRsLsbLsbRsbRsLsbLsRsbLsRsbLsbL
sbLsbRsbLsRsLsbRsbsbLsbLsLsLsmmbRsRsmbRsbRsbLsLsmbLsbRsLsbRsbsbLsbRsbs
bLsbRsbLsbsbsbLsbLsbRsLsbLsbRsbsbsbsbsbsbsbsbsbsbsbRsLsbsbsbsbsbLsbLsb
LsbsbsbsbsbRsbsbsbsbLsLsmbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbs
bsbsbsbsbsbsbsbsbsbsbRsbsbsbRsbsbsbsbLsbsbsbsbsbsbsbRsbsbRsbLsbLsbLsbs
bRsbsbsbsbRsbsbsbRsbsbsbsbsbsbsbsbLsbsbsbsbsbRsbLsbLsRsbsbsbsbsbsbLsbs
bRsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbRsbLsRsbLsbRsbsbsb
sbLsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 19; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 20; Drug: Control Apo 50 然
bLsbRsLsbRsbsbLsbRsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 21; Drug: Control Apo 50 然
bsbRjbRibRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 22; Drug: Control Apo 50 然
bRsRsRsRsRgRiRsRimmmmbRsReRsmbRsbRgRsmbRhbRebRsRsRsRsRsRgmmmmbRgbRebLs
bRebRgbRsRsmbRgbRsbsbsbLsRiRgbRebRsbsbRibLsbRsbsbRibRsbsbRsbRgbRgbsbsb
RibRgbRgbRgbRgbRibLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 23; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 24; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bLsbLsRsbLsbLsbLsbLsRsbLsbLsbLsbLsbsbsbLsLsmbLsRsbRsLsRsbLsLsmbRsbsbRs
bRsbLsbRsRsRsmmbLsbLsRsbsbsbsbsbsbsbsbRsbLsLsmbsbsbsbLsLsmbsbRsbLgLsbR
sLsbLsLsmbLsbLsbLgbLsbLsbLgbLsbLsbLsbLsbLsLsmbLgbLsbLeLibRsbRsbRgbRsbL
sbRsbRsbRsbRsbsbsbRsbLsRsbRsbLsLsmbLsRsbRsLsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bRsbRsbLsRsbRsbRsRsmbsbsbLsbLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bLsbRjbRjbLjbLsLsmbLcbLgbsbLoLsmbLcbRcLsbLcbLsbRsbLcbRiRcbRgRebReLhbLi
bRibReRsmbRsbLobRibRcbLsLsmbLsbRsbLsbsbRsRsmbsbRsRsmbRsbLsRsbRsLsbsbLs
bRsbRgbRsbRgbRiRsmbRhbsbRsbReRobRebLsbRgbRibRibLebRibsbsbLsbRsLsbsbsbs
bRsbRsbRsRsRsmmbRgbRgbsbRebRibRebRibLgbLebLobsbLsRcbLgbLgRsRsRjmbRobRe
bRibRcbLibRhLsbLcbRsbRibRibLsbRebRsbsbRgRibRcLibLcLcRsbLsbReLsbsbsbRoL
sbLeLsbRebRoLsbLiLsbsbLhb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bLsbRsbLsLsLsmmbRsbRgbLsLsRsmbLibRsLsLgbsbLsbLsLsLsmmbLsbLgbRsbLgbLibL
gbsbLiLsbLcRsLgbLsbLsbsbLsbLebLibRcbRgbRebRgbRhbRibLsRsRsmbRebLsbLsbLo
bRobRsRsmbRgbRsbRgbRgbRgbRsbsbRsbRsbRsbLsbRjLsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bRsbLsLsRsmbLsLsmbLsbLebRsbLobRsbLobRobLjbRebRobLebRobRebLsbRibRobRobL
ebLcbRobRgbRebLebLibLobLobLibLobRobLsbRcbLgbLobRebRobRobRsbLebLibRjbRg
bRebRobRebRebLjbRjbLcbRebRebLobRjbLebLobRobLjbLobRcbRjbLobRobLobLobRob
RebLobRobRebRobRobRobRebRsbRjbRobRjbLobLcbLobLobRjbRebLebLebRobRobRobR
obRobLobLgbRobRobLobLobRjbRcbRobRobLebRobRobRcbLobRobLebRjbLjbLobLsbLj
bLsbRsbLjbLsbLjbLcbLobRobLcbLjbRobLjbLjbLsbLcbLobRebLobLobRebRjbRjbLsb
RobLjbRobRebLjbLebLobRebRcbLobLsbLjbRobLcbLjbLobRebRobLobRgbRsbRebRobR
obLobRobLjbRcbRebRobLebRebRobLebLcbRobLcbRcbRjbLobRebLcbLebLsbLobRebRe
bRobLobRcbLsbLgbLobRsbRebRebLobRobLobLobLgbRobLjbRobRjbRjbRobLjbLebReb
RjbLibLjbRjbRcbRebRcbLjbRobRobLebLobRobRcbLobLebRcbRebLebLobLobRebLibR
obLobLobRobRsbLobLebLebRebRebLcbLobLobRebLobRebRibRsbRobRcbLebRsbRcbLo
bLcbLobLobLebLobLjbLebRobRobLobRebLebRobLobRobRjbLsbLebRgbRobLibRobRob
RjbLobRcbRgbLobLobLcbRobLibRobRobRebLcbRobRjbRjbLobLobRcbLobRebRebLobR
jbRobRebRibRobRcbLebRobRobRjbRibLjbLobLjbLebLjbRobRsbLobLobLobLobLebRo
bLobRsbLebLobLcbRebLobLobRgbLebLcbRobRcbRobRsbRsbRobLcbRobRobLcbRobLob
LgbRebLobRobRobRibRibLcbLebRobLobLobRobLebLebRcbLjbLobRcbLgbRebRobRcbL
ibRcbRobRcbRcbRobLjbRobLobRobRcbRobLebLobLjbRobLobRobRobRobRobRebRsbRe
bRebRobLibLobLcbRobRobRobLebLebLebRjbLebLobRebRebLjbRebLobLcbRcbRcbLob
RobLobRjbRjbRcbLsbRobRsbRcbLjbRebRcbRebLobRjbRebLobLcbLebLobRobRebLebR
ebRobLobLebLebRcbLjbLgbLobRebRebRjbLsbRsbRobRcbRebLobRebRcbLsbLcbLhbLe
bRgbRebLobRcbLobLobLjbRobLcbRjbLjbRobRibLcbRcbRebRibRobRobRjbLcbRobLeb
RobLjbLobRobLcbLobRjbRobRebRebLobLobRjbRobLsbRobLobLobRobLjbLobRebRjbR
sbRobLsbLjbRjbLebRjbLobLobLobRcbRebLebLcbLjbRebLebLebRobLobLebRobRsbLe
bRsbRobRobRcbLobLjbRcbRgbLjbRjbRebLebRebRjbRobRebRobRobLebRjbLsbLjbLob
LobRjbLjbLebRobLebRcbRjbLobLjbLjbLsbRobRjbLobRcbLcbRcbLobRebLcbLebRsbL
jbRcbLsbRobRobLobLcbRobLobRjbRobRebRebRjbLobRobLjbRobLjbLebLobLjbRjbRe
bRobRobRebLebRjbRobRcbLcbLobLcbRebLebRobRobLsbRjbLobLebLsbRobLobLcbLob
LobRebLobLcbRebLobLobRobLjbRjbLobLobRcbRobLobRobRobRobRobRjbRsbRjbRobL
obRjbLobRobLebRebLebLobRsbLcbRebLobRobLcbRobRcbLjbLjbLobRobRobRobRebRj
bRebLjbRobRjbRobLjbLobRcbRebRjbRobRobRobLebRjbRjbLebRebRjbLobRebRobReb
LebLsbRcbRobRcbRobLobRobLjbRobRjbLebLjbLjbRobRcbRobLobLgbRebLcbRjbRebR
jbLebLobRjbLobLjbRibLebLjbLobLebLjbRebRobRjbRcbRjbRjbLjbLjbRebRobLcbLo
bRobLcbRobRebRcbRsbLebRjbLobLobRcbLobLebLebRobRjbRebLcbLebLjbRobRobRcb
LebLjbLjbRebLebRobLobRebRjbLcbLcbLjbLebLebLobRsbLcbLebLjbLcbRebLjbLebL
ebLcbRobLebLebLebRobRobLcbRcbLobLobLobLjbRobRjbRobLjbLebRobLjbLobRjbLe
bLjbRcbLjbLebRjbLjbLebRobRobLobRobRobRebRjbLjbRobRobRebLobRsbRcbLobLsb
LcbLjbLebRsbLebLebRobLebRjbLjbLobLsbRobRobRobRebLjbLjbRebLobRebRebRcbL
ebLobLjb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bRsbRsbLebsbLsRsRsLsmbLsbLobLibRebRgRsmbRhRsmbRebRibRibRgbRgbRsbRgbReL
sbLsbRibRibRgbRgLsbRiLsbRgbRgLsbRsbRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bsbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbLsRsbLsbLsbRsbsbRsbRsbsbsbsbsbsbsbRsbLsbsbsbsbLsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bRsbsbRsRsRsRsRsmmmmbsbsbsbRsbLsbLsRsbsbLsbsbRsbRsLsbLsbsbsbsbsbsbsbsb
sbsbsbsbsbsbsbRsbsbsbLsbRsbRsbsbRsbLsbRsbRsbRsRsmbLsbLsbsbsbLsLsmbRsbs
bLsbRsRsmbsbRsbsbLsRsbRibRgbRsbLsbRsLsbLsRsRsmbRsRsmbLsbLsbsbRsbRsRsRg
mbRsRsmbRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bsbsbRsbRsLsbLsbRsRsmbLsRsbLsRsbRsRsmbLsbRsLsbRsbLsRsbLsLsmbRsbsbLsbRs
bsbsbsbsbsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bLsLsmbLsbRsLsbLsLsmbLsbLsLsmbRsbLgbLsbLsLsmbLgbsbsbLsbLsLsmbLsbLsbLsb
LsbLsbLsbRsLsbLgbLsbRsbLgbLsbLsbLsbLgbLgbLsbRsLsbLsbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bRsbRjRjbLhLsbRebLgbRibRibRibRgbRgbRgRsmbRsRsmbRsRsmbLsbRsbsbRsbRgbRsb
RsRsmbLsRsbRsLsbLsbRsRsmbsbRsLsbLsbRebRebReLsbRhRsmbRgbRsbRhLsbRcRsmbR
ebRibLjLsLsmmbLsbRsbRebRhbRibRsbLsbLsbLgbLgbLsbLgLsLsmbLgbLgbLgbLsbLsb
LgbLsLsmbLsbLsbLeLsbLcbLcbRibRsbRgbRebRgbRhbRgbLsbLibLsbLgbRibRgbRsLsb
RgRibLcbLgbRoLsbLsLobRsbLsLebRgbLgbRibsbLsbRsbRsbLcbRsbRsbsbLsbRsbRsbR
gbLsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bLsbRsbRebRsRsmbRsbRsRsmbRsbRsRsmbsbRsbsbRsbLobLsLsmbRsbRjbLgbLgRsRsmb
LsbLsbLsbLsbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 43; Drug: Control Apo 50 然
bLobRobRjbRsbRobLobRobLebRsbLsbRobLsbRjbRebLcbLsbRobLjbLsbLebLobLsbRob
LobRjbLcbLebRebLcbLjbRjbRebRebLjbRjbLcbLsbLsbLobRsbRsbRebLsbRsbLsbLebR
sbRsbRsbLsbLsRsbLsLsRsmbRcbLsbLsbRsbRjbRsbRsbLjbLsbLsbRsbLsLsmbLsbLsbL
sbRsbRsbRsbLsbRsbLsbRsbLsbRsbLsbRsbRsbLsbLsbLebLsbRsbRsbRsbLsbLsbLsbLs
bRsbRsbRsbRsbRsbLsbRsbLsbLsbRsbRsbLsbLsbLsRsbLsbLsbRsLsbRsbRsbLsbRsbLs
bRsbRsbLsbLsbRsbRsbRsbLsbLsbRsbLsbLsbLsLsmbRsbLsbRsLsLsmbRsbLsLsLsmmbR
sbLsbLsbRsbRsbLsbLsbRsbRsbLsbRsbLsLsmbLsbLsbLsLsmbLsLsmbLsRsbRsbRsbRsb
LsRsbRsbLsLsmbLsbLsbRsbRsLsRsbRsbRsbLsbLsbLsbLsbLsbRsbLsbRsbLsbRsbRsbL
sbRsbRsbLsbRsbLgbRobRsbLsbLebLsbLsbRsbLsbLsbRsRsmbLsbsbRsbRsRsmbsbsbRs
bLsbsbRsbLsbRsRsmbLsbLsbRsbLsbRsbRsbRsbRsbRsRsmbRsbRsbLsLobRjbRsLjbRsb
RsbLsbLobRjbRjbLobRobRjbRjbRjbLobLjbLsbRjbRjbLjbRsbLsbLjbLjbLjbLobRjbR
sbRsbRjbLobRsbLjbLobRsbRebRobRcbLebLobRsbRsbLjbLobLsbRobRsbLjbRsbLsbLj
bRsbRsbLsbLsbLsbRjbLsbLsbLsbRsbLsbLsbLsbLsbLjbRsbRsbLjbRjbRsbLsbLsbLsR
sbLsbRsLsbRsbRsbRsLsbRsbRsbRsbRsbLsbLsbRsbRsbRobLsbLsbLsbLsbRsbRsbLsbR
gbLgbLjbLgbLsbLgbLsbLsbLsbRsbLgbRsbLgbLsbRobRgbRsbLibRsRsmbRgbRsbRsbRs
bRobRsbLsbLjbRsbRsbRebRjbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 44; Drug: Control Apo 50 然
bRsbRgRsmbRgbRebRebRibRgbRsbsbsbsbsbsbsbLgbRsbLsRsbRsbLsbRebLgbLsbLebL
sLebLsbLsbLebLsbLsRsbLsbsbLgbLsbLibLebLsbLgbLibLgbLsbRsbLsbLsbsbLsbLgb
sbRsbRsLebLjbRibLcbLebRibLsbLeRsbRsLsbRgbLsbLgRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 45; Drug: Control Apo 50 然
bLsbRsbsbRsbRsbLebLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 46; Drug: Control Apo 50 然
bsbRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 47; Drug: Control Apo 50 然
bLsbRsbRsbRsbRsbLsbRsbRsbRsbRsbRgRsRsRsRsRsRsmmmmmmbRsRgRsRgRsmmbsbLcb
RsbLebLcbRibRebRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmmmmbRsRs
RsRiRgRsRsLsmmmmbLjbsbRsbsbLiLhbRsRsLsLsRsLsmmbLebLcbLjLebRjLsbRcbRcRs
mbRiRgbRgRiRsmbRgLsLsmbRgRgbRsRsRsRsmmmbRsRsRsmmbRgbRsRsRsmmbRsRsmbRsR
sRsRsRsmmmmbRsbsbReLgbLjLibLsbLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 125208; End: 125709;
Recording: 10-1; Individual: 48; Drug: Control Apo 50 然
bRsbRebRsbRsRjbsbLsbLsbLsbRsbsbsbRsbLsbLgbRsbLsbsbsbsbsbsbsbsbsbsbsbRs
bRsbsbsbRsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bRsbLsLsmbRsLsbRsbLgbLsbRoRoRobLsLoLsmbLibLgbLsbLiRsbLoLcbLjbLobLsLgbL
obRobRgbRsbLsLsmbLsbRsbLsRsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bsbsbLsLsmbLsbLebLsLgbRsbLsRsbsbRsbRsReRsmbRiRebRcRsmbRcbLgbLsRsRsRsRs
mmmbLsLsmbsbRsLsbRsbRgRsmbLsbLsRsbsbRsRsLsmbsbsbsbRsLsLsmbsbLsbsbRsbRs
RsmbRsbLsbRsLsbRobRsbRjLsbLsbLjbRebRgbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bsbRsbRsbLjbLsbRjbLsbRsbLsbRjbRsbRsbRsRebRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bRcbLibRcbLgbRcbLebLebLebLobRebRhbRebLcbRebRobLobRebRcbRobLobLebLsbLcb
RobLobLcbRobRobLebRebRcbLcbLcbLebLebRobLobRobLibRobRobRcbLsbRobLcbRcbL
obRobLebRebRgbRobLcbRobLebLobRobLobRobRebRobRebRebRcbRgbRobRobLobRsbLe
bLibLibRcbLobLcbRhbLobLebRobLcbRebLibRgbRebRobLobRobRcbRjbLobRebRobRob
LebLcbLebLebLebLobLebRobLebLebLebLcbRcbRebLhbRobRobRcbLcbRibRobRobLebL
ibRobRcbLobRibLcbLobRibRebRcbRobRebLobRebLjbLebRobLsbLebRjbRibLobRjbRj
bLjbLobRobLobLobLebLcbLjbRcbLibRobRobRcbLgbRobLgbLebRgbRibLobRcbRsbLob
LcbLcbLcbRebLcbLjbLebRcbRhbLebLebRebRobRebRibLcbRibLobLcbRhbRcbLgbRobL
obLobLebLgbRebLibLobLcbLebLgbRibLibRebLebRobRsbRcbLobRhbRjbRgbLsbRebLe
bRibLobLgbRobLobLobRebRibLcbLcbRebLgbLhbLcbLobRebRebRgbLobRobRsbRobRob
LibRobRobRebRobLsbRobRobLobLgbLobRgbRcbRhbRobLobRibRcbLcbRebRcbLobLebL
ebLsbLobRcbLobLobRobLebRebLibLibRhbRebRebLcbLobLcbLebRebRobLobRebLobRc
bLgbRjbLebLobLgbLobLobLsbRobLcbRcbRobLebRebRibLebRebLebLobRibRobLhbLob
RebRobRibRebRsbRsbRebRobRibLcbRebLobRobLsbLobRobLebLsbRebRobRebLebLcbR
obLebRobRobRebRobLobRgbLebLobRebLebRobLcbRobLebRobLcbLibRebLebLebRebRo
bLebLcbLobLebRebRobLebRebLobRhbLebRcbLcbLcbRobLcbRgbRcbRebLsbRebRsbRcb
RcbRobRibLsbLebLobRebLebLebRobLobLcbLobLebLcbLobRebLebLobRhbLobRcbLgbL
obLobLobRgbRibLcbRebRebLebLebRcbLgbLobRebLebRebLebLobLhbRibRebLebLibLo
bRobLebLebLebLobLgbLobLobLobRgbRsbLibRsbRobRebLebRebRibLebRobRibRgbRgb
RebRgbLebLobRobRebLcbRhbLibRobRebLebRobRcbRobLebLobLcbRibRobLobLobRebR
cbRobRebLobRobLebLobRibLibLibRibRobLobLhbRebRcbLgbLobLobRebLebLcbLibRo
bRebRibLibRebRsbLebLebLibLobLebRebLebRgbLgbRcbRobLsbLobLobRobLobRebLsb
LebLgbLhbRebRobLhbLobLibLebLobRsbLcbLebLcbRobRobRcbLobRobRebRebLobRobR
hbLgbLebRobRcbRcbRebRgbLebLcbLcbRobLobLobLobRobLebLobRcbRgbLobLgbLobRs
bRhbRobRgbRobRobRebLgbLebLobLebRebLobLebLgbRebLobRebLobLobRebRebLibRob
LebLebRcbRsbRobLcbLobRibLibLebLcbLobLebLebRobLobRobLobRebRebLsbLcbRebL
ebLebRobRobRebLcbLobRsbLcbRobRibLgbRebRcbLcbLobLobLebRcbLebRebLebLgbRe
bLgbLebRobRebRobLebLcbLobRobLebLibRobLjbRhbRobRebRobRcbLhbLobLcbLebLob
RcbRibLcbRsbLobRcbRobLebRobLsbLsbRobLsbLcbRgbRobRhbLibLebLobRcbRobLebR
ebLibLjbLobRebLobLsbRebLhbRebLobLebLebRcbRebRcbRebLcbLebLcbRibLebLcbRe
bLobRgbRebRibRcbLgbLobLcbRgbRsbLebLobLebRebRgbLobRobRebLobRebLebRibReb
LcbLobRebLibRibLebLebLgbRsbRibRcbLebLebLobRibRcbLgbLobLobLebLgbRgbRgbR
obLcbRebLcbLebLhbLcbRjbRgbRobLebRobLebRebLsbLobLobLcbLobRcbRcbLgbRsbLo
bLebLibRobRobRebRobLcbRebRobRebRobRgbLcbLebRobRobRgbLobRgbLebRebRobLob
RsbLcbLobLgbRcbRebLebRcbRgbLobRibLobLibLobRibLibLgbLcbRobLgbRobRobRebL
obLebRgbRobRibRebRobRibLobLebRebLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bRsbRsRsRgmbRebRebRobRcRsLsmbRcRsmbRgbLebLebRsLjbLgRsbLsLsLsmmbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bLsbLsbsbLsLsmbRjbReRsLsmbReRsmbRcRgbReRsRsRimmbReRsmbRiLsbLsRsLsbRgbR
iRsRsLsRgLsRgmmbLsbsbsbLsbRsbLsbRsbRsbLsLsmbsbsbsbsbsbsbRsRsmbLsbRgLoR
sRsRsRsRsRsmmmmmbRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bLobLsLsLsLsmmmbRjbRoRsRsLsLsmmmbRcbRcbLcbRjRcbRcbRhbLiRsbLgbLsRsbRsbL
sLsmbRsRsmbLsbsbLsbLibLgbsbLsLsmbLsbRcRsmbRgbRibRibRsbRibLsLcbRhbRsbLs
LsmbsbRsbRibReLibsbRsbLsRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bRsbLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bsbLsbsbLsbLsbRsbLsbRsbLsbLsbLsbLsbLgbLgbsbLsbLsbRsbsbLsbLsbLgbLgbLsbL
sbLsbRsbLgbLgbLgbLsbLsbLgbLsbLsbLgbLgbRsbLsbLsbLsbLsbRsbRsbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bLjbRibRjbRiRoRsRsRsRsmmmmbRibLsbsbsbsbRsbsbLsbsbLsbsbsbLsLsmbRsLsLsmb
LsbsbsbRsbReRsmbRsbsbRsLsbRibLsbReLsbLgbLoRsLsbLsLsLsmmbLgbLsLsmbsbLjb
LgLeLsbLgLgLhRsbLiLgLsbLibLiLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbLsbLsbsbsbRsbsbsbsbLsbsbsbsbsbsbsbsbsbsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bRgbLsbRsbLsbRgbRsRsmbRgbRsbRgbRsRsmbRsbRsbLsRsRsmbRgbRgbRgbRsRsmbLsRs
bRgbRsbLsRgbRsbRsRsmbRgbLsbRgbRsbRsLsbRsbLsbRsbRsbRgbRsbsbsbLsbRsbRsRs
mbLsbRsbLsbRsRsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bLhbRsLjLgLsbRjbRcbRcbLsRsRsmbRsbReRsmbRebRhbsbRibLgbRcbLcLsmbLhbsbsbs
bsbLsbsbsbLsbLsbLsbLjbsbLsbRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bLiLsbLcbLsLsmbRebLcLsLsmmbLcLsLsmmbRebRcRsmbRcbRibRiRsmbRsbRsRsmbRgRs
mbRhbRgbRsRsmbsbLsbRsbRgRsmbRiRsmbRiRsmbRsRiRsRsRsmmmbRsbLhLsbLsLsmbLs
bLsbLsLsLsLsLsLsmmmmmbsbLsLsLgLsLsmmbLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbLsL
smbLgLsLsmbsbsbsbsbLsLsLsmmbLsbRsLsbLsLsLsLsmmmbsbsbLsLsLsLsLsLsLsLsLs
LsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmbLsLsLsmmbLsLsmbsbsbLsLsRsRsLsLsmmm
bRsLsbLsbLsRsbRsbLcLsmbLcbRcbRgRsRsRcRsmmmbRebRsbRiRsmbRsRsRsmmbRsbRsR
smbRsRsRsmmbRsRsmbsbRsbRjRiRsRsmmbRgRhRsRcmbRgRsRsmmbLcLsmbReRsmbRhbRi
bRgbRgRgRgRsmbLgbLjLjLsLsLsmmmbLiLsbLgbLsbRibRsbRiRsmbLgLsbLsbRiRsmbLs
RsRsmbRsbLibLgLsLsLsmmbLgLsbRgbLsbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bLgLsbLcRsbLcbLibLcbRgbLcRsbLhbLiRsbLsLsmbLibLgLsbRsRsmbLobLsbLobLhbLg
bLsbLgLsbLsbRsLsbLgbReLgbRiRgRsmbRgRsRgRgmbRgbRibRsRsmbRgbLsbRsbLsRsbR
sRgbRcRsmbRebRjbRiRsRsmmbRiRsmbRgbRgbRebLibLobLgbLgLcLsmbLgbRgRsmbRgbL
ibLibLibLgbRebRiRsmbRgbRibRebRibRibRibRibRjbRibRebLebLgbLjbLcLsLsRsmmb
LgbLibLhLsbLiLsbRobRcbsbRibLhbReLjbRiLsbRsbReReReReRsmbLsRsbLsLsLsLsmm
mbRsbRsRgRsRsmmbRebRcb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bRsbsbsbsbsbRsbLsbLsbsbRsbRsbRsbRsbRsLsLsmbLsbRsRsmbRsLsbLsLsmbLsbRsbs
bRsbsbsbsbsbsbsbLsbsbsbLsbRsbRsbRsbsbLsbRsRsmbRsbLsLsRsmbRsbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 19; Drug: Control Apo 50 然
bLebLebLibLobRcbLjbRcbRobRcbRobRobRebRebLsbRebRibLebLcbRobRcbLobLcbLob
RebRobRobRebRibRobRebRcbLobLebRobLgbRcbRobRebRobRgbLcbLgbLjbLobRsbLgbL
ibLobLibLgbLgbLobRcbRgbRcbRjbRgbRobLebRobRebLsbLibLobLgbRcbRebLobLobRo
bLebLebLgbLobLhbRebRebLjbRebLsbLcbLebLgbLsbLcbRobLsbRebLibLgbRibRebLob
LcbRobLobRcbRgbRjbRobLgbLsbRebRobRcbLgbLsbRebRebLibLcbLebLobLebRcbRgbL
obRobRcbLebRobLibRobRobRobRebLobLobRobRobLgbRibRebRcbLcbLobLebLobLhbRe
bRebLobLebRobRibLobRebLcbLsbRgbRebLsbRebLebLibRebRgbLebLobLcbLgbLobReb
RebLibLsbLobRcbRcbRcbRebRebLibLebLsbLobRobLebRcbLhbRobRobLebRcbRobLobL
obRcbLobRcbRebLibRsbRobLsbLcbRcbRobRobRcbLobLgbLobLcbRcbLibLobLobRcbRc
bLebLcbLobRcbLebRgbLobLobLebLcbLibLgbLebRobRobRobRebLcbLcbLobRgbRsbReb
RobRgbLebLhbRcbLibLobRobLjbLobRobLobLobRsbLebLobRcbRobLobLcbLebRebRcbR
sbLobLcbLebLebLobRhbLobLobLgbRhbRebRcbLobLobLobLibLobRgbLcbRcbLibLgbLe
bLcbRcbRobLobLebRobLebLebRgbLgbRebRobLebRjbLebRhbRobLebRcbLebLobRobRgb
RobRobLhbLgbLcbLcbRjbRobLcbLobRobLcbRcbRebRcbRibLobLobRcbLobLibLebRobR
obRhbRebLobLcbRjbRobRobRcbLobLibRebLobLsbLebRobLibRebRgbRgbLebLcbLibRj
bLcbLebRcbRcbLebLobLebLebLcbLhbLcbRebRobRobLibLobLcbLebRcbRobRcbRgbRcb
LobRcbLobRsbLebLobRgbRobRebLobLebRobLobLibLcbLobLebRobLebRobLebRobRcbL
cbLobRebLobLebLcbLibRibLjbRobRobLebLobLcbRjbLcbRebLcbRcbRibLobRobRhbLh
bRobRhbRobLebLebRcbRobLobLobLsbLobRobRcbLebLebLcbLobLebLcbRgbLebLjbRib
RobLobRobRobRcbRcbRsbRcbLobRibLobLibLcbRcbRebRcbLcbRobRcbLobLsbLobRobL
ebLobRgbLobLibLobRebRebRgbRobRobRebLobRobRcbLobRobRobRibRebRobRobRebRe
bLobRcbRibRsbLobRcbLcbRcbRibRobLibLobLobLgbLhbRcbLobRcbRibLobLcbRcbRib
RobRobRobLcbLobLibLibRobRebLibLobLobLcbLobLobRebRjbLgbLcbLibLobLgbLebL
obLcbRebRobRhbRibRebRobLobRobLobLebLebLibRobLebLcbLibLebRobLebLgbRobRo
bLobRcbRcbLebRebRobLgbLobLobRobLebLobRobLibLebRobLebRibRebRibLebRcbRcb
LcbLcbLibLcbRobLcbRebLobRobRobRgbRebRibLibRobRcbLobRobRibLibRcbLobLebR
cbLgbRebRebLibLebLcbRebRibLobLcbRobRebLsbLcbRibLobRobRcbLcbLibRobLebLe
bLebLebRebLobLobLcbLebLobLsbRobLcbLebRobLobRebRcbLobRebRebRobLebLebLob
LebLcbLobLhbLsbRsbLobLibRcbLebRsbRsbRhbRobRhbRsbLobLebRoRebRsLsbLgRsLs
LsmbLcbLebRsbLoLsmbRoRsmbLsbRobRsbRsbRsbLsbRebRsbRsbRcbRibRebLobLobRib
LsbLobLobRgbRobRebLobLcbLobRcbLgbLcbRebRcbLobLobRobLobRcbLjbLebRcbLebL
gbLobRobLobRebRsbRebLibRobLgbLobLobRobLcbLebRebRibRcbLobRobLcbLobRebRe
bRobRgbLebLcbRebLcbRgbLebRebLibRgbLebLebLebRobLobLebRobRobLcbRgbRobLsb
LjbLobLebLhbRebLgbRobRjbLcbLebLsbRcbRobLebRcbRebLobRjbRebLgbRcbRibRebR
obRebRibLobLebLobRebRjbRobRobLcbLobLcbRobRcbLobLobRobRobLcbRhbRebRcbLo
bLobRebRobLob

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 20; Drug: Control Apo 50 然
bsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 21; Drug: Control Apo 50 然
bLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 22; Drug: Control Apo 50 然
bRcbLsbLcLebLiLsLgLsLsmbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 23; Drug: Control Apo 50 然
bLebRcbLcbLcbRcbLobLebLobLobRsbLobLobRcbLebRobRobLcbRibLobLcbLcbRsbReb
RobRsbRebLobRebRibRobLibLebLebRcbLobRibRcbRebRcbLobLobRgbLsbRobRobRobR
ibRobLobRhbLibRebRcbRobRsbRibLobLobRobRgbLobLobRgbLibLibRebLcbLibRobLo
bRibRobRobLobRobLcbRgbLcbRobRobLebRsbLebRobLebLobLobRobLobRcbLebLobRhb
LobRibLebRebLobRobLobLibLebLobLobRobRsbRcbRobRebLgbLcbLobLcbRebLibLebL
cbRebLobRgbLibLibLcbLobRebLobLobRobRobLibRobRgbRibLcbLobLebLebLobLcbRo
bLgbRhbRobRebLibRebLibRobLobLibLcbLebLsbRgbLebLebRsbLgbLcbLobLsbRobRhb
RobLibLcbLobRcbLebLobLjbLebLcbLsbRobLebRebLobRobLobRcbRobLgbRobLobLobR
obLibLebLobRibLibLebRcbRobLcbLobLibRhbRobLebLobLebRobLebLgbRgbRobRobLo
bLobLobRobLgbRebLobLgbRcbRebRebLcbLobLibLobRsbLcbLobRebLcbRibLibRebRcb
RcbLhbLcbLobLebRobRcbRobRsbRobLobRobLibLcbLebRobLcbLobLebRcbLobRobRobR
obRcbLsbLobLobLibLsbRobRibLobRebLcbRobLsbRobLobLobRobLcbRobLsbRcbLgbLo
bLobLobRibRobLhbRcbRcbRsbRebLsbRhbRobRobRgbRsbLobRibRebRobRobRobLobRsb
LibLebRgbLobLobLobLebLobRcbRcbRebRobLcbLibLebLobRcbRobLgbLobLebLsbRobR
hbRjbRebRobRebRobLebRcbRebRobLebLobRebLobLcbLobRibLgbLobLhbLebRobRobRi
bRobRcbLobLobRobLobRhbLobLobLobLcbRgbLsbRebLgbRebLibRobLsbLibLcbLcbLob
RsbLobLobRcbLibRcbLobLobLsbLobLobRgbLobRebLobLibLobRibRcbLebLibLsbLobL
obRobLcbRebLebRobLsbRibRobRobRebRebLebLobLcbRcbLebRcbRcbLobLobRibLgbRe
bLcbRebLebLobRebLgbRobRebLebRobRobRebLibRcbRcbRobLobLgbRobLjbRobLobRgb
LebRgbRcbRebRgbRobLsbRobRebLebLcbRsbLobRibRcbRsbLsbLobLebLibRobLobRcbL
obLebLobLobRgbRobRebLgbRobLebRibLobRebRobLcbRobLgbRebLobLobRebRsbRjbRo
bRebRobRobLebLcbRobLobLhbRcbRobLobLcbLobLgbRgbRobRebLobLebLobRcbLebLgb
RhbLgbLcbRobLjbRibLgbRibRcbRcbLobLobLibLebLobLobRsbLcbRcbLobRcbLgbLebR
cbLobLcbLobRebLobRcbRebLcbLcbRebRobLobLibLibLobLobLobLobLobRcbLobRobLo
bRsbLcbLgbRobRobLobLhbLobRebRgbRsbLebLcbRgbRobLebRcbRebLobRcbLobLobRgb
LibRobRcbLobRcbRobRsbLobLebRebLebRobRobLibLobRebRobLobLobRobLibLcbLobL
obLobRobLobLebRebRebLobLgbLebLibRebRobLobLobRibLebLobLgbLebRobRgbLobRe
bLibLobRebLhbRobRcbLebRcbLsbLebRobRgbRsbRcbRebRobRhbRebLcbLobRebLobRob
LcbLobRibLcbRobLcbLcbRobRebLgbLebRobRobLobRgbLebLobRcbRebLobLobLobLobR
ebLobLibLobRebLcbLgbLsbRebRobRgbRhbRebLgbRcbLobLebRebRobRcbLcbRobLebRo
bLobRebLobLobRobLcbLobLobRobLsbRobLobRebRobRobLobRcbLcbRebLebLobLcbLhb
RobLibRobLebRobLobLebRobRgbRobLobRebRebRebLobRcbLobLobLobRebRobRebLobR
ibLcbLobLibLcbRcbRobLcbLobLcbLobLgbLobRebLebLebRcbLobRibRibRebRobLebRo
bRsbLobRjbRebRibRobRobRebLobLebLgbLobLibLobRibLobRobLcbRcbLobRebRsbReb
RobLebRebRcbRebLcbRcbLcbRobRebLibLibRcbLebLcbRobLobRcbRibLebLobRibLobL
gbLsbLobRobLibLobRobLibRcbRobRebRobLebRhbRobLebLgbLobRebRibRsbLebLcbLo
bLhbLcbRhbLobRobRebRobRobLebLjbRcbRgbRibLsbLebRcbRcbRobRebRcbRobLibRob
RobLcbRcbLebLebRcbLcbRebRebLebLebLgbLebRsbRgbLobLobRebRcbRobRcbLobLobL
cbLebRcbLobRhbRsbRobRgbRcbRobLcbLcbLsbLgbLobLobLcbRgbRobLobLibLcbLobRe
bLebRebRcbRobRebRebLebRibLcbRobRobRobRcbRebRebRibLobLebRobLobRgbRobRgb
RsbRobLebRhbLgbRhbRebRebLcbLebRcbRobRobLsbRsbLobLobLobRobRobLobRibRebL
sb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 24; Drug: Control Apo 50 然
bLsbsbsbLsbRsbRsbRsbLsbLsbsbRsbLsLsmbsbRsbRsbsbLsbsbRsLsbsbRsbRcRsmbLo
LsmbRsRebRsbRsbLsbRjLsbLsbRsbRsbRjbRsbLjbLsbLsRsbRsLsbRjbRsbRsRsmbLsRs
bRsRsmbsbRjRsmbLebRsbRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bLsbsbsbLsbLsbsbRsbsbLsbsbsbsbRsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bsbRsbsbsbsbsbsbsbsbRsbRsLsbLsLsmbRsRsLsmbsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bsbsbsbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bLsbLsbRsbRsbRsLsbsbsbLsbRsLsbRibRiLiLgbRsbRibRibRsbRsbRsLsbLebLsbLgRs
RibRgbRsbRiLibRgbRgbLsbRsRsmbLobLcbRjRsmbLobRsbLgbLsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bRsbsbsbsbsbsbRebRjbLsbLsbRibRsbRsbLiRsbsbRgRsmbLsbReRcRsmbRsLsbLcbRoR
obRoRsmbLcLibLobRoRsRgmbLibLcbRoRsmbRsbRgbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bLsLsmbLsbLgbLibLobRcbLsbRsbRsbRsbRsRsLsmbRgbRsRsRsmmbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbLsb
LsbLsbsbsbRsbsbLsbsbRsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bRsbsbLsbRsRsmbRsLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bsbRsbRsRgbRsbRsRsRsRsmmmbRsbLsbLjbLebLsbRsbRsbLsbLsbRsbLobsbLobLjbLib
LjbLgbLsbsbRsbLsRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbsbLsRsbLgbsbsbsbsbsbLsbRsbsbsbsbLsbsbLsbLsbsbRsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bLsbLsbLgbLsbRsbLgbLsbLgLsbLsbLgbLsbLgbLibLsbLsbLgbsbLsbLsbLgLsLsmbLgb
LsbLsbLsbLgbRsLsbLsbLgbRsbLsbLsbLgRsbLsbLsbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bRobLsbRsbRgbLjbLsLebRsbRobRsRsmbLsbLebRsLsbsbRsbsbsbRsbsbsbsbsbsbLjbL
obRsLsLsmbLsLsmbLsbLsLsRembLeLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbRsbLsLsmbRhbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 43; Drug: Control Apo 50 然
bRsbRsbLsbRsbRobRsbRebRsbLjbRjbLjLobRsbLjbRsbLsbRjbRjbLsbRobRobLibLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 44; Drug: Control Apo 50 然
bLsbLoRsbRsbRsbsbsbRsbRsbRsbLsbLsRsbRsbRsRsmbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 45; Drug: Control Apo 50 然
bRgb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 46; Drug: Control Apo 50 然
bsbsbLsbsbRsbRsbsbRsLsLsmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 47; Drug: Control Apo 50 然
bsbLsbLsbRsLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 125710; End: 130211;
Recording: 11-1; Individual: 48; Drug: Control Apo 50 然
bsbLsbsbsbsbsbsbRsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
bRsbRsbLob

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bRgbLsLsRsmbsbRsbLsRsbRgRsmbRsbRsbRsbRsRsmbRiRsRgmbsbLgbLjRsbsbRsbRgRs
mbLsbsbsbRsRsmbLsbRsLsbRgRsmbRsbRsbRsRsmbLsbRsbRsbLsbLsbLsRsbRsbRsbRsb
RsRsmbLsbRgbLsbRsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bLobRcbLsbRcbLebRebRebRcbRebRobRebRobRebLsbRobRibRebRebRebRebLcbLibLob
LebRgbLobLcbRobLobRebRobLobLobRebLobRsbRobLcbRibLcbLobLobLsbLebRcbLibL
cbLcbRibLhbLebLebRobLsbRgbLgbLcbRsbRcbLcbRibRobRobRgbLebRhbLobLobLobLe
bRobLobRibRebRobLgbRibRobLobLobRcbLebLobLebLobLobRibLebLibLgbRebLcbRcb
LhbRcbLobRsbLebLobLobRcbLebLibRhbLgbRobRobLebRsbRebRebLcbLcbRebRibRibL
ibRobRgbRebRjbRobRobRsbLobRgbLgbLhbLobRobRibLobLebLobLebLobLibLebLebRo
bRobLebLgbRgbLebLobRibLcbLobLobRobRibRebRebLcbRobRebRobLebLibRebRgbLcb
LobLibRhbLibRobRobLibLobRobLebRebRebLobLobLsbLobRobRebRhbLebRobLjbLibL
obLebLebLjbRebRebRcbLgbRebRobLcbLobLebLsbLcbLobLobRcbRgbRobLgbLebRobLo
bLobRhbLgbLobRebRsbRobRebRebRgbLebRibLebRcbLobRgbRobLobLobLsbRobLebLcb
LobRibLcbLobLgbLobRobLobRhbRibLcbLobLebLhbRebLebLcbRobLebRobLebLobLcbL
obLobRgbRsbRcbLobLebRobLgbLgbRcbRcbRhbLcbLebRobLobRgbRsbLebLobLcbLobLe
bRebRcbLcbRobRobLobRobRibRobRobLobRebLobRobLobRebLebRcbLebLebRobRebRgb
RebLebRobRobRebLgbRibRobRgbRobRobRobLgbLebRhbLobRibLcbRebLebLobRobLebL
obRebRhbLobRcbRobRsbRobRebLibRcbRobRobLcbLhbRebLcbRebRebLobRebLobLebLc
bRebLcbRhbLobRobRcbLebRebRcbLcbRsbRobLobLobLebRobRobRebLcbRobLobLgbLsb
LobLibLobLebLobLhbLebRgbRcbRebRebRebRebLobLobRebLebRobRsbRcbRebRebLsbR
gbLsbLjbRebRebLcbLebRobRcbLebLebRcbLobLhbRibLsbLobRsbRobRebRgbRibRobLe
bLibRibLebRebRobLebLobLsbLebLobLobLobLgbLebLebRhbLgbLcbRobRjbLebLebReb
LobRsbLgbRobRebLsbRobLobLebLebRobRobRobLgbRibRsbRcbLgbLcbRobLcbRgbRebL
cbLcbRcbRobRobLgbRobLebLibRebLobLobRebLobLcbRcbRobLibLobRjbLjbRcbLobLe
bLobRebLebRobRsbRobLsbLcbRobLebLgbLcbRobLebRobLibRebLibRebLebRcbLobLcb
RobRebLobLibLobRobLcbRebLgbLcbRobRcbLsbRibRibLcbRebRsbLjbRobRhbRcbRibL
obLibLjbRjbLobRgbLebLibLebLobLcbRsbLobLcbRobLobRobRcbLibLebRebLhbRebLc
bLebRobLobRobRebRgbLobRebLcbRobRobRebLcbRobRobRebRobRobRebRobRebRsbRob
LobLebLsbLhbRgbLobLibRcbLebLgbRebRebRebLobRebLebLebRhbRcbLgbLebRsbRobL
obRebRobRobLcbRobRcbRibRebRebRjbRcbLobLgbLebLgbRobLjbRebLebLcbLebRebRo
bLebRobRobLsbRobLobLcbLjbLebRobLobRobLebLebRcbLebLebRobRobLobRobRobLeb
LsbLgbRgbLgbLibRcbRcbLcbRsbLobRobLcbRebRobRobLcbRobLgbLebLgbLebRibLibR
gbRibLobLhbLhbLobLcbLebLhbRgbRebRobLebRobRobLobRobRobLebLebRebLobLcbRs
bRobRcbRobLcbRgbRgbRebRobLebRcbRebRjbRgbRcbLcbLgbRobRebRsbLebRebLsbRob
RsbLobRcbRcbLebLobRcbLsbRobLobRebRebRsbLobLcbLobLobRebRcbRobLibRebRhbL
ebRobLebLobLobRcbRcbRcbRobLobRgbRebLobLobLebRcbRgbRgbRebRjbLobRebLsbRo
bLgbLebLebLobLcbLibRebRobLobRobRobRgbLobRcbLebLibRgbRcbLgbLobLebLcbRjb
LobRebLebLebRebRobRebRobRgbLobLebRcbLsbLobLobLebRebLcbRgbRebRebLebRcbL
gbRcbRcbRobRsbRgbLobRobLob

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
bRsbLsbLsbRsLsbRsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bLsbLsbLsbRsbLsbLgbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bLsRsbLjbLebLcRsbLebLcRsLsbLeLsbLgLiLibLsLsLsLgmmbLgLsbLgbLsbLsLsRsLsL
gLsRsmbLjRsRsLgmbLgLsRsLsLsLsmmbLsbLsRsbLsLsmbLsLsLsmmbLsLsmbLsLsRsRsm
mbsbLsLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bsbLgbsbsbsbsbsbsbsbsbsbsbLsbRsbRsLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bRibRcRsmbRcRsRsmmbLgbRobLebLgLgLsbLcbLcbLsbRgbRsbRiLsRsRsmbsbsbsbLsbL
sb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bsbRsbsbsbsbLsbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bRsbLjbRsbLsbRsbLsbLebRgbRebLjbRsbLsbRsbLobRcbRjbLobLjbLsbLjbLobLcbLeb
RobLobRobRebRobLobLobRjbRobRgbRobRebRobLebLebRcbLgbLebRebRibLsbRobLobR
ibLebLibRgbLcbLebLobLcbLobRebRobRibRobLobLobLobLobLcbLobRobRebRsbRobRo
bRebRobLobRcbRcbRobLobLebLobRjbRgbLsbLgbLobRebRebRobRobLgbRebLgbLgbRgb
LcbRgbRobRsbRobLobRcbRobRcbRobLebLobRcbRcbLobRebLobRebLebLjbRjbLebRobL
ebRjbLebLebLobRobLebRobLcbLcbLebRibLobRcbRcbLgbRobRobLobLgbLobRobLobRo
bLobLcbRobRebRobRebRsbLebRsbRebRobRebRjbLebRobRebRebLcbRobLobRgbRcbLeb
LsbLebLebRgbRcbRobRibRobRcbLgbLebRcbRobRebRcbRobLobLsbLibRcbRsbRobLebR
obRobRobRcbRcbLhbRibRgbLsbLobRebRsbLebLobLobRebLobLebRgbLcbLcbLibRebRo
bLobLebLebRobRcbRebRobRcbRcbRsbLibRobRcbRobLobRsbLebLgbLobRobLobLobReb
LgbRebLebLobLobLcbRobRibRebLcbLebLebRebLebRsbLebRcbRibLobLcbRobRebLibL
cbLgbRcbLebLebLibLobLibLebLobLgbLcbRebLcbRcbRobLcbRcbLcbRebLebLjbLobLo
bLjbLcbLcbLcbLibRgbRobLobLobLobRobLebRcbRebLebLcbRibLobRgbRebLobRobRob
LobRhbRcbRgbLobRobLibLobRebLebRebRobRcbRcbRebRobLebLcbLobRebLobLobLebL
ibRobRcbRobLgbRebLibLjbRobLobLebRebLhbRobLobLebRhbLebRcbLgbLebLsbLebLe
bLgbRgbLibRebRibRibRebRcbLobRcbRsbLebLebLibLobLgbLcbRibRebRobLjbRobRob
RcbLobLobLobRcbLobRebLobRobLhbLcbRebRcbLobLobRebLjbLobLobRhbRebLgbRobR
ibRcbLobLobRcbRobRobRobLebRobRcbRobRsbRebRibLsbLebRjbLhbLobRsbLgbLebRe
bLebRobRobRgbRebRcbRobRebRobRobRsbLebLobRobRebLibRobRebRsbLobLsbLebRob
LebLebRobLobRebLcbLibRibRgbRgbRebRsbRsbLobRebRebRcbLcbRobLobLobLobRebL
obRobLebLebLebLebRobLjbRgbRebLobLobLebRobRibLcbLobLebLobRobRebLobLcbRh
bRebLhbRobLobRobLcbLobLibRibLcbLibRjbLobRgbRobRebLebRsbLibLsbLibRgbLib
LcbRcbRobRobRibLobLobLibLobLobLcbRebLobRcbRobLobRobRgbRobRibRobRebRjbR
cbLobRcbRobRcbLobLobRobLcbRobRjbLgbRgbLebRsbRgbLebLebLobRobLcbRcbLobRo
bLobLcbLgbLcbRobRcbLobRobLcbRebRcbLcbLobLcbLibLobRcbLobLcbLobLebLobRob
LebLobRobLcbRebLebLobLobLcbRhbRobLsbRobLobLibRebRjbRcbLibLcbLcbRobRsbL
ebRsbRobLebRcbLebRgbRgbLcbRcbRibLcbLebRebRebRcbLobRebRibRcbLhbLobRebLo
bRebLebRobRebLobRebRebRobRobLcbRobLobRebLobRobRcbRibLibRobRcbLjbRibRob
RobRcbRebRobLobRebLobRjbLobRebRobLobRobRebRcbRsbLobRgbRobRgbLobRebRcbR
obLsbLebLcbLjbLobLobRibRebRobRobRobLebLebLobRebRebLhbLcbLebRcbLobLobLo
bRobRobLjbLsbRgbRobRebLibRobRobLcbLebLobLsbLebLobLcbRebLcbRcbRobLibRob
RobRhbRobRibLebLcbRsbRebRcbLobLobLcbRcbRebLebLibLobRebRebLibLjbLobLobR
jbLibRjbRobRobRobLebRobLobRebRobLcbLobLebLhbLobRcbRgbLobRobLcbLgbLjbRo
bRcbRcbRobRobRobRcbRsbLebLgbLebLsbLcbLcbRebLebLcbLcbLsbLcbRcbLcbRcbRob
RobLcbRebLcbRcbLcbRobLgbLibRobLebLobLebLebLobRobLobRobRobLibRobRgbRobL
cbRcbRibRobLgbLobRibRebRebLcbRibRebRebRebLgbRcbLgbRebLobRibLebRobLobRe
bRsbRcbRobRebLcbLobRobRobLebRobLobRsbLibRobLobRibLobLcbRebLcbRobRibRsb
LobLobRebRcbRebRsbRgbLobLebRhbLcbLobRcbLcbRobRibLibRcbLcbLcbLobLebRcbL
hbRobRobLobLobLgbLibRebRobLibLebRibRobRcbRob

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bRsbsbLsLsLsLsLgmmmbLsLsLsmmbLsLsLsLsRsLsLsLsmmmmmbLsbLsbLjLsmbLsbLsbL
ebRobRgRsmbReLsbRebRgLsLsmbLiLsbsbLeLsbLeLsLsLsmmbLoLsLsmmbRcRiRsmbRiR
smbLsbRcRsmbRcRsRsmmbRebRhRsmbRibLjLsmbLcLgbLeLsLsmbLcLsmbLcLsmbLebLcb
LsRsbRcRsRsmmbReRsRsmmbRcRsmbRjRsmbReRsRsmmbRjRsRsRsmmmbLcLgbLcLsmbRgb
RoLsbLjLsLsLsmmmbLcbLgbLcLsmbLcLsmbLgLsLiLsbRsbRsbRsRsRsmmbsbsbLjbLgbL
gLsbLiLsbsbLgbLsLsmbLsbLsbRsRsmbRsbLsbRsLgLibRsRsmbLoLsmbLeLgLsLsmbLib
LiLsbLsbLgLsLsLsmmbLjLsLsmmbsbLebLebLebLjLsmbLebLcbLebLjbLsLsmbLsbLsRs
bLsbLjbLgLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bRsRsRsRsLsmmmbRjRcbLsRcRsmbLgLcbLcbRsbLsbRsbLsLgLsLsLgmbRsLsbLhbRsRgb
LjbsbsbRsLgLgLsLgbRcRsRsmmbLcbsbsbRhbRsbLiLsbLsbRsRgRibRgRsmbLebLgLiRs
bRsLsbLgRsLsbLjRsbLjRsbLgbLsbLgRsLsbRsRsmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bRsRsmbRgbRsbRsbRobLibRhbLebLobRgLsbLjLsmbLiLsbRebRcbLiLsbLibRcRsmbRgR
smbRcRsmbLsRcRsmbRibRibRgbRibRsbLgbLibLiLsbLsbLsbLgbRcbRebRiLsbLsLsmbR
cbRcbRgbRibRsbRgbRgbRsRgbRgRsmbLjLsmbLhLsbReRsRsmmbRhbRobRcbRhbRgbRsbR
gRsmbRiLsLsmbRsbRebLebLibLcbLibLibLcbLhbLsbRsbRoRsmbRsbRsbRgbLgbLgbLsb
LibRjbLgbRsLsbLsbLjLsLsmmbLsbLsbLsbLsbLsbsbLibRsLsRsbsbLgbRibRebRhLsbR
ibRibRcbRgbRibLjbLibLgbLibLsLgbReRsmbLibsbLhbsbRibRebRgbRiLsbLobRhbRjb
RiLsbRjbRcbReRsmbLgbRsbLgbLgbLsLgbLsLsmbLsLsmbLsbLebLgLsbLsbLgLsbLsbLs
LsLsmmbLsLgbLsLsmbRjbLgLgbLgbLibLibLibLjLsmbLsbLjbRsbLjbLibRgbLcbLhbLi
bLibLgbRsRibRibRhbRhbsbLgbLgbLgRsbRcbRobLibLjLsmbLsbsbsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbsbsbsbLsbRsbLsbRsRsLsmbsbRsbRsbLsbLsbRsbRsbsbsbLsbLsLsmbLsbRsbL
sbsbRsRsmbLsbsbsbLsbLsbRsLsbLsbLsbLsbLsbRsbsbsbsbsbsbsbsbRsLsbLsbRsbLs
bRsbLsbsbLsbLsRsbsbsbsbRsbLsRsbsbsbsbsbsbLsRsRsRsmmbLsbRsbsbLsbLsbLsRs
bsbsbRsbsbsbsbLsbRsbLsbLsbsbsbsbsbsbsbsbRsbsbsbRsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 19; Drug: Control Apo 50 然
bRsLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 20; Drug: Control Apo 50 然
bLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 21; Drug: Control Apo 50 然
bsbsbLsRsbRsRsRsmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 22; Drug: Control Apo 50 然
bsbsbsbsbsbLsbRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 23; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 24; Drug: Control Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbLsbRsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsb
sbsbRsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbRsbsbsbsbsbsbRsbsbsbRsL
sbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbLsbRsbsbsbsbsbsbLsbsbsbsbRsbLsbsbsbLs
bsbsbsbsbLsbsbsbsbsbsbsbsbsbLsLsmbsbLsbsbsbsbsbsbsbsbLsbsbsbLsbsbsbLsb
sbLsbsbsbsbsbRsbsbsbRsbsbRsbLsbsbRsbsbsbsbsbsbRsbsbRsbsbRsbsbRsbsbLsRs
bsbsbsbsbsbRsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bsbsbsbRsbsbRsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bLgbLgbLgbLsRsbLobRibLebRsLsbRsbRgbRiLhbRcbLsbLeLsbLcLsmbsbLsbRsbRsbRj
bLgbLgbLsbLsbLsbLsbLsbLsbsbLsbsbLsbsbLsbRsbLsRsbRsbRsbRsbLsbLsbLgbLgbL
gbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bRobRsbRsRsmbLsbRsbsbsbLsbRsRsRsmmbLsbRsLsbsbRcbRsbLsLsRsRsmmbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
bRsbRsbRsRsmbRsbRsbLsbRsbLsbRsbsbRsbRsRsmbLsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
bRsbsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bRsRsLsmbRsLsRsbLsLsmbRsbLsbsbsbLsbRsbLsbLsbRsbsbRsbLsLsmbLsbLsRsLsbRs
RsmbLsbRsbRsbLsbLsbRsbRsLsRsbLsbLsbLsRsbRsbRsRsRsmmbLsRsLsbLsRsbLsLsmb
RsbRsRsLsLsmmbRsbRsbRsbLsbRsbLsRsbRsbRsLsRsbRsbLsRsbRsbRsLsLsmbRsbLsbR
sLsbLsbRsLsbRsRsLsmbRsbLsbRsbLsbLsbRsLsbRsbLsbLsRsRsmbLsRsbRsbRsbLsLsR
smbLsbRsLsbRsLsRsLsbRsbLsbLsRsLsLsmbRsbLsbLsRsbRsbLsLsmbLsbRsLsbRsLsbR
sbRsbRsLsbLsbRsbRsbRsRsmbLsRsbRsbLsbRsRsmbRsbRsLsbRsLsbRsLsbLsbLsbRsbL
sRsbRsbRsRsmbLsbRsbRsLsbRsRsmbLsRsbLsRsbLsbLsLsmbRsbLsbLsRsbLsbLsbLsbL
sLsmbRsbRsbRsbRsRsmbLsRsbRsRsmbLsLsLsLsmmmbLsbLsRsbRsbLsLsmbLsRsbLsbLs
bLsbLsbRsLsbLsbLsbRsRsmbLsbLsbRsbRsbRsRsLsmbRsbRsLsbRsRsmbLsbLsbLsRsbR
sLsbLsbLsRsRsmbRsbRsbLsbLsbRsbLsbLsLsmbRsbRsbLsbLsLsmbRsLsbLsbRsbRsbRs
bLsbRsbLsLsmbLsbRsbLsbRsbLsRsbLjbRsbLsbLsbLsbRsLsbRsbRsLsbRsRsRsmmbLsR
sLsLsmbRsbRsbRsLsbLsbLsLsRsLsmbRsRsmbRsbRsbRsLjbRsLsLsmbRsbLsRsbRsbLsb
LsbRsbLsbLsbLsbLsbRsbLsbRsLsbLsbRsRsLsRsRsmmbsbLsbLsbRsbLsbLsbLsRsbRsL
sRsbRsbRsbLsbRsbRsbRsRsmbLsbRsbRsLsLsmbLsbLsRsRsmbRsbLsbLsbRsbRsbRsbRs
bRsbLsRsbLsbLjbLsbRsbLsbRsbRsRsRsmmbLsRsbRsRsmbLsbsbLsbRsLsbRsbRsLsbLs
bLsLsmbLsbLsLsmbRsbLsbRsbRsbLsbRsRsmbLsRsbLsRsbRsLsbRsbRsbRsbLjRsbLsbR
sbRsbRsbRsLsLsLsLsmmmbRsbLsRsbLsbRsRsmbRsbLsRsbLsLsmbRsLsbLsLsmbRsbRsb
RsRsRsmmbRsRsmbRsLsbRsRsmbRsbLsbLsRsbRsbRsbLsLsmbLsLsRsRoRsLsLsmmmbLsb
RsbRsbRsLsLsmbRsLsLsRsLsLeRsLsRsRsLsLsRsRsLsRsRsLsLsmmmmmmbLsbRsRsLsLs
mmbLsRsLsbRsRsRsLsLsmmmbRsbLsbLsbRsbRsbLsbLsLsmbLsbRsLsRsbRsbRsLsbLsbR
sRsmbLsbLsbLsbLsbLsbLsLsLsRsmmbRsbRsRsmbLsRsbRsbRsRsmbRsRsmbRsbLsbLsbL
sLsRsmbRsbLsbLsbLsbLsbLsbRsLsLsmbLsbLsbRsRsRsLsmmbsbRsRsLsLsRsmmbLsbRs
bRgRsLsmbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bLsbLsbLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bLjbRobRebRjbRjbLobRebLjbLobLobLobRebLjbRobLebLcbRjbRebRobRebRobRjbLcb
RobLebLebLobRobLobRobRobLsbLobRobLcbLsbLobLebRjbLcbLjbRjbLobLcbRcbLcbL
ebLjbLebLjbLcbRjbLjbLjbLsbLobRcbRebRebRebLobRebRebLebLobLobRobRobLobRe
bRjbLebRcbLobRebRobLebLobLjbRcbLcbLobLsbLcbRobLobRebRobRjbLobLobLobRcb
RjbRjbRsbRjbRebRebRjbRcbLsbLobLsbLcbRcbRjbLebRjbRcbRobLobRjbLjbRebRcbL
ebLobLobLebLsbLebRebRobLebLobRobLobLobLebRebLebRobLobLobRjbRjbLjbRjbLo
bRebRobRobRsbLobLobRebRsbRjbLobRebLjbLsbLobLobLebLobRebRjbRobLobLjbRcb
LebLcbLjbRobLobRobRcbLobLjbLcbLebLcbLjbRobRjbLobRobRebRsbLsbLobLebLebR
jbLebLobRebLobLcbRjbRsbRobRjbRobRobRobLobRebRjbRjbRjbLobLobLobLsbLjbRc
bLobLjbRebRobLebRjbLcbRobRebRcbLebRobLsbRebLebRebLobRcbRebRebRebLobRob
LjbLobRobLobLsbRebRobLebRebLjbLcbLjbRobLobLobLobLjbRsbRebLjbLobLjbLobR
obRobLjbLobRebRjbLebRobRobLjbLobLebRjbLobLjbLsbRobLobRebRsbRobLebRobLo
bLjbLobLebLcbLebRcbLobLobRobLjbLsbLjbLebLobRebLobRcbRcbRobLobRcbLebLcb
LobRobLsbRebRsbRebLobLobRjbRebLebRobRobRjbRobLobRobRjbLobLsbRjbRobLgbR
jbLsbRsbRjbLobRebLobRcbRebRobRobLcbLcbLjbRobRobLobRobLebLobLobLsbLjbRs
bLobLebLobLobRcbLjbLjbLcbLobLebRobRjbRobLobLsbLobRjbLebLcbRjbLobLebLjb
LsbLebLjbRobRobLcbLebLebLebLjbLcbRjbRjbRobRebRobRhbLjbLjbRobRebLobRebR
obRebLobLjbRobLjbRsbRobLobLcbRobLebLebRobRobRobLjbRjbRobRobLebLjbLebRj
bRebLcbRebRebLebRebRcbRobLobLcbRobLebRcbLobLobLebRobRebRcbLebLobLsbLob
LobRgbLebLebRobLsbRobLobRibLjbRsbLobRsbLsbLjbRcbLjbLibRobLobLibRobRobR
obLhbRebRcbRobRibRobLcbLebLcbRebLobRebRobRobLcbRobRjbRobRobLobRcbRebRs
bLcbRobLobRcbRcbLobLibRobRebRebRobLebRobRebRobLgbRcbRjbLjbRjbLobRcbLib
RcbLjbLobRobRjbLobLobLgbLibRsbLobRobLcbLebLebRgbRibLobLgbLobRjbLobLjbL
ebLobLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bsbRsRsLsmbRsbsbsbLsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bRsbLsbLsLsmbRsbLsbRsbLsbLsbLsbRsbLsbLsRsbLsbsbLsbRsbRsbLsRsbRsbLsbRsb
RsbRsbRsbLsbRsLsbLsRsbRsbRsbRsbLsbRsbLsbRsbRsRsmbLsbLsRsbRsbRsbLsbLsLs
mbLsbRsbRsbRsbLsRsbRsbRsbRsbLsbLsbRsbLsbLsbLsLsmbRsbLsbRsbRsbLsbRsbRsb
RsbLsbLsbLsbLsbLsbRsbRsbRjbLsbLsbRsLsbLsbRsbLsbLsbRsbRsbRsbLsbLsbsbRsb
RsRsmbRsbRsbsbLsbLsRsbRsbRsbRsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bLsbRsbRsbsbLsRsLsbsbLsbRsbLsbRsLsbLsRsbRsRsmbLsRsRsmbsbRsLsRsbLsRsRsL
smbLsbLsbRsbRsRsmbsbLsLsLsmmbLsRsRsLsRsmbRsbLsbsbRsbLsbLsbLsLsRsRsmmbR
sbLsbsbRsbRsbsbsbsbLsbsbsbsbLsbsbLgbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bRsbLsRsbLsbLsbsbRsbLsbsbLsbLsbLsbRsbsbRsbRsbsbLsbLsbsbLsbLsbLsbRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
bLsbLob

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
bRsbRsbLjb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbsbLsbsbsbsbLsbsbRsbsbLsbsbsbLsLsmbsbsbsbsbsbRsbsbRsbLsbsbsbsbRs
Rsmbsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 43; Drug: Control Apo 50 然
bLjbRjbRsRsmbRsbRsbRsbLjbLjbRsbRjbLsbRobLcbRcbRebRsbLsbLobRobRjbLjbLob
RebLebLebLjbLcbLobLobLobRobRjbRobLjbRsbLobRebLebLobRebRebLebLobRobLcbL
ebLobLebRobLjbRsbRcbRsbRebRjbRjbLebRjbLebRcbLjbRobRebLjbLobLebRobLebRo
bRobRobLobRebRobRobLobRobRcbLebLebLebLebRebRobRsbLebLobRobLebLobLobRcb
LcbRobLobLebLcbRjbLobRobRjbRobLebLobRobRebLebLjbLebLobLobRjbRjbRebRjbR
ebRobLebRobLebLobLobRjbLobRcbRobRjbRsbRobLebLebLobLebRobRjbRebRobLebLo
bLebRebRobRcbRobRjbRsbLebLebRcbRjbLobRcbRobLjbRebRebRjbLebRobRcbLjbReb
LcbLcbRebLjbLobRcbRebRcbRsbLobLebRobLebRcbLcbRobRobLobLobLebRebRebLebR
obRobLebLobRobRebLobLobRibLjbLebRobRjbLobRjbRobLjbRebRebRjbLebRobRebLe
bRjbRgbLebRobLcbRobLobRebRebLobLjbRjbRsbLobRobRebRobRcbLobLebRcbRcbLjb
LobLobRgbRjbLobRebRobLebLjbLjbLjbLebLsbRsbLobRobLobLobRebRjbRobRjbRebR
ebLcbRobRgbRebRebRobLcbRobRebLobLobRobLobLobLsbRebLibRobRobRobLcbRobRo
bLobLobLobLcbRobLjbRjbLobLibLobLibRebLjbRebRcbRobLobLobLobLobRobLebRob
RobLjbLobRobRobLibRibRcbRcbLsbLobRgbRcbRebLjbRsbLhbRcbLobRsbLebRebLobL
cbLobRobRobLobRobRebRobRobLebLobLcbRobRebLobLcbLsbRebRobRobLobRebRcbLc
bLjbLgbRobRobRjbRebLobLcbRjbRobRebLobRjbRcbLcbRjbLobLobLobLobLcbRebLeb
LsbLcbLcbRjbRcbRobLjbLobRobLobRobRobRjbLebRebRjbLjbRsbRjbLjbLobRebRebR
cbRobRebRebRebLebRobRobRjbLobLjbRjbLobLebRjbRjbRobLobRebLebLcbRebLsbLo
bLebLobRobLobRjbLcbLobRobLsbLobRebRobLebLobRsbRjbRobRebRjbLcbRobLebLjb
LebRobRobRebLcbRobRobLobRjbLobRjbRcbRebRobRobLebLobLjbLobRebLebLobLebR
jbLebRjbRcbLjbLobRobLobLebRjbRcbLcbRobRebLjbLcbLebRjbLebLjbRobRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 44; Drug: Control Apo 50 然
bRsbRsbRsbLsbLjLsmbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 45; Drug: Control Apo 50 然
bRsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 46; Drug: Control Apo 50 然
bsbsbRsLsbLsbRsLsbsbRsbsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 47; Drug: Control Apo 50 然
bsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130213; End: 130714;
Recording: 12-1; Individual: 48; Drug: Control Apo 50 然
bsbRsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 1; Drug: Cariprazine 10 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 2; Drug: Cariprazine 10 然 Apo 50 然
bRsbLsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 3; Drug: Cariprazine 10 然 Apo 50 然
bRsbLsbLsbsbRsbsbsbsbsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 4; Drug: Cariprazine 10 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 5; Drug: Cariprazine 10 然 Apo 50 然
bsbLgLsbLsbLsbLsbLgLsbLhLsbLhLsLsmbLhbLibLcRsLsRgRcLsbRibRgbLsbLjRjbLs
bRgLsbRsLsLsmbLjbRcLgbRiRsmbLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 6; Drug: Cariprazine 10 然 Apo 50 然
bLsbsbRjLjbLsbLobLsbRsbRsbLebLsLsmbRsbLsbRsbRjbRsbLsbRsbRobLsRebRjbLsb
LsbLsbLjRjbRsbLsbRcbRsbRsbLcbRobLsbRcbLsbRsbLsbLcbRebRjbRsbLobRsbLsbLs
bLebLebRsbRebRebRsbRobRobLobLebRcbLjbRebLobRobLebLobRebLsbLsbRebLebRsb
LobLobRjbRcbLjbRobRjbRobRsbLsbRsbRebRobLcbRjbRebRobLsbRsbRjbLsbLsbRebL
jbLebRsbRobLobLobRsbRobLcbRjbRobRobRjbRobRjbRebRcbLobRobRobLcbRobRobRo
bLobLcbRjbRobLcbRjbLebLobLjbRebLebLobLebRobLsbRcbLobRcbLebLjbLobLebRcb
RebLebLjbLjbLebLcbLobLcbLobLebLobLjbLobLcbLjbLebLcbRobLobLjbLsbRobLsbR
jbLobLobLjbLebLebRjbRjbLobRobRcbLebLcbRcbRjbRebLebRjbRebLebRjbRobRebLo
bLebLcbLebLobLobRobRobLjbRebLobLcbLobRebRobLobLobLjbLobRebLebRsbLobReb
RjbLobRebRebRjbLsbRsbRobLobRebRebLobLcbLobLobRobRobRobLcbRcbLebLebLcbR
jbRobLcbRobLjbLobLjbRcbRobRobLobLobLobLebRjbLcbLobRobRobLobLebRebRjbLc
bRjbRebRobLobLobRcbRebRebLjbRobRebRobLobRebRsbRobRcbRobLjbLobRcbLebLsb
RebLobLgbRobRibRobRcbRcbRsbRjbLobLsbLcbRebLebLjbRcbRgbLobLebLebLobRjbR
ebLhbRobLobRibRobLsbLibLobLobRebRobRebLcbLobRobLcbLebRcbRobLjbRebLebLe
bRibRjbRjbLsbLebRobRobLobLobRobLobRcbRebLcbRcbLjbRgbRobLobLobLibLobReb
LobRebLobRgbLobRhbLjbLobLebRebLjbLebLcbLebRobRebLobRcbRebLobRobLobRcbL
obLobRjbRjbRjbRobLebRjbLjbRebLcbLobLjbRjbRobRebLjbRebLcbLsbRebLjbLebLs
bRjbLebLebLobRjbLobRebRjbLsbLebLebLebRobLcbLcbLebLobLebRebRobRcbLebRob
RebLobLibRobLobLibRobRebLobRebLobLcbRobLobLcbRebRobRebRcbLjbLebRjbLobR
obRjbRobLebRcbLcbLebRobRjbRebRebLsbLcbRcbLcbLsbRcbRobLebLjbLobRebLcbRo
bLebLob

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 7; Drug: Cariprazine 3 然 Apo 50 然
bLsLsLsmmbRsbLsbLsbLsLsLsLsmmmb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 8; Drug: Cariprazine 3 然 Apo 50 然
bsbsbsbLsLsmbsbsbLsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 9; Drug: Cariprazine 3 然 Apo 50 然
bLobRibRjbLjbRsbLsbRebRjbLebRsbRsbLobLebRsbRgbLcbLsbRebLobLobLobRsbLob
RibRcbLebLobLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 10; Drug: Cariprazine 3 然 Apo 50 然
bRcbLobRobLebRebLebLebRebLgbRebLsbRebRebLcbRebLgbLcbRobLobRcbRebLobLob
RobRebRobRobLjbRebLebLcbLobLobRebLibRebRebLebRobRcbRobLebRebLsbLobRobL
ebRobLobLobLobRobRobLobLobLobLobLobLcbRobLcbRgbLcbLobRcbRobRobRobRebRc
bRobLobRgbRebRobRobLebRcbRibLsbRibRobRibRibLcbLebLibLhbRgbLibLobRhbLib
LobLebLobRcbRebLgbRobRobLobLebLobRobLgbRobLebLsbRibLobRsbRebLobRobLebL
gbLobLobRcbRjbRebRjbLcbRcbRgbLgbRobRobLebRobLcbRobLcbLebRobLobLibLsbLh
bRebLobRobLjbRobLebLsbLobLgbRibLobLcbRobRobRibLobRsbLobRjbRcbLcbRcbRob
LobRobLcbLcbRebLcbLobRebLebRebRobRhbLebRebRebLebRjbRobRobRobLobLobRobR
obRobLobLebLebRibRobLebRebRhbRsbLobLobRobRebLobLibLobLebLebRobRebRcbLo
bRsbRebLcbLebLobLobLcbLgbLobRcbLebRobLsbRebRobRebLobRobRibRebRebRibRob
LebLobLobRebRobRebRgbRebLsbRgbLibLobLobRibLobLcbRgbLjbRobRobRcbRcbLebR
ebLibRebRobRcbLsbRcbRobRsbLobLobLibLcbRebLobRobLebRcbRcbRgbRobLebRcbRe
bLobLebRcbLcbRobRgbLebLobLjbRobRgbLebRgbLobLobRebRibLobRgbRebLobRcbLeb
RcbRebRcbRcbLebLhbRgbRhbRibLgbLcbRcbLobRcbRobLcbRobLobLebRcbLebRhbRobL
gbRgbRibLcbRebRobRebRebLebRobRhbLobRibRobRebRobRobLobLjbLhbLgbLobRcbLe
bRobLgbLebLibLobRebLobLobLibLgbRebRgbRcbLebRcbLobRobLebLsbLebLgbRcbRgb
LibRobLgbLebRobLibRobRebLebRebLibLebRobLobRobRebLcbRobLebRobLcbRhbLobR
hbRobRebLcbRgbLcbRcbRebRsbLgbRobLebLebRobLebLobLcbLebRobLibLcbLgbLebRo
bLobLobRobRobLebRhbLobRobRebLibLobRebLibRobRobRobLcbLebLobRcbRgbLebRob
LobRcbLibRobLebLobLobLobRobLsbLibRobRobLcbRcbRobLobRcbRobRobLobLebLobL
sbRebLcbRobRhbRibRobRebLebRhbLebLsbLebLobLcbLobLobRobRcbRobLcbRjbLobLo
bLobLibLebRebRebLebRebLcbRcbRebRebLgbLebLgbLsbRobRebLcbLobRobLobRobRjb
LobRebRibRibLebLcbRobRebRibLebRcbRcbLgbRcbRibLcbRobRhbLobRobRibRobLobL
cbRobRibRebRebRebLebLebLcbLebRibRgbLebRebRsbLobLgbRcbRibLcbRcbLobRobLe
bRebLobLhbLcbLcbRcbLobRobRebLebLhbLobLgbLebLobLobLcbLebRhbLibRgbRibLob
LebLsbLobRibRsbRobLibRobRobLcbLgbLebRobLgbLobLgbLcbRobLcbLebRebLebLobL
ebRgbRebLcbLobRcbRebRebRgbRibLobLgbLcbLobRobLobRgbRibRobLsbRcbRobLcbLo
bRobRobRebLgbLibLhbLgbRcbLobLobRebRgbRobLebLebLobRobRsbRebLcbRebLebLsb
LobLobRobLebRcbRebLcbRobRebLcbLjbLobLibLhbRobRobLobLobRobRibLebRgbRobR
ibRhbRcbRobLobLebLcbLobRebRcbRebLobLibLcbLcbRhbRsbRobLebRebLsbLobRhbLo
bLobRcbRebLobRobRobRobLjbRebLsbLhbRobRcbLobLebRobRcbRobRobLobLgbLibRob
LebLcbLobRobRobLobRobRobLobRobLebRebRibLobRibLobLcbLebRebRobRobLobRebR
obLobRjbRobLebLobRjbRjbLsbLebRobLebRjbLebLebRebLjbLobLebRebRebRebLjbRs
bLebRsbLcbLsbRjbRjbLjbRsbRjbLobRobRobLebRjbLjbRebLibRebLjbRebLebLobReb
LebRebRebRebRebLobRobLgbLcbRebLebLobLebRebRobRobLobLebRebLjbRobRibRebR
jbRjbLjbRcbRgbRebLobRsbRobRebRibLcbRobRebRebRsbRebLobLebLebLebLjbRcbLc
bLebLcbLebLjbLjbLebLjbRcbLjbLsbLobLobRebLjbRjbLobLobRobLebRebLjbRebReb
RobRjbRjbRebLobRsbRobRebRobLobRobLobLgbRebLcbRebRgbLgbRebLobRibLebLjbR
obRebRobRobRibLobLobRobRobLsbLcbLgbRebLebLobRcbLcbRcbLobRobLibRebLcbRc
bLobLebLhbLcbLebRibRcbLcbRobLobLebRibLebRebRcbRobRobLobLobLcbRibLobLob
LebLibLobRibLsbLobRobRibRebRobLebLebRebLcbRebLebLcbLebLebLsbLobLebRebR
obRobLcbLobRobRjbRobRebLobLcbRsbLobLebLjbRobRobRjbRibLebRebRebLobRsbRi
bRcbRobRobLobLebLobLcbLcbRobLcbRobLhbRibRobLebRobRobRobLsbRebRobLobLeb
RobLebRobLsbRebLobLebLcbLsbLobLebRcbRsbLgbLgbLibRobLsbLsbRobRcbLcbLebL
hbRebLobLebLobLjbRebLgbLibRcbRebRsbRjbLebLgbRebRobLibRobLobLobLsbRobRj
bRsbLebRjbLcbLcbRobLebRgbRobLebRcbLobLjbRcbLobLcbRebLebLebLcbLobLebRob
RobLgbLobRibRebLebRobRobRebLcbLobLobRibRobRebRobLebRsbLebLebRcbLjbLcbL
ibRcbLsbLobRhbRobRebRebLcbLobRcbRobRobRebLebLcbRgbRob

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 11; Drug: Cariprazine 3 然 Apo 50 然
bRebLebRobLgbLobRcbRobRsbRobLobRobLcbRobLobRobLobRobLibLobLsbLgbLibLob
LebLobLobLebRebLobLobLobRebRobLsbLcbLcbRobLgbLebRobRobLsbRobLebLibRcbR
obRobLobRcbRcbLebRgbLobRsbLsbRebRobRobLobRjbLgbLobLsbRobLgbRcbLobLibRe
bRgbLobRobLebRebRobLobRobRobRobRebLebRobRobRgbRebRebRobLibLobLgbLobLeb
RcbRjbRobLebRcbRcbRebLobLobLobLobLebRobRobRobRobRebLsbLobLebRebRcbRgbR
obLobLebRobLobRobRobRcbRobLobRebLgbLobRcbRebRcbRobLcbLcbRebLobRcbLobRo
bRobLebLobRobRobLibLobLobRobRjbRsbRcbRebRobLcbRcbLobLebLhbLcbLebLobLib
LgbLibRcbRebRobRobLobLibRsbLobRcbLcbLgbRobLibRebLjbRobRibRobLcbRebLebR
sbRebRcbRobLobRobRobRgbRgbLobRebRobLobRobRebLibRobLibRebLebRebRebLcbLc
bRebLcbRobRgbLobLebLcbRcbRobRibRobLsbLebRhbRobLsbLobRcbRcbLcbRsbLcbLgb
LebLobRobRsbRobLcbLobLibRobLobLebRibRobRgbRobLibRibRobRcbLobLobRebRgbR
gbRcbRebLobLobLobRobLebRebRebRobLobLgbLobLgbLhbRobLsbLebRsbLcbRcbRobLh
bRsbLhbLobLobRebRobLobLebRebRgbLsbLobRibRgbRcbLebRobLobLjbLebRebRibRcb
LibLobRobLcbLcbRgbLebLobLcbLobRebLjbRobRebLibLobRebRebLsbLobLcbRobRobL
cbRebRjbLcbRobRebLobRebLobLobLobRobLsbLobLobRobLcbLobLobLobRebLcbLobRo
bLebRebRibLebRobRobRhbRibLebRcbLebRobRobRcbLobRcbRobLobRgbRobRobLibLcb
LobLibRgbRobLobLcbRsbRobRcbRebLobRobRgbRobLobLobLcbRebLobRobRebLobRcbR
obRobLobLobRebRobLcbLebLebLobRobRibRibRebLebRebRibLcbRobLebLebLcbRobRc
bRgbLobLebLcbRebRebRobRobLobLobLobRjbRebRobRobRebLobLobRobLsbLobLebLob
RobRgbLobRobLobLobLobRobLgbRcbRobRcbRobLsbLcbRebLobRebRebLebRobRgbLebR
obRobLibLsbRgbLebLobLcbRcbLobLebRebRobLgbLobRobLobRcbRobRobLcbLebRobRc
bLcbLobLebRobLebLobLobLobLobRobLjbRgbRobRibLgbLobRobLgbLebRgbLhbRobRcb
RobLcbRcbRebRebRcbLcbLobRibRibLebLobLcbRobRobLebLibLebLibLobRebLhbRsbR
ebLhbRibLobRcbLebLobRebRebLcbLebLobRobLobLobRibRobRebRebRsbLsbLcbLobRc
bLhbLcbLibLobLcbLebRebLobLobLobLhbLobRcbLobRcbLobRgbLobLhbLobRebLobLib
RobLgbLobRobRcbRebRobLebLobLibRobRebLebRibLobLobLobRobLibRcbRcbRebLcbL
obRobRobLsbRebLibRobLibRcbLobLhbRobLgbRebLobRgbRobRibRcbRobRibLibLobRo
bLgbRcbRebLgbRebRebLobRobLcbLebRebRebLobRobRobRcbLobRcbRobRcbRobLobRob
LobLibLobLobLobLobRobLobRsbRibRibRobLebRibLobRobLobRibLobRobRobRebRcbR
ebRgbLobLobRebLjbLgbLobRcbLhbLobLobLibRebLobLobRebRcbRobRebLcbLobLobLi
bRibLobLobRobLobLobRobRebRobLjbLebLebRebRobLobLobRebRebLobLobRebLobLib
RcbLobRebLgbLobRcbRebRibRobLebRebRobLebLebLebLobRobLebRibLebRobRibLebL
obLebRebRobRibLebLcbRobRsbLcbLsbLebRebRebRobLsbRebLgbRcbRgbLobRobLobLc
bRobRobRobLobLcbRobRibLebRobLhbLebLobLobRhbLobRebRibRobLcbRsbLobLobLeb
LobRcbRgbRobRcbRsbLobLobRsbRsbLebLobLobLcbLobLcbRobLobRcbLobRgbLcbLibR
ebRebLobLobLebLobLobLobRobRobLobRhbLhbLcbLobLcbRcbRobRobRobRcbRcbLcbRg
bLobLobRcbLebLibRobLibRgbLebRcbRgbRobLebRebRebLebLobRibRgbRcbLobLcbLob
LhbRobLibLcbLebLgbLhbRcbRobLebRcbLibRobLgbLobLobRobLobRobRsbRibLibLcbL
ibLobLobRsbLebLgbLobRcbRobRebRobLebRcbLobLobLobRgbRobLobLobLebLobLobRo
bLobRcbLebLobRobRebRibLobLobLgbLibLibRebRobLobLcbLibRcbLobRobLobLobRob
RebLobLibRobRcbLobRebRobLobRcbRebRobLcbLib

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 12; Drug: Cariprazine 3 然 Apo 50 然
bRsRsmbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbLsRsbRsLsbRsbRsbsbsbs
bsbsbLsbsbsbsbsbsbsbsbLsbLsbsbsbsbsbRsbsbsbLsbRsbsbsbsbsbsbsbsbsbsbsbR
sbRsbsbsbsbLsbsbsbsbRsbRsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbRsbsbsbsbsbsb
sbsbLsbsbsbsbsbsbsbsbRsbsbsbLsbLsRsRsmbLsRsbLsbLsbLsbsbsbsbsbsbsbLsbRs
LsbLsbRsbRsbLsbRsbLsbRsbLsLsmbsbLsbRsbRsLsRsbsbRsLsbsbsbsbLsbsbLsbLsbs
bLsbsbsbRsbsbLsbRsbRsbRsbRsRsmbsbsbRsbsbRsbRsbLsbsbsbsbsbsbsbsbsbsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbLsbLsRsRsmbRsRsmbLsbRsbRsbRsRsmbRsRs
mbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 13; Drug: Cariprazine 1 然 Apo 50 然
bLobRebRcbLsbLobLobRsbLebLobRebRebLobLhbLcbRcbRcbLobRsbRibRcbRobLobLob
RobRobLobRcbLobRgbRgbLobLibLebLcbRebRobRobRgbRebRcbRgbLhbLgbRhbLebLebL
obLobLobLebLebLobLobRgbLobRebRobLgbRgbRibLobLobLobRsbRobLcbLgbLjbRobRo
bLebLgbLcbLebLobRobRgbLobRobLebLobLobLobLobLcbLjbRcbLcbLgbLobLibRobLob
RebRobRgbRjbRobRebRebRebRcbRobLgbLobRibLobLibRcbLebRcbRgbLebRcbRebRebL
hbLobRobRebLebRibRobLobRobRobLsbRebRobLobLobLjbRebLobRebRobRsbRgbRebRj
bRebLibRebRobLhbLebRibRobRobLcbRhbRebLgbRobRobRsbRobRebLcbRcbRebLobRob
LebLibLebLobRibLgbRebRobRgbLobRhbLebLibLcbRgbRibLobLobRobLcbLobLebRobR
obRobRobRobRcbRcbLobLibLobLobLsbLebRobRibLobLibLsbRebLebRcbLobLebLobLi
bLobRebLobLcbLobRcbLjbLebLebLebRobLcbRebRobLcbRsbRcbLebLebRhbLobLsbReb
RsbRobLcbLjbRobRobLebLebLobLebLebLobLobLobRobRcbRcbLcbRebLgbRobLobLgbR
ebRebLcbRibLobLobRobRsbRjbLobRcbRobLibLcbRobRsbRobRobRcbRsbRobRsbRgbLo
bRgbLebRobLobLebRgbRobRsbLsbLsbRibLobLobLobRebRobRobRgbRebLibLcbLebLob
RobLobLebRebRibRobRobRsbRebLebRcbRobLebRobRibLobLhbRebLsbLebRebLebRibR
ebRobRobRobLobRibRobLobLobRgbRobRobLobLebLgbRebLebLebRobRibLobRsbLobLc
bRobRcbLobLobLsbLobLcbRebRobRobRobLebRobLebLsbLebRobLebRobLebLobLcbReb
RibRobRobRobRibLobRibLebLobLobLjbLcbRgbLsbRebLobRcbLobLsbLebLjbLebRibR
obRobRgbLebRobLcbRgbRobRebRcbRobLobRobRebRibLhbLsbLgbRcbLcbRobRebLobRc
bLcbRsbRebRebRgbLcbRhbRobRobLobLibLobRobLibRobLobRcbLobLobLobLobRobRgb
LibLobRibLobLebRobRobLobRebLebLcbRcbLebRebRebLgbLhbLobRobRebRobLobRobR
gbLobLobRibRibRcbLebLobRebRsbRobLibRobRobRgbRcbLgbLobRobRobRebLobLobLe
bRobRobRjbLobRobLobLebLobLcbLobRcbRobLobLsbRhbLobLobRobRobLebLobRobRob
RobRobLsbLebRcbRcbLebRobLobLobLhbLcbLcbRebRgbLobRobLgbLcbLobRobRibLobR
cbLcbLcbLebLobRebLcbRcbRcbRibLobRgbRobRobLgbLebRebLobLcbRobLebRcbRcbRo
bLobRobLcbLobLcbLibLebRgbRobRibLhbLobRobRobRobLgbRobRebRebRgbRobLebRsb
LobLebRcbRibLcbRcbLgbLibLebLcbRobRebRgbRebRobRobRobRobRobRobRebLcbRobL
obLibRobRcbLebLibRcbRibRobLobLobRcbRobLebLgbLhbRobLebLcbLebLcbLobRebRc
bLobLobRcbRebRobLcbRibLobRobRibLobLobLibLhbRobRobRebLebRobLobLebRebLeb
RobLcbLcbRebRebLsbRebLobRgbRcbLobRebRibLobRcbRebRobRobRobRsbLcbLobLcbL
ebLobLgbRsbLcbRgbLcbRobRobRibLcbRobRobRcbLcbLobRhbRhbRobLobRobRebRobLo
bLsbLjbRobRcbRebRcbLibLobLobLebLibRcbLcbLebLobRobRibLobLcbRobLibLobLob
RobRebRcbLgbRcbRgbLsbRcbLebRobRsbLebLsbRobLobLobLcbRobRobLobLebLobRobR
ebLobLcbLsbLebLebLhbLebLibRebLibLobLebRgbRebLibLibRebLobRebLcbRebRsbRo
bLobRcbLebRobLobLcbRebRsbRebRibLobLobRobRobLobRcbLebLebRebRcbLsbRsbLob
RobLcbRebRobLibRibLgbRebRobRobLobRgbLobRobLebRebRcbLsbLobRobLsbRobLibR
obLebLobLobRibLsbLebRebLhbRobLobLcbRebLgbRobLebLobLgbLibRobRcbRsbLobRo
bRibLsbLjbRsbRobLobLcbLebRobRobRobLebRobLobRibLobRebRsbRibLcbRibRobLob
LsbRobRobRobRcbLibLobRobRobRcbRobRsbRhbLobRcbLgbLobRebRobRobLobRibLobL
ebRcbRobRobLebRebRhbRcbLobLobLobRcbRcbRobRibLobRebRobLgbRcbRobLebLobLc
bLcbLobRobLcbRebRebRebLsbRobLebRcbLobRcbLebLobLebLgbRcbLobLobRobRcbLcb
LobLebRebRcbRibRgbLobLobRcbRobLobRebRobLhbLcbLobLebRibRobLebRobLebRobR
obRebLobRgbRsbRcbLcbLgbLebLebRobRebRgbLebLobRibRibRebLcbRsbLobRobRcbRo
bRobRobLobLobRsbRcbRobLobLobRcbRhbRobRobRcbLobLebLjbRobRebLebLebRobLob
RebRobRobLebRibRobRcbLobLcbRcbLebRjbLobRebRebRsbLobRcbRobRebLebLobLibR
gbRcbReb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 14; Drug: Cariprazine 1 然 Apo 50 然
bLsbRsRsRgLcmbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLsLsmmbLsbsbLsLsmbLsLsLsmmb
LsbRsbRsRsmbsbLsbLsbRebLobRgbRibRsbRsRsmbRibRsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 15; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbRsRsmbsbRsbLgbsbsbsbsbsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 16; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 17; Drug: Cariprazine 1 然 Apo 50 然
bLsbsbLgbsbLsbLgbRcbRobLebsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 18; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 19; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 20; Drug: Control Apo 50 然
bsbsbRsbsbRsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 21; Drug: Control Apo 50 然
bsbsbsbLsbLsLsmbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 22; Drug: Control Apo 50 然
bRebLcbLobRjbLobRjbRsbLsRjbLebLjbRebRobRobRebRebRjbLebLsbRsbRobRjbRsbR
cbLsbRobRsbRsbLebLsbLebRjbLobLebLobRhbLcbLjbLebRobLobRebRsbLjbLobLjbLs
bLobRcbLcbRobRebRobRobRobLobRebRjbRjbRebLobRjbRsbRobLgbRobRjbLobRebRob
RcbRjbRjbRebLobRobRebLcbRebLebLcbRobLsbRobRcbRebRobRobRobLobRobRibRobR
sbRobLcbLibRebRibRobRobLobRobLobLobLebRobLebLgbRhbLebLcbRsbRebLebRobRi
bLebRebLebRebLjbLebRhbLcbLhbRhbLobRebRobRcbLgbRebRebLebRobLebLcbLebLgb
RobRebLibRebLobRobLebRebLebRcbLsbLebRcbRobLobLobLobRobLgbRobLcbLsbLsbL
ebLobRobRobLcbRibRgbRcbLgbLsbLsbRobLebRebLobLobLgbRcbRobLcbRibLobLcbLi
bRobLsbLobRibLibLobLobLobRebRgbRobLobLcbLobRobRibLobLobLobLsbLebLcbLsb
RebRcbLcbLobRgbRebRobLobRebLobLobLibLebRebLobLibRcbRgbRibLgbLcbRcbRcbR
sbRobRhbRibRobRsbRibRcbLebLobRsbRebRhbRobLobRobLobLgbLsbLhbRebLobLgbLc
bLobRgbLobRobRcbLcbLebRebRgbRobRobRobRebLibLobRcbRsbRcbRhbRobRobRcbLcb
LobRsbLcbLobRobLobLebLebLcbLobLebRobRebRgbRobLobLobRebLsbRcbLobRcbRebR
ebRebRebRobLcbLgbLobRobRjbLobLobLobRobLobLobRibRebLhbRibLebRsbRebRobRc
bRebLibLgbRcbLobRcbLobRobLobRcbRebRsbLobLhbLobLsbLhbRibLebRebRibRebRob
LcbLgbLobRebLgbLibLebLobRebRobLobLcbRebLobLsbRgbLobRobLobLcbLsbRibRcbL
hbLcbLobLcbLgbLsbRobLebRobRgbRobRgbRebLebRobRhbRgbRcbRobRobRcbLobLcbLe
bRcbRobRebRcbRjbLebLobRebRebRobLobRsbLcbRobLibLobRhbRobLebLobLcbRgbLsb
LebLgbRobLhbLebRcbRobRibLgbLsbRobLibLobLcbRobRcbLcbRobRcbRibRobLibLobL
ebRcbRobRobLobRobRhbRebLebLibRobRobRobRobLebLobLjbRgbRebRgbRobLgbLobRs
bRobLcbLobLibRcbRebRobRcbLebRobRcbRobLibRebLebLobLobLebLcbRebLobRobRob
LobLobRebLobLcbRebLobLebLobLobLcbRobRobRobLobRsbRobRcbRobLgbLobRebRebR
ibRobRebRobLcbRcbLcbRobLobLsbRebLcbLobRobLebRgbRhbRobRobRcbLebRcbRcbLe
bLobLobLebLobLobLebRobRcbLibRibLibLobRgbLobLobLibRcbRibRibRobLobRebRob
RibLibRobRobLhbRobRcbRobRobRebRgbRcbRebLgbLobRgbLibLobLebRgbRobLcbRobL
cbRobRobLebLobLibRhbRjbRobLobRebRobRobRjbLobLobLebRebLobRibLcbLobLhbLo
bRibLobRcbLibRcbRobRhbRobLobRebRobLobLgbLcbLhbRibLobLobRgbRcbLcbLobReb
RebRgbLcbRjbLibLsbRobLobLebLebLobRgbRobLgbRgbLobRebRobLobRcbLobLobLcbR
ebLhbLobLobRobLhbLobRobRebRobRcbLcbRcbRebRobRebRcbRobLhbLgbLcbRobRobLs
bLebRgbRebLobLcbRobLebLcbRobRebLobRibLobLobRibLcbLebRebLsbLobRobLobLob
RgbLgbRobRobLobRcbRobLebLobLobLobLgbLobRobLobLebLobRgbRcbRcbLobLobRebL
ebRgbLobRjbRobLebLobRobRebLobRobLebLebRgbRobLobLobLobRobLjbLobLebLebRe
bLsbLobRobRsbLobRobRebLcbRebLsbRobLsbLebLobRobRobLgbLobLhbRebRobLsbLeb
LebLobRsbLebLsbLcbLsbRsbLjbRobRsbLcbLobRobLobLobLsbRgbLebLsbRsbRobLobR
sbLgbLgbRobRobLobLobRsbRobLcbRibRsLebRcbLobRsbRcbLobRsbRsLeb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 23; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 24; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 25; Drug: Cariprazine 10 然 Apo 50 然
bLsbLjbLobLobLebRebRobRebLcbLobRjbLcbLobLobRcbLibLobLobLjbRcbRjbLcbLob
LebRsbLebRjbLjbLobLsbRobLobRgbLobRjbLobRebRebRcbLobLobRcbRebRobLobLobR
obLebRcbRjbLjbLjbRobRsbRcbLobRcbRobLobLobLcbRjbRobRjbLobLjbLcbLebRobLj
bLjbRobLobRsbRobLjbLobLjbRebRgbRobLobLobRjbLebRobLobLebLebRsbLobLjbLob
LebRebRcbLebLjbRebRobRjbLebRobRobRcbLsbRjbLjbRjbRebRobRjbRobLebLobRcbR
obLsbLebLobRjbRjbLobLobLjbLjbRobLcbRobLebLjbRjbRobRjbLjbLobRcbRcbLcbRj
bRobRobLjbLjbLhbRobLebRobLobLcbLebLjbLcbRobRcbRsbRsbLobRobLebLobRebLob
RobRebLebRobLjbLsbLobRjbLobLobLobRobLobLebLobRsbRcbRobRobLsbRcbRjbLobR
obRcbRobRcbLobRebLobRcbRobRobRobLebLobRebRebRebLsbRobRobLjbLjbRjbLobRc
bRobLobRjbLebLcbRebLsbLebLebLcbLobRobRjbLcbLjbLobLobLjbLebLebRebLobLsb
RobLebLebLebLobLibLsbRjbLobRsbRsbLebLjbRjbLebRcbRobRobLcbRobRcbLjbRebR
jbRobRobRebLsbLobLobRgbLibLcbLobLobLjbLebLobRobRjbRcbLebLebLobLjbRobRc
bRgbRcbRobLjbRobLobRibRobLebRjbRobRobRsbRobRcbRobLcbRobRebRhbRobLjbLeb
LcbRobLobLebRsbLobRjbRcbLcbLobLobRobRjbLobLebRjbRjbLobLcbRsbRobRgbRjbL
sbLcbRcbRjbRebRobLobLebLebLobLjbRgbRebLcbLebRsbLhbRebRjbLjbLobRebRobRo
bLobRcbLobRobRjbLjbRsbLebRebLobLebLebLobLobLebLobLobRebLjbLjbLobLobLob
RibLebLebRobRcbRobRjbLebLcbRcbLebRobLebLobLobRcbRebRebRobRsbLcbLobRebL
obRgbRobRebLebRjbLjbLsbRobLebLobRjbLebLjbRobLobRobRibLobRobLobRobLobRj
bLcbLsbLobLobRobRebRobLjbRobRcbRobLebLcbLebRebLobRebLjbLjbRcbLsbLobRjb
RobRebLobRcbRobRobRobLjbRhbLcbRobRsbRobRcbRebRobRobLobLjbRjbLebRebRebL
obRjbLebLebLjbLsbRebLcbLobLsbRjbRobRsbRsbLobLcbRjbLcbRebLjbLobRobRcbRj
bRobRjbRobRcbRjbLcbLobRjbLjbRebLebLebLebLjbRobLcbRjbRobRobRobLebLebRob
RobLcbRjbRcbRebLjbRobLsbRcbLobLobRebRebLcbRebRobRjbLjbRjbRebLjbRobRcbL
ebRobLobLcbLobRcbRobLebRobRebRjbLjbRebRobLobRobLsbLjbLobLebLcbLobLcbLo
bRcbLobLebLobRjbLebLebLobRibLcbLjbRjbLjbLebLobRebRobRobLcbRjbRobRcbLjb
RebLobLobLebLobLebLsbLjbRjbRobLcbLcbRebRcbRsbRjbLobLebLobLjbLsbLobLobL
obRobLebRebRobRcbLjbRobLjbLcbRebRobRobRebLjbRebLobRjbRjbLebRobRebLebRo
bLcbLjbLobLjbLobRjbLobRobLcbRjbRjbRobLobRebRcbRjbLobRobRjbLobRcbLcbRcb
RobLjbRjbLcbRebLsbRobLobLebRjbRebLjbLebLebLjbRobRjbRobLobLebRjbRobRcbR
ebLjbLsbRobLcbLebLobLebLobRobRobLsbLobLjbRsbRjbLebLobRebRgbLobRebRobLo
bRsbRebRobLebLebLjbLobLobLebRobRsbRobLjbLebRsbRobLsbLobLcbRobRjbLjbReb
LobLobLsbRebLobRobRsbRsbRebLsbLsbRcbLsbRsLsLsmbRsbRsbRsbRsbRsbLsbRsRsm
bLsbRsbRsbLsbRsbRsbRsbLsbRsbRsbLsLsmbLsbRsbLsbRsLsbLsbRsbRsbLsbRsRsmbR
sLsLsRsLsLsmmbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 26; Drug: Cariprazine 10 然 Apo 50 然
bsbRsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbsbsbRsbsbsbLsbsbsbRsbsbL
sbsbsbsbsbsbsbRsRsmbRsbRiRsmbRcbRiRsmbRibRcbReRsmbRjbLgbLgLgLsLsmbLebL
sbLsbLeLgbRsbLgRsbLgLsbLgLgLgbLgbLsbLsbLsbLsbLgbLgbsbLsbsbsbLgbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 27; Drug: Cariprazine 10 然 Apo 50 然
bsbLsLsmbsbLsLsmbLsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 28; Drug: Cariprazine 10 然 Apo 50 然
bsbLsbLsLsLsmmbLsbLsbLsbLsbLsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 29; Drug: Cariprazine 10 然 Apo 50 然
bRgbRcbRsRsmbRibLgbLgbRsLjbLjbLgLgbLibRjbLgbRcbLjbRiLsLsmbLcLsLsmmbLgb
LsbLsLgbLsbLgLsbRsbRgbLgLsbLsRcbLsbRgbLjLibRobRgRgbRjbRsbLsbLibLgRsRsR
sRsRsmmmmbRiRsRsmmbRsbRcLsRsRsmbLsbsbRsLcbRsRobRgbRsRsmbRgRsmbLsbRebRc
RsmbRsbLiLeLsLsmbLsLsLsLsmmmbRgLsbLgLsbsbRcRiLsRsRsRsRsmmmbLgbLjbRoRsm
bLsLsmbRgbRsLsbRsbRgbRgRsmbRgbRgbRsbLsbRsbRgbLsbsbLgRsbsbLsbLsbRsRsmbR
sLsLsmb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 30; Drug: Cariprazine 10 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 31; Drug: Cariprazine 3 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 32; Drug: Cariprazine 3 然 Apo 50 然
bRsLsbsbRsLsbRsbRsbRsbLsbLsbRsbRsbLsbLsbRsbsbLsbRsbRsLsbRsbLsbRsbRsbLs
bLsbsbRsbLsbLsbRsbRsbRjbLebRjbLsbRsbLebLobRjbLobLobRobLebLobRebLebLcbL
obLjbRobLebLobLebRobLobRobLebLobRebRobLobLjbLjbRebRibLjbRebRebRobRobRo
bLobLebLobRebRebRobRebLebRobRobRsbRgbRsbRsbLcbLobRobRobRebLcbLsbLobRcb
LebLebLjbRobRebRebLebRobRsbRobLebLsbLsbLebRjbRsbLsbLsbLobRobRebLobLsbR
obLsbRjbRobRebRjbLebLobLebLjbLebRsbLebRobLsbLobRsbRobLgbLebRobLebLsbLi
bLobRebLsbRobRebLobRebRobRobLsbLsbRsbRsRebRsbRsbRebRobLsbLgbLsbLibRgbR
sbRsbLsRsbLsbLjbRsbRsbRsbLsbRobLobRebRobLsbLsbLsbRsbRgbRoLsbLsbRgbRsbR
sbRsbLsbRsLebRsbLebRebLsbLsbRobLebRsbRebRobLobLebLebLcbRebRsbRebRgbRob
LcbLgbRgbRobLobRobRsbLebRobRobRobLsLsmbLebRobRibRobLsbLsbLsbRsbRsbLsbR
obRsbLsRsbLsbRsbRsRsmbRsLsbLgbLebRobLsbRsbLsbRsbLsbLsbRebRsbLebLebLsbL
sbLsbRsbRsbLsbLsbRgRsmbLsbLsbRsbLsbLsbLsbRsbLsbLsbLsbRsbRsbLsbRgbRjbRs
bLgb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 33; Drug: Cariprazine 3 然 Apo 50 然
bLsLsmbLgbLsbLsLsmbLgbLgLsbRgbRebLcb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 34; Drug: Cariprazine 3 然 Apo 50 然
bLsbLsbLsbRjbLsbRsbRsbLsbLsbRsbLsbRsbRsbRsbRjbRsbLsbLsbRsLsbRjbLsbRsbL
sbRsbRsbRsbRsbLsbLsbLsbLsRsbRsbLsbRsbLsbLsbRsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 35; Drug: Cariprazine 3 然 Apo 50 然
bRsbRobLeRsbRsbLsbLobLobRjbRsRjbLobRsbLobRsLsbRsbLsLsmbLsbLjRsbRsbRsbR
sbRsLsbLsRsLsbRsbLsbRobLsbLobLobRsbLsRsbLsLebRobLobLsbRobLobRebRobLsRs
bLoLsmbLjbRsbRoRsmbLjbRjbLebRobLjbRsbLsbLsbLjbLsbRobLsbLcbRcbLebRebRob
RebRsbLsbLobRebLsbLsbLebRsbRsbRebLjbLobLjbLsbLoRsbRsbLcbRsbLebRcbLobLo
bLebLebLcbRobLobRsbRsbRebLobRjbLjbLebRsbRobLsbLebRebLobLjbRjRsmbLebLcb
RebLebRobRgbLobRebRsbRobLebRsbLjbLcbRobLobLsbRsbLsbLjbRebRgbRsbRsbLjbR
ebRebRebRebRjbLjbLcbLjbRebRcbRcbRobRobLsbRsbRebRsbRsbLobRsbRebRsbRobRo
bLebRgbRjbLsbRhbLcbLobRebLjbLebRebLobRobRobRsbRobRebLsbRebRobRobRobLeb
RobLcbRebLebRobLobRebLobLebRebLobRcbLjbLsbRobRobLsbLebRebRobLjbRebRjbL
jbRjbRobRobRcbRcbLjbLebRobRobRebLibRsbRebRjbLobLebRjbLebRobRsbLebRsbRe
bLobRebRsbLgbLebLobRsbLobRobRobLjbRobLebLebLobLobLebRcbLsbRobRobRobReb
LobLebLobLsbLjbLsbRjbLjbLcbRibRobRjbLobRobLebLobRobLobRsbRobLjbLsbLjbR
obRgbLobRsbLobRebRobLobRobRibRobLebRobLjbRibLobRobRgbRsbRebLobRobLjbLo
bLobLjbRobLebRgbLobLibRcbLobRobLibRcbRebLebLobRcbLibRobRgbLobLobRebReb
LobLibLobLhbRobRgbRobRobLobRsbLgbLobLebRebRhbRebLobLibLobLibRsbLsbRebL
ebRebRcbLobLgbRibRhbLcbRhbLobLebLobRobLobRobLobLibLebRobLebLebRobLjbLo
bLobLobLebRjbLjbLobRobRcbRobLobRcbRibRebLobLobLebLobLibRebRjbRebLebLeb
RobLcbLgbLobLibLsbLobLebRobRgbLobLcbLebLobLobLcbRcbRjbLobRebLebLobRsbL
ibRsbLjbLcbRcbRobLcbLobLgbLebLobLobLsbLebLjbRjbRobRobLsbLgbRebRobLebRc
bLobRjbLebLjbLobRcbLebRebRobRjbRcbLjbLebRcbRobRobRjbLcbLjbLcbRgbLjbLsb
RebRjbRsbLobLobLobLebLobRobRobLgbRjbRebLsbRhbLobRobRjbLobRjbRobLjbRobR
obLibRsbRebRobRjbLebLobRebLjbRebRsbLsbLsbRsbLebLcbLhbLobLebRobRobRcbRs
bLobRobRebRsbRcbLcbRsbRibRebRhbRgbRobRebLibLcbLebLobLobRobLobLebLobLsb
LebRobLobLibLobRhbLobRobRhbLobRsbLibRhbLsbRebRobLebLobLebLsbLobLebLobL
jbRebLobLcbRobRobRcbRebLcbRobRsbRjbRobLebLjbLsbRjbRebRobRebRsbRsbRobLs
bLebRsbRobRsbLjbLjbRsbLcbRcbRebRebRsbLobRobRebRoRebLebLibRsbRsbLebRcbL
sbRsbRjbLsbRjbRjbLjbLebRebLebLebRebRobRsbRebRobLsbLsbRjbLobRjbLebLsbLs
bRobLsbRebRobLsbLobLobLebRobRsbRsbLsbRsbLsbRjbLjbRebRsLsLsmbRsbLobRobL
jbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 36; Drug: Cariprazine 3 然 Apo 50 然
bLsbRsLsbLsRsbLsbRhb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 37; Drug: Cariprazine 1 然 Apo 50 然
bLsbRsbLsRsbRsbRsbRsbLjbRsLsbLsbRsbLsbLjbRsbLsRsbRsbRsbLgbLsRsRsmbRsbL
sbLsbRsbRsRsmbRsbRsbLsbRsbRjRsmbRsbRsbLsbLsLsmbLsbRsLsbRsbRsbRsbsbLsbL
sbLsbRjLsbLsbRsbLsbRsbLjbRgbLsbsbRsbLgbRsbRsbRsRsmbLsRsbLsbRsbLsbRsbRg
bRsLsbLsbRsbRsLsbLgbRsbRsbLsbLsRsbLsbRsbLsbLsbLsbLsbRsbRsbRsbRsbRsbLsb
RsbLsRsbLjbRsbRsbRsRsmbLsbLsbRsRsmbLgbRsbLjbLsbRsbRsbLsbRgbRsbLsbRebRs
bLsbLgbLgbRsbRsbLsbRsRsmbLsbRsbRsbLsbRsbLsbRjbLjbLsLgbLsbRgbLsbLsbRsbR
sbLsbRsbLsbRgbRjbRsbRgbRjbLsbLsbRgbLjbLsbRsbRsbRsbRsbLsbRsbRgbRsbLgbRs
bRsbLsbLjbLsbLsbRsbLsbLgbLjbLgbRsbLgbLjbLgbRgbLsbLjbLgbLjbRsbRobRsbRjb
LjbLsbRjbRsbRjbLgbRjbRgbRjbLsLjbRsbRsbLjbLjbRobLcbLsbRgbRoRsRsmmbRsLsb
RobLsbRsbLsRsRsmbsbLsbRsbRsbLsRsRsmbLsbRsbRsbLsLsmbRsbsbLsbRsLsbLsbRsb
sbLsbsbLsLsmbLsRsbsbRsbRsbLsRsbRsbLsbRsbLsbLsbsbsbRsbRsbRsbRsRsmbRsLsb
RsbLsbRsbRsbLsLsmbRsbLsbLsRsbsbLsRsbsbRsRsmbRsbLsbsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 38; Drug: Cariprazine 1 然 Apo 50 然
bsbRsbRsRsmbsbsbsbLsbsbsbsbRsbLsbLsRsbRsLsRsbLsRsRsmbsbRsbRsbLsRsbLsbR
sbsbRsLsbRsRsmbsbsbRsbsbRsRsmbsbLsbsbLsRsbLsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 39; Drug: Cariprazine 1 然 Apo 50 然
bRsbRsbLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 40; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 41; Drug: Cariprazine 1 然 Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 42; Drug: Cariprazine 1 然 Apo 50 然
bsbsbsbsbsbsbLsbRsLsbLsbLsRsbRsbLsbRsLsRsLsbRebLsbRsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 43; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 44; Drug: Control Apo 50 然
bLobRebRsbLebLcbRibRebRgbRsbRcbRgbLobRobRgbRgbRebLibLibLcbLibLebRebRob
LobRobRcbRobRcbLobLcbRobLjbLebRebLjbRebLobRsbLobRebRebLebRebLobRebRebR
obLobLjbRebRjbRjbLjbRcbRcbLebRebRjbRobLcbLobLcbRjbLebLebRobLobRjbLobRj
bRobLebLobRobRobLebRebLobLsbRobLcbRebRcbRobLobLebRobLjbLcbLebRobLjbRjb
RsbLjbRobRjbLcbLsbLebLcbRobLebLebLobLcbRcbRebLebLobRobLebLobRebRcbRcbL
obLjbLjbRobRebLebRobRebRcbLsbLsbLobRebRjbLobLcbLobRsbRobLjbRobLcbLobRj
bLebRebRebLsbRobLjbLsbRcbRjbRjbLebRobRcbRcbLobLebRebLobLcbLsbLobLobLeb
LebRsbRsbLsbRobLobRsbLobLebLebRsbLebLobRjbLobRebLjbRgbLsbLebLjbRjbRebL
jbRebLebLcbLobLebLebRsbRobRebRebLobRcbLobRjbLjbRebRebLsbLebRsbLsbLsbRs
bRjbRobLsbRjbLebLcbLebLebLebRebLsbRobRsbRjbLebLsbRsbRsbLsbRsbLsbRobLsR
sbRsbRobLsbRsbLsbLsRsbLsbRsbRsRsmbLsbLsbRsRsmbLsbRsbRsbLsRsbLsbLsbRsLs
bRsLsbLsbLsRsbRsbLsbRjbLsLsmbRsbRob

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 45; Drug: Control Apo 50 然
bsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 46; Drug: Control Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsb
LsRsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 47; Drug: Control Apo 50 然
bsbsbsbsb

>ZF Recording 2016-08-24; tW: 300s; Start: 130715; End: 131216;
Recording: 13-1; Individual: 48; Drug: Control Apo 50 然
bRsLsbRsbRsLsLsmbLsbLsbsbsbsbsb

